1	Glucose	NN	O	glucose	_	0	SENT_1	[p1l97t82r881b155],
2	—	CD	NUMBER	—	number	3	SENT_1	[p1l97t82r881b155],
3	6	CD	NUMBER	6	num	7	SENT_1	[p1l97t82r881b155],
4	—	NN	O	—	nn	7	SENT_1	[p1l97t82r881b155],
5	phosphate	NN	O	phosphate	nn	7	SENT_1	[p1l97t82r881b155],
6	dehydrogenase	NN	O	dehydrogenase	nn	7	SENT_1	[p1l911t82r1489b155],
7	deficiency	NN	O	deficiency	nsubj	9	SENT_1	[p1l1519t81r1899b154],
8	severely	RB	O	severely	advmod	7	SENT_1	[p1l94t166r386b239],
9	restricts	VBZ	O	restrict	rcmod	1	SENT_1	[p1l417t166r678b226],
10	the	DT	O	the	det	11	SENT_1	[p1l705t166r822b225],
11	biotransformation	NN	O	biotransformation	dobj	9	SENT_1	[p1l854t166r1486b225],
12	of	IN	O	of	_	0	SENT_1	[p1l1518t165r1588b224],
13	daunorubicin	NN	O	daunorubicin	prep_of	11	SENT_1	[p1l96t250r576b309],
14	in	IN	O	in	_	0	SENT_1	[p1l609t250r661b308],
15	human	JJ	O	human	amod	16	SENT_1	[p1l694t250r945b308],
16	erythrocytes	NNS	O	erythrocyte	prep_in	13	SENT_1	[p1l977t249r1419b322],

1	YONA	NNP	ORGANIZATION	YONA	nn	2	SENT_2	[p1l92t398r227b436],
2	AM	NNP	O	AM	_	0	SENT_2	[p1l244t399r427b442],
3	|	JJ	O	|	amod	4	SENT_2	[p1l244t399r427b442],
4	TAl	NN	O	tal	dep	2	SENT_2	[p1l244t399r427b442],
5	,	,	O	,	_	0	SENT_2	[p1l244t399r427b442],
6	*	CD	NUMBER	*	num	8	SENT_2	[p1l244t399r427b442],
7	THANIKACHALAM	NN	O	thanikachalam	nn	8	SENT_2	[p1l445t398r833b436],
8	BHOOMA	NN	O	bhooma	dep	2	SENT_2	[p1l853t398r1070b441],
9	,	,	O	,	_	0	SENT_2	[p1l853t398r1070b441],
10	and	CC	O	and	_	0	SENT_2	[p1l1089t399r1175b436],
11	HENRI	NNP	PERSON	HENRI	nn	12	SENT_2	[p1l1194t398r1317b435],
12	FRISCHER	NNP	PERSON	FRISCHER	dep	2	SENT_2	[p1l1337t397r1537b435],

1	CHICAGO	NNP	LOCATION	CHICAGO	_	0	SENT_3	[p1l93t484r265b517],
2	,	,	O	,	_	0	SENT_3	[p1l93t484r265b517],
3	ILLINOIS	NNP	LOCATION	ILLINOIS	appos	1	SENT_3	[p1l279t485r405b512],

1	Recognition	NN	O	recognition	nsubj	23	SENT_4	[p1l570t592r776b631],
2	and	CC	O	and	_	0	SENT_4	[p1l797t593r866b623],
3	analysis	NN	O	analysis	nsubj	23	SENT_4	[p1l886t592r1025b629],
4	of	IN	O	of	_	0	SENT_4	[p1l1044t592r1078b623],
5	distinct	JJ	O	distinct	amod	6	SENT_4	[p1l1097t592r1219b623],
6	mechanisms	NNS	O	mechanism	prep_of	1	SENT_4	[p1l1239t592r1461b623],
7	by	IN	O	by	_	0	SENT_4	[p1l1481t593r1525b629],
8	which	WDT	O	which	rel	14	SENT_4	[p1l1545t592r1648b622],
9	primaquine	NN	O	primaquine	nsubj	14	SENT_4	[p1l1669t592r1869b629],
10	and	CC	O	and	_	0	SENT_4	[p1l1889t593r1958b623],
11	other	JJ	O	other	amod	13	SENT_4	[p1l1979t592r2068b623],
12	hemolytic	JJ	O	hemolytic	amod	13	SENT_4	[p1l569t638r741b675],
13	drugs	NNS	O	drug	conj_and	9	SENT_4	[p1l755t638r851b676],
14	activate	VBP	O	activate	rcmod	6	SENT_4	[p1l863t637r1007b668],
15	the	DT	O	the	det	18	SENT_4	[p1l1019t637r1074b668],
16	hexose	NN	O	hexose	nn	18	SENT_4	[p1l1087t638r1213b668],
17	monophosphate	NN	O	monophosphate	nn	18	SENT_4	[p1l1227t638r1517b674],
18	shunt	NN	O	shunt	dobj	14	SENT_4	[p1l1529t638r1621b668],
19	(	CD	NUMBER	(	num	20	SENT_4	[p1l1634t637r1734b673],
20	HMS	NNP	O	HMS	dep	18	SENT_4	[p1l1634t637r1734b673],
21	)	CD	NUMBER	)	num	20	SENT_4	[p1l1634t637r1734b673],
22	have	VBP	O	have	aux	23	SENT_4	[p1l1749t638r1836b668],
23	suggested	VBN	O	suggest	_	0	SENT_4	[p1l1849t638r2031b676],
24	a	DT	O	a	det	28	SENT_4	[p1l2044t645r2066b668],
25	hitherto	RB	O	hitherto	advmod	26	SENT_4	[p1l569t683r699b714],
26	unsuspected	JJ	O	unsuspected	amod	28	SENT_4	[p1l716t683r939b720],
27	pharmacogenetic	JJ	O	pharmacogenetic	amod	28	SENT_4	[p1l956t683r1275b722],
28	interaction	NN	O	interaction	dobj	23	SENT_4	[p1l1293t683r1477b714],
29	between	IN	O	between	_	0	SENT_4	[p1l1494t683r1647b714],
30	daunorubicin	NN	O	daunorubicin	nn	31	SENT_4	[p1l1665t683r1896b714],
31	metabolism	NN	O	metabolism	prep_between	28	SENT_4	[p1l1914t683r2066b714, p1l569t730r634b760],
32	and	CC	O	and	_	0	SENT_4	[p1l647t730r716b760],
33	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	34	SENT_4	[p1l729t730r1106b768],
34	dehydrogenase	NN	O	dehydrogenase	conj_and	28	SENT_4	[p1l1119t729r1399b768],
35	(	CD	NUMBER	(	num	38	SENT_4	[p1l1413t729r1533b765],
36	G6PD	NN	O	g6pd	nn	38	SENT_4	[p1l1413t729r1533b765],
37	)	NN	O	)	nn	38	SENT_4	[p1l1413t729r1533b765],
38	deﬁciency	NN	O	deﬁciency	dep	34	SENT_4	[p1l1547t730r1740b767],
39	.	.	O	.	_	0	SENT_4	[p1l1547t730r1740b767],

1	Because	IN	O	because	mark	6	SENT_5	[p1l1756t731r1906b761],
2	this	DT	O	this	det	3	SENT_5	[p1l1918t730r1975b761],
3	deficiency	NN	O	deficiency	nsubj	6	SENT_5	[p1l1987t729r2065b760, p1l569t775r689b812],
4	is	VBZ	O	be	cop	6	SENT_5	[p1l708t775r731b805],
5	very	RB	O	very	advmod	6	SENT_5	[p1l748t782r824b812],
6	common	JJ	O	common	dep	25	SENT_5	[p1l842t781r1010b810],
7	,	,	O	,	_	0	SENT_5	[p1l842t781r1010b810],
8	and	CC	O	and	_	0	SENT_5	[p1l1030t775r1099b806],
9	because	IN	O	because	mark	14	SENT_5	[p1l1118t775r1272b806],
10	anthracyclines	NNS	O	anthracycline	nsubj	14	SENT_5	[p1l1290t775r1548b812],
11	are	VBP	O	be	cop	14	SENT_5	[p1l1566t782r1624b806],
12	indispensable	JJ	O	indispensable	amod	14	SENT_5	[p1l1643t776r1884b812],
13	antitumor	NN	O	antitumor	nn	14	SENT_5	[p1l1902t776r2068b807],
14	antibiotics	NNS	O	antibiotic	conj_and	6	SENT_5	[p1l568t820r746b851],
15	that	WDT	O	that	nsubjpass	17	SENT_5	[p1l755t821r823b851],
16	are	VBP	O	be	auxpass	17	SENT_5	[p1l832t827r890b852],
17	biotransfonned	VBN	O	biotransfonn	rcmod	14	SENT_5	[p1l900t821r1164b852],
18	mainly	RB	O	mainly	advmod	17	SENT_5	[p1l1175t821r1292b858],
19	by	IN	O	by	_	0	SENT_5	[p1l1302t821r1347b858],
20	carbonyl	NN	O	carbonyl	nn	21	SENT_5	[p1l1356t821r1512b858],
21	reductase	NN	O	reductase	agent	17	SENT_5	[p1l1524t821r1707b856],
22	,	,	O	,	_	0	SENT_5	[p1l1524t821r1707b856],
23	we	PRP	O	we	nsubj	25	SENT_5	[p1l1718t828r1771b852],
24	have	VBP	O	have	aux	25	SENT_5	[p1l1782t822r1870b852],
25	compared	VBN	O	compare	_	0	SENT_5	[p1l1880t822r2066b859],
26	the	DT	O	the	det	28	SENT_5	[p1l568t867r623b896],
27	reductase-mediated	JJ	O	reductase-mediated	amod	28	SENT_5	[p1l638t866r1000b897],
28	conversion	NN	O	conversion	dobj	25	SENT_5	[p1l1014t867r1204b897],
29	of	IN	O	of	_	0	SENT_5	[p1l1218t867r1252b897],
30	daunorubicin	NN	O	daunorubicin	prep_of	28	SENT_5	[p1l1264t866r1496b897],
31	to	TO	O	to	_	0	SENT_5	[p1l1509t867r1543b897],
32	daunorubicinol	NN	O	daunorubicinol	prep_to	25	SENT_5	[p1l1556t867r1820b898],
33	and	CC	O	and	_	0	SENT_5	[p1l1833t867r1903b898],
34	the	DT	O	the	det	35	SENT_5	[p1l1915t867r1971b898],
35	conversion	NN	O	conversion	prep_to	25	SENT_5	[p1l1985t873r2065b897, p1l568t911r691b943],
36	of	IN	O	of	_	0	SENT_5	[p1l708t911r742b942],
37	doxorubicin	NN	O	doxorubicin	prep_of	35	SENT_5	[p1l756t912r964b943],
38	to	TO	O	to	_	0	SENT_5	[p1l980t912r1015b942],
39	doxorubicinol	NN	O	doxorubicinol	prep_to	25	SENT_5	[p1l1030t912r1270b943],
40	in	IN	O	in	_	0	SENT_5	[p1l1287t912r1315b942],
41	G6PD-deﬁcient	NN	O	g6pd-deﬁcient	nn	44	SENT_5	[p1l1332t912r1596b943],
42	and	CC	O	and	_	0	SENT_5	[p1l1611t913r1680b943],
43	nondeficient	JJ	O	nondeficient	conj_and	41	SENT_5	[p1l1697t912r1915b943],
44	erythrocytes	NNS	O	erythrocyte	prep_in	39	SENT_5	[p1l1930t913r2065b950, p1l568t958r669b995],
45	.	.	O	.	_	0	SENT_5	[p1l1930t913r2065b950, p1l568t958r669b995],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l683t958r741b995],
2	found	VBD	O	find	_	0	SENT_6	[p1l750t958r851b988],
3	that	IN	O	that	complm	5	SENT_6	[p1l863t958r931b988],
4	even	RB	O	even	advmod	5	SENT_6	[p1l942t964r1029b989],
5	without	IN	O	without	dep	2	SENT_6	[p1l1041t958r1168b989],
6	G6PD	NN	O	g6pd	nn	7	SENT_6	[p1l1179t958r1275b989],
7	deﬁciency	NN	O	deﬁciency	pobj	5	SENT_6	[p1l1288t958r1481b996],
8	,	,	O	,	_	0	SENT_6	[p1l1288t958r1481b996],
9	the	DT	O	the	det	15	SENT_6	[p1l1494t958r1550b989],
10	HMS	NNP	O	HMS	nn	11	SENT_6	[p1l1563t958r1638b989],
11	dehydrogenases	NNS	O	dehydrogenase	npadvmod	13	SENT_6	[p1l1650t959r1947b997],
12	selectively	RB	O	selectively	advmod	11	SENT_6	[p1l1958t958r2065b989, p1l568t1004r660b1042],
13	limited	JJ	O	limited	amod	15	SENT_6	[p1l677t1004r793b1035],
14	daunorubicin	NN	O	daunorubicin	nn	15	SENT_6	[p1l810t1004r1042b1036],
15	metabolism	NN	O	metabolism	appos	7	SENT_6	[p1l1061t1005r1274b1040],
16	,	,	O	,	_	0	SENT_6	[p1l1061t1005r1274b1040],
17	as	IN	O	as	mark	18	SENT_6	[p1l1293t1011r1332b1035],
18	contrasted	VBN	O	contrast	advcl	2	SENT_6	[p1l1349t1005r1536b1036],
19	with	IN	O	with	_	0	SENT_6	[p1l1553t1005r1621b1035],
20	that	DT	O	that	prep_with	18	SENT_6	[p1l1638t1005r1707b1036],
21	of	IN	O	of	_	0	SENT_6	[p1l1722t1005r1756b1036],
22	doxorubicin	NN	O	doxorubicin	prep_of	20	SENT_6	[p1l1772t1005r1989b1036],
23	.	.	O	.	_	0	SENT_6	[p1l1772t1005r1989b1036],

1	The	DT	O	the	det	3	SENT_7	[p1l2007t1005r2067b1036],
2	milder	JJR	O	milder	amod	3	SENT_7	[p1l569t1050r678b1081],
3	GdA	NN	O	gda	_	0	SENT_7	[p1l690t1050r793b1081],
4	‘	CD	NUMBER	‘	num	5	SENT_7	[p1l690t1050r793b1081],
5	variety	NN	O	variety	dep	3	SENT_7	[p1l809t1050r928b1087],
6	of	IN	O	of	_	0	SENT_7	[p1l941t1050r975b1081],
7	G6PD	NN	O	g6pd	nn	8	SENT_7	[p1l987t1050r1083b1081],
8	deﬁciency	NN	O	deﬁciency	prep_of	5	SENT_7	[p1l1097t1050r1283b1088],
9	restricted	JJ	O	restricted	amod	22	SENT_7	[p1l1298t1051r1457b1082],
10	the	DT	O	the	det	11	SENT_7	[p1l1470t1051r1526b1081],
11	biotranstormation	NN	O	biotranstormation	nn	22	SENT_7	[p1l1540t1050r1844b1081],
12	of	IN	O	of	_	0	SENT_7	[p1l1858t1050r1892b1081],
13	daunorubicin	NN	O	daunorubicin	prep_of	11	SENT_7	[p1l1904t1051r2065b1082, p1l569t1096r652b1126],
14	at	IN	O	at	_	0	SENT_7	[p1l666t1096r701b1126],
15	therapeutic	JJ	O	therapeutic	amod	16	SENT_7	[p1l713t1096r915b1133],
16	levels	NNS	O	level	prep_at	13	SENT_7	[p1l928t1096r1034b1131],
17	,	,	O	,	_	0	SENT_7	[p1l928t1096r1034b1131],
18	in	IN	O	in	_	0	SENT_7	[p1l1049t1097r1078b1126],
19	hemolysates	NNS	O	hemolysate	prep_in	13	SENT_7	[p1l1092t1096r1313b1133],
20	and	CC	O	and	_	0	SENT_7	[p1l1325t1096r1394b1127],
21	intact	JJ	O	intact	conj_and	11	SENT_7	[p1l1408t1096r1506b1127],
22	erythrocytes	NNS	O	erythrocyte	dep	3	SENT_7	[p1l1518t1097r1742b1134],
23	,	,	O	,	_	0	SENT_7	[p1l1518t1097r1742b1134],
24	within	IN	O	within	_	0	SENT_7	[p1l1756t1096r1855b1127],
25	15	CD	DURATION	15	num	26	SENT_7	[p1l1873t1097r1908b1127],
26	minutes	NNS	NUMBER	minute	prep_within	22	SENT_7	[p1l1922t1097r2065b1132],
27	,	,	O	,	_	0	SENT_7	[p1l1922t1097r2065b1132],
28	for	IN	O	for	_	0	SENT_7	[p1l567t1141r612b1171],
29	at	IN	DURATION	at	quantmod	31	SENT_7	[p1l624t1142r659b1171],
30	least	JJS	DURATION	least	mwe	29	SENT_7	[p1l672t1142r754b1171],
31	24	CD	DURATION	24	num	32	SENT_7	[p1l765t1141r806b1171],
32	hours	NNS	NUMBER	hour	prep_for	3	SENT_7	[p1l819t1141r919b1172],
33	.	.	O	.	_	0	SENT_7	[p1l819t1141r919b1172],

1	The	DT	O	the	det	3	SENT_8	[p1l933t1141r993b1172],
2	bioconversion	NN	O	bioconversion	nn	3	SENT_8	[p1l1007t1141r1253b1172],
3	defect	NN	O	defect	nsubj	7	SENT_8	[p1l1266t1141r1381b1172],
4	was	VBD	O	be	cop	7	SENT_8	[p1l1392t1148r1462b1172],
5	even	RB	O	even	advmod	7	SENT_8	[p1l1474t1148r1561b1172],
6	more	RBR	O	more	advmod	7	SENT_8	[p1l1575t1148r1666b1173],
7	severe	JJ	O	severe	_	0	SENT_8	[p1l1679t1148r1796b1173],
8	in	IN	O	in	_	0	SENT_8	[p1l1809t1142r1837b1172],
9	Gd	NNP	MISC	Gd	nn	12	SENT_8	[p1l1851t1142r1905b1173],
10	Mediterranean	NNP	MISC	Mediterranean	nn	12	SENT_8	[p1l1919t1142r2064b1173, p1l569t1193r692b1217],
11	G-6PD	NN	O	g-6pd	nn	12	SENT_8	[p1l712t1186r808b1217],
12	deﬁciency	NN	O	deﬁciency	prep_in	7	SENT_8	[p1l827t1187r1021b1224],
13	.	.	O	.	_	0	SENT_8	[p1l827t1187r1021b1224],

1	Primaquine	NNP	O	Primaquine	nn	2	SENT_9	[p1l1042t1187r1237b1224],
2	aldehyde	NN	O	aldehyde	nsubj	3	SENT_9	[p1l1255t1187r1424b1224],
3	competed	VBD	O	compete	_	0	SENT_9	[p1l1443t1188r1628b1224],
4	with	IN	O	with	_	0	SENT_9	[p1l1646t1188r1715b1218],
5	daunorubicin	NN	O	daunorubicin	prep_with	3	SENT_9	[p1l1734t1188r1966b1218],
6	as	IN	O	as	_	0	SENT_9	[p1l1985t1194r2024b1218],
7	a	DT	O	a	det	8	SENT_9	[p1l2043t1195r2065b1218],
8	substrate	NN	O	substrate	prep_as	3	SENT_9	[p1l567t1232r724b1262],
9	for	IN	O	for	_	0	SENT_9	[p1l733t1232r778b1262],
10	carbonyl	NN	O	carbonyl	nn	11	SENT_9	[p1l788t1232r943b1269],
11	reductase	NN	O	reductase	prep_for	8	SENT_9	[p1l955t1232r1139b1263],
12	.	.	O	.	_	0	SENT_9	[p1l955t1232r1139b1263],

1	These	DT	O	these	det	2	SENT_10	[p1l1149t1233r1249b1263],
2	studies	NNS	O	study	nsubj	3	SENT_10	[p1l1259t1232r1378b1263],
3	show	VBP	O	show	_	0	SENT_10	[p1l1388t1233r1478b1263],
4	that	IN	O	that	complm	8	SENT_10	[p1l1487t1233r1555b1263],
5	HMS	NNP	O	HMS	nn	7	SENT_10	[p1l1565t1232r1640b1263],
6	dehydrogenase	NN	O	dehydrogenase	nn	7	SENT_10	[p1l1650t1233r1930b1271],
7	activity	NN	O	activity	nsubj	8	SENT_10	[p1l1940t1233r2066b1270],
8	controls	VBZ	O	control	ccomp	3	SENT_10	[p1l568t1279r705b1308],
9	carbonyl	NN	O	carbonyl	nn	10	SENT_10	[p1l715t1279r870b1316],
10	reductcIse	NN	O	reductcise	dobj	8	SENT_10	[p1l882t1278r1076b1309],
11	-	:	O	-	_	0	SENT_10	[p1l882t1278r1076b1309],
12	dependent	JJ	O	dependent	amod	13	SENT_10	[p1l1081t1279r1278b1315],
13	biotransformation	NN	O	biotransformation	dep	10	SENT_10	[p1l1287t1278r1600b1310],
14	.	.	O	.	_	0	SENT_10	[p1l1287t1278r1600b1310],

1	New	JJ	O	new	amod	2	SENT_11	[p1l1613t1279r1691b1310],
2	issues	NNS	O	issue	nsubj	3	SENT_11	[p1l1702t1279r1801b1310],
3	arise	VBP	O	arise	_	0	SENT_11	[p1l1811t1280r1893b1310],
4	concerning	VBG	O	concern	xcomp	3	SENT_11	[p1l1904t1286r2064b1310, p1l568t1325r620b1362],
5	possible	JJ	O	possible	amod	6	SENT_11	[p1l635t1324r777b1362],
6	effects	NNS	O	effect	dobj	4	SENT_11	[p1l792t1324r907b1355],
7	of	IN	O	of	_	0	SENT_11	[p1l922t1325r955b1355],
8	G6PD	NN	O	g6pd	nn	9	SENT_11	[p1l969t1325r1064b1355],
9	deficiency	NN	O	deficiency	prep_of	6	SENT_11	[p1l1080t1324r1266b1362],
10	on	IN	O	on	_	0	SENT_11	[p1l1280t1331r1323b1355],
11	the	DT	O	the	det	15	SENT_11	[p1l1339t1326r1394b1355],
12	oncolytic	JJ	O	oncolytic	amod	15	SENT_11	[p1l1409t1325r1571b1362],
13	and	CC	O	and	_	0	SENT_11	[p1l1585t1326r1654b1356],
14	toxic	JJ	O	toxic	amod	15	SENT_11	[p1l1669t1325r1754b1356],
15	properties	NNS	O	property	prep_on	4	SENT_11	[p1l1769t1326r1943b1363],
16	of	IN	O	of	_	0	SENT_11	[p1l1959t1325r1991b1356],
17	anthracyclines	NNS	O	anthracycline	prep_of	15	SENT_11	[p1l2006t1332r2063b1356, p1l566t1370r780b1407],
18	that	WDT	O	that	nsubj	21	SENT_11	[p1l797t1370r864b1401],
19	are	VBP	O	be	cop	21	SENT_11	[p1l881t1376r939b1400],
20	effective	JJ	O	effective	amod	21	SENT_11	[p1l957t1370r1108b1401],
21	substrates	NNS	O	substrate	rcmod	17	SENT_11	[p1l1126t1370r1298b1401],
22	for	IN	O	for	_	0	SENT_11	[p1l1315t1370r1361b1401],
23	carbonyl	NN	O	carbonyl	nn	24	SENT_11	[p1l1378t1370r1533b1407],
24	reductase	NN	O	reductase	prep_for	21	SENT_11	[p1l1553t1371r1728b1402],
25	and	CC	O	and	_	0	SENT_11	[p1l1746t1371r1815b1401],
26	also	RB	O	also	advmod	4	SENT_11	[p1l1833t1371r1904b1402],
27	on	IN	O	on	_	0	SENT_11	[p1l1922t1377r1965b1401],
28	nonxenobiotic	JJ	O	nonxenobiotic	amod	29	SENT_11	[p1l1986t1377r2064b1401, p1l566t1416r752b1447],
29	reactions	NNS	O	reaction	prep_on	4	SENT_11	[p1l766t1416r925b1446],
30	catalyzed	VBN	O	catalyze	partmod	29	SENT_11	[p1l938t1416r1112b1452],
31	by	IN	O	by	_	0	SENT_11	[p1l1125t1416r1169b1453],
32	this	DT	O	this	det	33	SENT_11	[p1l1180t1416r1237b1446],
33	enzyme	NN	O	enzyme	agent	30	SENT_11	[p1l1249t1423r1397b1453],
34	.	.	O	.	_	0	SENT_11	[p1l1249t1423r1397b1453],

1	(	NN	O	(	nn	3	SENT_12	[p1l1413t1416r1439b1451],
2	J	NN	O	j	nn	3	SENT_12	[p1l1413t1416r1439b1451],
3	Lab	NN	O	lab	_	0	SENT_12	[p1l1455t1417r1517b1447],
4	Clin	NNP	O	Clin	nn	5	SENT_12	[p1l1529t1417r1594b1447],
5	Med	NNP	O	Med	dep	3	SENT_12	[p1l1608t1416r1687b1447],
6	1996	CD	DATE	1996	num	8	SENT_12	[p1l1703t1416r1988b1452],
7	;	:	O	;	_	0	SENT_12	[p1l1703t1416r1988b1452],
8	127:588	CD	NUMBER	127:588	dep	5	SENT_12	[p1l1703t1416r1988b1452],
9	-98	CD	NUMBER	-98	num	10	SENT_12	[p1l1703t1416r1988b1452],
10	)	NN	O	)	dep	3	SENT_12	[p1l1703t1416r1988b1452],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_13	[p1l566t1528r797b1556],
2	:	:	O	:	_	0	SENT_13	[p1l566t1528r797b1556],
3	BCNU	NN	O	bcnu	dep	1	SENT_13	[p1l812t1529r900b1556],
4	=	JJ	O	=	amod	5	SENT_13	[p1l917t1539r938b1549],
5	i,3-bis	NN	O	i,3-bi	dep	3	SENT_13	[p1l957t1529r1516b1563],
6	-	:	O	-	_	0	SENT_13	[p1l957t1529r1516b1563],
7	(	NN	O	(	nn	8	SENT_13	[p1l957t1529r1516b1563],
8	2-chloroethyl	NN	O	2-chloroethyl	dep	3	SENT_13	[p1l957t1529r1516b1563],
9	)	CD	NUMBER	)	num	10	SENT_13	[p1l957t1529r1516b1563],
10	-1	CD	NUMBER	-1	dep	8	SENT_13	[p1l957t1529r1516b1563],
11	-	:	O	-	_	0	SENT_13	[p1l957t1529r1516b1563],
12	nitrosourea	NN	O	nitrosourea	nn	13	SENT_13	[p1l957t1529r1516b1563],
13	(	NN	O	(	dep	3	SENT_13	[p1l1530t1529r1738b1563],
14	carmustine	NN	O	carmustine	nn	15	SENT_13	[p1l1530t1529r1738b1563],
15	)	NN	O	)	dep	13	SENT_13	[p1l1530t1529r1738b1563],
16	;	:	O	;	_	0	SENT_13	[p1l1530t1529r1738b1563],
17	Fe	NNP	O	Fe	dep	3	SENT_13	[p1l1754t1529r1828b1563],
18	(	CD	NUMBER	(	num	19	SENT_13	[p1l1754t1529r1828b1563],
19	l	NN	O	l	tmod	17	SENT_13	[p1l1754t1529r1828b1563],
20	|	CD	NUMBER	|	num	21	SENT_13	[p1l1754t1529r1828b1563],
21	)	NN	O	)	dep	17	SENT_13	[p1l1754t1529r1828b1563],
22	=	JJ	O	=	amod	24	SENT_13	[p1l1845t1540r1865b1549],
23	ferrous	JJ	O	ferrous	amod	24	SENT_13	[p1l1879t1529r1986b1557],
24	iron	NN	O	iron	dep	21	SENT_13	[p1l1999t1530r2062b1559],
25	;	:	O	;	_	0	SENT_13	[p1l1999t1530r2062b1559],
26	Fe	NNP	O	Fe	nn	28	SENT_13	[p1l567t1571r649b1605],
27	(	CD	NUMBER	(	num	28	SENT_13	[p1l567t1571r649b1605],
28	lll	NN	O	lll	dep	3	SENT_13	[p1l567t1571r649b1605],
29	)	NN	O	)	nn	32	SENT_13	[p1l567t1571r649b1605],
30	=	JJ	O	=	amod	32	SENT_13	[p1l664t1582r684b1591],
31	ferric	JJ	O	ferric	amod	32	SENT_13	[p1l698t1571r777b1598],
32	iron	NN	O	iron	dep	28	SENT_13	[p1l790t1571r854b1600],
33	;	:	O	;	_	0	SENT_13	[p1l790t1571r854b1600],
34	G6PD	NN	O	g6pd	dep	3	SENT_13	[p1l867t1571r957b1598],
35	=	JJ	O	=	amod	37	SENT_13	[p1l972t1582r993b1591],
36	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	37	SENT_13	[p1l1007t1571r1350b1605],
37	dehydrogenase	NN	O	dehydrogenase	dep	34	SENT_13	[p1l1361t1572r1626b1605],
38	;	:	O	;	_	0	SENT_13	[p1l1361t1572r1626b1605],
39	HMS	NNP	O	HMS	nn	42	SENT_13	[p1l1640t1572r1709b1599],
40	=	JJ	O	=	amod	42	SENT_13	[p1l1722t1582r1743b1592],
41	hexose	NN	O	hexose	nn	42	SENT_13	[p1l1758t1572r1870b1599],
42	monophos	NNS	O	monopho	nsubj	43	SENT_13	[p1l1883t1572r2064b1605],
43	—	VBP	O	—	dep	3	SENT_13	[p1l1883t1572r2064b1605],
44	phate	NN	O	phate	nn	45	SENT_13	[p1l567t1612r663b1645],
45	shunt	NN	O	shunt	dobj	43	SENT_13	[p1l673t1612r764b1641],
46	;	:	O	;	_	0	SENT_13	[p1l673t1612r764b1641],
47	GSH	NN	O	gsh	nn	49	SENT_13	[p1l775t1612r841b1639],
48	=	JJ	O	=	amod	49	SENT_13	[p1l854t1623r876b1632],
49	glutathione	NN	O	glutathione	nsubj	50	SENT_13	[p1l887t1612r1071b1646],
50	reduced	VBD	O	reduce	parataxis	43	SENT_13	[p1l1081t1612r1218b1640],
51	form	NN	O	form	dobj	50	SENT_13	[p1l1228t1613r1308b1641],
52	;	:	O	;	_	0	SENT_13	[p1l1228t1613r1308b1641],
53	GSSG	NN	O	gssg	nn	55	SENT_13	[p1l1319t1612r1409b1640],
54	=	JJ	O	=	amod	55	SENT_13	[p1l1421t1623r1442b1633],
55	glutathione	NN	O	glutathione	dep	1	SENT_13	[p1l1453t1613r1637b1647],
56	oxidized	VBN	O	oxidize	partmod	55	SENT_13	[p1l1647t1613r1777b1640],
57	form	NN	O	form	nn	61	SENT_13	[p1l1786t1613r1858b1640],
58	(	NN	O	(	nn	61	SENT_13	[p1l1868t1613r2064b1646],
59	glutathione	NN	O	glutathione	nn	61	SENT_13	[p1l1868t1613r2064b1646],
60	disulfide	NN	O	disulfide	nn	61	SENT_13	[p1l567t1654r716b1688],
61	)	NN	O	)	dobj	56	SENT_13	[p1l567t1654r716b1688],
62	;	:	O	;	_	0	SENT_13	[p1l567t1654r716b1688],
63	G-SSG	NNP	O	G-SSG	dep	61	SENT_13	[p1l732t1654r853b1682],
64	.	.	O	.	_	0	SENT_13	[p1l732t1654r853b1682],

1	—	NN	O	—	_	0	SENT_14	[p1l732t1654r853b1682],
2	.	.	O	.	_	0	SENT_14	[p1l732t1654r853b1682],

1	R	NN	O	r	_	0	SENT_15	[p1l732t1654r853b1682],
2	=	JJ	O	=	amod	4	SENT_15	[p1l871t1665r891b1674],
3	glutathione	NN	O	glutathione	nn	4	SENT_15	[p1l908t1654r1092b1688],
4	reductase	NN	O	reductase	dep	1	SENT_15	[p1l1108t1655r1278b1684],
5	;	:	O	;	_	0	SENT_15	[p1l1108t1655r1278b1684],
6	HPLC	NN	O	hplc	dep	1	SENT_15	[p1l1295t1655r1377b1682],
7	=	JJ	O	=	amod	10	SENT_15	[p1l1395t1665r1415b1674],
8	high-performance	JJ	O	high-performance	amod	10	SENT_15	[p1l1433t1655r1726b1689],
9	liquid	JJ	O	liquid	amod	10	SENT_15	[p1l1741t1655r1824b1688],
10	chromatography	NN	O	chromatography	dep	6	SENT_15	[p1l1840t1655r2065b1689, p1l567t1697r632b1730],
11	;	:	O	;	_	0	SENT_15	[p1l1840t1655r2065b1689, p1l567t1697r632b1730],
12	NADP	NN	O	nadp	dep	1	SENT_15	[p1l652t1696r744b1724],
13	=	JJ	O	=	amod	17	SENT_15	[p1l763t1707r784b1717],
14	nicotine	NN	O	nicotine	nn	17	SENT_15	[p1l804t1696r932b1724],
15	adenine	NN	O	adenine	nn	17	SENT_15	[p1l949t1697r1084b1724],
16	dinucleotide	NN	O	dinucleotide	nn	17	SENT_15	[p1l1101t1697r1303b1724],
17	phosphate	NN	O	phosphate	dep	12	SENT_15	[p1l1321t1697r1502b1730],
18	;	:	O	;	_	0	SENT_15	[p1l1321t1697r1502b1730],
19	NADPH	NN	O	nadph	dep	1	SENT_15	[p1l1522t1697r1635b1724],
20	=	JJ	O	=	amod	19	SENT_15	[p1l1655t1708r1676b1717],
21	reduced	VBN	O	reduce	partmod	1	SENT_15	[p1l1696t1697r1834b1725],
22	nicotinamide	NN	O	nicotinamide	nn	25	SENT_15	[p1l1852t1697r2064b1725],
23	adenine	NN	LOCATION	adenine	nn	25	SENT_15	[p1l567t1738r701b1765],
24	dinucleotide	NN	O	dinucleotide	nn	25	SENT_15	[p1l714t1738r916b1765],
25	phosphate	NN	O	phosphate	dep	21	SENT_15	[p1l930t1738r1111b1771],
26	;	:	O	;	_	0	SENT_15	[p1l930t1738r1111b1771],
27	O2	CD	NUMBER	o2	num	28	SENT_15	[p1l1126t1739r1186b1772],
28	‘	NN	O	‘	dep	25	SENT_15	[p1l1126t1739r1186b1772],
29	=	JJ	O	=	amod	30	SENT_15	[p1l1203t1748r1224b1758],
30	superoxide	NN	O	superoxide	dep	28	SENT_15	[p1l1239t1739r1421b1772],
31	:	:	O	:	_	0	SENT_15	[p1l1239t1739r1421b1772],
32	RBC	NN	O	rbc	nn	36	SENT_15	[p1l1437t1739r1501b1765],
33	=	JJ	O	=	amod	36	SENT_15	[p1l1516t1748r1537b1759],
34	red	JJ	O	red	amod	36	SENT_15	[p1l1553t1739r1604b1766],
35	blood	NN	O	blood	nn	36	SENT_15	[p1l1619t1739r1711b1766],
36	cell	NN	O	cell	dep	25	SENT_15	[p1l1725t1739r1779b1766],

1	From	IN	O	from	dep	15	SENT_16	[p1l9t1949r190b2008],
2	the	DT	O	the	det	3	SENT_16	[p1l224t1947r327b2005],
3	Departments	NNP	O	Departments	pobj	1	SENT_16	[p1l361t1949r791b2024],
4	of	IN	O	of	_	0	SENT_16	[p1l827t1947r893b2005],
5	Pharmacology	NNP	O	Pharmacology	nn	8	SENT_16	[p1l923t1946r1392b2024],
6	(	NNP	O	(	nn	8	SENT_16	[p1l1426t1946r1768b2027],
7	Genetics	NNP	O	Genetics	nn	8	SENT_16	[p1l1426t1946r1768b2027],
8	)	NN	O	)	prep_of	3	SENT_16	[p1l1426t1946r1768b2027],
9	and	CC	O	and	_	0	SENT_16	[p1l1806t1947r1923b2005],
10	Medicine	NN	O	medicine	nn	13	SENT_16	[p1l1957t1946r2153b2005, p1l8t2044r142b2103],
11	(	CD	NUMBER	(	num	13	SENT_16	[p1l175t2044r652b2122],
12	Hematology	NNP	O	Hematology	nn	13	SENT_16	[p1l175t2044r652b2122],
13	)	NNP	O	)	conj_and	8	SENT_16	[p1l175t2044r652b2122],
14	,	,	O	,	_	0	SENT_16	[p1l175t2044r652b2122],
15	Rush-Presbyterian	NNP	PERSON	Rush-Presbyterian	_	0	SENT_16	[p1l686t2044r1418b2121],
16	.	.	O	.	_	0	SENT_16	[p1l686t2044r1418b2121],

1	—	NN	O	—	_	0	SENT_17	[p1l686t2044r1418b2121],
2	.	.	O	.	_	0	SENT_17	[p1l686t2044r1418b2121],

1	St.	NNP	PERSON	St.	_	0	SENT_18	[p1l686t2044r1418b2121],
2	Luke	NNP	PERSON	Luke	poss	5	SENT_18	[p1l1451t2046r1668b2105],
3	’s	POS	O	’s	_	0	SENT_18	[p1l1451t2046r1668b2105],
4	Medical	NNP	O	Medical	nn	5	SENT_18	[p1l1700t2043r1963b2105],
5	Center	NNP	O	Center	dep	1	SENT_18	[p1l1996t2046r2151b2110, p1l8t2151r116b2215],
6	,	,	O	,	_	0	SENT_18	[p1l1996t2046r2151b2110, p1l8t2151r116b2215],
7	Rush	NNP	ORGANIZATION	Rush	nn	8	SENT_18	[p1l148t2142r318b2201],
8	University	NNP	ORGANIZATION	University	appos	5	SENT_18	[p1l347t2141r701b2219],
9	.	.	O	.	_	0	SENT_18	[p1l347t2141r701b2219],

1	Supported	VBN	O	support	_	0	SENT_19	[p1l8t2298r353b2377],
2	in	IN	O	in	_	0	SENT_19	[p1l384t2298r445b2358],
3	part	NN	O	part	prep_in	1	SENT_19	[p1l477t2308r610b2376],
4	by	IN	O	by	_	0	SENT_19	[p1l642t2299r717b2374],
5	Chicago	NNP	ORGANIZATION	Chicago	nn	7	SENT_19	[p1l748t2298r1014b2374],
6	Community	NNP	ORGANIZATION	Community	nn	7	SENT_19	[p1l1050t2299r1436b2374],
7	Trust	NNP	ORGANIZATION	Trust	prep_by	1	SENT_19	[p1l1468t2299r1659b2369],
8	,	,	O	,	_	0	SENT_19	[p1l1468t2299r1659b2369],
9	Toxicon	NNP	ORGANIZATION	Toxicon	nn	10	SENT_19	[p1l1693t2298r1958b2358],
10	Consortium	NNP	ORGANIZATION	Consortium	prep_by	1	SENT_19	[p1l1992t2299r2151b2358, p1l11t2395r276b2463],
11	,	,	O	,	_	0	SENT_19	[p1l1992t2299r2151b2358, p1l11t2395r276b2463],
12	Chicago	NNP	LOCATION	Chicago	prep_by	1	SENT_19	[p1l310t2394r594b2467],
13	,	,	O	,	_	0	SENT_19	[p1l310t2394r594b2467],
14	Ill.	NNP	LOCATION	Ill.	appos	12	SENT_19	[p1l628t2394r733b2463],
15	;	:	O	;	_	0	SENT_19	[p1l628t2394r733b2463],
16	National	NNP	ORGANIZATION	National	nn	17	SENT_19	[p1l767t2395r1051b2453],
17	Institutes	NNPS	ORGANIZATION	Institutes	conj_and	7	SENT_19	[p1l1083t2395r1387b2453],
18	of	IN	ORGANIZATION	of	_	0	SENT_19	[p1l1419t2394r1487b2451],
19	Health	NNP	ORGANIZATION	Health	nn	21	SENT_19	[p1l1514t2395r1740b2453],
20	Grant	NNP	ORGANIZATION	Grant	nn	21	SENT_19	[p1l1771t2397r1965b2453],
21	GM49813	NN	O	gm49813	prep_of	17	SENT_19	[p1l1996t2397r2153b2453, p1l6t2489r216b2559],
22	;	:	O	;	_	0	SENT_19	[p1l1996t2397r2153b2453, p1l6t2489r216b2559],
23	and	CC	O	and	_	0	SENT_19	[p1l270t2491r388b2548],
24	United	NNP	ORGANIZATION	United	nn	27	SENT_19	[p1l438t2489r668b2548],
25	Nations	NNP	ORGANIZATION	Nations	nn	27	SENT_19	[p1l716t2491r972b2548],
26	Development	NNP	ORGANIZATION	Development	nn	27	SENT_19	[p1l1020t2491r1468b2566],
27	ProgramIne	NNP	O	ProgramIne	prep_by	1	SENT_19	[p1l1516t2491r2151b2564],
28	'	POS	O	'	_	0	SENT_19	[p1l1516t2491r2151b2564],
29	.	.	O	.	_	0	SENT_19	[p1l1516t2491r2151b2564],

1	—	NN	O	—	_	0	SENT_20	[p1l1516t2491r2151b2564],
2	.	.	O	.	_	0	SENT_20	[p1l1516t2491r2151b2564],

1	World	NNP	ORGANIZATION	World	nn	3	SENT_21	[p1l1516t2491r2151b2564],
2	Health	NNP	ORGANIZATION	Health	nn	3	SENT_21	[p1l8t2583r232b2642],
3	Organization	NNP	ORGANIZATION	Organization	_	0	SENT_21	[p1l257t2585r687b2660],
4	Special	JJ	ORGANIZATION	special	amod	5	SENT_21	[p1l707t2585r940b2660],
5	Programme	NNP	ORGANIZATION	Programme	dep	3	SENT_21	[p1l962t2585r1346b2660],
6	for	IN	ORGANIZATION	for	_	0	SENT_21	[p1l1368t2585r1462b2642],
7	Research	NNP	ORGANIZATION	Research	prep_for	5	SENT_21	[p1l1482t2585r1789b2644],
8	and	CC	O	and	_	0	SENT_21	[p1l1811t2585r1928b2642],
9	Training	NNP	O	Training	prep_for	5	SENT_21	[p1l1948t2585r2151b2644, p1l8t2679r107b2754],
10	in	IN	O	in	_	0	SENT_21	[p1l136t2679r195b2738],
11	Tropical	JJ	O	tropical	amod	12	SENT_21	[p1l224t2679r501b2756],
12	Diseases	NNS	O	disease	prep_in	3	SENT_21	[p1l530t2678r831b2738],
13	.	.	O	.	_	0	SENT_21	[p1l530t2678r831b2738],

1	Submitted	VBN	O	submit	_	0	SENT_22	[p1l8t2786r346b2844],
2	for	IN	O	for	_	0	SENT_22	[p1l370t2787r466b2844],
3	publication	NN	O	publication	prep_for	1	SENT_22	[p1l491t2786r858b2863],
4	Sept.	NNP	DATE	Sept.	tmod	1	SENT_22	[p1l885t2787r1044b2862],
5	20	CD	DATE	20	num	4	SENT_22	[p1l1073t2787r1165b2855],
6	,	,	DATE	,	_	0	SENT_22	[p1l1073t2787r1165b2855],
7	1995	CD	DATE	1995	num	4	SENT_22	[p1l1196t2786r1362b2858],
8	;	:	O	;	_	0	SENT_22	[p1l1196t2786r1362b2858],
9	revision	NN	O	revision	nsubj	10	SENT_22	[p1l1391t2786r1647b2846],
10	submitted	VBD	O	submit	parataxis	1	SENT_22	[p1l1672t2787r1995b2846],
11	Jan.	NNP	DATE	Jan.	dobj	10	SENT_22	[p1l2020t2789r2148b2846],
12	2	CD	DATE	2	num	11	SENT_22	[p1l8t2882r60b2951],
13	,	,	DATE	,	_	0	SENT_22	[p1l8t2882r60b2951],
14	1996	CD	DATE	1996	num	11	SENT_22	[p1l97t2881r262b2953],
15	;	:	O	;	_	0	SENT_22	[p1l97t2881r262b2953],
16	accepted	VBN	O	accept	partmod	11	SENT_22	[p1l296t2884r582b2957],
17	Jan.	NNP	DATE	Jan.	tmod	16	SENT_22	[p1l611t2884r740b2941],
18	5	CD	DATE	5	num	17	SENT_22	[p1l772t2884r826b2953],
19	,	,	DATE	,	_	0	SENT_22	[p1l772t2884r826b2953],
20	1996	CD	DATE	1996	num	17	SENT_22	[p1l860t2882r1023b2941],
21	.	.	O	.	_	0	SENT_22	[p1l860t2882r1023b2941],

1	Reprint	JJ	O	reprint	amod	2	SENT_23	[p1l9t2989r255b3064],
2	requests	NNS	O	request	_	0	SENT_23	[p1l282t2996r559b3065],
3	:	:	O	:	_	0	SENT_23	[p1l282t2996r559b3065],
4	Henri	NNP	PERSON	Henri	nn	5	SENT_23	[p1l588t2987r775b3046],
5	Frischer	NNP	PERSON	Frischer	dep	2	SENT_23	[p1l802t2987r1077b3060],
6	,	,	O	,	_	0	SENT_23	[p1l802t2987r1077b3060],
7	MD	NNP	O	MD	appos	5	SENT_23	[p1l1108t2989r1253b3057],
8	,	,	O	,	_	0	SENT_23	[p1l1108t2989r1253b3057],
9	PhD	NNP	O	PhD	appos	5	SENT_23	[p1l1282t2989r1443b3057],
10	,	,	O	,	_	0	SENT_23	[p1l1282t2989r1443b3057],
11	Department	NNP	ORGANIZATION	Department	appos	5	SENT_23	[p1l1472t2989r1861b3065],
12	of	IN	ORGANIZATION	of	_	0	SENT_23	[p1l1890t2986r1956b3046],
13	Pharmacology	NNP	ORGANIZATION	Pharmacology	nn	16	SENT_23	[p1l1978t2989r2151b3046, p1l8t3083r311b3156],
14	(	NNP	O	(	nn	16	SENT_23	[p1l331t3080r548b3159],
15	Blood	NNP	O	Blood	nn	16	SENT_23	[p1l331t3080r548b3159],
16	Genetics	NNP	O	Genetics	prep_of	11	SENT_23	[p1l570t3083r847b3140],
17	and	CC	O	and	_	0	SENT_23	[p1l867t3083r984b3140],
18	Pharmacogenetics	NNP	O	Pharmacogenetics	prep_of	11	SENT_23	[p1l1004t3083r1603b3159],
19	)	CD	NUMBER	)	num	18	SENT_23	[p1l1004t3083r1603b3159],
20	and	CC	O	and	_	0	SENT_23	[p1l1630t3085r1745b3140],
21	Department	NNP	ORGANIZATION	Department	prep_of	11	SENT_23	[p1l1764t3085r2153b3158],
22	of	IN	ORGANIZATION	of	_	0	SENT_23	[p1l8t3174r77b3231],
23	Medicine	NNP	ORGANIZATION	Medicine	nn	25	SENT_23	[p1l106t3175r401b3234],
24	(	NNP	O	(	nn	25	SENT_23	[p1l437t3174r896b3253],
25	Hematology	NNP	O	Hematology	prep_of	21	SENT_23	[p1l437t3174r896b3253],
26	)	RB	O	)	advmod	25	SENT_23	[p1l437t3174r896b3253],
27	,	,	O	,	_	0	SENT_23	[p1l437t3174r896b3253],
28	Rush	NN	PERSON	rush	appos	5	SENT_23	[p1l929t3177r1619b3252],
29	.	.	O	.	_	0	SENT_23	[p1l929t3177r1619b3252],

1	—	NN	O	—	_	0	SENT_24	[p1l929t3177r1619b3252],
2	.	.	O	.	_	0	SENT_24	[p1l929t3177r1619b3252],

1	Presbyterian-St	NN	O	presbyterian-st	_	0	SENT_25	[p1l929t3177r1619b3252],
2	.	.	O	.	_	0	SENT_25	[p1l929t3177r1619b3252],

1	Luke	NNP	PERSON	Luke	poss	4	SENT_26	[p1l1655t3177r1863b3236],
2	’s	POS	O	’s	_	0	SENT_26	[p1l1655t3177r1863b3236],
3	Medical	NNP	O	Medical	nn	4	SENT_26	[p1l1897t3177r2151b3236],
4	Center	NNP	O	Center	_	0	SENT_26	[p1l13t3269r244b3339],
5	,	,	O	,	_	0	SENT_26	[p1l13t3269r244b3339],
6	1753	CD	DATE	1753	num	9	SENT_26	[p1l275t3271r415b3328],
7	W.	NNP	O	W.	nn	9	SENT_26	[p1l442t3271r531b3328],
8	Congress	NNP	ORGANIZATION	Congress	nn	9	SENT_26	[p1l563t3271r851b3344],
9	Parkway	NNP	ORGANIZATION	Parkway	appos	4	SENT_26	[p1l878t3271r1160b3346],
10	,	,	O	,	_	0	SENT_26	[p1l878t3271r1160b3346],
11	Chicago	NNP	LOCATION	Chicago	dep	4	SENT_26	[p1l1189t3269r1462b3346],
12	,	,	O	,	_	0	SENT_26	[p1l1189t3269r1462b3346],
13	IL	NN	O	il	appos	11	SENT_26	[p1l1488t3273r1566b3328],
14	60612	CD	NUMBER	60612	num	13	SENT_26	[p1l1590t3271r1789b3330],
15	.	.	O	.	_	0	SENT_26	[p1l1590t3271r1789b3330],

1	any	DT	O	any	det	2	SENT_27	[p2l420t153r560b226],
2	agents	NNS	O	agent	nsubj	8	SENT_27	[p2l596t141r876b226],
3	,	,	O	,	_	0	SENT_27	[p2l596t141r876b226],
4	including	VBG	O	include	_	0	SENT_27	[p2l912t132r1290b226],
5	antitumor	NN	O	antitumor	nn	6	SENT_27	[p2l1328t132r1736b205],
6	anthracyclines	NNS	O	anthracycline	prep_including	2	SENT_27	[p2l1772t132r2152b228, p2l417t250r667b335],
7	,	,	O	,	_	0	SENT_27	[p2l1772t132r2152b228, p2l417t250r667b335],
8	activate	VBP	O	activate	conj_and	8	SENT_27	[p2l708t248r1020b321],
9	the	DT	O	the	det	10	SENT_27	[p2l1054t248r1183b321],
10	HMS	NNP	O	HMS	dobj	8	SENT_27	[p2l1219t250r1436b323],
11	in	IN	O	in	_	0	SENT_27	[p2l1475t248r1550b321],
12	normal	JJ	O	normal	amod	13	SENT_27	[p2l1584t250r1877b321],
13	erythrocytes	NNS	O	erythrocyte	prep_in	8	SENT_27	[p2l1914t250r2149b342, p2l420t376r706b460],
14	and	CC	O	and	_	0	SENT_27	[p2l763t364r913b437],
15	to	TO	O	to	_	0	SENT_27	[p2l968t376r1048b440],
16	a	DT	O	a	det	19	SENT_27	[p2l1107t387r1148b437],
17	much	JJ	O	much	amod	19	SENT_27	[p2l1205t366r1429b439],
18	lesser	JJR	O	lesser	amod	19	SENT_27	[p2l1486t366r1715b439],
19	extent	NN	O	extent	prep_to	8	SENT_27	[p2l1772t376r2022b440],
20	in	IN	O	in	_	0	SENT_27	[p2l2079t366r2154b440],
21	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	22	SENT_27	[p2l11t480r655b557],
22	erythrocytes	NNS	O	erythrocyte	prep_in	19	SENT_27	[p2l687t483r1206b577],
23	.	.	O	.	_	0	SENT_27	[p2l687t483r1206b577],

1	To	TO	O	to	dep	5	SENT_28	[p2l1240t485r1352b557],
2	better	JJR	O	better	amod	3	SENT_28	[p2l1381t485r1629b559],
3	understandhow	NN	O	understandhow	pobj	1	SENT_28	[p2l1658t483r2149b557, p2l8t602r177b672],
4	drugs	NNS	O	drug	nsubj	5	SENT_28	[p2l206t602r428b693],
5	interact	VBP	O	interact	_	0	SENT_28	[p2l455t602r769b675],
6	with	IN	O	with	dep	21	SENT_28	[p2l794t602r971b675],
7	the	DT	O	the	det	8	SENT_28	[p2l998t602r1125b672],
8	HMS	NNP	O	HMS	pobj	6	SENT_28	[p2l1156t602r1373b675],
9	and	CC	O	and	_	0	SENT_28	[p2l1405t602r1555b675],
10	to	TO	O	to	aux	11	SENT_28	[p2l1581t611r1661b675],
11	understand	VB	O	understand	conj_and	6	SENT_28	[p2l1688t602r2154b675],
12	their	PRP$	O	they	poss	13	SENT_28	[p2l6t715r200b788],
13	propensity	NN	O	propensity	dobj	11	SENT_28	[p2l248t718r681b811],
14	to	TO	O	to	aux	15	SENT_28	[p2l726t727r806b788],
15	destroy	VB	O	destroy	infmod	13	SENT_28	[p2l857t718r1157b809],
16	RBCS	NN	O	rbc	dobj	15	SENT_28	[p2l1205t718r1469b804],
17	,	,	O	,	_	0	SENT_28	[p2l1205t718r1469b804],
18	we	PRP	O	we	nsubj	21	SENT_28	[p2l1514t739r1629b788],
19	have	VBP	O	have	aux	21	SENT_28	[p2l1677t711r1866b790],
20	previously	RB	DATE	previously	advmod	21	SENT_28	[p2l1914t718r2149b811, p2l8t834r218b927],
21	carried	VBN	O	carry	ccomp	5	SENT_28	[p2l252t834r539b906],
22	out	RP	O	out	prt	21	SENT_28	[p2l575t845r709b906],
23	studies	NNS	O	study	dobj	21	SENT_28	[p2l745t834r1025b906],
24	to	TO	O	to	aux	25	SENT_28	[p2l1061t843r1139b906],
25	characterize	VB	O	characterize	xcomp	21	SENT_28	[p2l1177t834r1675b906],
26	and	CC	O	and	_	0	SENT_28	[p2l1714t836r1861b907],
27	distin	VB	O	distin	conj_and	25	SENT_28	[p2l1897t834r2152b906, p2l4t90r370b442],

1	*	NN	O	*	_	0	SENT_29	[p2l11t1105r149b1162],
2	D1	NN	O	d1	nn	3	SENT_29	[p2l11t1105r149b1162],
3	‘	NN	O	‘	dep	1	SENT_29	[p2l11t1105r149b1162],
4	.	.	O	.	_	0	SENT_29	[p2l11t1105r149b1162],

1	Amitai	NNP	PERSON	Amitai	nsubj	2	SENT_30	[p2l173t1102r400b1162],
2	was	VBD	O	be	_	0	SENT_30	[p2l420t1121r539b1162],
3	on	IN	O	on	_	0	SENT_30	[p2l564t1121r644b1162],
4	sabbatical	JJ	O	sabbatical	amod	5	SENT_30	[p2l668t1103r990b1164],
5	leave	NN	O	leave	prep_on	2	SENT_30	[p2l1012t1105r1180b1162],
6	from	IN	O	from	_	0	SENT_30	[p2l1203t1105r1362b1162],
7	the	DT	O	the	det	9	SENT_30	[p2l1384t1105r1485b1162],
8	Hadassah	NNP	ORGANIZATION	Hadassah	nn	9	SENT_30	[p2l1509t1105r1826b1162],
9	Hospital	NNP	ORGANIZATION	Hospital	prep_from	2	SENT_30	[p2l1849t1105r2147b1180],
10	,	,	O	,	_	0	SENT_30	[p2l1849t1105r2147b1180],
11	Mount	NNP	ORGANIZATION	Mount	nn	12	SENT_30	[p2l6t1202r230b1273],
12	Scopus	NNP	ORGANIZATION	Scopus	appos	9	SENT_30	[p2l259t1200r504b1275],
13	,	,	O	,	_	0	SENT_30	[p2l259t1200r504b1275],
14	Jerusalem	NNP	LOCATION	Jerusalem	appos	9	SENT_30	[p2l536t1200r885b1269],
15	,	,	O	,	_	0	SENT_30	[p2l536t1200r885b1269],
16	Israel	NNP	LOCATION	Israel	appos	9	SENT_30	[p2l914t1200r1115b1259],
17	.	.	O	.	_	0	SENT_30	[p2l914t1200r1115b1259],

1	Copyright	NN	O	copyright	_	0	SENT_31	[p2l6t1306r332b1381],
2	©	CD	NUMBER	©	num	3	SENT_31	[p2l364t1308r418b1362],
3	1996	CD	DATE	1996	dep	1	SENT_31	[p2l454t1306r600b1365],
4	by	IN	O	by	_	0	SENT_31	[p2l629t1306r704b1384],
5	Mosby	NNP	PERSON	Mosby	prep_by	3	SENT_31	[p2l731t1306r1153b1383],
6	.	.	O	.	_	0	SENT_31	[p2l731t1306r1153b1383],

1	—	NN	O	—	_	0	SENT_32	[p2l731t1306r1153b1383],
2	.	.	O	.	_	0	SENT_32	[p2l731t1306r1153b1383],

1	Year	NN	DURATION	year	nn	2	SENT_33	[p2l731t1306r1153b1383],
2	Book	NN	O	book	_	0	SENT_33	[p2l1182t1306r1373b1376],
3	,	,	O	,	_	0	SENT_33	[p2l1182t1306r1373b1376],
4	Inc.	NNP	O	Inc.	appos	2	SENT_33	[p2l1405t1308r1522b1365],
5	0022-2143/96	CD	DURATION	0022-2143/96	num	4	SENT_33	[p2l6t1411r435b1474],
6	$	$	MONEY	$	dep	4	SENT_33	[p2l466t1408r634b1475],
7	5.00	CD	MONEY	5.00	num	6	SENT_33	[p2l466t1408r634b1475],
8	+	CC	O	+	_	0	SENT_33	[p2l671t1418r718b1465],
9	O	NN	O	o	nn	12	SENT_33	[p2l752t1411r788b1467],
10	5/1/71835	CD	NUMBER	5/1/71835	num	12	SENT_33	[p2l870t1413r1176b1474],
11	J	NN	O	j	nn	12	SENT_33	[p2l6t1505r37b1565],
12	Lab	NN	O	lab	conj_+	4	SENT_33	[p2l73t1505r205b1565],
13	Clin	NNP	O	Clin	nn	14	SENT_33	[p2l236t1505r369b1566],
14	Med	NNP	O	Med	dep	12	SENT_33	[p2l405t1504r567b1565],
15	Volume	NN	O	volume	dep	2	SENT_33	[p2l6t1603r290b1664],
16	127	CD	NUMBER	127	num	15	SENT_33	[p2l329t1600r459b1668],
17	,	,	O	,	_	0	SENT_33	[p2l329t1600r459b1668],
18	Number	NNP	O	Number	appos	15	SENT_33	[p2l499t1601r795b1664],
19	6	CD	NUMBER	6	num	18	SENT_33	[p2l821t1603r859b1664],

1	guish	NN	O	guish	_	0	SENT_34	[p2l8t1843r219b1939],
2	the	DT	O	the	det	3	SENT_34	[p2l269t1842r396b1915],
3	effects	NNS	O	effect	dep	1	SENT_34	[p2l446t1843r698b1918],
4	of	IN	O	of	_	0	SENT_34	[p2l748t1842r834b1915],
5	primaquine	NN	O	primaquine	prep_of	3	SENT_34	[p2l875t1843r1345b1938],
6	and	CC	O	and	_	0	SENT_34	[p2l1395t1843r1544b1918],
7	several	JJ	O	several	amod	9	SENT_34	[p2l1593t1843r1871b1918],
8	other	JJ	O	other	amod	9	SENT_34	[p2l1923t1843r2138b1918],
9	drugs	NNS	O	drug	conj_and	1	SENT_34	[p2l11t1957r231b2052],
10	that	WDT	O	that	nsubj	13	SENT_34	[p2l264t1957r424b2031],
11	are	VBP	O	be	cop	13	SENT_34	[p2l460t1980r585b2031],
12	particularly	RB	O	particularly	advmod	13	SENT_34	[p2l621t1956r1090b2055],
13	hemolytic	JJ	O	hemolytic	rcmod	9	SENT_34	[p2l1121t1956r1518b2052],
14	in	IN	O	in	_	0	SENT_34	[p2l1554t1959r1629b2031],
15	G6PD	NN	O	g6pd	nn	16	SENT_34	[p2l1665t1959r1917b2034],
16	deﬁciency	NN	O	deﬁciency	prep_in	13	SENT_34	[p2l1957t1959r2136b2031, p2l8t2061r316b2171],
17	.1	CD	NUMBER	.1	dep	1	SENT_34	[p2l1957t1959r2136b2031, p2l8t2061r316b2171],
18	We	PRP	O	we	nsubj	20	SENT_34	[p2l342t2080r482b2148],
19	were	VBD	O	be	cop	20	SENT_34	[p2l506t2099r700b2151],
20	able	JJ	O	able	rcmod	17	SENT_34	[p2l729t2078r896b2148],
21	to	TO	O	to	aux	22	SENT_34	[p2l923t2089r1002b2150],
22	dissect	VB	O	dissect	xcomp	20	SENT_34	[p2l1031t2078r1299b2150],
23	the	DT	O	the	det	24	SENT_34	[p2l1326t2080r1454b2151],
24	activation	NN	O	activation	dobj	22	SENT_34	[p2l1483t2078r1877b2151],
25	of	IN	O	of	_	0	SENT_34	[p2l1904t2078r1988b2148],
26	the	DT	O	the	det	27	SENT_34	[p2l2008t2080r2136b2151],
27	HMS	NNP	O	HMS	prep_of	24	SENT_34	[p2l13t2197r228b2268],
28	in	IN	O	in	_	0	SENT_34	[p2l283t2192r359b2265],
29	intact	JJ	O	intact	amod	31	SENT_34	[p2l412t2195r640b2268],
30	human	JJ	O	human	amod	31	SENT_34	[p2l690t2195r972b2268],
31	RBCS	NN	O	rbc	prep_in	27	SENT_34	[p2l1026t2195r1265b2268],
32	by	IN	O	by	_	0	SENT_34	[p2l1315t2195r1410b2288],
33	using	VBG	O	use	prepc_by	22	SENT_34	[p2l1460t2195r1673b2288],
34	BCNU	NNP	O	BCNU	nsubj	36	SENT_34	[p2l1724t2195r2006b2268],
35	to	TO	O	to	aux	36	SENT_34	[p2l2059t2206r2136b2268],
36	inhibit	VB	O	inhibit	xcomp	33	SENT_34	[p2l13t2309r274b2382],
37	GSSG	NN	O	gssg	dobj	36	SENT_34	[p2l310t2310r670b2382],
38	.	.	O	.	_	0	SENT_34	[p2l310t2310r670b2382],

1	—	NN	O	—	_	0	SENT_35	[p2l310t2310r670b2382],
2	.	.	O	.	_	0	SENT_35	[p2l310t2310r670b2382],

1	R	NN	O	r	nsubjpass	39	SENT_36	[p2l310t2310r670b2382],
2	almost	RB	O	almost	advmod	1	SENT_36	[p2l706t2310r974b2383],
3	completely	RB	O	completely	advmod	1	SENT_36	[p2l1008t2310r1451b2406],
4	without	IN	O	without	_	0	SENT_36	[p2l1478t2310r1790b2384],
5	disturbing	JJ	O	disturbing	amod	6	SENT_36	[p2l1826t2310r2136b2385, p2l13t2428r136b2523],
6	G6PD	NN	O	g6pd	prep_without	1	SENT_36	[p2l160t2430r415b2502],
7	and	CC	O	and	_	0	SENT_36	[p2l444t2430r592b2502],
8	6-phosphogluconic	JJ	O	6-phosphogluconic	amod	10	SENT_36	[p2l616t2428r1387b2526],
9	dehydrogenase	NN	O	dehydrogenase	nn	10	SENT_36	[p2l1409t2414r2138b2525],
10	.2	NN	NUMBER	.2	prep_without	1	SENT_36	[p2l1409t2414r2138b2525],
11	'	''	O	'	_	0	SENT_36	[p2l1409t2414r2138b2525],
12	4	CD	NUMBER	4	num	13	SENT_36	[p2l1409t2414r2138b2525],
13	Agents	NNS	O	agent	dep	1	SENT_36	[p2l11t2546r297b2639],
14	such	JJ	O	such	_	0	SENT_36	[p2l333t2546r514b2619],
15	as	IN	O	as	_	0	SENT_36	[p2l550t2569r627b2619],
16	ascorbate	NN	O	ascorbate	prep_such_as	13	SENT_36	[p2l663t2546r1071b2632],
17	,	,	O	,	_	0	SENT_36	[p2l663t2546r1071b2632],
18	which	WDT	O	which	nsubj	19	SENT_36	[p2l1105t2544r1343b2619],
19	mobilize	VBP	O	mobilize	rcmod	16	SENT_36	[p2l1377t2543r1723b2619],
20	the	DT	O	the	det	21	SENT_36	[p2l1757t2546r1882b2619],
21	dehydrogenases	NNS	O	dehydrogenase	dobj	19	SENT_36	[p2l1923t2546r2138b2639, p2l15t2663r466b2756],
22	of	IN	O	of	_	0	SENT_36	[p2l504t2663r590b2736],
23	the	DT	O	the	det	24	SENT_36	[p2l619t2661r747b2736],
24	HMS	NNP	O	HMS	prep_of	21	SENT_36	[p2l782t2663r998b2736],
25	by	IN	O	by	_	0	SENT_36	[p2l1033t2663r1129b2756],
26	oxidizing	VBG	O	oxidize	prepc_by	19	SENT_36	[p2l1162t2661r1527b2756],
27	NADPH	NN	O	nadph	dobj	26	SENT_36	[p2l1561t2663r1917b2736],
28	indirectly	RB	O	indirectly	advmod	26	SENT_36	[p2l1955t2661r2138b2736, p2l13t2780r237b2873],
29	in	IN	O	in	_	0	SENT_36	[p2l276t2778r350b2850],
30	a	DT	O	a	det	32	SENT_36	[p2l389t2801r433b2850],
31	GSH	NN	O	gsh	nn	32	SENT_36	[p2l471t2778r1143b2873],
32	—	NN	O	—	npadvmod	33	SENT_36	[p2l471t2778r1143b2873],
33	dependent	JJ	O	dependent	amod	34	SENT_36	[p2l471t2778r1143b2873],
34	manner	NN	O	manner	prep_in	26	SENT_36	[p2l1181t2801r1514b2866],
35	,	,	O	,	_	0	SENT_36	[p2l1181t2801r1514b2866],
36	are	VBP	O	be	auxpass	39	SENT_36	[p2l1559t2801r1682b2850],
37	almost	RB	O	almost	advmod	38	SENT_36	[p2l1722t2780r1990b2853],
38	totally	RB	O	totally	advmod	39	SENT_36	[p2l2026t2789r2138b2853, p2l15t2893r189b2989],
39	blocked	VBN	O	block	_	0	SENT_36	[p2l239t2893r558b2969],
40	by	IN	O	by	_	0	SENT_36	[p2l614t2896r707b2987],
41	BCNU	NN	O	bcnu	agent	39	SENT_36	[p2l762t2894r1064b2968],
42	.	.	O	.	_	0	SENT_36	[p2l762t2894r1064b2968],

1	In	IN	O	in	_	0	SENT_37	[p2l1126t2896r1212b2966],
2	contrast	NN	O	contrast	prep_in	28	SENT_37	[p2l1268t2905r1615b2982],
3	,	,	O	,	_	0	SENT_37	[p2l1268t2905r1615b2982],
4	compounds	NNS	O	compound	nsubj	28	SENT_37	[p2l1674t2894r2140b2991],
5	such	JJ	O	such	_	0	SENT_37	[p2l15t3014r196b3086],
6	as	IN	O	as	_	0	SENT_37	[p2l253t3034r330b3086],
7	methylene	NN	O	methylene	dep	8	SENT_37	[p2l384t3014r806b3107],
8	blue	JJ	O	blue	prep_such_as	4	SENT_37	[p2l861t3014r1034b3086],
9	or	CC	O	or	_	0	SENT_37	[p2l1091t3034r1177b3084],
10	pyrroline	JJ	O	pyrroline	amod	11	SENT_37	[p2l1229t3013r1599b3110],
11	carboxylate	NN	O	carboxylate	prep_such_as	4	SENT_37	[p2l1655t3014r2138b3107],
12	,	,	O	,	_	0	SENT_37	[p2l1655t3014r2138b3107],
13	which	WDT	O	which	nsubj	14	SENT_37	[p2l11t3130r249b3202],
14	activate	VBP	O	activate	rcmod	8	SENT_37	[p2l296t3130r606b3202],
15	the	DT	O	the	det	16	SENT_37	[p2l651t3128r779b3200],
16	HMS	NNP	O	HMS	dobj	14	SENT_37	[p2l826t3130r1041b3203],
17	by	IN	O	by	_	0	SENT_37	[p2l1086t3127r1179b3223],
18	oxidizing	VBG	O	oxidize	prepc_by	14	SENT_37	[p2l1225t3128r1587b3223],
19	NADPH	NN	O	nadph	dobj	18	SENT_37	[p2l1632t3130r1988b3203],
20	directly	RB	O	directly	advmod	18	SENT_37	[p2l2035t3130r2138b3200, p2l13t3246r240b3339],
21	without	IN	O	without	_	0	SENT_37	[p2l287t3244r601b3319],
22	ﬁrst	NN	O	ﬁrst	prep_without	18	SENT_37	[p2l658t3242r813b3319],
23	involving	VBG	O	involve	partmod	22	SENT_37	[p2l870t3244r1237b3339],
24	GSH	NN	O	gsh	dobj	23	SENT_37	[p2l1296t3244r1518b3332],
25	,	,	O	,	_	0	SENT_37	[p2l1296t3244r1518b3332],
26	are	VBP	O	be	cop	28	SENT_37	[p2l1579t3267r1705b3317],
27	markedly	RB	O	markedly	advmod	28	SENT_37	[p2l1761t3244r2142b3339],
28	insensitive	JJ	O	insensitive	_	0	SENT_37	[p2l15t3359r438b3434],
29	to	TO	O	to	_	0	SENT_37	[p2l492t3371r571b3434],
30	the	DT	O	the	det	31	SENT_37	[p2l626t3360r753b3435],
31	nitrosourea	NN	O	nitrosourea	prep_to	28	SENT_37	[p2l808t3360r1297b3435],
32	.	.	O	.	_	0	SENT_37	[p2l808t3360r1297b3435],

1	Chemicals	NNS	O	chemical	nsubj	5	SENT_38	[p2l1356t3360r1774b3435],
2	such	JJ	O	such	_	0	SENT_38	[p2l1830t3359r2009b3434],
3	as	IN	O	as	_	0	SENT_38	[p2l2063t3383r2140b3434],
4	primaquine	NN	O	primaquine	prep_such_as	1	SENT_38	[p3l13t29r484b125],
5	trigger	VBP	O	trigger	_	0	SENT_38	[p3l522t29r792b124],
6	the	DT	O	the	det	7	SENT_38	[p3l828t29r954b101],
7	HMS	NNP	O	HMS	dobj	5	SENT_38	[p3l992t29r1210b101],
8	by	IN	O	by	_	0	SENT_38	[p3l1248t29r1341b124],
9	independently	RB	O	independently	advmod	10	SENT_38	[p3l1377t26r1958b124],
10	oxidizing	VBG	O	oxidize	prepc_by	5	SENT_38	[p3l1994t29r2140b101, p3l15t146r258b242],
11	both	DT	O	both	preconj	12	SENT_38	[p3l292t144r477b218],
12	NADPH	NN	O	nadph	dobj	10	SENT_38	[p3l511t146r871b219],
13	and	CC	O	and	_	0	SENT_38	[p3l909t146r1055b218],
14	GSH	NN	O	gsh	conj_and	12	SENT_38	[p3l1093t146r1316b219],
15	.	.	O	.	_	0	SENT_38	[p3l1093t146r1316b219],

1	While	IN	O	while	mark	2	SENT_39	[p3l112t261r355b337],
2	studying	VBG	O	study	advcl	10	SENT_39	[p3l393t264r733b357],
3	anthracyclines	NNS	O	anthracycline	dobj	2	SENT_39	[p3l769t262r1348b357],
4	in	IN	O	in	_	0	SENT_39	[p3l1386t264r1461b337],
5	the	DT	O	the	det	7	SENT_39	[p3l1499t264r1624b334],
6	above	JJ	O	above	amod	7	SENT_39	[p3l1665t264r1898b337],
7	manner	NN	O	manner	prep_in	2	SENT_39	[p3l1936t285r2142b336, p3l15t404r168b470],
8	,	,	O	,	_	0	SENT_39	[p3l1936t285r2142b336, p3l15t404r168b470],
9	we	PRP	O	we	nsubj	10	SENT_39	[p3l216t401r330b453],
10	found	VBD	O	find	_	0	SENT_39	[p3l377t378r617b453],
11	that	IN	O	that	complm	15	SENT_39	[p3l665t379r825b451],
12	doxorubicin	NN	O	doxorubicin	nsubj	15	SENT_39	[p3l874t378r1357b453],
13	and	CC	O	and	_	0	SENT_39	[p3l1407t378r1553b453],
14	daunorubicin	NN	O	daunorubicin	conj_and	12	SENT_39	[p3l1602t378r2142b453],
15	enhanced	VBD	O	enhance	ccomp	10	SENT_39	[p3l18t494r406b570],
16	the	DT	O	the	det	17	SENT_39	[p3l458t497r585b569],
17	HMS	NNP	O	HMS	dobj	15	SENT_39	[p3l637t497r852b569],
18	by	IN	O	by	_	0	SENT_39	[p3l904t494r998b590],
19	different	JJ	O	different	amod	20	SENT_39	[p3l1050t494r1394b567],
20	mechanisms	NNS	O	mechanism	prep_by	15	SENT_39	[p3l1444t495r1958b570],
21	.	.	O	.	_	0	SENT_39	[p3l1444t495r1958b570],

1	Although	IN	O	although	mark	6	SENT_40	[p3l2012t497r2140b567, p3l18t612r302b707],
2	both	DT	O	both	det	3	SENT_40	[p3l340t611r528b684],
3	agents	NNS	O	agent	nsubj	6	SENT_40	[p3l568t621r825b707],
4	were	VBD	O	be	cop	6	SENT_40	[p3l861t634r1060b684],
5	potent	JJ	O	potent	amod	6	SENT_40	[p3l1098t623r1364b707],
6	stimulators	NNS	O	stimulator	advcl	12	SENT_40	[p3l1404t612r1855b687],
7	of	IN	O	of	_	0	SENT_40	[p3l1897t612r1981b684],
8	the	DT	O	the	det	9	SENT_40	[p3l2017t611r2142b684],
9	HMS	NNP	O	HMS	prep_of	6	SENT_40	[p3l18t733r256b819],
10	,	,	O	,	_	0	SENT_40	[p3l18t733r256b819],
11	doxorubicin	NN	O	doxorubicin	nsubj	12	SENT_40	[p3l319t729r802b803],
12	behaved	VBD	O	behave	_	0	SENT_40	[p3l858t731r1198b803],
13	like	IN	O	like	_	0	SENT_40	[p3l1255t731r1401b803],
14	ascorbate	NN	O	ascorbate	prep_like	12	SENT_40	[p3l1462t731r1868b819],
15	,	,	O	,	_	0	SENT_40	[p3l1462t731r1868b819],
16	while	IN	O	while	mark	18	SENT_40	[p3l1932t731r2142b803],
17	daunorubicin	NN	O	daunorubicin	nsubj	18	SENT_40	[p3l18t846r558b919],
18	behaved	VBD	O	behave	advcl	12	SENT_40	[p3l584t844r924b918],
19	like	IN	O	like	_	0	SENT_40	[p3l950t846r1094b919],
20	primaquine	NN	O	primaquine	prep_like	18	SENT_40	[p3l1121t844r1613b942],
21	.	.	O	.	_	0	SENT_40	[p3l1121t844r1613b942],

1	Thus	RB	O	thus	advmod	7	SENT_41	[p3l1641t846r1843b919],
2	in	IN	O	in	_	0	SENT_41	[p3l1872t844r1946b916],
3	normal	JJ	O	normal	amod	4	SENT_41	[p3l1973t867r2140b918, p3l15t963r164b1035],
4	RBCS	NN	O	rbc	prep_in	7	SENT_41	[p3l206t963r468b1049],
5	,	,	O	,	_	0	SENT_41	[p3l206t963r468b1049],
6	doxorubicin	NN	O	doxorubicin	nsubj	7	SENT_41	[p3l513t961r997b1035],
7	activated	VBD	O	activate	_	0	SENT_41	[p3l1040t961r1403b1035],
8	the	DT	O	the	det	9	SENT_41	[p3l1446t961r1571b1033],
9	HMS	NNP	O	HMS	dobj	7	SENT_41	[p3l1614t963r1829b1035],
10	almost	RB	O	almost	advmod	11	SENT_41	[p3l1876t961r2142b1033],
11	exclusively	RB	O	exclusively	advmod	7	SENT_41	[p3l20t1079r449b1172],
12	through	IN	O	through	_	0	SENT_41	[p3l474t1079r795b1172],
13	NADP	NN	ORGANIZATION	nadp	prep_through	7	SENT_41	[p3l824t1079r1104b1152],
14	generated	VBN	O	generate	partmod	13	SENT_41	[p3l1130t1077r1534b1173],
15	by	IN	O	by	_	0	SENT_41	[p3l1561t1079r1656b1172],
16	GSSG	NN	ORGANIZATION	gssg	agent	14	SENT_41	[p3l1683t1079r2043b1152],
17	.	.	O	.	_	0	SENT_41	[p3l1683t1079r2043b1152],

1	—	NN	O	—	_	0	SENT_42	[p3l1683t1079r2043b1152],
2	.	.	O	.	_	0	SENT_42	[p3l1683t1079r2043b1152],

1	R	NN	O	r	_	0	SENT_43	[p3l1683t1079r2043b1152],
2	in	IN	O	in	_	0	SENT_43	[p3l2070t1079r2145b1152],
3	response	NN	O	response	prep_in	1	SENT_43	[p3l18t1219r373b1291],
4	to	TO	O	to	_	0	SENT_43	[p3l439t1208r516b1268],
5	rising	VBG	O	rise	amod	7	SENT_43	[p3l582t1194r806b1289],
6	glutathione	NN	O	glutathione	nn	7	SENT_43	[p3l868t1194r1332b1289],
7	disulﬁde	NN	O	disulﬁde	prep_to	3	SENT_43	[p3l1395t1193r1760b1269],
8	.	.	O	.	_	0	SENT_43	[p3l1395t1193r1760b1269],

1	On	IN	O	on	_	0	SENT_44	[p3l1828t1194r1953b1268],
2	the	DT	O	the	det	4	SENT_44	[p3l2017t1193r2142b1268],
3	other	JJ	O	other	amod	4	SENT_44	[p3l18t1311r233b1383],
4	hand	NN	O	hand	pobj	1	SENT_44	[p3l280t1311r502b1399],
5	,	,	O	,	_	0	SENT_44	[p3l280t1311r502b1399],
6	daunorubicin	NN	O	daunorubicin	nn	7	SENT_44	[p3l554t1308r1339b1385],
7	—	NN	O	—	appos	4	SENT_44	[p3l554t1308r1339b1385],
8	but	CC	O	but	_	0	SENT_44	[p3l554t1308r1339b1385],
9	not	RB	O	not	_	0	SENT_44	[p3l1386t1320r1518b1383],
10	doXorubicin	NN	O	doxorubicin	pobj	1	SENT_44	[p3l1565t1308r2147b1383],
11	.	.	O	.	_	0	SENT_44	[p3l1565t1308r2147b1383],

1	—	NN	O	—	_	0	SENT_45	[p3l1565t1308r2147b1383],
2	.	.	O	.	_	0	SENT_45	[p3l1565t1308r2147b1383],

1	-	:	O	-	_	0	SENT_46	[p3l1565t1308r2147b1383],
2	could	MD	O	could	aux	5	SENT_46	[p3l20t1432r240b1502],
3	not	RB	O	not	neg	5	SENT_46	[p3l280t1439r413b1502],
4	only	RB	O	only	advmod	5	SENT_46	[p3l453t1430r624b1525],
5	oxidize	VB	O	oxidize	_	0	SENT_46	[p3l665t1430r949b1503],
6	GSH	NN	O	gsh	dobj	5	SENT_46	[p3l992t1429r1196b1502],
7	but	CC	O	but	_	0	SENT_46	[p3l1231t1430r1366b1502],
8	also	RB	O	also	advmod	9	SENT_46	[p3l1409t1430r1562b1502],
9	stimulate	VBP	O	stimulate	conj_but	5	SENT_46	[p3l1605t1429r1977b1502],
10	the	DT	O	the	det	11	SENT_46	[p3l2017t1430r2145b1500],
11	HMS	NNP	O	HMS	dobj	9	SENT_46	[p3l18t1545r235b1618],
12	by	IN	O	by	_	0	SENT_46	[p3l269t1543r364b1638],
13	utilizing	VBG	O	utilize	prepc_by	11	SENT_46	[p3l395t1545r721b1639],
14	NADPH	NN	O	nadph	nsubj	16	SENT_46	[p3l757t1543r1115b1617],
15	directly	RB	O	directly	advmod	16	SENT_46	[p3l1151t1543r1454b1638],
16	(	VBD	O	(	ccomp	13	SENT_46	[p3l1489t1540r1649b1638],
17	the	DT	O	the	det	18	SENT_46	[p3l1489t1540r1649b1638],
18	reason	NN	O	reason	dobj	16	SENT_46	[p3l1685t1566r1954b1618],
19	why	WRB	O	why	advmod	23	SENT_46	[p3l1983t1543r2147b1638],
20	doxorubicin	NN	O	doxorubicin	nsubj	23	SENT_46	[p3l20t1659r500b1736],
21	and	CC	O	and	_	0	SENT_46	[p3l540t1660r687b1734],
22	daunorubicin	NN	O	daunorubicin	nsubj	23	SENT_46	[p3l725t1659r1265b1734],
23	activate	VBP	O	activate	advcl	16	SENT_46	[p3l1303t1662r1613b1734],
24	the	DT	O	the	det	25	SENT_46	[p3l1651t1662r1778b1734],
25	HMS	NNP	O	HMS	nsubjpass	32	SENT_46	[p3l1814t1659r2032b1734],
26	in	IN	O	in	_	0	SENT_46	[p3l2068t1660r2145b1732],
27	such	PDT	O	such	predet	30	SENT_46	[p3l18t1777r198b1850],
28	a	DT	O	a	det	30	SENT_46	[p3l234t1800r277b1849],
29	diiferent	JJ	O	diiferent	amod	30	SENT_46	[p3l312t1775r657b1850],
30	manner	NN	O	manner	prep_in	25	SENT_46	[p3l690t1797r1005b1849],
31	is	VBZ	O	be	auxpass	32	SENT_46	[p3l1038t1777r1097b1849],
32	addressed	VBN	O	address	ccomp	23	SENT_46	[p3l1135t1774r1537b1849],
33	in	IN	O	in	_	0	SENT_46	[p3l1572t1774r1647b1847],
34	the	DT	O	the	det	36	SENT_46	[p3l1683t1777r1808b1847],
35	Discussion	NN	O	discussion	nn	36	SENT_46	[p3l1844t1777r2142b1847, p3l20t1890r240b1989],
36	)	NN	O	)	prep_in	32	SENT_46	[p3l1844t1777r2142b1847, p3l20t1890r240b1989],
37	.	.	O	.	_	0	SENT_46	[p3l1844t1777r2142b1847, p3l20t1890r240b1989],

1	These	DT	O	these	det	2	SENT_47	[p3l112t2011r357b2084],
2	data	NNS	O	datum	nsubj	14	SENT_47	[p3l395t2009r590b2098],
3	,	,	O	,	_	0	SENT_47	[p3l395t2009r590b2098],
4	based	VBN	O	base	partmod	2	SENT_47	[p3l628t2009r862b2082],
5	on	IN	O	on	_	0	SENT_47	[p3l900t2032r1000b2082],
6	the	DT	O	the	det	7	SENT_47	[p3l1038t2009r1163b2082],
7	production	NN	O	production	prep_on	4	SENT_47	[p3l1199t2007r1649b2102],
8	of	IN	O	of	_	0	SENT_47	[p3l1688t2009r1772b2082],
9	CO2	NN	O	co2	prep_of	7	SENT_47	[p3l1805t2009r1981b2103],
10	derived	VBN	O	derive	partmod	9	SENT_47	[p3l2019t2009r2145b2082, p3l18t2127r219b2200],
11	from	IN	O	from	_	0	SENT_47	[p3l276t2127r472b2199],
12	glucose	NN	O	glucose	prep_from	10	SENT_47	[p3l527t2127r848b2221],
13	,	,	O	,	_	0	SENT_47	[p3l527t2127r848b2221],
14	complement	NN	O	complement	_	0	SENT_47	[p3l909t2125r1412b2218],
15	remarkably	RB	O	remarkably	advmod	17	SENT_47	[p3l1469t2125r1930b2218],
16	well	RB	O	well	advmod	17	SENT_47	[p3l1980t2127r2145b2197],
17	pharmacologic	JJ	O	pharmacologic	amod	18	SENT_47	[p3l18t2243r620b2338],
18	studies	NNS	O	study	dobj	14	SENT_47	[p3l665t2243r942b2316],
19	of	IN	O	of	_	0	SENT_47	[p3l987t2243r1074b2315],
20	the	DT	O	the	det	21	SENT_47	[p3l1112t2241r1239b2313],
21	biotransformation	NN	O	biotransformation	prep_of	18	SENT_47	[p3l1282t2240r2023b2316],
22	of	IN	O	of	_	0	SENT_47	[p3l2068t2243r2152b2315],
23	anthracyclines	NNS	O	anthracycline	prep_of	21	SENT_47	[p3l20t2360r620b2454],
24	.	.	O	.	_	0	SENT_47	[p3l20t2360r620b2454],

1	Daunorubicin	NNP	O	Daunorubicin	nsubjpass	4	SENT_48	[p3l651t2358r1219b2433],
2	is	VBZ	O	be	auxpass	4	SENT_48	[p3l1245t2358r1304b2430],
3	indeed	RB	O	indeed	advmod	4	SENT_48	[p3l1333t2358r1610b2430],
4	converted	VBN	O	convert	_	0	SENT_48	[p3l1637t2358r2039b2430],
5	to	TO	O	to	_	0	SENT_48	[p3l2065t2369r2145b2430],
6	its	PRP$	O	its	poss	9	SENT_48	[p3l20t2477r108b2549],
7	main	JJ	O	main	amod	9	SENT_48	[p3l142t2477r343b2549],
8	metabolite	NN	O	metabolite	nn	9	SENT_48	[p3l377t2477r813b2549],
9	daunorubicinol	NN	O	daunorubicinol	prep_to	4	SENT_48	[p3l849t2477r1467b2549],
10	by	IN	O	by	_	0	SENT_48	[p3l1501t2475r1594b2567],
11	an	DT	O	a	det	14	SENT_48	[p3l1628t2498r1723b2547],
12	NADPHrequiring	NN	O	nadphrequiring	nn	14	SENT_48	[p3l1757t2475r2142b2547, p3l18t2590r392b2687],
13	carbonyl	NN	O	carbonyl	nn	14	SENT_48	[p3l418t2590r767b2683],
14	reductase	NN	O	reductase	agent	4	SENT_48	[p3l794t2590r1205b2678],
15	,	,	O	,	_	0	SENT_48	[p3l794t2590r1205b2678],
16	EC	NNP	ORGANIZATION	EC	appos	14	SENT_48	[p3l1236t2592r1368b2662],
17	1.1.1.184,5	CD	NUMBER	1.1.1.184,5	number	18	SENT_48	[p3l1400t2574r1903b2678],
18	'13	CD	NUMBER	'13	dep	16	SENT_48	[p3l1400t2574r1903b2678],
19	while	IN	O	while	mark	32	SENT_48	[p3l1927t2590r2145b2662],
20	the	DT	O	the	det	21	SENT_48	[p3l20t2710r145b2783],
21	capacity	NN	O	capacity	nsubj	32	SENT_48	[p3l193t2710r523b2805],
22	of	IN	O	of	_	0	SENT_48	[p3l566t2710r652b2782],
23	this	DT	O	this	det	24	SENT_48	[p3l690t2708r832b2780],
24	system	NN	O	system	prep_of	21	SENT_48	[p3l879t2719r1147b2803],
25	to	TO	O	to	aux	26	SENT_48	[p3l1192t2717r1272b2780],
26	convert	VB	O	convert	infmod	24	SENT_48	[p3l1317t2717r1620b2780],
27	doxorubicin	NN	O	doxorubicin	dobj	26	SENT_48	[p3l1667t2708r2147b2780],
28	into	IN	O	into	_	0	SENT_48	[p3l20t2825r175b2898],
29	doxorubicinol	NN	O	doxorubicinol	prep_into	26	SENT_48	[p3l206t2823r767b2898],
30	is	VBZ	O	be	cop	32	SENT_48	[p3l794t2823r852b2895],
31	very	RB	O	very	advmod	32	SENT_48	[p3l877t2846r1050b2918],
32	low	JJ	O	low	conj_or	32	SENT_48	[p3l1075t2823r1216b2895],
33	in	IN	O	in	_	0	SENT_48	[p3l1243t2823r1316b2895],
34	human	JJ	O	human	amod	35	SENT_48	[p3l1344t2822r1624b2895],
35	erythrocytes	NNS	O	erythrocyte	prep_in	32	SENT_48	[p3l1653t2823r2145b2916],
36	without	IN	O	without	_	0	SENT_48	[p3l15t2942r327b3017],
37	or	CC	O	or	_	0	SENT_48	[p3l379t2965r466b3015],
38	with	IN	O	with	_	0	SENT_48	[p3l513t2942r691b3015],
39	G6PD	NN	O	g6pd	nn	40	SENT_48	[p3l745t2942r998b3015],
40	deﬁciency	NN	O	deﬁciency	prep_without	32	SENT_48	[p3l1054t2924r1555b3035],
41	.	.	O	.	_	0	SENT_48	[p3l1054t2924r1555b3035],

1	”	NN	O	”	nn	2	SENT_49	[p3l1054t2924r1555b3035],
2	Persons	NNS	O	person	nsubj	8	SENT_49	[p3l1605t2942r1921b3015],
3	with	IN	O	with	_	0	SENT_49	[p3l1971t2940r2145b3012],
4	G6PD	NN	O	g6pd	nn	5	SENT_49	[p3l24t3059r274b3131],
5	deﬁciency	NN	O	deﬁciency	prep_with	2	SENT_49	[p3l317t3057r721b3152],
6	are	VBP	O	be	cop	8	SENT_49	[p3l757t3079r882b3129],
7	particularly	RB	O	particularly	advmod	8	SENT_49	[p3l918t3056r1387b3152],
8	susceptible	JJ	O	susceptible	_	0	SENT_49	[p3l1423t3056r1866b3152],
9	to	TO	O	to	_	0	SENT_49	[p3l1904t3068r1981b3129],
10	the	DT	O	the	det	12	SENT_49	[p3l2019t3057r2147b3129],
11	hemolytic	JJ	O	hemolytic	amod	12	SENT_49	[p3l20t3174r417b3269],
12	toxicity	NN	O	toxicity	prep_to	8	SENT_49	[p3l460t3158r756b3267],
13	of	IN	O	of	_	0	SENT_49	[p3l798t3174r885b3246],
14	primaquine	NN	O	primaquine	prep_of	12	SENT_49	[p3l923t3155r1548b3269],
15	.5	CD	NUMBER	.5	num	14	SENT_49	[p3l923t3155r1548b3269],
16	‘	CD	NUMBER	‘	number	17	SENT_49	[p3l923t3155r1548b3269],
17	18	CD	NUMBER	18	dep	14	SENT_49	[p3l923t3155r1548b3269],
18	This	DT	O	this	det	19	SENT_49	[p3l1593t3174r1767b3247],
19	vulnerability	NN	O	vulnerability	dep	17	SENT_49	[p3l1810t3174r2145b3247, p4l18t18r224b111],

1	is	VBZ	O	be	cop	2	SENT_50	[p4l257t21r316b91],
2	evident	JJ	O	evident	_	0	SENT_50	[p4l354t19r652b91],
3	not	RB	O	not	neg	4	SENT_50	[p4l688t28r822b88],
4	only	RB	O	only	nsubj	2	SENT_50	[p4l861t19r1032b111],
5	when	WRB	O	when	advmod	10	SENT_50	[p4l1063t19r1281b88],
6	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	9	SENT_50	[p4l1321t18r1960b91],
7	and	CC	O	and	_	0	SENT_50	[p4l2001t18r2147b88],
8	nondeﬁcient	JJ	O	nondeﬁcient	amod	9	SENT_50	[p4l22t132r528b208],
9	persons	NNS	O	person	nsubj	10	SENT_50	[p4l573t156r885b228],
10	are	VBP	O	be	dep	4	SENT_50	[p4l932t156r1058b205],
11	compared	VBN	O	compare	prep	10	SENT_50	[p4l1105t133r1509b229],
12	but	CC	O	but	cc	66	SENT_50	[p4l1554t133r1686b205],
13	also	RB	O	also	advmod	20	SENT_50	[p4l1734t133r1889b205],
14	when	WRB	O	when	advmod	20	SENT_50	[p4l1932t133r2149b205],
15	the	DT	O	the	det	16	SENT_50	[p4l20t253r148b324],
16	eifect	NN	O	eifect	nsubjpass	20	SENT_50	[p4l193t251r408b323],
17	of	IN	O	of	_	0	SENT_50	[p4l451t251r537b323],
18	primaquine	NN	O	primaquine	prep_of	16	SENT_50	[p4l573t251r1041b347],
19	is	VBZ	O	be	auxpass	20	SENT_50	[p4l1084t249r1143b321],
20	contrasted	VBN	O	contrast	dep	66	SENT_50	[p4l1188t249r1613b323],
21	with	IN	O	with	_	0	SENT_50	[p4l1651t251r1827b323],
22	that	DT	O	that	prep_with	20	SENT_50	[p4l1867t249r2025b321],
23	of	IN	O	of	_	0	SENT_50	[p4l2068t251r2154b321],
24	another	DT	O	another	det	26	SENT_50	[p4l22t369r339b439],
25	hemolytic	JJ	O	hemolytic	amod	26	SENT_50	[p4l379t367r779b460],
26	agent	NN	O	agent	prep_of	22	SENT_50	[p4l821t379r1041b460],
27	such	JJ	O	such	_	0	SENT_50	[p4l1084t367r1265b437],
28	as	IN	O	as	_	0	SENT_50	[p4l1310t390r1387b439],
29	diaminodiphenylsu1fone	NN	O	diaminodiphenylsu1fone	prep_such_as	26	SENT_50	[p4l1432t364r2147b462, p4l20t466r410b555],
30	.19	CD	NUMBER	.19	num	29	SENT_50	[p4l1432t364r2147b462, p4l20t466r410b555],
31	The	DT	O	the	det	33	SENT_50	[p4l474t485r634b555],
32	special	JJ	O	special	amod	33	SENT_50	[p4l702t483r975b578],
33	sensitivity	NN	O	sensitivity	nsubj	37	SENT_50	[p4l1040t483r1440b576],
34	to	TO	O	to	_	0	SENT_50	[p4l1503t492r1580b555],
35	primaquine	NN	O	primaquine	nn	36	SENT_50	[p4l1646t483r2145b578],
36	—	NN	O	—	prep_to	33	SENT_50	[p4l1646t483r2145b578],
37	induced	VBD	O	induce	rcmod	29	SENT_50	[p4l22t600r343b674],
38	hemolysis	NN	O	hemolysis	nsubjpass	41	SENT_50	[p4l398t600r793b695],
39	has	VBZ	O	have	aux	41	SENT_50	[p4l849t599r981b672],
40	been	VBN	O	be	auxpass	41	SENT_50	[p4l1033t602r1230b672],
41	linked	VBN	O	link	ccomp	37	SENT_50	[p4l1282t600r1534b672],
42	to	TO	O	to	_	0	SENT_50	[p4l1589t611r1666b672],
43	the	DT	O	the	det	44	SENT_50	[p4l1722t599r1848b672],
44	drug	NN	O	drug	poss	46	SENT_50	[p4l1904t602r2149b693],
45	’s	POS	O	’s	_	0	SENT_50	[p4l1904t602r2149b693],
46	capacity	NN	O	capacity	prep_to	41	SENT_50	[p4l22t721r353b814],
47	to	TO	O	to	aux	48	SENT_50	[p4l386t730r463b791],
48	oxidize	VB	O	oxidize	infmod	46	SENT_50	[p4l504t718r786b791],
49	NADPH	NN	O	nadph	dep	48	SENT_50	[p4l824t721r1184b791],
50	both	CC	O	both	dep	51	SENT_50	[p4l1218t721r1403b791],
51	directly	RB	O	directly	advmod	49	SENT_50	[p4l1441t719r1744b812],
52	and	CC	O	and	_	0	SENT_50	[p4l1780t719r1926b791],
53	indi	NN	O	indus	nn	55	SENT_50	[p4l1962t719r2147b789],
54	~	NN	O	~	nn	55	SENT_50	[p4l1962t719r2147b789],
55	rectlylg	NN	O	rectlylg	dep	48	SENT_50	[p4l20t821r300b931],
56	moreover	RB	O	moreover	advmod	55	SENT_50	[p4l333t858r747b922],
57	,	,	O	,	_	0	SENT_50	[p4l333t858r747b922],
58	the	DT	O	the	det	60	SENT_50	[p4l782t836r908b906],
59	dual	JJ	O	dual	amod	60	SENT_50	[p4l941t833r1115b908],
60	manner	NN	O	manner	nsubjpass	66	SENT_50	[p4l1146t856r1458b908],
61	of	IN	O	of	_	0	SENT_50	[p4l1487t836r1576b906],
62	activating	VBG	O	activate	prepc_of	60	SENT_50	[p4l1600t833r1990b927],
63	the	DT	O	the	det	64	SENT_50	[p4l2019t836r2147b906],
64	HMS	NNP	O	HMS	dobj	62	SENT_50	[p4l22t954r237b1025],
65	is	VBZ	O	be	auxpass	66	SENT_50	[p4l285t952r343b1024],
66	shared	VBN	O	share	pcomp	11	SENT_50	[p4l391t952r659b1025],
67	by	IN	O	by	_	0	SENT_50	[p4l702t952r797b1043],
68	primaquine	NN	O	primaquine	agent	66	SENT_50	[p4l840t952r1309b1045],
69	and	CC	O	and	_	0	SENT_50	[p4l1356t950r1504b1022],
70	daunorubicin	NN	O	daunorubicin	nsubj	2	SENT_50	[p4l1549t936r2145b1024],
71	}	CD	NUMBER	}	num	70	SENT_50	[p4l1549t936r2145b1024],
72	These	DT	O	these	det	73	SENT_50	[p4l20t1071r265b1142],
73	considerations	NNS	O	consideration	nsubj	74	SENT_50	[p4l294t1069r885b1142],
74	suggested	VBD	O	suggest	rcmod	70	SENT_50	[p4l916t1069r1309b1163],
75	that	IN	O	that	complm	78	SENT_50	[p4l1340t1069r1497b1139],
76	there	EX	O	there	expl	78	SENT_50	[p4l1529t1067r1739b1139],
77	might	MD	O	might	aux	78	SENT_50	[p4l1768t1067r2002b1160],
78	exist	VB	O	exist	ccomp	74	SENT_50	[p4l2033t1090r2147b1139, p4l22t1186r111b1259],
79	a	DT	O	a	det	85	SENT_50	[p4l153t1209r196b1259],
80	hitherto	RB	O	hitherto	advmod	81	SENT_50	[p4l234t1186r558b1259],
81	unrecognized	JJ	O	unrecognized	amod	85	SENT_50	[p4l598t1184r1150b1279],
82	pharmacogenetic	JJ	O	pharmacogenetic	amod	85	SENT_50	[p4l1185t1186r1889b1279],
83	inter	NN	O	inter	nn	85	SENT_50	[p4l1927t1184r2147b1256],
84	—	NN	O	—	nn	85	SENT_50	[p4l1927t1184r2147b1256],
85	action	NN	O	action	dobj	78	SENT_50	[p4l24t1305r270b1376],
86	between	IN	O	between	_	0	SENT_50	[p4l301t1303r643b1376],
87	the	DT	O	the	det	88	SENT_50	[p4l676t1303r802b1376],
88	metabolism	NN	O	metabolism	prep_between	85	SENT_50	[p4l838t1303r1311b1376],
89	of	IN	O	of	_	0	SENT_50	[p4l1344t1303r1428b1376],
90	certain	JJ	O	certain	amod	91	SENT_50	[p4l1457t1301r1739b1376],
91	anthracyAmitoi	NNS	O	anthracyamitous	prep_of	88	SENT_50	[p4l1773t1301r2149b1396, p4l795t1430r1046b1496],
92	,	,	O	,	_	0	SENT_50	[p4l1773t1301r2149b1396, p4l795t1430r1046b1496],
93	Bhoomo	NNP	PERSON	Bhoomo	prep_of	88	SENT_50	[p4l1084t1431r1409b1498],
94	,	,	O	,	_	0	SENT_50	[p4l1084t1431r1409b1498],
95	and	CC	O	and	_	0	SENT_50	[p4l1445t1431r1590b1491],
96	Frischer	NNP	PERSON	Frischer	prep_of	88	SENT_50	[p4l1626t1431r1896b1494],
97	589	CD	NUMBER	589	num	96	SENT_50	[p4l2013t1430r2139b1491],

1	clines	NNS	O	cline	_	0	SENT_51	[p4l9t1676r237b1749],
2	like	IN	O	like	_	0	SENT_51	[p4l267t1674r413b1748],
3	daunorubicin	NN	O	daunorubicin	nn	6	SENT_51	[p4l445t1676r988b1749],
4	and	CC	O	and	_	0	SENT_51	[p4l1019t1676r1166b1749],
5	G6PD	NN	O	g6pd	nn	6	SENT_51	[p4l1200t1676r1453b1751],
6	deﬁciency	NN	O	deﬁciency	prep_like	1	SENT_51	[p4l1487t1676r1910b1769],
7	.	.	O	.	_	0	SENT_51	[p4l1487t1676r1910b1769],

1	Such	PDT	O	such	predet	3	SENT_52	[p4l1946t1676r2139b1749],
2	an	DT	O	a	det	3	SENT_52	[p4l9t1816r105b1865],
3	interaction	NN	O	interaction	nsubj	6	SENT_52	[p4l139t1793r580b1868],
4	could	MD	O	could	aux	6	SENT_52	[p4l614t1792r837b1867],
5	potentially	RB	O	potentially	advmod	6	SENT_52	[p4l869t1793r1307b1888],
6	affect	VB	O	affect	_	0	SENT_52	[p4l1339t1793r1558b1868],
7	antitumor	JJ	O	antitumor	amod	8	SENT_52	[p4l1591t1795r1995b1868],
8	selectivity	NN	O	selectivity	dobj	6	SENT_52	[p4l2029t1816r2137b1868, p4l7t1913r323b2006],
9	and	CC	O	and	_	0	SENT_52	[p4l371t1915r518b1985],
10	drug	NN	O	drug	nn	11	SENT_52	[p4l565t1915r749b2006],
11	toxicity	NN	O	toxicity	dobj	6	SENT_52	[p4l797t1915r1106b2006],
12	.	.	O	.	_	0	SENT_52	[p4l797t1915r1106b2006],

1	Furthermore	RB	O	furthermore	advmod	9	SENT_53	[p4l1158t1915r1708b2001],
2	,	,	O	,	_	0	SENT_53	[p4l1158t1915r1708b2001],
3	anthracy	NN	O	anthracy	nsubj	9	SENT_53	[p4l1760t1912r2137b2008],
4	—	CD	NUMBER	—	num	5	SENT_53	[p4l1760t1912r2137b2008],
5	clines	NNS	O	cline	dep	3	SENT_53	[p4l9t2027r235b2099],
6	are	VBP	O	be	cop	9	SENT_53	[p4l331t2050r457b2099],
7	indispensable	JJ	O	indispensable	amod	9	SENT_53	[p4l551t2027r1101b2123],
8	antitumor	NN	O	antitumor	nn	9	SENT_53	[p4l1198t2029r1602b2102],
9	antibiotics	NNS	O	antibiotic	_	0	SENT_53	[p4l1696t2027r2134b2115],
10	,	,	O	,	_	0	SENT_53	[p4l1696t2027r2134b2115],
11	G6PD	NN	O	g6pd	nn	12	SENT_53	[p4l12t2146r263b2219],
12	deﬁciency	NN	O	deﬁciency	nsubj	15	SENT_53	[p4l304t2143r708b2239],
13	is	VBZ	O	be	cop	15	SENT_53	[p4l741t2146r800b2218],
14	extremely	RB	O	extremely	advmod	15	SENT_53	[p4l839t2146r1236b2239],
15	common	JJ	O	common	dep	9	SENT_53	[p4l1269t2169r1643b2232],
16	,	,	O	,	_	0	SENT_53	[p4l1269t2169r1643b2232],
17	and	CC	O	and	_	0	SENT_53	[p4l1684t2146r1831b2219],
18	the	DT	O	the	det	19	SENT_53	[p4l1867t2146r1993b2219],
19	inﬂuence	NN	O	inﬂuence	nsubjpass	32	SENT_53	[p4l2031t2146r2137b2219, p4l7t2262r302b2335],
20	of	IN	O	of	_	0	SENT_53	[p4l331t2262r416b2335],
21	this	DT	O	this	det	22	SENT_53	[p4l438t2264r580b2337],
22	enzymopathy	NN	O	enzymopathy	prep_of	19	SENT_53	[p4l609t2262r1150b2360],
23	on	IN	O	on	_	0	SENT_53	[p4l1177t2285r1277b2335],
24	the	DT	O	the	det	25	SENT_53	[p4l1304t2264r1430b2337],
25	bioconversion	NN	O	bioconversion	prep_on	22	SENT_53	[p4l1459t2262r2028b2337],
26	of	IN	O	of	_	0	SENT_53	[p4l2057t2264r2144b2337],
27	daunorubicin	NN	O	daunorubicin	prep_of	25	SENT_53	[p4l12t2380r552b2453],
28	has	VBZ	O	have	aux	32	SENT_53	[p4l577t2382r710b2455],
29	not	RB	O	not	neg	32	SENT_53	[p4l737t2391r870b2455],
30	yet	RB	O	yet	advmod	32	SENT_53	[p4l892t2394r1013b2476],
31	been	VBN	O	be	auxpass	32	SENT_53	[p4l1038t2380r1236b2453],
32	addressed	VBN	O	address	conj_and	9	SENT_53	[p4l1262t2382r1666b2455],
33	in	IN	O	in	_	0	SENT_53	[p4l1693t2382r1768b2455],
34	previous	JJ	O	previous	amod	35	SENT_53	[p4l1793t2382r2137b2478],
35	studies	NNS	O	study	prep_in	32	SENT_53	[p4l12t2498r312b2571],
36	.	.	O	.	_	0	SENT_53	[p4l12t2498r312b2571],

1	For	IN	O	for	_	0	SENT_54	[p4l361t2500r506b2571],
2	these	DT	O	these	det	3	SENT_54	[p4l554t2500r765b2571],
3	reasons	NNS	O	reason	prep_for	6	SENT_54	[p4l813t2521r1120b2573],
4	we	PRP	O	we	nsubj	6	SENT_54	[p4l1161t2521r1273b2573],
5	have	VBP	O	have	aux	6	SENT_54	[p4l1323t2500r1509b2573],
6	compared	VBN	O	compare	_	0	SENT_54	[p4l1557t2500r1963b2596],
7	the	DT	O	the	det	8	SENT_54	[p4l2011t2500r2137b2573],
8	rate	NN	O	rate	dobj	6	SENT_54	[p4l9t2623r168b2686],
9	and	CC	O	and	_	0	SENT_54	[p4l209t2614r353b2686],
10	extent	NN	O	extent	dobj	6	SENT_54	[p4l392t2623r640b2686],
11	of	IN	O	of	_	0	SENT_54	[p4l676t2614r763b2686],
12	biotransformation	NN	O	biotransformation	prep_of	8	SENT_54	[p4l790t2614r1534b2689],
13	of	IN	O	of	_	0	SENT_54	[p4l1570t2616r1655b2689],
14	daunorubicin	NN	O	daunorubicin	prep_of	12	SENT_54	[p4l1689t2616r2137b2689, p4l12t2734r128b2807],

1	to	TO	O	to	_	0	SENT_55	[p4l171t2743r249b2807],
2	daunorubicinol	NN	O	daunorubicinol	pobj	1	SENT_55	[p4l294t2731r911b2807],
3	and	CC	O	and	_	0	SENT_55	[p4l954t2734r1101b2807],
4	of	IN	O	of	conj_and	1	SENT_55	[p4l1144t2734r1231b2807],
5	doxorubicin	NN	O	doxorubicin	pobj	4	SENT_55	[p4l1267t2734r1750b2807],
6	to	TO	O	to	_	0	SENT_55	[p4l1791t2746r1870b2809],
7	doxorubicinol	NN	O	doxorubicinol	prep_to	5	SENT_55	[p4l1913t2734r2137b2807, p4l12t2848r372b2921],
8	in	IN	O	in	_	0	SENT_55	[p4l412t2848r488b2921],
9	the	DT	O	the	det	10	SENT_55	[p4l526t2851r654b2921],
10	blood	NN	O	blood	prep_in	5	SENT_55	[p4l690t2849r925b2921],
11	of	IN	O	of	_	0	SENT_55	[p4l964t2849r1050b2924],
12	persons	NNS	O	person	prep_of	10	SENT_55	[p4l1082t2872r1393b2945],
13	with	IN	O	with	_	0	SENT_55	[p4l1429t2848r1606b2921],
14	and	CC	O	and	_	0	SENT_55	[p4l1647t2851r1794b2924],
15	without	IN	O	without	_	0	SENT_55	[p4l1828t2851r2139b2924],
16	G6PD	NN	O	g6pd	nn	17	SENT_55	[p4l14t2967r267b3040],
17	deﬁciency	NN	O	deﬁciency	prep_with	12	SENT_55	[p4l308t2965r712b3061],
18	of	IN	O	of	_	0	SENT_55	[p4l751t2967r837b3040],
19	the	DT	O	the	det	20	SENT_55	[p4l871t2967r997b3042],
20	GdA	NN	O	gda	prep_of	17	SENT_55	[p4l1040t2967r1294b3040],
21	"	''	O	"	punct	5	SENT_55	[p4l1040t2967r1294b3040],
22	and	CC	O	and	_	0	SENT_55	[p4l1339t2967r1488b3040],
23	Mediterranean	JJ	MISC	mediterranean	amod	24	SENT_55	[p4l1526t2967r2139b3042],
24	types	NNS	O	type	conj_and	5	SENT_55	[p4l9t3095r226b3180],
25	.	.	O	.	_	0	SENT_55	[p4l9t3095r226b3180],

1	To	TO	O	to	aux	2	SENT_56	[p4l262t3086r372b3159],
2	obtain	VB	O	obtain	purpcl	16	SENT_56	[p4l405t3086r652b3159],
3	additional	JJ	O	additional	amod	4	SENT_56	[p4l686t3084r1078b3159],
4	information	NN	O	information	dobj	2	SENT_56	[p4l1112t3083r1578b3159],
5	regarding	VBG	O	regard	_	0	SENT_56	[p4l1608t3086r1984b3182],
6	the	DT	O	the	det	7	SENT_56	[p4l2015t3086r2137b3159],
7	control	NN	O	control	prep_regarding	4	SENT_56	[p4l12t3200r291b3275],
8	of	IN	O	of	_	0	SENT_56	[p4l324t3200r407b3275],
9	cellular	JJ	O	cellular	amod	11	SENT_56	[p4l436t3200r722b3275],
10	anthracycline	NN	O	anthracycline	nn	11	SENT_56	[p4l757t3199r1275b3295],
11	metabolism	NN	O	metabolism	prep_of	7	SENT_56	[p4l1309t3202r1785b3291],
12	,	,	O	,	_	0	SENT_56	[p4l1309t3202r1785b3291],
13	we	PRP	O	we	nsubj	16	SENT_56	[p4l1816t3225r1926b3275],
14	have	VBP	O	have	aux	16	SENT_56	[p4l1960t3202r2139b3277],
15	also	RB	O	also	advmod	16	SENT_56	[p4l14t3319r163b3394],
16	investigated	VBN	O	investigate	_	0	SENT_56	[p4l218t3318r682b3415],
17	whether	IN	O	whether	complm	25	SENT_56	[p4l730t3321r1055b3394],
18	carbonyl	NN	O	carbonyl	nn	20	SENT_56	[p4l1105t3319r1439b3417],
19	reductase	NN	O	reductase	nn	20	SENT_56	[p4l1492t3321r2139b3394, p4l12t3435r180b3508],
20	—	NN	O	—	nsubjpass	25	SENT_56	[p4l1492t3321r2139b3394, p4l12t3435r180b3508],
21	mediated	VBN	O	mediate	partmod	20	SENT_56	[p4l1492t3321r2139b3394, p4l12t3435r180b3508],
22	drug	NN	O	drug	nn	23	SENT_56	[p4l239t3436r418b3531],
23	bioconversion	NN	O	bioconversion	dobj	21	SENT_56	[p4l473t3436r1020b3511],
24	was	VBD	O	be	auxpass	25	SENT_56	[p4l1075t3459r1220b3510],
25	limited	VBN	O	limit	ccomp	16	SENT_56	[p4l1279t3435r1553b3511],
26	by	IN	O	by	_	0	SENT_56	[p4l1610t3438r1701b3531],
27	metabolic	JJ	O	metabolic	amod	28	SENT_56	[p4l1756t3438r2141b3511],
28	NADPH	NN	O	nadph	agent	25	SENT_56	[p4l14t3553r365b3626],
29	or	CC	O	or	_	0	SENT_56	[p4l389t3576r474b3626],
30	by	IN	O	by	_	0	SENT_56	[p4l494t3553r585b3649],
31	the	DT	O	the	det	32	SENT_56	[p4l609t3551r731b3626],
32	amount	NN	O	amount	conj_or	28	SENT_56	[p4l760t3562r1060b3629],
33	of	IN	O	of	_	0	SENT_56	[p4l1084t3553r1169b3626],
34	constitutive	JJ	O	constitutive	amod	35	SENT_56	[p4l1186t3553r1634b3629],
35	enzyme	NN	O	enzyme	prep_of	32	SENT_56	[p4l1661t3576r1977b3649],
36	.	.	O	.	_	0	SENT_56	[p4l1661t3576r1977b3649],

1	We	PRP	O	we	nsubj	4	SENT_57	[p4l2004t3555r2139b3629],
2	have	VBP	O	have	aux	4	SENT_57	[p4l12t3671r193b3744],
3	also	RB	O	also	advmod	4	SENT_57	[p4l225t3669r374b3744],
4	examined	VBN	O	examine	_	0	SENT_57	[p4l405t3671r784b3744],
5	Whether	IN	O	whether	_	0	SENT_57	[p4l806t3671r1131b3746],
6	daunorubicin	NN	O	daunorubicin	prep_whether	4	SENT_57	[p4l1161t3671r1680b3746],
7	and	CC	O	and	_	0	SENT_57	[p4l1709t3671r1852b3746],
8	primaquine	NN	O	primaquine	prep_whether	4	SENT_57	[p4l1881t3673r2139b3767, p5l14t20r230b114],

1	aldehyde	NN	O	aldehyde	nsubj	3	SENT_58	[p5l266t18r615b117],
2	can	MD	O	can	aux	3	SENT_58	[p5l649t41r782b93],
3	compete	VB	O	compete	_	0	SENT_58	[p5l813t29r1150b117],
4	for	IN	O	for	_	0	SENT_58	[p5l1181t20r1298b93],
5	carbonyl	NN	O	carbonyl	nn	6	SENT_58	[p5l1330t20r1662b116],
6	reductase	NN	O	reductase	prep_for	3	SENT_58	[p5l1696t22r2088b95],
7	.	.	O	.	_	0	SENT_58	[p5l1696t22r2088b95],

1	METHODS	NNS	O	method	_	0	SENT_59	[p5l16t291r404b363],

1	Materials	NNPS	O	Materials	_	0	SENT_60	[p5l111t456r462b520],
2	.	.	O	.	_	0	SENT_60	[p5l111t456r462b520],

1	The	DT	O	the	det	3	SENT_61	[p5l487t454r629b520],
2	following	VBG	O	follow	amod	3	SENT_61	[p5l653t452r993b538],
3	substances	NNS	O	substance	nsubjpass	5	SENT_61	[p5l1015t451r1402b520],
4	were	VBD	O	be	auxpass	5	SENT_61	[p5l1422t472r1599b517],
5	obtained	VBN	O	obtain	_	0	SENT_61	[p5l1621t452r1942b520],
6	from	IN	O	from	_	0	SENT_61	[p5l1967t454r2141b520],
7	Sigma	NNP	ORGANIZATION	Sigma	nn	9	SENT_61	[p5l16t560r240b645],
8	Chemical	NNP	ORGANIZATION	Chemical	nn	9	SENT_61	[p5l269t561r613b627],
9	Co.	NNP	ORGANIZATION	Co.	prep_from	5	SENT_61	[p5l644t561r789b638],
10	,	,	O	,	_	0	SENT_61	[p5l644t561r789b638],
11	St.	NNP	LOCATION	St.	nn	12	SENT_61	[p5l822t561r911b627],
12	Louis	NNP	LOCATION	Louis	appos	9	SENT_61	[p5l945t561r1166b641],
13	,	,	O	,	_	0	SENT_61	[p5l945t561r1166b641],
14	Mo.	NNP	LOCATION	Mo.	dep	22	SENT_61	[p5l1200t563r1365b627],
15	:	:	O	:	_	0	SENT_61	[p5l1200t563r1365b627],
16	daunorubicin	NN	O	daunorubicin	nn	22	SENT_61	[p5l1401t561r1907b638],
17	,	,	O	,	_	0	SENT_61	[p5l1401t561r1907b638],
18	doxorubicin	NN	O	doxorubicin	dep	22	SENT_61	[p5l1941t560r2141b627, p5l14t665r288b744],
19	,	,	O	,	_	0	SENT_61	[p5l1941t560r2141b627, p5l14t665r288b744],
20	NADP	NN	O	nadp	dep	22	SENT_61	[p5l334t667r585b730],
21	monosodium	NN	O	monosodium	nn	22	SENT_61	[p5l628t667r1106b732],
22	salt	NN	O	salt	conj_and	5	SENT_61	[p5l1151t665r1291b746],
23	,	,	O	,	_	0	SENT_61	[p5l1151t665r1291b746],
24	NADPH	NN	O	nadph	nn	26	SENT_61	[p5l1337t667r1660b733],
25	tetrasodium	NN	O	tetrasodium	nn	26	SENT_61	[p5l1703t665r2144b732],
26	salt	NN	O	salt	appos	22	SENT_61	[p5l14t771r156b850],
27	,	,	O	,	_	0	SENT_61	[p5l14t771r156b850],
28	and	CC	O	and	_	0	SENT_61	[p5l206t769r339b837],
29	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	31	SENT_61	[p5l385t771r1138b857],
30	monosodiurn	NN	O	monosodiurn	nn	31	SENT_61	[p5l1186t771r1664b839],
31	salt	NN	O	salt	dep	32	SENT_61	[p5l1712t771r1836b837],
32	crystalline	JJ	O	crystalline	conj_and	5	SENT_61	[p5l1881t771r2141b855, p5l14t880r166b946],
33	.	.	O	.	_	0	SENT_61	[p5l1881t771r2141b855, p5l14t880r166b946],

1	Idarubicin	NN	PERSON	idarubicin	nsubjpass	3	SENT_62	[p5l209t878r587b946],
2	was	VBD	O	be	auxpass	3	SENT_62	[p5l623t899r756b946],
3	donated	VBN	O	donate	_	0	SENT_62	[p5l797t880r1097b946],
4	by	IN	O	by	_	0	SENT_62	[p5l1135t880r1219b965],
5	Farmitalia	NNP	PERSON	Farmitalia	agent	3	SENT_62	[p5l1255t878r1657b957],
6	,	,	O	,	_	0	SENT_62	[p5l1255t878r1657b957],
7	Carlo	NNP	PERSON	Carlo	nn	8	SENT_62	[p5l1700t878r1900b946],
8	Erba	NNP	PERSON	Erba	appos	5	SENT_62	[p5l1943t880r2139b960],
9	,	,	O	,	_	0	SENT_62	[p5l1943t880r2139b960],
10	Milan	NNP	LOCATION	Milan	appos	5	SENT_62	[p5l16t985r249b1062],
11	,	,	O	,	_	0	SENT_62	[p5l16t985r249b1062],
12	Italy	NNP	LOCATION	Italy	appos	5	SENT_62	[p5l306t985r485b1069],
13	.	.	O	.	_	0	SENT_62	[p5l306t985r485b1069],

1	Primaquine	NNP	O	Primaquine	nn	2	SENT_63	[p5l540t985r967b1071],
2	aldehyde	NN	O	aldehyde	nsubjpass	4	SENT_63	[p5l1022t984r1349b1069],
3	was	VBD	O	be	auxpass	4	SENT_63	[p5l1397t1006r1530b1050],
4	prepared	VBN	O	prepare	_	0	SENT_63	[p5l1582t985r1917b1072],
5	from	IN	O	from	_	0	SENT_63	[p5l1967t984r2144b1050],
6	primaquine	NN	O	primaquine	prep_from	4	SENT_63	[p5l14t1093r437b1179],
7	as	IN	O	as	mark	9	SENT_63	[p5l491t1113r562b1158],
8	previously	RB	DATE	previously	advmod	9	SENT_63	[p5l614t1090r990b1179],
9	described	VBN	O	describe	advcl	4	SENT_63	[p5l1042t1078r1481b1158],
10	?	.	O	?	_	0	SENT_63	[p5l1042t1078r1481b1158],

1	“	NN	O	“	nn	2	SENT_64	[p5l1042t1078r1481b1158],
2	BCNU	NN	O	bcnu	nsubjpass	4	SENT_64	[p5l1534t1093r1787b1158],
3	was	VBD	O	be	auxpass	4	SENT_64	[p5l1839t1111r1972b1158],
4	obtained	VBN	O	obtain	_	0	SENT_64	[p5l2027t1093r2141b1158, p5l14t1199r242b1267],
5	from	IN	O	from	_	0	SENT_64	[p5l274t1199r450b1267],
6	Bristol-Myers	NNP	O	Bristol-Myers	prep_from	4	SENT_64	[p5l484t1199r1004b1285],
7	,	,	O	,	_	0	SENT_64	[p5l484t1199r1004b1285],
8	Evansville	NNP	LOCATION	Evansville	nn	10	SENT_64	[p5l1038t1201r1430b1281],
9	,	,	O	,	_	0	SENT_64	[p5l1038t1201r1430b1281],
10	Ind.	NNP	LOCATION	Ind.	appos	6	SENT_64	[p5l1466t1201r1606b1264],
11	.	.	O	.	_	0	SENT_64	[p5l1466t1201r1606b1264],

1	Blood	NN	O	blood	_	0	SENT_65	[p5l111t1320r312b1383],
2	samples	NNS	O	sample	dep	1	SENT_65	[p5l350t1322r647b1395],
3	and	CC	O	and	_	0	SENT_65	[p5l686t1322r826b1383],
4	red	JJ	O	red	amod	7	SENT_65	[p5l869t1322r983b1383],
5	cell	NN	O	cell	nn	7	SENT_65	[p5l1024t1320r1148b1381],
6	enzyme	NN	O	enzyme	nn	7	SENT_65	[p5l1188t1334r1474b1397],
7	assays	NNS	O	assay	conj_and	2	SENT_65	[p5l1515t1334r1766b1397],
8	.	.	O	.	_	0	SENT_65	[p5l1515t1334r1766b1397],

1	Informed	JJ	O	informed	amod	2	SENT_66	[p5l1809t1318r2144b1383],
2	consent	NN	O	consent	nsubjpass	4	SENT_66	[p5l16t1433r286b1489],
3	was	VBD	O	be	auxpass	4	SENT_66	[p5l313t1445r444b1489],
4	obtained	VBN	O	obtain	conj_or	4	SENT_66	[p5l477t1424r786b1490],
5	from	IN	O	from	_	0	SENT_66	[p5l815t1424r988b1489],
6	apparently	RB	O	apparently	advmod	7	SENT_66	[p5l1022t1424r1395b1511],
7	healthy	JJ	O	healthy	amod	9	SENT_66	[p5l1425t1424r1685b1508],
8	adult	JJ	O	adult	amod	9	SENT_66	[p5l1714t1424r1893b1489],
9	volunteers	NNS	O	volunteer	prep_from	4	SENT_66	[p5l1920t1424r2144b1490, p5l16t1541r184b1598],
10	with	IN	O	with	_	0	SENT_66	[p5l216t1530r369b1598],
11	or	CC	O	or	_	0	SENT_66	[p5l403t1551r478b1598],
12	without	IN	O	without	_	0	SENT_66	[p5l507t1532r779b1598],
13	G6PD	NN	O	g6pd	nn	14	SENT_66	[p5l813t1532r1037b1598],
14	deﬁciency	NN	O	deﬁciency	prep_with	4	SENT_66	[p5l1073t1530r1440b1616],
15	.	.	O	.	_	0	SENT_66	[p5l1073t1530r1440b1616],

1	Venous	JJ	MISC	venous	amod	2	SENT_67	[p5l1476t1532r1748b1598],
2	blood	NN	O	blood	_	0	SENT_67	[p5l1781t1529r1984b1598],
3	was	VBD	O	be	auxpass	4	SENT_67	[p5l2013t1553r2144b1598],
4	withdrawn	VBN	O	withdraw	rcmod	2	SENT_67	[p5l9t1638r383b1705],
5	into	IN	O	into	_	0	SENT_67	[p5l408t1639r543b1705],
6	ethylenediaminetetraacetic	JJ	O	ethylenediaminetetraacetic	amod	7	SENT_67	[p5l570t1638r1523b1723],
7	acid	NN	O	acid	prep_into	4	SENT_67	[p5l1545t1639r1981b1705],
8	—	SYM	O	—	dep	10	SENT_67	[p5l1545t1639r1981b1705],
9	-	:	O	-	_	0	SENT_67	[p5l1545t1639r1981b1705],
10	treated	VBN	O	treat	dep	2	SENT_67	[p5l1545t1639r1981b1705],
11	vacuum	NN	O	vacuum	nn	12	SENT_67	[p5l2001t1660r2144b1705, p5l19t1767r177b1811],
12	tubes	NNS	O	tube	nsubj	13	SENT_67	[p5l202t1746r388b1811],
13	(	VBP	O	(	ccomp	10	SENT_67	[p5l417t1746r858b1833],
14	Vacutainer	NN	O	vacutainer	dobj	13	SENT_67	[p5l417t1746r858b1833],
15	;	:	O	;	_	0	SENT_67	[p5l417t1746r858b1833],
16	Beckton	NNP	ORGANIZATION	Beckton	nn	19	SENT_67	[p5l887t1748r1180b1811],
17	Dickinson	NNP	ORGANIZATION	Dickinson	nn	19	SENT_67	[p5l1205t1746r1562b1811],
18	Vacutainer	NNP	ORGANIZATION	Vacutainer	nn	19	SENT_67	[p5l1589t1746r1984b1811],
19	Systems	NNPS	ORGANIZATION	Systems	dep	14	SENT_67	[p5l2008t1746r2144b1830, p5l16t1861r200b1931],
20	,	,	O	,	_	0	SENT_67	[p5l2008t1746r2144b1830, p5l16t1861r200b1931],
21	Rutherford	NNP	LOCATION	Rutherford	nn	24	SENT_67	[p5l225t1852r643b1931],
22	,	,	O	,	_	0	SENT_67	[p5l225t1852r643b1931],
23	N.J.	NNP	LOCATION	N.J.	appos	24	SENT_67	[p5l665t1851r851b1938],
24	)	NNP	O	)	appos	19	SENT_67	[p5l665t1851r851b1938],
25	.	.	O	.	_	0	SENT_67	[p5l665t1851r851b1938],

1	We	PRP	O	we	nsubj	3	SENT_68	[p5l876t1854r997b1917],
2	also	RB	O	also	advmod	3	SENT_68	[p5l1019t1852r1155b1917],
3	used	VBD	O	use	_	0	SENT_68	[p5l1177t1854r1338b1917],
4	blood	NN	O	blood	nn	5	SENT_68	[p5l1357t1852r1560b1917],
5	samples	NNS	O	sample	conj_and	5	SENT_68	[p5l1580t1851r1859b1938],
6	without	IN	O	without	_	0	SENT_68	[p5l1874t1852r2146b1918],
7	and	CC	O	and	_	0	SENT_68	[p5l19t1960r147b2023],
8	with	IN	O	with	_	0	SENT_68	[p5l165t1957r318b2024],
9	G6PD	NN	O	g6pd	nn	10	SENT_68	[p5l343t1957r566b2023],
10	deﬁciency	NN	O	deﬁciency	prep_without	5	SENT_68	[p5l593t1958r944b2044],
11	identiﬁed	VBD	O	identiﬁed	ccomp	3	SENT_68	[p5l966t1958r1298b2026],
12	as	IN	O	as	mark	13	SENT_68	[p5l1325t1981r1393b2026],
13	follows	VBZ	O	follow	advcl	11	SENT_68	[p5l1415t1958r1680b2023],
14	.	.	O	.	_	0	SENT_68	[p5l1415t1958r1680b2023],

1	The	DT	O	the	det	2	SENT_69	[p5l1705t1958r1847b2023],
2	remainder	NN	O	remainder	nsubjpass	12	SENT_69	[p5l1872t1958r2144b2023, p5l16t2067r133b2133],
3	of	IN	O	of	_	0	SENT_69	[p5l153t2067r228b2133],
4	sequential	JJ	O	sequential	amod	5	SENT_69	[p5l243t2067r603b2151],
5	samples	NNS	O	sample	prep_of	2	SENT_69	[p5l623t2067r902b2151],
6	used	VBN	O	use	partmod	5	SENT_69	[p5l922t2065r1087b2133],
7	for	IN	O	for	_	0	SENT_69	[p5l1105t2067r1208b2133],
8	routine	JJ	O	routine	amod	10	SENT_69	[p5l1228t2067r1484b2133],
9	blood	NN	O	blood	nn	10	SENT_69	[p5l1503t2065r1706b2133],
10	counts	NNS	O	count	prep_for	6	SENT_69	[p5l1728t2076r1956b2133],
11	were	VBD	O	be	auxpass	12	SENT_69	[p5l1974t2088r2144b2133],
12	selected	VBN	O	select	_	0	SENT_69	[p5l16t2172r298b2240],
13	for	IN	O	for	_	0	SENT_69	[p5l317t2172r420b2237],
14	G6PD	NN	O	g6pd	nn	16	SENT_69	[p5l440t2174r664b2240],
15	deﬁciency	NN	O	deﬁciency	nn	16	SENT_69	[p5l686t2172r1036b2258],
16	screening	NN	O	screening	prep_for	12	SENT_69	[p5l1054t2174r1391b2258],
17	if	IN	O	if	mark	26	SENT_69	[p5l1408t2172r1460b2240],
18	all	DT	O	all	predet	20	SENT_69	[p5l1476t2172r1555b2238],
19	the	DT	O	the	det	20	SENT_69	[p5l1575t2172r1687b2237],
20	values	NNS	O	value	nsubj	26	SENT_69	[p5l1705t2174r1924b2240],
21	of	IN	O	of	_	0	SENT_69	[p5l1943t2174r2019b2237],
22	the	DT	O	the	det	25	SENT_69	[p5l2034t2171r2144b2237],
23	complete	JJ	O	complete	amod	25	SENT_69	[p5l19t2279r342b2365],
24	blood	NN	O	blood	nn	25	SENT_69	[p5l375t2279r576b2345],
25	counts	NNS	O	count	prep_of	20	SENT_69	[p5l612t2288r840b2345],
26	were	VBD	O	be	advcl	12	SENT_69	[p5l871t2300r1043b2345],
27	within	IN	O	within	_	0	SENT_69	[p5l1073t2279r1294b2345],
28	normal	JJ	O	normal	amod	29	SENT_69	[p5l1327t2276r1581b2345],
29	limits	NNS	O	limit	prep_within	26	SENT_69	[p5l1615t2279r1824b2347],
30	.	.	O	.	_	0	SENT_69	[p5l1615t2279r1824b2347],

1	Enzyme	NN	O	enzyme	nn	2	SENT_70	[p5l1860t2279r2146b2365],
2	activities	NNS	O	activity	nsubjpass	8	SENT_70	[p5l19t2387r321b2453],
3	and	CC	O	and	_	0	SENT_70	[p5l355t2387r485b2450],
4	the	DT	O	the	det	6	SENT_70	[p5l519t2387r629b2453],
5	Gd	JJ	MISC	gd	amod	6	SENT_70	[p5l665t2384r775b2450],
6	phenotypes	NNS	O	phenotype	conj_and	2	SENT_70	[p5l806t2385r1210b2471],
7	were	VBD	O	be	auxpass	8	SENT_70	[p5l1239t2408r1412b2453],
8	veriﬁed	VBN	O	veriﬁed	_	0	SENT_70	[p5l1443t2384r1727b2464],
9	,	,	O	,	_	0	SENT_70	[p5l1443t2384r1727b2464],
10	and	CC	O	and	_	0	SENT_70	[p5l1765t2385r1893b2453],
11	neighboring	VBG	O	neighbor	amod	12	SENT_70	[p5l1927t2385r2146b2471, p5l14t2493r244b2579],
12	samples	NNS	O	sample	nsubjpass	19	SENT_70	[p5l271t2493r550b2579],
13	without	IN	O	without	_	0	SENT_70	[p5l575t2491r847b2559],
14	or	CC	O	or	_	0	SENT_70	[p5l876t2514r951b2559],
15	with	IN	O	with	_	0	SENT_70	[p5l973t2491r1127b2559],
16	G6PD	NN	O	g6pd	nn	17	SENT_70	[p5l1156t2493r1379b2559],
17	deﬁciency	NN	O	deﬁciency	prep_with	12	SENT_70	[p5l1411t2490r1762b2580],
18	were	VBD	O	be	auxpass	19	SENT_70	[p5l1784t2511r1954b2559],
19	used	VBN	O	use	conj_and	8	SENT_70	[p5l1983t2493r2146b2559],
20	for	IN	O	for	_	0	SENT_70	[p5l16t2598r119b2663],
21	the	DT	O	the	det	23	SENT_70	[p5l171t2600r281b2666],
22	metabolic	JJ	O	metabolic	amod	23	SENT_70	[p5l334t2600r682b2666],
23	studies	NNS	O	study	prep_for	19	SENT_70	[p5l732t2598r974b2666],
24	with	IN	O	with	_	0	SENT_70	[p5l1022t2598r1175b2663],
25	anthracyclines	NNS	O	anthracycline	prep_with	23	SENT_70	[p5l1228t2600r1745b2682],
26	.	.	O	.	_	0	SENT_70	[p5l1228t2600r1745b2682],

1	Complete	JJ	O	complete	amod	3	SENT_71	[p5l1802t2598r2148b2685],
2	blood	NN	O	blood	nn	3	SENT_71	[p5l16t2704r219b2771],
3	counts	NNS	O	count	nsubjpass	5	SENT_71	[p5l266t2714r495b2771],
4	were	VBD	O	be	auxpass	5	SENT_71	[p5l540t2723r710b2771],
5	obtained	VBN	O	obtain	_	0	SENT_71	[p5l760t2704r1069b2773],
6	by	IN	O	by	_	0	SENT_71	[p5l1117t2704r1199b2789],
7	standard	JJ	O	standard	amod	10	SENT_71	[p5l1246t2705r1553b2771],
8	automated	JJ	O	automated	amod	10	SENT_71	[p5l1601t2705r1979b2771],
9	cell	NN	O	cell	nn	10	SENT_71	[p5l2027t2704r2146b2771],
10	counter	NN	O	counter	agent	5	SENT_71	[p5l16t2822r288b2879],
11	analysis	NN	O	analysis	nn	14	SENT_71	[p5l317t2813r585b2895],
12	(	CD	NUMBER	(	num	14	SENT_71	[p5l619t2813r916b2899],
13	Coulter	NNP	O	Coulter	nn	14	SENT_71	[p5l619t2813r916b2899],
14	Counter	NNP	O	Counter	dep	10	SENT_71	[p5l945t2813r1257b2890],
15	;	:	O	;	_	0	SENT_71	[p5l945t2813r1257b2890],
16	Coulter	NNP	O	Coulter	nn	17	SENT_71	[p5l1290t2811r1560b2879],
17	Electronics	NNP	O	Electronics	dep	10	SENT_71	[p5l1587t2811r2000b2890],
18	,	,	O	,	_	0	SENT_71	[p5l1587t2811r2000b2890],
19	X	NN	O	x	nn	21	SENT_71	[p5l2031t2813r2146b2876],
20	"	''	O	"	punct	21	SENT_71	[p5l2031t2813r2146b2876],
21	ak	NN	O	ak	appos	17	SENT_71	[p5l2031t2813r2146b2876],
22	+	CC	O	+	_	0	SENT_71	[p5l2031t2813r2146b2876],
23	aleah	NN	O	aleah	dep	10	SENT_71	[p5l21t2920r226b3000],
24	,	,	O	,	_	0	SENT_71	[p5l21t2920r226b3000],
25	Fla.	NNP	LOCATION	Fla.	appos	23	SENT_71	[p5l269t2918r451b3005],
26	)	CD	NUMBER	)	num	25	SENT_71	[p5l269t2918r451b3005],
27	.	.	O	.	_	0	SENT_71	[p5l269t2918r451b3005],

1	G6PD	NN	O	g6pd	_	0	SENT_72	[p5l498t2920r740b2997],
2	,	,	O	,	_	0	SENT_72	[p5l498t2920r740b2997],
3	6PGD	NN	O	6pgd	conj_and	1	SENT_72	[p5l785t2920r1027b3000],
4	,	,	O	,	_	0	SENT_72	[p5l785t2920r1027b3000],
5	and	CC	O	and	_	0	SENT_72	[p5l1075t2920r1203b2983],
6	GSSG-R	NN	O	gssg-r	conj_and	1	SENT_72	[p5l1249t2920r1565b2986],
7	were	VBD	O	be	auxpass	8	SENT_72	[p5l1603t2941r1775b2986],
8	screened	VBN	O	screen	rcmod	1	SENT_72	[p5l1818t2920r2146b2997],
9	,	,	O	,	_	0	SENT_72	[p5l1818t2920r2146b2997],
10	assayed	VBN	O	assay	dep	8	SENT_72	[p5l19t3026r302b3110],
11	,	,	O	,	_	0	SENT_72	[p5l19t3026r302b3110],
12	and	CC	O	and	_	0	SENT_72	[p5l348t3026r476b3092],
13	phenotyped	JJ	O	phenotyped	dep	8	SENT_72	[p5l519t3025r937b3112],
14	electrophoretically	RB	O	electrophoretically	advmod	13	SENT_72	[p5l980t3025r1639b3112],
15	as	IN	O	as	mark	17	SENT_72	[p5l1679t3046r1748b3091],
16	previously	RB	DATE	previously	advmod	17	SENT_72	[p5l1791t3025r2150b3112],
17	described	VBN	O	describe	ccomp	13	SENT_72	[p5l19t3122r518b3200],
18	.21	CD	NUMBER	.21	num	19	SENT_72	[p5l19t3122r518b3200],
19	’22	CD	NUMBER	’22	dobj	17	SENT_72	[p5l19t3122r518b3200],

1	Drug	NN	O	drug	nn	2	SENT_73	[p5l116t3246r284b3318],
2	incubations	NNS	O	incubation	_	0	SENT_73	[p5l322t3243r749b3307],
3	in	IN	O	in	_	0	SENT_73	[p5l785t3244r842b3305],
4	whole	JJ	O	whole	amod	5	SENT_73	[p5l878t3244r1099b3307],
5	blood	NN	O	blood	prep_in	2	SENT_73	[p5l1135t3246r1349b3307],
6	and	CC	O	and	_	0	SENT_73	[p5l1385t3246r1528b3307],
7	in	IN	O	in	_	0	SENT_73	[p5l1564t3246r1623b3305],
8	hemolysates	NNS	O	hemolysate	prep_in	2	SENT_73	[p5l1661t3244r2144b3319],
9	.	.	O	.	_	0	SENT_73	[p5l1661t3244r2144b3319],

1	The	DT	O	the	det	2	SENT_74	[p5l19t3346r161b3411],
2	biotransformation	NN	O	biotransformation	nsubjpass	8	SENT_74	[p5l211t3343r881b3409],
3	of	IN	O	of	_	0	SENT_74	[p5l929t3346r1006b3409],
4	daunorubicin	NN	O	daunorubicin	prep_of	2	SENT_74	[p5l1052t3344r1537b3411],
5	or	CC	O	or	_	0	SENT_74	[p5l1589t3364r1667b3409],
6	doxorubicin	NN	O	doxorubicin	prep_of	2	SENT_74	[p5l1716t3343r2148b3409],
7	was	VBD	O	be	auxpass	8	SENT_74	[p5l16t3473r149b3518],
8	studied	VBN	O	study	conj_and	8	SENT_74	[p5l174t3451r439b3518],
9	at	IN	O	at	_	0	SENT_74	[p5l463t3463r529b3518],
10	37	CD	NUMBER	37	number	11	SENT_74	[p5l551t3452r664b3518],
11	°	CD	NUMBER	°	num	12	SENT_74	[p5l551t3452r664b3518],
12	C	NN	O	c	prep_at	8	SENT_74	[p5l690t3452r749b3518],
13	in	IN	O	in	_	0	SENT_74	[p5l771t3452r837b3518],
14	whole	JJ	O	whole	amod	15	SENT_74	[p5l857t3454r1076b3518],
15	blood	NN	O	blood	prep_in	12	SENT_74	[p5l1098t3451r1308b3518],
16	as	RB	O	as	_	0	SENT_74	[p5l1332t3473r1403b3518],
17	well	RB	O	well	_	0	SENT_74	[p5l1422t3452r1571b3518],
18	as	IN	O	as	_	0	SENT_74	[p5l1596t3473r1664b3518],
19	in	IN	O	in	_	0	SENT_74	[p5l1689t3454r1757b3518],
20	ghost-free	JJ	O	ghost-free	amod	21	SENT_74	[p5l1779t3452r2148b3537],
21	hemolysate	NN	O	hemolysate	prep_in	8	SENT_74	[p5l19t3560r451b3642],
22	.	.	O	.	_	0	SENT_74	[p5l19t3560r451b3642],

1	For	IN	O	for	_	0	SENT_75	[p5l489t3562r620b3626],
2	the	DT	O	the	det	5	SENT_75	[p5l653t3560r768b3624],
3	whole	JJ	O	whole	amod	5	SENT_75	[p5l799t3560r1018b3626],
4	blood	NN	O	blood	nn	5	SENT_75	[p5l1052t3560r1261b3624],
5	studies	NNS	O	study	prep_for	12	SENT_75	[p5l1297t3558r1567b3638],
6	,	,	O	,	_	0	SENT_75	[p5l1297t3558r1567b3638],
7	the	DT	O	the	det	10	SENT_75	[p5l1603t3560r1717b3624],
8	freshly	RB	O	freshly	advmod	10	SENT_75	[p5l1751t3560r1998b3643],
9	obtained	VBN	O	obtain	amod	10	SENT_75	[p5l2031t3560r2146b3624, p5l19t3664r247b3730],
10	sample	NN	O	sample	nsubjpass	12	SENT_75	[p5l292t3667r550b3751],
11	was	VBD	O	be	auxpass	12	SENT_75	[p5l591t3686r726b3730],
12	incubated	VBN	O	incubate	_	0	SENT_75	[p5l771t3665r1131b3733],
13	with	IN	O	with	_	0	SENT_75	[p5l1175t3667r1333b3731],
14	a	DT	O	a	det	16	SENT_75	[p5l1381t3688r1419b3733],
15	known	JJ	O	known	amod	16	SENT_75	[p5l1462t3665r1704b3731],
16	amount	NN	O	amount	prep_with	12	SENT_75	[p5l1751t3674r2030b3733],
17	of	IN	O	of	_	0	SENT_75	[p5l2078t3667r2153b3730],
18	anthracycline	NN	O	anthracycline	prep_of	16	SENT_75	[p6l21t18r508b100],
19	without	IN	O	without	_	0	SENT_75	[p6l545t18r828b84],
20	adding	VBG	O	add	prepc_without	12	SENT_75	[p6l869t20r1115b102],
21	G6P	NN	O	g6p	dobj	20	SENT_75	[p6l1156t20r1335b98],
22	,	,	O	,	_	0	SENT_75	[p6l1156t20r1335b98],
23	NADP	NN	O	nadp	conj_or	21	SENT_75	[p6l1376t20r1648b95],
24	,	,	O	,	_	0	SENT_75	[p6l1376t20r1648b95],
25	or	CC	O	or	_	0	SENT_75	[p6l1691t39r1768b84],
26	NADPH	NN	O	nadph	conj_or	21	SENT_75	[p6l1807t20r2146b84],
27	.	.	O	.	_	0	SENT_75	[p6l1807t20r2146b84],

1	For	IN	O	for	_	0	SENT_76	[p6l21t125r149b188],
2	the	DT	O	the	det	3	SENT_76	[p6l188t125r302b191],
3	experiments	NNS	O	experiment	prep_for	10	SENT_76	[p6l343t125r789b209],
4	in	IN	O	in	_	0	SENT_76	[p6l827t124r895b188],
5	hemolysates	NNS	O	hemolysate	prep_in	3	SENT_76	[p6l934t125r1400b209],
6	,	,	O	,	_	0	SENT_76	[p6l934t125r1400b209],
7	the	DT	O	the	det	8	SENT_76	[p6l1441t125r1555b188],
8	drug	NN	O	drug	nsubjpass	10	SENT_76	[p6l1596t124r1762b209],
9	was	VBD	O	be	auxpass	10	SENT_76	[p6l1795t143r1928b189],
10	incubated	VBN	O	incubate	_	0	SENT_76	[p6l1969t124r2148b188, p6l16t232r221b298],
11	in	IN	O	in	_	0	SENT_76	[p6l248t230r316b298],
12	parallel	NN	O	parallel	prep_in	10	SENT_76	[p6l341t232r620b316],
13	either	CC	O	either	preconj	10	SENT_76	[p6l646t232r860b298],
14	with	IN	O	with	_	0	SENT_76	[p6l880t232r1041b298],
15	1	CD	NUMBER	1	num	17	SENT_76	[p6l1070t232r1101b295],
16	mmol/L	NN	O	mmol/l	nn	17	SENT_76	[p6l1131t232r1423b305],
17	NADP	NN	O	nadp	prep_with	10	SENT_76	[p6l1445t232r1697b298],
18	and	CC	O	and	_	0	SENT_76	[p6l1726t232r1859b298],
19	G6P	NN	O	g6p	conj_and	17	SENT_76	[p6l1886t232r2046b298],
20	or	CC	O	or	_	0	SENT_76	[p6l2073t253r2151b298],
21	with	IN	O	with	_	0	SENT_76	[p6l16t338r175b405],
22	1	CD	NUMBER	1	num	24	SENT_76	[p6l229t341r260b404],
23	mmol/L	NN	O	mmol/l	nn	24	SENT_76	[p6l313t339r606b411],
24	NADPH	NN	O	nadph	prep_with	10	SENT_76	[p6l651t338r976b404],
25	alone	RB	O	alone	advmod	10	SENT_76	[p6l1026t339r1240b405],
26	.	.	O	.	_	0	SENT_76	[p6l1026t339r1240b405],

1	The	DT	O	the	det	2	SENT_77	[p6l1295t341r1437b405],
2	effects	NNS	O	effect	_	0	SENT_77	[p6l1489t338r1718b405],
3	of	IN	O	of	_	0	SENT_77	[p6l1770t341r1847b405],
4	various	JJ	O	various	prep_of	2	SENT_77	[p6l1886t339r2151b404],

1	590	CD	NUMBER	590	num	4	SENT_78	[p6l28t457r156b521],
2	Amitai	NNP	PERSON	Amitai	nn	4	SENT_78	[p6l272t460r524b527],
3	,	,	O	,	_	0	SENT_78	[p6l272t460r524b527],
4	Bhooma	NNP	PERSON	Bhooma	nsubjpass	17	SENT_78	[p6l560t460r886b525],
5	,	,	O	,	_	0	SENT_78	[p6l560t460r886b525],
6	and	CC	O	and	_	0	SENT_78	[p6l919t462r1066b523],
7	Frischer	NNP	PERSON	Frischer	nn	10	SENT_78	[p6l1099t462r1370b523],
8	putative	JJ	O	putative	amod	10	SENT_78	[p6l23t704r319b788],
9	competitive	JJ	O	competitive	amod	10	SENT_78	[p6l357t702r784b789],
10	substrates	NNS	O	substrate	conj_and	4	SENT_78	[p6l825t702r1188b770],
11	or	CC	O	or	_	0	SENT_78	[p6l1226t723r1303b767],
12	inhibitors	NNS	O	inhibitor	nsubjpass	17	SENT_78	[p6l1341t701r1690b770],
13	of	IN	O	of	_	0	SENT_78	[p6l1728t704r1805b770],
14	carbonyl	NN	O	carbonyl	nn	15	SENT_78	[p6l1839t702r2151b788],
15	reductase	NN	O	reductase	prep_of	12	SENT_78	[p6l26t810r374b878],
16	were	VBD	O	be	auxpass	17	SENT_78	[p6l403t830r579b876],
17	studied	VBN	O	study	_	0	SENT_78	[p6l615t810r881b875],
18	in	IN	O	in	_	0	SENT_78	[p6l913t812r980b878],
19	hemolysate	NN	O	hemolysate	nn	20	SENT_78	[p6l1014t809r1425b896],
20	systems	NNS	O	system	prep_in	17	SENT_78	[p6l1459t819r1734b894],
21	containing	VBG	O	contain	xcomp	17	SENT_78	[p6l1767t810r2151b896],
22	daunorubicin	NN	O	daunorubicin	dobj	21	SENT_78	[p6l25t916r510b985],
23	and	CC	O	and	_	0	SENT_78	[p6l546t917r679b983],
24	NADPH	NN	O	nadph	conj_and	22	SENT_78	[p6l710t916r1052b985],
25	.	.	O	.	_	0	SENT_78	[p6l710t916r1052b985],

1	The	DT	O	the	det	3	SENT_79	[p6l1088t919r1231b982],
2	timed	VBN	O	time	amod	3	SENT_79	[p6l1265t917r1476b982],
3	samples	NNS	O	sample	nsubjpass	8	SENT_79	[p6l1509t919r1796b1005],
4	of	IN	O	of	_	0	SENT_79	[p6l1829t917r1906b985],
5	whole	JJ	O	whole	amod	6	SENT_79	[p6l1931t917r2151b984],
6	blood	NN	O	blood	prep_of	3	SENT_79	[p6l23t1024r232b1093],
7	were	VBD	O	be	auxpass	8	SENT_79	[p6l261t1048r439b1093],
8	analyzed	VBN	O	analyze	_	0	SENT_79	[p6l475t1025r791b1111],
9	for	IN	O	for	_	0	SENT_79	[p6l825t1025r932b1093],
10	anthracyclines	NNS	O	anthracycline	prep_for	8	SENT_79	[p6l968t1024r1487b1111],
11	and	CC	O	and	_	0	SENT_79	[p6l1523t1025r1655b1090],
12	their	PRP$	O	they	poss	13	SENT_79	[p6l1689t1027r1863b1093],
13	metabolites	NNS	O	metabolite	prep_for	8	SENT_79	[p6l1896t1025r2148b1093, p6l25t1132r218b1200],
14	separately	RB	O	separately	advmod	8	SENT_79	[p6l256t1132r628b1218],
15	in	IN	O	in	_	0	SENT_79	[p6l661t1132r729b1198],
16	plasma	NN	O	plasma	prep_in	8	SENT_79	[p6l765t1132r1022b1218],
17	and	CC	O	and	_	0	SENT_79	[p6l1060t1132r1192b1198],
18	red	JJ	O	red	amod	19	SENT_79	[p6l1228t1132r1347b1198],
19	cells	NNS	O	cell	prep_in	8	SENT_79	[p6l1385t1130r1559b1198],
20	.	.	O	.	_	0	SENT_79	[p6l1385t1130r1559b1198],

1	The	DT	O	the	det	2	SENT_80	[p6l1597t1132r1741b1198],
2	blood	NN	O	blood	nsubjpass	4	SENT_80	[p6l1774t1132r1985b1198],
3	was	VBD	O	be	auxpass	4	SENT_80	[p6l2016t1150r2151b1198],
4	centrifuged	VBN	O	centrifuge	_	0	SENT_80	[p6l23t1241r439b1327],
5	(	CD	NUMBER	(	num	7	SENT_80	[p6l475t1240r674b1327],
6	3000	CD	NUMBER	3000	num	7	SENT_80	[p6l475t1240r674b1327],
7	g	NN	O	g	dobj	4	SENT_80	[p6l698t1262r743b1325],
8	for	IN	O	for	_	0	SENT_80	[p6l772t1241r879b1306],
9	10	CD	DURATION	10	num	10	SENT_80	[p6l915t1243r992b1306],
10	minutes	NNS	NUMBER	minute	prep_for	4	SENT_80	[p6l1023t1240r1314b1307],
11	at	IN	O	at	_	0	SENT_80	[p6l1348t1250r1413b1306],
12	room	NN	O	room	nn	13	SENT_80	[p6l1445t1259r1641b1306],
13	temperature	NN	O	temperature	prep_at	10	SENT_80	[p6l1673t1250r2146b1327],
14	,	,	O	,	_	0	SENT_80	[p6l1673t1250r2146b1327],
15	model	NN	O	model	nn	16	SENT_80	[p6l23t1348r250b1416],
16	HN-S/IEC	NN	O	hn-s/iec	appos	13	SENT_80	[p6l295t1348r702b1427],
17	;	:	O	;	_	0	SENT_80	[p6l295t1348r702b1427],
18	International	NNP	ORGANIZATION	International	nn	20	SENT_80	[p6l751t1348r1234b1416],
19	Equipment	NNP	ORGANIZATION	Equipment	nn	20	SENT_80	[p6l1277t1348r1688b1435],
20	Co.	NNP	ORGANIZATION	Co.	nsubj	29	SENT_80	[p6l1735t1350r1876b1430],
21	,	,	O	,	_	0	SENT_80	[p6l1735t1350r1876b1430],
22	Needham	NNP	LOCATION	Needham	nn	23	SENT_80	[p6l1924t1348r2148b1414, p6l23t1455r181b1521],
23	Heights	NNP	LOCATION	Heights	appos	20	SENT_80	[p6l203t1458r508b1542],
24	,	,	O	,	_	0	SENT_80	[p6l203t1458r508b1542],
25	Mass.	NNP	LOCATION	Mass.	nn	26	SENT_80	[p6l535t1456r794b1542],
26	)	NNP	O	)	appos	23	SENT_80	[p6l535t1456r794b1542],
27	,	,	O	,	_	0	SENT_80	[p6l535t1456r794b1542],
28	to	TO	O	to	aux	29	SENT_80	[p6l818t1465r890b1521],
29	obtain	VB	O	obtain	parataxis	4	SENT_80	[p6l915t1458r1148b1524],
30	buffy	JJ	O	buffy	amod	31	SENT_80	[p6l1168t1455r1349b1540],
31	coat	NN	O	coat	dobj	29	SENT_80	[p6l1371t1456r1711b1524],
32	—	RB	O	—	advmod	33	SENT_80	[p6l1371t1456r1711b1524],
33	free	JJ	O	free	amod	34	SENT_80	[p6l1371t1456r1711b1524],
34	plasma	NN	O	plasma	dep	31	SENT_80	[p6l1735t1455r1992b1542],
35	and	CC	O	and	_	0	SENT_80	[p6l2018t1456r2148b1521],
36	red	JJ	O	red	amod	37	SENT_80	[p6l23t1564r144b1629],
37	cells	NNS	O	cell	dobj	29	SENT_80	[p6l187t1563r363b1632],
38	.	.	O	.	_	0	SENT_80	[p6l187t1563r363b1632],

1	Plasma	NN	O	plasma	nsubjpass	3	SENT_81	[p6l408t1564r672b1629],
2	was	VBD	O	be	auxpass	3	SENT_81	[p6l707t1582r844b1630],
3	analyzed	VBN	O	analyze	_	0	SENT_81	[p6l889t1564r1206b1651],
4	as	IN	O	as	mark	8	SENT_81	[p6l1251t1585r1321b1629],
5	for	IN	O	for	_	0	SENT_81	[p6l1364t1564r1471b1629],
6	hernolysates	NNS	O	hernolysate	prep_for	8	SENT_81	[p6l1514t1564r1957b1650],
7	(	CD	NUMBER	(	nsubj	8	SENT_81	[p6l2004t1564r2148b1650],
8	see	VBP	O	see	advcl	3	SENT_81	[p6l2004t1564r2148b1650],
9	below	IN	O	below	_	0	SENT_81	[p6l23t1671r289b1759],
10	)	NN	O	)	prep_below	8	SENT_81	[p6l23t1671r289b1759],
11	.	.	O	.	_	0	SENT_81	[p6l23t1671r289b1759],

1	The	DT	O	the	det	4	SENT_82	[p6l323t1671r467b1739],
2	packed	JJ	O	packed	amod	4	SENT_82	[p6l498t1671r759b1757],
3	red	JJ	O	red	amod	4	SENT_82	[p6l790t1671r909b1737],
4	cells	NNS	O	cell	nsubjpass	6	SENT_82	[p6l942t1674r1098b1739],
5	were	VBD	O	be	auxpass	6	SENT_82	[p6l1127t1692r1303b1739],
6	washed	VBN	O	wash	_	0	SENT_82	[p6l1330t1671r1602b1737],
7	three	CD	NUMBER	three	num	8	SENT_82	[p6l1634t1667r1833b1739],
8	times	NNS	O	time	npadvmod	6	SENT_82	[p6l1855t1674r2049b1739],
9	in	IN	O	in	_	0	SENT_82	[p6l2083t1671r2151b1736],
10	twice	RB	O	twice	advmod	12	SENT_82	[p6l23t1777r211b1845],
11	their	PRP$	O	they	poss	12	SENT_82	[p6l247t1779r418b1845],
12	Volume	NN	O	volume	prep_in	6	SENT_82	[p6l450t1779r720b1845],
13	of	IN	O	of	_	0	SENT_82	[p6l758t1776r835b1845],
14	normal	JJ	O	normal	amod	16	SENT_82	[p6l864t1779r1125b1845],
15	saline	NN	O	saline	nn	16	SENT_82	[p6l1161t1779r1370b1845],
16	solution	NN	O	solution	prep_of	12	SENT_82	[p6l1405t1777r1718b1861],
17	,	,	O	,	_	0	SENT_82	[p6l1405t1777r1718b1861],
18	hemolyzed	VBN	O	hemolyze	partmod	16	SENT_82	[p6l1756t1779r2151b1865],
19	with	IN	O	with	_	0	SENT_82	[p6l21t1885r179b1950],
20	Tris	NNP	O	Tris	nn	22	SENT_82	[p6l210t1887r354b1953],
21	buffer	NN	O	buffer	nn	22	SENT_82	[p6l385t1885r603b1950],
22	solution	NN	O	solution	prep_with	18	SENT_82	[p6l636t1884r930b1950],
23	(	CD	NUMBER	(	num	25	SENT_82	[p6l965t1885r1139b1971],
24	0.05	CD	NUMBER	0.05	num	25	SENT_82	[p6l965t1885r1139b1971],
25	mol/L	NN	O	mol/l	tmod	18	SENT_82	[p6l1175t1885r1413b1964],
26	,	,	O	,	_	0	SENT_82	[p6l1175t1885r1413b1964],
27	pH	NN	O	ph	nn	29	SENT_82	[p6l1447t1884r1563b1971],
28	7.4	CD	NUMBER	7.4	num	29	SENT_82	[p6l1597t1885r1729b1974],
29	)	NN	O	)	appos	25	SENT_82	[p6l1597t1885r1729b1974],
30	containing	VBG	O	contain	xcomp	18	SENT_82	[p6l1767t1885r2151b1971],
31	20	CD	NUMBER	20	num	33	SENT_82	[p6l23t1993r105b2058],
32	mg/dl	NN	O	mg/dl	nn	33	SENT_82	[p6l141t1995r344b2079],
33	saponin	NN	O	saponin	dobj	30	SENT_82	[p6l383t1993r685b2079],
34	,	,	O	,	_	0	SENT_82	[p6l383t1993r685b2079],
35	and	CC	O	and	_	0	SENT_82	[p6l726t1993r858b2058],
36	the	DT	O	the	det	37	SENT_82	[p6l896t1995r1010b2061],
37	ghosts	NNS	O	ghost	nsubjpass	39	SENT_82	[p6l1048t1993r1273b2079],
38	were	VBD	O	be	auxpass	39	SENT_82	[p6l1306t2014r1485b2059],
39	removed	VBN	O	remove	conj_and	6	SENT_82	[p6l1521t1995r1840b2061],
40	by	IN	O	by	_	0	SENT_82	[p6l1876t1995r1962b2079],
41	centrifugation	NN	O	centrifugation	agent	39	SENT_82	[p6l1995t2014r2146b2061, p6l23t2100r409b2186],
42	(	CD	NUMBER	(	num	41	SENT_82	[p6l459t2100r724b2189],
43	17,000	CD	NUMBER	17,000	num	44	SENT_82	[p6l459t2100r724b2189],
44	g	NN	O	g	dobj	39	SENT_82	[p6l760t2120r805b2186],
45	at	IN	O	at	_	0	SENT_82	[p6l850t2109r916b2165],
46	4	CD	NUMBER	4	number	47	SENT_82	[p6l961t2102r1031b2168],
47	°	CD	NUMBER	°	num	49	SENT_82	[p6l961t2102r1031b2168],
48	C	NN	O	c	nn	49	SENT_82	[p6l1058t2100r1165b2188],
49	)	NN	O	)	prep_at	44	SENT_82	[p6l1058t2100r1165b2188],
50	.	.	O	.	_	0	SENT_82	[p6l1058t2100r1165b2188],

1	Incubations	NNS	O	incubation	nsubjpass	10	SENT_83	[p6l1214t2100r1642b2165],
2	of	IN	O	of	_	0	SENT_83	[p6l1689t2102r1766b2168],
3	anthracy	NN	O	anthracy	nn	5	SENT_83	[p6l1809t2102r2146b2186],
4	—	CD	NUMBER	—	num	5	SENT_83	[p6l1809t2102r2146b2186],
5	clines	NNS	O	cline	prep_of	1	SENT_83	[p6l23t2207r227b2275],
6	in	IN	O	in	_	0	SENT_83	[p6l263t2209r331b2275],
7	ghost-free	JJ	O	ghost-free	amod	8	SENT_83	[p6l364t2209r734b2295],
8	hemolysate	NN	O	hemolysate	prep_in	1	SENT_83	[p6l770t2207r1183b2295],
9	were	VBD	O	be	auxpass	10	SENT_83	[p6l1214t2228r1390b2275],
10	carried	VBN	O	carry	_	0	SENT_83	[p6l1426t2207r1683b2275],
11	out	RP	O	out	prt	10	SENT_83	[p6l1719t2218r1840b2275],
12	in	IN	O	in	_	0	SENT_83	[p6l1873t2209r1941b2275],
13	samples	NNS	O	sample	prep_in	10	SENT_83	[p6l1977t2228r2148b2275, p6l21t2315r165b2399],
14	adjusted	VBN	O	adjust	partmod	13	SENT_83	[p6l196t2315r503b2401],
15	to	TO	O	to	_	0	SENT_83	[p6l532t2324r605b2381],
16	a	DT	O	a	det	18	SENT_83	[p6l638t2336r676b2381],
17	hemoglobin	NN	O	hemoglobin	nn	18	SENT_83	[p6l705t2315r1139b2401],
18	concentration	NN	O	concentration	prep_to	14	SENT_83	[p6l1170t2313r1678b2381],
19	of	IN	O	of	_	0	SENT_83	[p6l1707t2315r1784b2381],
20	2.5	CD	NUMBER	2.5	num	21	SENT_83	[p6l1811t2315r1911b2381],
21	gm/dl	NN	O	gm/dl	prep_of	18	SENT_83	[p6l1942t2315r2148b2401],
22	with	IN	O	with	_	0	SENT_83	[p6l19t2422r176b2488],
23	0.01	CD	NUMBER	0.01	num	25	SENT_83	[p6l214t2424r358b2490],
24	mol/L	NN	O	mol/l	nn	25	SENT_83	[p6l401t2422r621b2497],
25	potassium	NN	O	potassium	prep_with	21	SENT_83	[p6l657t2422r1026b2508],
26	dihydrogen	NN	O	dihydrogen	nn	28	SENT_83	[p6l1067t2422r1478b2509],
27	phosphate	NN	O	phosphate	nn	28	SENT_83	[p6l1516t2421r1895b2508],
28	buffer	NN	O	buffer	dobj	14	SENT_83	[p6l1933t2422r2148b2487],
29	adjusted	VBN	O	adjust	partmod	28	SENT_83	[p6l23t2530r331b2614],
30	to	TO	O	to	_	0	SENT_83	[p6l373t2541r444b2598],
31	pH	NN	O	ph	prep_to	29	SENT_83	[p6l484t2532r602b2616],
32	7.4	CD	NUMBER	7.4	num	31	SENT_83	[p6l643t2532r748b2595],
33	with	IN	O	with	_	0	SENT_83	[p6l786t2530r946b2598],
34	NaOH	NN	O	naoh	prep_with	29	SENT_83	[p6l986t2532r1250b2598],
35	.	.	O	.	_	0	SENT_83	[p6l986t2532r1250b2598],

1	Hemoglobin	NN	O	hemoglobin	nsubjpass	3	SENT_84	[p6l1295t2530r1754b2614],
2	was	VBD	O	be	auxpass	3	SENT_84	[p6l1790t2551r1925b2598],
3	measured	VBN	O	measure	_	0	SENT_84	[p6l1968t2550r2148b2598, p6l23t2640r222b2706],
4	by	IN	O	by	_	0	SENT_84	[p6l254t2640r337b2724],
5	the	DT	O	the	det	8	SENT_84	[p6l367t2640r483b2703],
6	standard	JJ	O	standard	amod	8	SENT_84	[p6l516t2638r833b2703],
7	Drabkin	NNP	PERSON	Drabkin	nn	8	SENT_84	[p6l864t2640r1167b2706],
8	method	NN	O	method	agent	3	SENT_84	[p6l1201t2638r1499b2703],
9	.	.	O	.	_	0	SENT_84	[p6l1201t2638r1499b2703],

1	Sample	NN	O	sample	nn	2	SENT_85	[p6l115t2751r393b2828],
2	preparation	NN	O	preparation	_	0	SENT_85	[p6l433t2751r865b2826],
3	and	CC	O	and	_	0	SENT_85	[p6l903t2753r1047b2814],
4	extraction	NN	O	extraction	conj_and	2	SENT_85	[p6l1085t2753r1457b2814],
5	for	IN	O	for	_	0	SENT_85	[p6l1495t2750r1591b2812],
6	drug	NN	O	drug	nn	7	SENT_85	[p6l1627t2753r1794b2830],
7	analysis	NN	O	analysis	prep_for	2	SENT_85	[p6l1832t2753r2144b2828],
8	.	.	O	.	_	0	SENT_85	[p6l1832t2753r2144b2828],

1	Idarubicin	NN	PERSON	idarubicin	nsubjpass	3	SENT_86	[p6l21t2852r400b2921],
2	was	VBD	O	be	auxpass	3	SENT_86	[p6l431t2873r566b2921],
3	used	VBN	O	use	_	0	SENT_86	[p6l602t2853r771b2921],
4	as	IN	O	as	_	0	SENT_86	[p6l809t2873r877b2918],
5	an	DT	O	a	det	7	SENT_86	[p6l917t2876r1001b2921],
6	internal	JJ	O	internal	amod	7	SENT_86	[p6l1039t2853r1323b2921],
7	standard	NN	O	standard	prep_as	3	SENT_86	[p6l1359t2852r1694b2921],
8	.	.	O	.	_	0	SENT_86	[p6l1359t2852r1694b2921],

1	Samples	NNS	O	sample	nsubj	9	SENT_87	[p6l1737t2855r2038b2941],
2	of	IN	O	of	_	0	SENT_87	[p6l2076t2855r2153b2921],
3	0.2	CD	NUMBER	0.2	num	4	SENT_87	[p6l21t2963r128b3026],
4	ml	NN	O	ml	prep_of	1	SENT_87	[p6l154t2963r245b3029],
5	of	IN	O	of	_	0	SENT_87	[p6l274t2963r351b3029],
6	plasma	NN	O	plasma	prep_of	4	SENT_87	[p6l373t2963r630b3047],
7	or	CC	O	or	_	0	SENT_87	[p6l659t2982r736b3026],
8	RBCS	NN	O	rbc	prep_of	4	SENT_87	[p6l765t2963r980b3029],
9	hemolyzed	VBD	O	hemolyze	_	0	SENT_87	[p6l1007t2960r1402b3047],
10	as	IN	O	as	mark	14	SENT_87	[p6l1433t2982r1503b3026],
11	described	VBN	O	describe	csubjpass	14	SENT_87	[p6l1532t2961r1881b3029],
12	earlier	JJR	O	earlier	advmod	11	SENT_87	[p6l1910t2963r2148b3029],
13	were	VBD	O	be	auxpass	14	SENT_87	[p6l19t3088r195b3133],
14	supplemented	VBN	O	supplement	advcl	9	SENT_87	[p6l219t3070r736b3157],
15	with	IN	O	with	_	0	SENT_87	[p6l756t3068r916b3135],
16	idarubicin	NN	O	idarubicin	prep_with	14	SENT_87	[p6l938t3067r1307b3136],
17	and	CC	O	and	_	0	SENT_87	[p6l1334t3068r1464b3136],
18	extracted	VBN	O	extract	advcl	9	SENT_87	[p6l1491t3070r1828b3136],
19	for	IN	O	for	_	0	SENT_87	[p6l1850t3070r1957b3136],
20	drug	NN	O	drug	nn	21	SENT_87	[p6l1981t3070r2146b3154],
21	analysis	NN	O	analysis	prep_for	18	SENT_87	[p6l23t3172r301b3261],
22	as	IN	O	as	mark	23	SENT_87	[p6l336t3196r404b3241],
23	follows	VBZ	O	follow	advcl	18	SENT_87	[p6l438t3175r715b3241],
24	.	.	O	.	_	0	SENT_87	[p6l438t3175r715b3241],

1	In	IN	O	in	_	0	SENT_88	[p6l751t3175r828b3238],
2	a	DT	O	a	det	4	SENT_88	[p6l862t3193r900b3238],
3	glass	NN	O	glass	nn	4	SENT_88	[p6l931t3175r1102b3261],
4	tube	NN	O	tube	nsubj	5	SENT_88	[p6l1136t3175r1296b3241],
5	containing	VBG	O	contain	prepc_in	17	SENT_88	[p6l1327t3173r1713b3261],
6	the	DT	O	the	det	10	SENT_88	[p6l1744t3175r1858b3243],
7	plasma	NN	O	plasma	nn	10	SENT_88	[p6l1889t3175r2148b3261],
8	or	CC	O	or	_	0	SENT_88	[p6l21t3301r100b3348],
9	hemolysate	NN	O	hemolysate	nn	10	SENT_88	[p6l122t3282r536b3367],
10	sample	NN	O	sample	dobj	5	SENT_88	[p6l560t3283r835b3366],
11	,	,	O	,	_	0	SENT_88	[p6l560t3283r835b3366],
12	3	CD	NUMBER	3	num	13	SENT_88	[p6l862t3283r900b3348],
13	ml	NN	O	ml	nsubjpass	17	SENT_88	[p6l926t3285r1017b3348],
14	of	IN	O	of	_	0	SENT_88	[p6l1041t3285r1119b3350],
15	acetonitrile	NN	O	acetonitrile	prep_of	13	SENT_88	[p6l1138t3283r1554b3348],
16	was	VBD	O	be	auxpass	17	SENT_88	[p6l1576t3303r1711b3351],
17	added	VBN	O	add	_	0	SENT_88	[p6l1735t3285r1976b3350],
18	.	.	O	.	_	0	SENT_88	[p6l1735t3285r1976b3350],

1	Ten	CD	DATE	ten	num	2	SENT_89	[p6l2002t3285r2146b3348],
2	minutes	NNS	DATE	minute	tmod	10	SENT_89	[p6l21t3390r310b3457],
3	later	RB	DATE	later	advmod	2	SENT_89	[p6l341t3389r529b3469],
4	,	,	O	,	_	0	SENT_89	[p6l341t3389r529b3469],
5	100	CD	NUMBER	100	num	8	SENT_89	[p6l567t3390r688b3455],
6	mg	NN	O	mg	nn	8	SENT_89	[p6l719t3410r828b3473],
7	N	NN	O	n	nn	8	SENT_89	[p6l859t3392r923b3455],
8	aCl	NN	O	acl	nsubjpass	10	SENT_89	[p6l929t3392r1049b3457],
9	was	VBD	O	be	auxpass	10	SENT_89	[p6l1076t3410r1211b3457],
10	added	VBN	O	add	_	0	SENT_89	[p6l1244t3390r1485b3469],
11	,	,	O	,	_	0	SENT_89	[p6l1244t3390r1485b3469],
12	and	CC	O	and	_	0	SENT_89	[p6l1521t3392r1653b3455],
13	after	IN	O	after	mark	21	SENT_89	[p6l1684t3392r1856b3458],
14	5	CD	NUMBER	5	num	16	SENT_89	[p6l1885t3392r1923b3457],
15	more	JJR	O	more	quantmod	14	SENT_89	[p6l1956t3410r2146b3457],
16	minutes	NNS	DURATION	minute	tmod	21	SENT_89	[p7l19t19r328b101],
17	,	,	O	,	_	0	SENT_89	[p7l19t19r328b101],
18	the	DT	O	the	det	19	SENT_89	[p7l383t21r497b87],
19	tubes	NNS	O	tube	nsubjpass	42	SENT_89	[p7l548t18r741b87],
20	were	VBD	O	be	auxpass	21	SENT_89	[p7l790t40r966b87],
21	centrifuged	VBN	O	centrifuge	advcl	69	SENT_89	[p7l1018t21r1436b105],
22	for	IN	O	for	_	0	SENT_89	[p7l1488t21r1593b87],
23	7	CD	DURATION	7	num	24	SENT_89	[p7l1645t23r1685b89],
24	minutes	NNS	NUMBER	minute	prep_for	21	SENT_89	[p7l1735t21r2026b87],
25	at	IN	O	at	_	0	SENT_89	[p7l2078t30r2146b87],
26	1500	CD	DATE	1500	num	27	SENT_89	[p7l23t126r188b192],
27	g.	NN	O	g.	prep_at	21	SENT_89	[p7l208t147r268b213],
28	A	NN	O	a	nn	31	SENT_89	[p7l300t129r368b192],
29	2	CD	NUMBER	2	num	31	SENT_89	[p7l394t129r434b192],
30	ml	NN	O	ml	nn	31	SENT_89	[p7l461t126r554b192],
31	sample	NN	O	sample	nsubjpass	36	SENT_89	[p7l583t127r838b214],
32	of	IN	O	of	_	0	SENT_89	[p7l869t129r946b192],
33	the	DT	O	the	det	34	SENT_89	[p7l970t129r1082b195],
34	supernatant	NN	O	supernatant	prep_of	31	SENT_89	[p7l1113t136r1549b213],
35	was	VBD	O	be	auxpass	36	SENT_89	[p7l1574t148r1708b195],
36	transferred	VBN	O	transfer	rcmod	27	SENT_89	[p7l1737t126r2144b195],
37	into	IN	O	into	_	0	SENT_89	[p7l19t235r160b300],
38	another	DT	O	another	det	40	SENT_89	[p7l194t235r478b300],
39	glass	NN	O	glass	nn	40	SENT_89	[p7l505t235r676b321],
40	tube	NN	O	tube	prep_into	36	SENT_89	[p7l705t235r865b300],
41	and	CC	O	and	_	0	SENT_89	[p7l896t235r1029b303],
42	evaporated	VBN	O	evaporate	conj_and	21	SENT_89	[p7l1058t235r1466b321],
43	under	IN	O	under	_	0	SENT_89	[p7l1495t235r1711b303],
44	nitrogen	NN	O	nitrogen	prep_under	42	SENT_89	[p7l1739t237r2047b321],
45	at	IN	O	at	_	0	SENT_89	[p7l2078t246r2144b300],
46	60	CD	NUMBER	60	number	47	SENT_89	[p7l21t340r130b408],
47	°	CD	NUMBER	°	prep_at	42	SENT_89	[p7l21t340r130b408],
48	C.	NNP	O	C.	nn	49	SENT_89	[p7l157t344r232b410],
49	The	NNP	O	The	nsubj	60	SENT_89	[p7l258t342r402b408],
50	residue	NN	O	residue	nsubjpass	52	SENT_89	[p7l426t342r692b408],
51	was	VBD	O	be	auxpass	52	SENT_89	[p7l712t363r847b408],
52	reconstituted	VBN	O	reconstitute	rcmod	49	SENT_89	[p7l873t342r1356b410],
53	into	IN	O	into	_	0	SENT_89	[p7l1378t342r1522b408],
54	200	CD	NUMBER	200	num	55	SENT_89	[p7l1546t344r1671b410],
55	pl	NN	O	pl	prep_into	52	SENT_89	[p7l1700t344r1773b428],
56	of	IN	O	of	_	0	SENT_89	[p7l1799t344r1876b410],
57	mobile	JJ	O	mobile	amod	59	SENT_89	[p7l1894t344r2144b410],
58	phase	NN	O	phase	nn	59	SENT_89	[p7l19t449r227b535],
59	(	NN	O	(	prep_of	55	SENT_89	[p7l256t449r400b537],
60	see	VBP	O	see	ccomp	42	SENT_89	[p7l256t449r400b537],
61	below	IN	O	below	_	0	SENT_89	[p7l422t448r690b535],
62	)	NN	O	)	prep_below	60	SENT_89	[p7l422t448r690b535],
63	,	,	O	,	_	0	SENT_89	[p7l422t448r690b535],
64	and	CC	O	and	_	0	SENT_89	[p7l717t449r851b514],
65	40	CD	NUMBER	40	dep	66	SENT_89	[p7l873t448r955b517],
66	it	PRP	O	it	conj_and	42	SENT_89	[p7l984t451r1056b533],
67	]	NN	O	]	nsubjpass	69	SENT_89	[p7l984t451r1056b533],
68	was	VBD	O	be	auxpass	69	SENT_89	[p7l1076t469r1211b517],
69	injected	VBN	O	inject	conj_and	10	SENT_89	[p7l1235t449r1524b535],
70	into	IN	O	into	_	0	SENT_89	[p7l1548t448r1690b517],
71	the	DT	O	the	det	72	SENT_89	[p7l1714t451r1828b517],
72	column	NN	O	column	prep_into	69	SENT_89	[p7l1852t451r2141b517],
73	.	.	O	.	_	0	SENT_89	[p7l1852t451r2141b517],

1	HPLC	NN	O	hplc	nn	2	SENT_90	[p7l115t561r298b622],
2	analysis	NN	O	analysis	_	0	SENT_90	[p7l323t563r616b636],
3	of	IN	O	of	_	0	SENT_90	[p7l643t561r713b622],
4	anlhracyclines	NNS	O	anlhracycline	prep_of	2	SENT_90	[p7l735t561r1301b636],
5	.	.	O	.	_	0	SENT_90	[p7l735t561r1301b636],

1	Daunorubicin	NNP	O	Daunorubicin	nsubjpass	11	SENT_91	[p7l1329t558r1858b638],
2	,	,	O	,	_	0	SENT_91	[p7l1329t558r1858b638],
3	daunorubicinol	NN	O	daunorubicinol	nsubjpass	11	SENT_91	[p7l1887t559r2141b624, p7l16t664r361b744],
4	,	,	O	,	_	0	SENT_91	[p7l1887t559r2141b624, p7l16t664r361b744],
5	doxorubicin	NN	O	doxorubicin	nsubjpass	11	SENT_91	[p7l399t664r849b744],
6	,	,	O	,	_	0	SENT_91	[p7l399t664r849b744],
7	and	CC	O	and	_	0	SENT_91	[p7l887t667r1019b730],
8	doxorubicinol	NN	O	doxorubicinol	nn	9	SENT_91	[p7l1051t665r1556b730],
9	levels	NNS	O	level	conj_and	1	SENT_91	[p7l1590t665r1789b733],
10	were	VBD	O	be	auxpass	11	SENT_91	[p7l1818t688r1994b733],
11	determined	VBN	O	determine	_	0	SENT_91	[p7l2028t667r2141b730, p7l16t773r349b839],
12	with	IN	O	with	_	0	SENT_91	[p7l371t773r529b838],
13	HPLC	NN	O	hplc	prep_with	11	SENT_91	[p7l553t773r791b838],
14	by	IN	O	by	_	0	SENT_91	[p7l813t773r900b859],
15	using	VBG	O	use	agent	11	SENT_91	[p7l922t775r1114b859],
16	a	DT	O	a	det	17	SENT_91	[p7l1141t794r1178b838],
17	modiﬁcation	NN	O	modiﬁcation	dobj	15	SENT_91	[p7l1203t772r1665b841],
18	of	IN	O	of	_	0	SENT_91	[p7l1691t775r1768b841],
19	a	DT	O	a	det	22	SENT_91	[p7l1790t796r1826b838],
20	recently	RB	DATE	recently	advmod	21	SENT_91	[p7l1852t773r2144b859],
21	described	VBN	O	describe	amod	22	SENT_91	[p7l19t880r365b946],
22	method	NN	O	method	prep_of	17	SENT_91	[p7l392t869r759b946],
23	.	.	O	.	_	0	SENT_91	[p7l392t869r759b946],

1	”	NN	O	”	nsubj	5	SENT_92	[p7l392t869r759b946],
2	The	DT	O	the	det	4	SENT_92	[p7l786t880r930b946],
3	HPLC	NN	O	hplc	nn	4	SENT_92	[p7l954t880r1192b946],
4	instrumentation	NN	O	instrumentation	dep	1	SENT_92	[p7l1217t880r1803b949],
5	included	VBD	O	include	_	0	SENT_92	[p7l1829t880r2141b946],
6	a	DT	O	a	det	10	SENT_92	[p7l19t1006r56b1051],
7	Gilson	NN	PERSON	gilson	nn	10	SENT_92	[p7l88t986r328b1056],
8	620	CD	NUMBER	620	num	10	SENT_92	[p7l360t990r483b1053],
9	Data	NNS	O	datum	nn	10	SENT_92	[p7l514t990r695b1053],
10	Master	NN	O	master	dobj	5	SENT_92	[p7l724t990r983b1056],
11	with	IN	O	with	_	0	SENT_92	[p7l1007t988r1167b1055],
12	model	NN	O	model	prep_with	5	SENT_92	[p7l1196t988r1423b1053],
13	302	CD	NUMBER	302	num	14	SENT_92	[p7l1454t988r1582b1053],
14	pumps	NNS	O	pump	dep	12	SENT_92	[p7l1608t1008r1872b1076],
15	,	,	O	,	_	0	SENT_92	[p7l1608t1008r1872b1076],
16	21	CD	NUMBER	21	num	18	SENT_92	[p7l1905t1009r1943b1056],
17	ﬂuorescence	NN	O	ﬂuorescence	nn	18	SENT_92	[p7l1972t988r2141b1056, p7l16t1113r331b1163],
18	detector	NN	O	detector	appos	14	SENT_92	[p7l366t1095r685b1174],
19	,	,	O	,	_	0	SENT_92	[p7l366t1095r685b1174],
20	and	CC	O	and	_	0	SENT_92	[p7l726t1095r856b1160],
21	a	DT	O	a	det	24	SENT_92	[p7l892t1115r932b1163],
22	Waters	NNP	O	Waters	nn	24	SENT_92	[p7l963t1097r1225b1163],
23	(	NNP	O	(	nn	24	SENT_92	[p7l1263t1094r1593b1183],
24	Milford	NNP	LOCATION	Milford	conj_and	12	SENT_92	[p7l1263t1094r1593b1183],
25	,	,	O	,	_	0	SENT_92	[p7l1263t1094r1593b1183],
26	Mass.	NNP	LOCATION	Mass.	appos	24	SENT_92	[p7l1631t1095r1867b1183],
27	)	CD	NUMBER	)	num	26	SENT_92	[p7l1631t1095r1867b1183],
28	intelligent	JJ	O	intelligent	amod	30	SENT_92	[p7l1905t1097r2141b1163, p7l16t1212r174b1287],
29	sample	NN	O	sample	nn	30	SENT_92	[p7l201t1205r455b1289],
30	processor	NN	O	processor	dep	26	SENT_92	[p7l482t1224r854b1289],
31	.	.	O	.	_	0	SENT_92	[p7l482t1224r854b1289],

1	A	DT	O	a	det	6	SENT_93	[p7l880t1205r948b1271],
2	Spherisorb	NN	O	spherisorb	nn	6	SENT_93	[p7l975t1203r1367b1289],
3	phenyl	NN	O	phenyl	nn	6	SENT_93	[p7l1396t1203r1639b1289],
4	4.6	CD	NUMBER	4.6	num	6	SENT_93	[p7l1666t1205r1771b1271],
5	mm	NN	O	mm	nn	6	SENT_93	[p7l1797t1226r1936b1271],
6	X	NN	O	x	dep	17	SENT_93	[p7l1972t1214r2024b1266],
7	25	CD	NUMBER	25	num	9	SENT_93	[p7l2060t1205r2139b1271],
8	cm	NN	O	cm	nn	9	SENT_93	[p7l16t1330r123b1375],
9	column	NN	O	column	dep	6	SENT_93	[p7l152t1312r423b1378],
10	with	IN	O	with	_	0	SENT_93	[p7l447t1310r607b1375],
11	a	DT	O	a	det	14	SENT_93	[p7l636t1330r676b1375],
12	Spherisorb	JJ	MISC	spherisorb	amod	14	SENT_93	[p7l705t1310r1100b1396],
13	phenyl	NN	O	phenyl	nn	14	SENT_93	[p7l1129t1309r1374b1396],
14	guard	NN	O	guard	prep_with	9	SENT_93	[p7l1403t1310r1612b1396],
15	column	NN	O	column	dep	17	SENT_93	[p7l1643t1312r1913b1378],
16	(	CD	NUMBER	(	num	15	SENT_93	[p7l1945t1312r2141b1398, p7l16t1437r368b1498],
17	Phenomenex	NNP	PERSON	Phenomenex	dep	24	SENT_93	[p7l1945t1312r2141b1398, p7l16t1437r368b1498],
18	,	,	O	,	_	0	SENT_93	[p7l1945t1312r2141b1398, p7l16t1437r368b1498],
19	Torrance	NNP	LOCATION	Torrance	appos	17	SENT_93	[p7l403t1419r761b1496],
20	,	,	O	,	_	0	SENT_93	[p7l403t1419r761b1496],
21	Calif.	NNP	LOCATION	Calif.	appos	17	SENT_93	[p7l800t1416r1024b1506],
22	)	CD	NUMBER	)	num	21	SENT_93	[p7l800t1416r1024b1506],
23	were	VBD	O	be	auxpass	24	SENT_93	[p7l1058t1440r1234b1485],
24	used	VBN	O	use	_	0	SENT_93	[p7l1267t1419r1436b1485],
25	for	IN	O	for	_	0	SENT_93	[p7l1470t1417r1575b1485],
26	the	DT	O	the	det	27	SENT_93	[p7l1608t1419r1722b1485],
27	assay	NN	O	assay	prep_for	24	SENT_93	[p7l1758t1440r1962b1503],
28	.	.	O	.	_	0	SENT_93	[p7l1758t1440r1962b1503],

1	The	DT	O	the	det	5	SENT_94	[p7l1998t1419r2141b1485],
2	ﬂuorescence	NN	O	ﬂuorescence	nn	5	SENT_94	[p7l14t1524r471b1592],
3	detection	NN	O	detection	nn	5	SENT_94	[p7l521t1524r863b1592],
4	(	CD	NUMBER	(	num	5	SENT_94	[p7l915t1526r1174b1612],
5	model	NN	O	model	_	0	SENT_94	[p7l915t1526r1174b1612],
6	121	CD	NUMBER	121	dep	5	SENT_94	[p7l1228t1526r1367b1606],
7	;	:	O	;	_	0	SENT_94	[p7l1228t1526r1367b1606],
8	Gilson	NNP	PERSON	Gilson	nn	13	SENT_94	[p7l1424t1523r1681b1605],
9	,	,	O	,	_	0	SENT_94	[p7l1424t1523r1681b1605],
10	Middleton	NNP	LOCATION	Middleton	appos	13	SENT_94	[p7l1733t1526r2137b1605],
11	,	,	O	,	_	0	SENT_94	[p7l1733t1526r2137b1605],
12	Mass.	NNP	LOCATION	Mass.	appos	13	SENT_94	[p7l14t1631r252b1719],
13	)	NNP	O	)	dep	5	SENT_94	[p7l14t1631r252b1719],
14	was	VBD	O	be	auxpass	15	SENT_94	[p7l288t1654r420b1699],
15	set	VBN	O	set	rcmod	13	SENT_94	[p7l461t1642r561b1696],
16	at	IN	O	at	_	0	SENT_94	[p7l599t1642r665b1696],
17	480	CD	NUMBER	480	num	18	SENT_94	[p7l700t1633r826b1696],
18	nm	NN	O	nm	prep_at	15	SENT_94	[p7l862t1651r978b1699],
19	for	IN	O	for	_	0	SENT_94	[p7l1014t1633r1123b1699],
20	excitation	NN	O	excitation	prep_for	18	SENT_94	[p7l1159t1633r1512b1699],
21	and	CC	O	and	_	0	SENT_94	[p7l1551t1635r1683b1699],
22	590	CD	NUMBER	590	num	23	SENT_94	[p7l1719t1635r1847b1699],
23	nm	NN	O	nm	prep_at	15	SENT_94	[p7l1882t1654r1998b1699],
24	for	IN	O	for	_	0	SENT_94	[p7l2034t1633r2139b1699],
25	emission	NN	O	emission	prep_for	23	SENT_94	[p7l16t1738r349b1806],
26	.	.	O	.	_	0	SENT_94	[p7l16t1738r349b1806],

1	The	DT	O	the	det	3	SENT_95	[p7l413t1740r556b1803],
2	mobile	JJ	O	mobile	amod	3	SENT_95	[p7l615t1737r867b1803],
3	phase	NN	O	phase	nsubj	4	SENT_95	[p7l924t1740r1135b1826],
4	consisted	VBD	O	consist	_	0	SENT_95	[p7l1196t1737r1531b1806],
5	of	IN	O	of	_	0	SENT_95	[p7l1592t1740r1669b1806],
6	acetonitrile	NN	O	acetonitrile	amod	10	SENT_95	[p7l1726t1740r2139b1806],
7	(	CD	PERCENT	(	num	6	SENT_95	[p7l16t1845r241b1933],
8	30	CD	PERCENT	30	num	9	SENT_95	[p7l16t1845r241b1933],
9	%	NN	PERCENT	%	dep	6	SENT_95	[p7l16t1845r241b1933],
10	)	NN	O	)	prep_of	4	SENT_95	[p7l16t1845r241b1933],
11	and	CC	O	and	_	0	SENT_95	[p7l272t1847r404b1913],
12	citrate	NN	O	citrate	nn	15	SENT_95	[p7l433t1847r665b1913],
13	buffer	NN	O	buffer	nn	15	SENT_95	[p7l691t1844r909b1910],
14	(	CD	NUMBER	(	num	15	SENT_95	[p7l938t1844r1084b1933],
15	pH	NN	O	ph	conj_and	10	SENT_95	[p7l938t1844r1084b1933],
16	4.0	CD	NUMBER	4.0	num	17	SENT_95	[p7l1111t1845r1268b1931],
17	)	NN	O	)	dobj	4	SENT_95	[p7l1111t1845r1268b1931],
18	,	,	O	,	_	0	SENT_95	[p7l1111t1845r1268b1931],
19	0.03	CD	NUMBER	0.03	num	20	SENT_95	[p7l1297t1847r1441b1913],
20	mol/L	NN	O	mol/l	appos	17	SENT_95	[p7l1472t1845r1692b1917],
21	(	CD	PERCENT	(	number	22	SENT_95	[p7l1719t1847r1966b1933],
22	70	CD	PERCENT	70	num	23	SENT_95	[p7l1719t1847r1966b1933],
23	%	NN	PERCENT	%	dep	20	SENT_95	[p7l1719t1847r1966b1933],
24	)	CD	NUMBER	)	dep	20	SENT_95	[p7l1719t1847r1966b1933],
25	.	.	O	.	_	0	SENT_95	[p7l1719t1847r1966b1933],

1	The	DT	O	the	det	3	SENT_96	[p7l1995t1847r2139b1913],
2	ﬂow	NN	O	ﬂow	nn	3	SENT_96	[p7l12t1953r165b2018],
3	rate	NN	O	rate	nsubj	10	SENT_96	[p7l201t1964r344b2021],
4	for	IN	O	for	_	0	SENT_96	[p7l380t1955r487b2018],
5	the	DT	O	the	det	7	SENT_96	[p7l523t1953r639b2018],
6	mobile	JJ	O	mobile	amod	7	SENT_96	[p7l675t1952r925b2021],
7	phase	NN	O	phase	prep_for	3	SENT_96	[p7l961t1955r1172b2039],
8	was	VBD	O	be	cop	10	SENT_96	[p7l1205t1974r1337b2018],
9	1.5	CD	NUMBER	1.5	num	10	SENT_96	[p7l1380t1953r1478b2018],
10	ml/min	NN	O	ml/min	_	0	SENT_96	[p7l1516t1953r1791b2028],
11	.	.	O	.	_	0	SENT_96	[p7l1516t1953r1791b2028],

1	Doxoru	FW	MISC	doxoru	nn	3	SENT_97	[p7l1832t1957r2139b2021],
2	—	FW	O	—	nn	3	SENT_97	[p7l1832t1957r2139b2021],
3	bicinol	NN	O	bicinol	nsubj	6	SENT_97	[p7l12t2061r259b2127],
4	and	CC	O	and	_	0	SENT_97	[p7l307t2064r439b2127],
5	doxorubicin	NN	O	doxorubicin	conj_and	3	SENT_97	[p7l484t2061r918b2128],
6	eluted	VBD	O	elute	_	0	SENT_97	[p7l965t2062r1192b2127],
7	at	IN	O	at	_	0	SENT_97	[p7l1240t2071r1305b2127],
8	5.8	CD	NUMBER	5.8	num	11	SENT_97	[p7l1350t2064r1453b2127],
9	and	CC	O	and	_	0	SENT_97	[p7l1502t2062r1635b2128],
10	6.5	CD	DURATION	6.5	num	11	SENT_97	[p7l1680t2064r1780b2130],
11	minutes	NNS	NUMBER	minute	prep_at	6	SENT_97	[p7l1827t2062r2137b2141],
12	,	,	O	,	_	0	SENT_97	[p7l1827t2062r2137b2141],
13	respectively	RB	O	respectively	advmod	6	SENT_97	[p7l9t2171r460b2255],
14	;	:	O	;	_	0	SENT_97	[p7l9t2171r460b2255],
15	daunorubicinol	NN	O	daunorubicinol	nsubj	21	SENT_97	[p7l507t2169r1082b2251],
16	,	,	O	,	_	0	SENT_97	[p7l507t2169r1082b2251],
17	daunorubicin	NN	O	daunorubicin	nsubj	21	SENT_97	[p7l1127t2171r1632b2248],
18	,	,	O	,	_	0	SENT_97	[p7l1127t2171r1632b2248],
19	and	CC	O	and	_	0	SENT_97	[p7l1675t2171r1807b2237],
20	idarubicin	NN	O	idarubicin	conj_and	15	SENT_97	[p7l1850t2171r2137b2237, p7l12t2277r116b2340],
21	eluted	VBD	O	elute	parataxis	6	SENT_97	[p7l150t2277r379b2342],
22	at	IN	O	at	_	0	SENT_97	[p7l413t2286r478b2342],
23	7.4	CD	NUMBER	7.4	prep_at	21	SENT_97	[p7l512t2279r635b2354],
24	,	,	O	,	_	0	SENT_97	[p7l512t2279r635b2354],
25	9.9	CD	NUMBER	9.9	prep_at	21	SENT_97	[p7l671t2277r794b2354],
26	,	,	O	,	_	0	SENT_97	[p7l671t2277r794b2354],
27	and	CC	O	and	_	0	SENT_97	[p7l832t2279r964b2342],
28	11.3	CD	DURATION	11.3	num	29	SENT_97	[p7l1002t2279r1142b2342],
29	minutes	NNS	NUMBER	minute	prep_at	21	SENT_97	[p7l1177t2276r1485b2356],
30	,	,	O	,	_	0	SENT_97	[p7l1177t2276r1485b2356],
31	respectively	RB	O	respectively	advmod	21	SENT_97	[p7l1521t2276r1966b2363],
32	.	.	O	.	_	0	SENT_97	[p7l1521t2276r1966b2363],

1	Recovery	NN	O	recovery	nsubj	11	SENT_98	[p7l2005t2279r2137b2342, p7l12t2405r250b2471],
2	of	IN	O	of	_	0	SENT_98	[p7l277t2389r354b2452],
3	idarubicin	NN	O	idarubicin	prep_of	1	SENT_98	[p7l380t2386r748b2452],
4	from	IN	O	from	_	0	SENT_98	[p7l777t2386r955b2452],
5	red	JJ	O	red	amod	6	SENT_98	[p7l984t2389r1105b2452],
6	cells	NNS	O	cell	prep_from	3	SENT_98	[p7l1136t2389r1291b2452],
7	or	CC	O	or	_	0	SENT_98	[p7l1323t2407r1400b2452],
8	plasma	NN	O	plasma	prep_from	3	SENT_98	[p7l1426t2387r1685b2470],
9	was	VBD	O	be	cop	11	SENT_98	[p7l1710t2407r1844b2452],
10	71	CD	PERCENT	71	num	11	SENT_98	[p7l1875t2389r2035b2454],
11	%	NN	PERCENT	%	_	0	SENT_98	[p7l1875t2389r2035b2454],
12	:10	CD	PERCENT	:10	num	13	SENT_98	[p7l2076t2396r2130b2450, p7l16t2491r195b2558],
13	%	NN	PERCENT	%	dep	11	SENT_98	[p7l2076t2396r2130b2450, p7l16t2491r195b2558],
14	.	.	O	.	_	0	SENT_98	[p7l2076t2396r2130b2450, p7l16t2491r195b2558],

1	Individual	JJ	O	individual	amod	3	SENT_99	[p7l258t2493r630b2558],
2	standard	JJ	O	standard	amod	3	SENT_99	[p7l691t2493r1008b2558],
3	curves	NNS	O	curve	nsubj	29	SENT_99	[p7l1067t2514r1296b2558],
4	for	IN	O	for	_	0	SENT_99	[p7l1357t2495r1464b2558],
5	daunorubicin	NN	O	daunorubicin	prep_for	3	SENT_99	[p7l1523t2493r2010b2572],
6	in	IN	O	in	_	0	SENT_99	[p7l2069t2495r2137b2558],
7	plasma	NN	O	plasma	prep_in	5	SENT_99	[p7l9t2599r268b2683],
8	and	CC	O	and	_	0	SENT_99	[p7l320t2601r453b2664],
9	RBCS	NN	O	rbc	prep_in	5	SENT_99	[p7l505t2601r720b2664],
10	were	VBD	O	be	cop	29	SENT_99	[p7l767t2619r943b2666],
11	linear	JJ	O	linear	nn	29	SENT_99	[p7l995t2601r1206b2667],
12	over	IN	O	over	_	0	SENT_99	[p7l1258t2619r1416b2664],
13	the	DT	O	the	det	15	SENT_99	[p7l1468t2601r1579b2664],
14	concentration	NN	O	concentration	nn	15	SENT_99	[p7l1631t2601r2137b2666],
15	range	NN	O	range	prep_over	11	SENT_99	[p7l12t2726r215b2790],
16	of	IN	O	of	_	0	SENT_99	[p7l247t2708r324b2771],
17	50	CD	NUMBER	50	number	19	SENT_99	[p7l348t2708r430b2773],
18	to	TO	O	to	dep	19	SENT_99	[p7l461t2717r531b2771],
19	200	CD	NUMBER	200	num	20	SENT_99	[p7l562t2708r688b2771],
20	ng/ml	NN	O	ng/ml	prep_of	15	SENT_99	[p7l719t2708r923b2790],
21	in	IN	O	in	_	0	SENT_99	[p7l952t2708r1019b2773],
22	plasma	NN	O	plasma	prep_in	20	SENT_99	[p7l1048t2708r1307b2792],
23	and	CC	O	and	_	0	SENT_99	[p7l1336t2708r1469b2771],
24	RBCs	NNS	O	rbc	conj_and	20	SENT_99	[p7l1500t2707r1715b2773],
25	(	CD	NUMBER	(	num	26	SENT_99	[p7l1749t2708r1807b2794],
26	r	NN	O	r	dep	24	SENT_99	[p7l1749t2708r1807b2794],
27	=	JJ	O	=	amod	29	SENT_99	[p7l1845t2733r1897b2755],
28	0.99	CD	NUMBER	0.99	tmod	27	SENT_99	[p7l1935t2708r2135b2794],
29	)	NN	O	)	_	0	SENT_99	[p7l1935t2708r2135b2794],
30	.	.	O	.	_	0	SENT_99	[p7l1935t2708r2135b2794],

1	Plasma	NN	O	plasma	nsubjpass	8	SENT_100	[p7l12t2814r273b2879],
2	and	CC	O	and	_	0	SENT_100	[p7l309t2814r441b2879],
3	red	JJ	O	red	amod	6	SENT_100	[p7l477t2814r596b2879],
4	cell	NN	O	cell	nn	6	SENT_100	[p7l631t2814r755b2879],
5	drug	NN	O	drug	nn	6	SENT_100	[p7l790t2814r955b2900],
6	levels	NNS	O	level	conj_and	1	SENT_100	[p7l989t2816r1190b2879],
7	were	VBD	O	be	auxpass	8	SENT_100	[p7l1221t2835r1397b2879],
8	determined	VBN	O	determine	_	0	SENT_100	[p7l1433t2814r1853b2882],
9	from	IN	O	from	_	0	SENT_100	[p7l1887t2816r2063b2882],
10	a	DT	O	a	det	12	SENT_100	[p7l2101t2835r2137b2879],
11	four	CD	NUMBER	four	num	12	SENT_100	[p7l9t2921r162b2986],
12	point	NN	O	point	prep_from	8	SENT_100	[p7l212t2923r402b3009],
13	standard	JJ	O	standard	amod	14	SENT_100	[p7l454t2921r773b2989],
14	curve	NN	O	curve	dep	12	SENT_100	[p7l823t2941r1038b2989],
15	.	.	O	.	_	0	SENT_100	[p7l823t2941r1038b2989],

1	In	IN	O	in	_	0	SENT_101	[p7l1092t2925r1169b2988],
2	experiments	NNS	O	experiment	prep_in	16	SENT_101	[p7l1219t2923r1665b3007],
3	with	IN	O	with	_	0	SENT_101	[p7l1712t2923r1870b2989],
4	whole	JJ	O	whole	amod	5	SENT_101	[p7l1915t2923r2135b2989],
5	blood	NN	O	blood	prep_with	2	SENT_101	[p7l7t3030r236b3108],
6	,	,	O	,	_	0	SENT_101	[p7l7t3030r236b3108],
7	the	DT	O	the	det	8	SENT_101	[p7l277t3030r391b3096],
8	concentrations	NNS	O	concentration	nsubjpass	16	SENT_101	[p7l429t3030r969b3096],
9	of	IN	O	of	_	0	SENT_101	[p7l1007t3033r1084b3097],
10	the	DT	O	the	det	12	SENT_101	[p7l1115t3031r1229b3096],
11	parent	NN	O	parent	nn	12	SENT_101	[p7l1267t3040r1506b3115],
12	compounds	NNS	O	compound	prep_of	8	SENT_101	[p7l1541t3033r1964b3117],
13	and	CC	O	and	_	0	SENT_101	[p7l2004t3031r2135b3096],
14	metabolites	NNS	O	metabolite	conj_and	12	SENT_101	[p7l12t3136r437b3201],
15	were	VBD	O	be	auxpass	16	SENT_101	[p7l477t3156r655b3201],
16	determined	VBN	O	determine	_	0	SENT_101	[p7l705t3136r1125b3204],
17	separately	RB	O	separately	advmod	16	SENT_101	[p7l1171t3138r1542b3222],
18	in	IN	O	in	_	0	SENT_101	[p7l1587t3138r1653b3204],
19	plasma	NN	O	plasma	prep_in	16	SENT_101	[p7l1698t3138r1957b3224],
20	and	CC	O	and	_	0	SENT_101	[p7l2004t3138r2135b3201],
21	RBCS	NN	O	rbc	conj_and	19	SENT_101	[p7l14t3246r248b3311],
22	.	.	O	.	_	0	SENT_101	[p7l14t3246r248b3311],

1	Values	NNS	O	value	nsubjpass	3	SENT_102	[p7l295t3246r547b3311],
2	were	VBD	O	be	auxpass	3	SENT_102	[p7l588t3264r766b3309],
3	expressed	VBN	O	express	_	0	SENT_102	[p7l811t3246r1167b3329],
4	in	IN	O	in	_	0	SENT_102	[p7l1212t3246r1280b3309],
5	nmol/dl	JJ	O	nmol/dl	amod	7	SENT_102	[p7l1323t3246r1602b3315],
6	whole	JJ	O	whole	amod	7	SENT_102	[p7l1645t3245r1863b3311],
7	blood	NN	O	blood	prep_in	3	SENT_102	[p7l1905t3245r2135b3322],
8	,	,	O	,	_	0	SENT_102	[p7l1905t3245r2135b3322],
9	taking	VBG	O	take	xcomp	3	SENT_102	[p7l14t3351r238b3434],
10	into	IN	O	into	_	0	SENT_102	[p7l260t3353r402b3416],
11	account	NN	O	account	prep_into	9	SENT_102	[p7l426t3362r711b3416],
12	the	DT	O	the	det	16	SENT_102	[p7l733t3350r847b3416],
13	measured	VBN	O	measure	amod	16	SENT_102	[p7l869t3353r1225b3416],
14	donor	NN	O	donor	nn	16	SENT_102	[p7l1249t3353r1466b3416],
15	blood	NN	O	blood	nn	16	SENT_102	[p7l1486t3353r1694b3418],
16	hematocrit	NN	O	hematocrit	dobj	9	SENT_102	[p7l1717t3353r2132b3418],
17	.	.	O	.	_	0	SENT_102	[p7l1717t3353r2132b3418],

1	J	NN	O	j	nn	2	SENT_103	[p7l1584t3455r1617b3517],
2	Lob	NN	O	lob	_	0	SENT_103	[p7l1653t3455r1786b3516],
3	Clin	NNP	O	Clin	nn	4	SENT_103	[p7l1817t3453r1950b3514],
4	Med	NNP	O	Med	dep	2	SENT_103	[p7l1984t3452r2149b3514],

1	June	NNP	DATE	June	_	0	SENT_104	[p7l1776t3553r1955b3613],
2	1996	CD	DATE	1996	dep	1	SENT_104	[p7l1991t3552r2152b3613],

1	The	DT	O	the	det	2	SENT_105	[p8l20t95r164b161],
2	rate	NN	O	rate	nsubjpass	29	SENT_105	[p8l196t104r338b160],
3	of	IN	O	of	_	0	SENT_105	[p8l372t94r447b160],
4	disappearance	NN	O	disappearance	prep_of	2	SENT_105	[p8l476t95r1002b179],
5	of	IN	O	of	_	0	SENT_105	[p8l1033t94r1111b161],
6	daunorubicin	NN	O	daunorubicin	prep_of	4	SENT_105	[p8l1137t95r1626b161],
7	(	CD	NUMBER	(	num	6	SENT_105	[p8l1660t95r1768b182],
8	or	CC	O	or	_	0	SENT_105	[p8l1660t95r1768b182],
9	doxorubicin	NN	O	doxorubicin	nn	10	SENT_105	[p8l1799t94r2152b160, p8l22t198r178b286],
10	)	NN	O	)	prep_of	4	SENT_105	[p8l1799t94r2152b160, p8l22t198r178b286],
11	,	,	O	,	_	0	SENT_105	[p8l1799t94r2152b160, p8l22t198r178b286],
12	or	CC	O	or	_	0	SENT_105	[p8l233t221r310b266],
13	the	DT	O	the	det	14	SENT_105	[p8l358t200r472b266],
14	rate	NN	O	rate	prep_of	4	SENT_105	[p8l522t209r666b263],
15	of	IN	O	of	_	0	SENT_105	[p8l716t200r794b266],
16	appearance	NN	O	appearance	prep_of	14	SENT_105	[p8l841t221r1261b286],
17	of	IN	O	of	_	0	SENT_105	[p8l1313t200r1391b266],
18	daunorubicinol	NN	O	daunorubicinol	prep_of	16	SENT_105	[p8l1436t200r1994b268],
19	(	CD	NUMBER	(	num	18	SENT_105	[p8l2046t200r2154b286],
20	or	CC	O	or	_	0	SENT_105	[p8l2046t200r2154b286],
21	doxorubicinol	NN	O	doxorubicinol	nn	22	SENT_105	[p8l22t305r581b393],
22	)	NN	O	)	prep_of	16	SENT_105	[p8l22t305r581b393],
23	,	,	O	,	_	0	SENT_105	[p8l22t305r581b393],
24	by	IN	O	by	_	0	SENT_105	[p8l635t307r720b393],
25	carbonyl	NN	O	carbonyl	nn	27	SENT_105	[p8l774t307r1087b393],
26	reductase	NN	O	reductase	nn	27	SENT_105	[p8l1142t307r1495b375],
27	activity	NN	O	activity	prep_by	4	SENT_105	[p8l1551t309r1809b393],
28	was	VBD	O	be	auxpass	29	SENT_105	[p8l1857t328r1992b375],
29	expressed	VBN	O	express	_	0	SENT_105	[p8l2049t330r2152b375, p8l20t415r299b501],
30	as	IN	O	as	_	0	SENT_105	[p8l330t436r400b480],
31	nanomoles	NNS	O	nanomole	prep_as	29	SENT_105	[p8l434t415r833b483],
32	per	IN	O	per	_	0	SENT_105	[p8l864t436r988b501],
33	hour	NN	DURATION	hour	prep_per	31	SENT_105	[p8l1017t415r1189b480],
34	per	IN	O	per	_	0	SENT_105	[p8l1221t436r1342b501],
35	gram	NN	O	gram	prep_per	33	SENT_105	[p8l1373t436r1559b499],
36	of	IN	O	of	_	0	SENT_105	[p8l1593t417r1670b483],
37	hemoglobin	NN	O	hemoglobin	prep_of	35	SENT_105	[p8l1697t414r2149b501],
38	.	.	O	.	_	0	SENT_105	[p8l1697t414r2149b501],

1	Statistical	JJ	O	statistical	amod	2	SENT_106	[p8l115t527r463b588],
2	analysis	NN	O	analysis	_	0	SENT_106	[p8l487t527r801b602],
3	.	.	O	.	_	0	SENT_106	[p8l487t527r801b602],

1	The	DT	O	the	det	4	SENT_107	[p8l825t523r970b588],
2	mean	NN	O	mean	nn	4	SENT_107	[p8l992t544r1194b588],
3	conversion	NN	O	conversion	nn	4	SENT_107	[p8l1216t525r1613b591],
4	rate	NN	O	rate	nsubjpass	17	SENT_107	[p8l1635t534r1779b591],
5	of	IN	O	of	_	0	SENT_107	[p8l1801t525r1879b591],
6	daunorubicin	NN	O	daunorubicin	prep_of	4	SENT_107	[p8l1898t525r2154b591, p8l20t633r275b696],
7	to	TO	O	to	_	0	SENT_107	[p8l321t642r393b696],
8	daunorubicinol	NN	O	daunorubicinol	prep_to	6	SENT_107	[p8l441t631r999b699],
9	in	IN	O	in	_	0	SENT_107	[p8l1045t633r1113b696],
10	subjects	NNS	O	subject	conj_and	10	SENT_107	[p8l1160t631r1446b717],
11	without	IN	O	without	_	0	SENT_107	[p8l1489t633r1772b699],
12	and	CC	O	and	_	0	SENT_107	[p8l1820t633r1950b699],
13	with	IN	O	with	_	0	SENT_107	[p8l1993t633r2152b699],
14	G6PD	NN	O	g6pd	nn	15	SENT_107	[p8l22t741r250b807],
15	deﬁciency	NN	O	deﬁciency	prep_with	10	SENT_107	[p8l304t738r669b823],
16	was	VBD	O	be	auxpass	17	SENT_107	[p8l714t760r847b807],
17	compared	VBN	O	compare	_	0	SENT_107	[p8l899t739r1266b825],
18	by	IN	O	by	_	0	SENT_107	[p8l1313t739r1400b825],
19	the	DT	O	the	det	22	SENT_107	[p8l1447t741r1562b807],
20	two-tailed	JJ	O	two-tailed	amod	22	SENT_107	[p8l1614t738r1980b807],
21	unpaired	JJ	O	unpaired	amod	22	SENT_107	[p8l2033t760r2152b807, p8l20t847r252b933],
22	Student	NN	O	student	agent	17	SENT_107	[p8l286t849r571b915],
23	I	PRP	O	I	nsubj	24	SENT_107	[p8l601t861r625b912],
24	test	VBP	O	test	rcmod	22	SENT_107	[p8l656t856r803b915],
25	.	.	O	.	_	0	SENT_107	[p8l656t856r803b915],

1	RESULTS	NNS	O	result	_	0	SENT_108	[p8l22t1108r333b1179],

1	Fig	NN	O	fig	_	0	SENT_109	[p8l117t1263r266b1356],
2	.	.	O	.	_	0	SENT_109	[p8l117t1263r266b1356],

1	1	CD	NUMBER	1	_	0	SENT_110	[p8l307t1263r340b1335],
2	illustrates	VBZ	O	illustrate	dep	1	SENT_110	[p8l376t1263r773b1335],
3	the	DT	O	the	det	5	SENT_110	[p8l804t1262r930b1335],
4	chromatographic	JJ	O	chromatographic	amod	5	SENT_110	[p8l962t1263r1659b1360],
5	separations	NNS	O	separation	nsubj	31	SENT_110	[p8l1690t1262r2152b1360],
6	in	IN	O	in	_	0	SENT_110	[p8l20t1380r95b1450],
7	blood	NN	O	blood	prep_in	5	SENT_110	[p8l152t1378r387b1452],
8	of	IN	O	of	_	0	SENT_110	[p8l446t1378r532b1450],
9	doxorubicinol	NN	O	doxorubicinol	nn	11	SENT_110	[p8l587t1378r1150b1453],
10	(	CD	NUMBER	(	num	11	SENT_110	[p8l1214t1378r1444b1475],
11	peak	NN	O	peak	prep_of	7	SENT_110	[p8l1214t1378r1444b1475],
12	1	CD	NUMBER	1	num	11	SENT_110	[p8l1505t1380r1603b1475],
13	)	NN	O	)	nn	31	SENT_110	[p8l1505t1380r1603b1475],
14	,	,	O	,	_	0	SENT_110	[p8l1505t1380r1603b1475],
15	doxorubicin	NN	O	doxorubicin	dep	31	SENT_110	[p8l1667t1380r2149b1453],
16	(	CD	NUMBER	(	num	31	SENT_110	[p8l22t1493r252b1591],
17	peak	NN	O	peak	nn	31	SENT_110	[p8l22t1493r252b1591],
18	2	CD	NUMBER	2	num	31	SENT_110	[p8l309t1492r412b1588],
19	)	NN	O	)	nn	31	SENT_110	[p8l309t1492r412b1588],
20	,	,	O	,	_	0	SENT_110	[p8l309t1492r412b1588],
21	daunorubicinol	NN	O	daunorubicinol	dep	31	SENT_110	[p8l476t1492r1094b1567],
22	(	CD	NUMBER	(	num	31	SENT_110	[p8l1158t1493r1388b1590],
23	peak	NN	O	peak	nn	31	SENT_110	[p8l1158t1493r1388b1590],
24	3	CD	NUMBER	3	num	31	SENT_110	[p8l1443t1492r1546b1591],
25	)	NN	O	)	nn	31	SENT_110	[p8l1443t1492r1546b1591],
26	,	,	O	,	_	0	SENT_110	[p8l1443t1492r1546b1591],
27	daunorubicin	NN	O	daunorubicin	dep	31	SENT_110	[p8l1609t1495r2152b1567],
28	(	CD	NUMBER	(	num	31	SENT_110	[p8l22t1608r252b1703],
29	peak	NN	O	peak	nn	31	SENT_110	[p8l22t1608r252b1703],
30	4	CD	NUMBER	4	num	31	SENT_110	[p8l281t1605r382b1703],
31	)	NN	O	)	xcomp	2	SENT_110	[p8l281t1605r382b1703],
32	,	,	O	,	_	0	SENT_110	[p8l281t1605r382b1703],
33	and	CC	O	and	dep	1	SENT_110	[p8l420t1608r567b1680],
34	idarubicin	NN	O	idarubicin	dep	1	SENT_110	[p8l596t1608r1030b1696],
35	,	,	O	,	_	0	SENT_110	[p8l596t1608r1030b1696],
36	which	WDT	O	which	nsubjpass	38	SENT_110	[p8l1059t1608r1298b1680],
37	was	VBD	O	be	auxpass	38	SENT_110	[p8l1325t1631r1474b1683],
38	used	VBN	O	use	dep	34	SENT_110	[p8l1505t1610r1691b1683],
39	as	IN	O	as	_	0	SENT_110	[p8l1725t1631r1802b1683],
40	internal	JJ	O	internal	amod	45	SENT_110	[p8l1834t1610r2149b1683],
41	standard	JJ	O	standard	amod	45	SENT_110	[p8l20t1724r372b1797],
42	(	NN	O	(	nn	45	SENT_110	[p8l409t1721r639b1820],
43	peak	NN	O	peak	nn	45	SENT_110	[p8l409t1721r639b1820],
44	5	CD	NUMBER	5	num	45	SENT_110	[p8l665t1724r768b1822],
45	)	NN	O	)	prep_as	38	SENT_110	[p8l665t1724r768b1822],
46	.	.	O	.	_	0	SENT_110	[p8l665t1724r768b1822],

1	In	IN	O	in	_	0	SENT_111	[p8l804t1726r888b1797],
2	samples	NNS	O	sample	prep_in	20	SENT_111	[p8l920t1724r1240b1820],
3	processed	VBN	O	process	partmod	2	SENT_111	[p8l1271t1726r1675b1820],
4	40	CD	DURATION	40	num	5	SENT_111	[p8l1704t1726r1798b1799],
5	minutes	NNS	NUMBER	minute	tmod	3	SENT_111	[p8l1829t1724r2149b1799],
6	after	IN	O	after	_	0	SENT_111	[p8l20t1841r213b1914],
7	the	DT	O	the	det	8	SENT_111	[p8l247t1841r375b1914],
8	addition	NN	O	addition	prep_after	3	SENT_111	[p8l413t1838r750b1914],
9	of	IN	O	of	_	0	SENT_111	[p8l786t1841r872b1914],
10	daunorubicin	NN	O	daunorubicin	prep_of	8	SENT_111	[p8l904t1841r1446b1914],
11	and	CC	O	and	_	0	SENT_111	[p8l1484t1843r1631b1916],
12	doxorubicin	NN	O	doxorubicin	conj_and	10	SENT_111	[p8l1669t1841r2152b1916],
13	to	TO	O	to	_	0	SENT_111	[p8l20t1965r97b2029],
14	whole	JJ	O	whole	amod	15	SENT_111	[p8l133t1956r379b2028],
15	blood	NN	O	blood	prep_to	3	SENT_111	[p8l415t1953r671b2042],
16	,	,	O	,	_	0	SENT_111	[p8l415t1953r671b2042],
17	the	DT	O	the	det	19	SENT_111	[p8l712t1956r840b2028],
18	red	JJ	O	red	amod	19	SENT_111	[p8l878t1956r1011b2028],
19	cells	NNS	O	cell	nsubj	20	SENT_111	[p8l1052t1956r1226b2029],
20	(	VBP	O	(	_	0	SENT_111	[p8l1269t1953r1451b2051],
21	Fig	NN	O	fig	dobj	20	SENT_111	[p8l1269t1953r1451b2051],
22	.	.	O	.	_	0	SENT_111	[p8l1269t1953r1451b2051],

1	1	CD	NUMBER	1	nsubj	3	SENT_112	[p8l1498t1958r1559b2044],
2	,	,	O	,	_	0	SENT_112	[p8l1498t1958r1559b2044],
3	A	DT	O	a	_	0	SENT_112	[p8l1589t1956r1950b2051],
4	)	SYM	O	)	dep	3	SENT_112	[p8l1589t1956r1950b2051],
5	-	:	O	-	_	0	SENT_112	[p8l1589t1956r1950b2051],
6	.	.	O	.	_	0	SENT_112	[p8l1589t1956r1950b2051],

1	—	NN	O	—	_	0	SENT_113	[p8l1589t1956r1950b2051],
2	.	.	O	.	_	0	SENT_113	[p8l1589t1956r1950b2051],

1	and	CC	O	and	cc	2	SENT_114	[p8l1589t1956r1950b2051],
2	to	TO	O	to	_	0	SENT_114	[p8l1989t1968r2068b2029],
3	a	DT	O	a	det	6	SENT_114	[p8l2109t1979r2152b2028],
4	somewhat	RB	O	somewhat	advmod	5	SENT_114	[p8l20t2070r428b2142],
5	lesser	JJR	O	lesser	amod	6	SENT_114	[p8l483t2070r713b2144],
6	extent	NN	O	extent	pobj	2	SENT_114	[p8l767t2081r1016b2145],
7	the	DT	O	the	det	10	SENT_114	[p8l1068t2072r1196b2144],
8	plasma	NN	O	plasma	nn	10	SENT_114	[p8l1248t2069r1539b2165],
9	(	CD	NUMBER	(	num	10	SENT_114	[p8l1595t2069r1779b2167],
10	Fig	NN	O	fig	dep	6	SENT_114	[p8l1595t2069r1779b2167],
11	.	.	O	.	_	0	SENT_114	[p8l1595t2069r1779b2167],

1	1	CD	NUMBER	1	nsubj	5	SENT_115	[p8l1843t2074r1902b2160],
2	,	,	O	,	_	0	SENT_115	[p8l1843t2074r1902b2160],
3	B	NN	O	b	nn	4	SENT_115	[p8l1954t2070r2154b2167, p8l18t2185r419b2259],
4	)	NN	O	)	appos	1	SENT_115	[p8l1954t2070r2154b2167, p8l18t2185r419b2259],
5	contained	VBD	O	contain	_	0	SENT_115	[p8l1954t2070r2154b2167, p8l18t2185r419b2259],
6	daunorubicinol	NN	O	daunorubicinol	dobj	5	SENT_115	[p8l453t2186r1074b2261],
7	as	RB	O	as	_	0	SENT_115	[p8l1107t2209r1187b2259],
8	well	RB	O	well	_	0	SENT_115	[p8l1216t2185r1381b2259],
9	as	IN	O	as	_	0	SENT_115	[p8l1415t2211r1495b2261],
10	a	DT	O	a	det	12	SENT_115	[p8l1528t2211r1571b2261],
11	trace	NN	O	trace	nn	12	SENT_115	[p8l1602t2197r1805b2263],
12	amount	NN	O	amount	dobj	5	SENT_115	[p8l1841t2197r2149b2261],
13	of	IN	O	of	_	0	SENT_115	[p8l18t2301r104b2374],
14	doxorubicinol	NN	O	doxorubicinol	prep_of	12	SENT_115	[p8l131t2298r713b2376],
15	.	.	O	.	_	0	SENT_115	[p8l131t2298r713b2376],

1	No	DT	O	no	det	2	SENT_116	[p8l749t2303r870b2373],
2	metabolite	NN	O	metabolite	nsubjpass	4	SENT_116	[p8l904t2301r1339b2376],
3	was	VBD	O	be	auxpass	4	SENT_116	[p8l1366t2324r1515b2376],
4	found	VBN	O	find	_	0	SENT_116	[p8l1549t2303r1786b2376],
5	in	IN	O	in	_	0	SENT_116	[p8l1820t2303r1895b2376],
6	the	DT	O	the	prep_in	4	SENT_116	[p8l1926t2303r2052b2376],
7	to	TO	O	to	_	0	SENT_116	[p8l2086t2313r2149b2396],
8	samples	NNS	O	sample	prep_to	6	SENT_116	[p8l18t2417r340b2512],
9	processed	VBN	O	process	partmod	8	SENT_116	[p8l367t2419r770b2513],
10	immediately	RB	O	immediately	advmod	9	SENT_116	[p8l800t2417r1303b2512],
11	after	IN	O	after	_	0	SENT_116	[p8l1329t2419r1520b2494],
12	addition	NN	O	addition	prep_after	9	SENT_116	[p8l1549t2419r1886b2494],
13	of	IN	O	of	_	0	SENT_116	[p8l1912t2419r2001b2492],
14	the	DT	O	the	det	16	SENT_116	[p8l2021t2419r2149b2492],
15	parent	NN	O	parent	nn	16	SENT_116	[p8l18t2544r282b2629],
16	compounds	NNS	O	compound	prep_of	12	SENT_116	[p8l316t2535r787b2628],
17	to	TO	O	to	_	0	SENT_116	[p8l820t2546r900b2607],
18	whole	JJ	O	whole	amod	19	SENT_116	[p8l931t2534r1175b2608],
19	blood	NN	O	blood	prep_to	9	SENT_116	[p8l1207t2535r1462b2624],
20	,	,	O	,	_	0	SENT_116	[p8l1207t2535r1462b2624],
21	and	CC	O	and	_	0	SENT_116	[p8l1501t2537r1647b2610],
22	incubations	NNS	O	incubation	nsubj	29	SENT_116	[p8l1681t2534r2149b2607],
23	with	IN	O	with	_	0	SENT_116	[p8l13t2648r190b2724],
24	either	CC	O	either	preconj	25	SENT_116	[p8l226t2649r465b2722],
25	daunorubicin	NN	O	daunorubicin	prep_with	22	SENT_116	[p8l501t2649r1041b2724],
26	or	CC	O	or	_	0	SENT_116	[p8l1077t2674r1162b2724],
27	doxorubicin	NN	O	doxorubicin	prep_with	22	SENT_116	[p8l1197t2651r1682b2727],
28	alone	RB	O	alone	advmod	29	SENT_116	[p8l1718t2651r1939b2726],
29	conﬁrmed	VBD	O	conﬁrmed	conj_and	4	SENT_116	[p8l1975t2674r2147b2726, p8l18t2764r285b2837],
30	the	DT	O	the	det	31	SENT_116	[p8l330t2764r458b2837],
31	assignment	NN	O	assignment	dobj	29	SENT_116	[p8l506t2765r958b2858],
32	of	IN	O	of	_	0	SENT_116	[p8l1003t2767r1090b2840],
33	peak	NN	O	peak	prep_of	31	SENT_116	[p8l1128t2767r1328b2860],
34	1	CD	NUMBER	1	num	33	SENT_116	[p8l1376t2767r1411b2837],
35	to	TO	O	to	_	0	SENT_116	[p8l1461t2779r1539b2840],
36	doxorubicinol	NN	O	doxorubicinol	prep_to	29	SENT_116	[p8l1588t2767r2149b2840],
37	and	CC	O	and	_	0	SENT_116	[p8l18t2880r164b2952],
38	peak	NN	O	peak	conj_and	36	SENT_116	[p8l200t2880r396b2975],
39	3	CD	NUMBER	3	nsubj	45	SENT_116	[p8l432t2880r472b2952],
40	to	TO	O	to	_	0	SENT_116	[p8l511t2889r588b2952],
41	daunorubicinol	JJ	O	daunorubicinol	amod	43	SENT_116	[p8l626t2879r1247b2955],
42	(	NN	O	(	nn	43	SENT_116	[p8l1285t2880r1495b2978],
43	data	NNS	O	datum	prep_to	39	SENT_116	[p8l1285t2880r1495b2978],
44	not	RB	O	not	neg	45	SENT_116	[p8l1531t2891r1664b2957],
45	shown	VBN	O	show	rcmod	36	SENT_116	[p8l1699t2880r2013b2978],
46	)	NN	O	)	dobj	45	SENT_116	[p8l1699t2880r2013b2978],
47	.	.	O	.	_	0	SENT_116	[p8l1699t2880r2013b2978],

1	Fig	NN	O	fig	_	0	SENT_117	[p8l113t2996r262b3091],
2	.	.	O	.	_	0	SENT_117	[p8l113t2996r262b3091],

1	2	CD	NUMBER	2	nsubj	2	SENT_118	[p8l298t2995r343b3068],
2	shows	VBZ	O	show	_	0	SENT_118	[p8l376t2996r613b3068],
3	the	DT	O	the	det	4	SENT_118	[p8l647t2998r775b3071],
4	biotransformation	NN	O	biotransformation	dobj	2	SENT_118	[p8l806t2998r1550b3073],
5	of	IN	O	of	_	0	SENT_118	[p8l1584t2998r1668b3071],
6	daunorubicin	NN	O	daunorubicin	nn	8	SENT_118	[p8l1695t2998r2145b3071, p8l15t3112r132b3185],
7	(	CD	NUMBER	(	num	8	SENT_118	[p8l184t3112r366b3208],
8	Fig	NN	O	fig	prep_of	4	SENT_118	[p8l184t3112r366b3208],
9	.	.	O	.	_	0	SENT_118	[p8l184t3112r366b3208],

1	2	CD	NUMBER	2	_	0	SENT_119	[p8l418t3112r481b3201],
2	,	,	O	,	_	0	SENT_119	[p8l418t3112r481b3201],
3	A	DT	O	a	det	4	SENT_119	[p8l520t3110r629b3208],
4	)	NN	O	)	appos	1	SENT_119	[p8l520t3110r629b3208],
5	or	CC	O	or	_	0	SENT_119	[p8l679t3138r766b3187],
6	doxorubicin	NN	O	doxorubicin	nn	8	SENT_119	[p8l813t3112r1298b3187],
7	(	CD	NUMBER	(	num	8	SENT_119	[p8l1348t3112r1529b3210],
8	Fig	NN	O	fig	appos	1	SENT_119	[p8l1348t3112r1529b3210],
9	.	.	O	.	_	0	SENT_119	[p8l1348t3112r1529b3210],

1	2	CD	NUMBER	2	_	0	SENT_120	[p8l1581t3117r1645b3203],
2	,	,	O	,	_	0	SENT_120	[p8l1581t3117r1645b3203],
3	B	NN	O	b	nn	4	SENT_120	[p8l1688t3114r1788b3211],
4	)	NN	O	)	appos	1	SENT_120	[p8l1688t3114r1788b3211],
5	in	IN	O	in	_	0	SENT_120	[p8l1841t3114r1916b3187],
6	nonG6PD-deﬁcient	JJ	O	nong6pd-deﬁcient	amod	7	SENT_120	[p8l1961t3138r2145b3187, p8l18t3226r660b3301],
7	hemolysates	NNS	O	hemolysate	prep_in	4	SENT_120	[p8l719t3228r1215b3324],
8	supplemented	VBN	O	supplement	partmod	7	SENT_120	[p8l1276t3230r1851b3327],
9	either	CC	O	either	preconj	8	SENT_120	[p8l1910t3230r2147b3303],
10	with	IN	O	with	_	0	SENT_120	[p8l11t3344r187b3416],
11	buffer	NN	O	buffer	prep_with	8	SENT_120	[p8l233t3344r474b3416],
12	alone	RB	O	alone	amod	11	SENT_120	[p8l522t3344r743b3416],
13	(	RB	O	(	advmod	11	SENT_120	[p8l793t3344r1175b3439],
14	control	JJ	O	control	amod	15	SENT_120	[p8l793t3344r1175b3439],
15	)	NN	O	)	dep	11	SENT_120	[p8l793t3344r1175b3439],
16	,	,	O	,	_	0	SENT_120	[p8l793t3344r1175b3439],
17	with	IN	O	with	_	0	SENT_120	[p8l1221t3344r1397b3416],
18	NADP	NN	ORGANIZATION	nadp	prep_with	11	SENT_120	[p8l1443t3348r1724b3419],
19	and	CC	O	and	_	0	SENT_120	[p8l1771t3346r1920b3419],
20	G6P	NN	O	g6p	nn	22	SENT_120	[p8l1970t3346r2147b3419],
21	(	CD	NUMBER	(	num	22	SENT_120	[p8l18t3457r266b3556],
22	HMS	NNP	O	HMS	conj_and	18	SENT_120	[p8l18t3457r266b3556],
23	dehydrogenase-coupled	JJ	O	dehydrogenase-coupled	amod	26	SENT_120	[p8l304t3460r1275b3556],
24	carbonyl	NN	O	carbonyl	nn	26	SENT_120	[p8l1311t3465r1657b3558],
25	reductase	NN	O	reductase	nn	26	SENT_120	[p8l1693t3460r2142b3558],
26	)	NN	O	)	dep	22	SENT_120	[p8l1693t3460r2142b3558],
27	,	,	O	,	_	0	SENT_120	[p8l1693t3460r2142b3558],
28	or	CC	O	or	_	0	SENT_120	[p8l13t3596r100b3649],
29	with	IN	O	with	_	0	SENT_120	[p8l145t3574r324b3646],
30	NADPH	NN	O	nadph	prep_with	8	SENT_120	[p8l374t3576r734b3648],
31	without	IN	O	without	_	0	SENT_120	[p8l781t3576r1094b3649],
32	G6P	NN	O	g6p	prep_without	8	SENT_120	[p8l1147t3576r1326b3648],
33	(	CD	NUMBER	(	num	39	SENT_120	[p8l1380t3573r1631b3671],
34	HMS	NNP	O	HMS	nn	39	SENT_120	[p8l1380t3573r1631b3671],
35	dehydrogenase-independent	JJ	O	dehydrogenase-independent	amod	39	SENT_120	[p8l1686t3576r2142b3671, p8l13t3690r743b3785],
36	direct	JJ	O	direct	amod	39	SENT_120	[p8l774t3692r1006b3764],
37	carbonyl	NN	O	carbonyl	nn	39	SENT_120	[p8l1038t3690r1386b3785],
38	reductase	NN	O	reductase	nn	39	SENT_120	[p8l1417t3692r1865b3787],
39	)	NN	O	)	dep	8	SENT_120	[p8l1417t3692r1865b3787],
40	.	.	O	.	_	0	SENT_120	[p8l1417t3692r1865b3787],

1	In	IN	O	in	_	0	SENT_121	[p8l1901t3694r1985b3765],
2	the	DT	O	the	det	4	SENT_121	[p8l2016t3692r2145b3764],
3	control	NN	O	control	nn	4	SENT_121	[p9l13t15r303b90],
4	systems	NNS	O	system	prep_in	8	SENT_121	[p9l346t26r673b111],
5	,	,	O	,	_	0	SENT_121	[p9l346t26r673b111],
6	no	DT	O	no	det	7	SENT_121	[p9l719t40r817b90],
7	metabolite	NN	O	metabolite	nsubj	8	SENT_121	[p9l860t17r1296b90],
8	appeared	VBD	O	appear	_	0	SENT_121	[p9l1339t19r1719b115],
9	within	IN	O	within	_	0	SENT_121	[p9l1755t19r2010b92],
10	24	CD	DURATION	24	num	11	SENT_121	[p9l2051t19r2145b90],
11	hours	NNS	NUMBER	hour	prep_within	8	SENT_121	[p9l13t133r262b205],
12	.	.	O	.	_	0	SENT_121	[p9l13t133r262b205],

1	Fig	NN	O	fig	_	0	SENT_122	[p9l302t130r451b226],
2	.	.	O	.	_	0	SENT_122	[p9l302t130r451b226],

1	2	CD	NUMBER	2	_	0	SENT_123	[p9l492t133r558b219],
2	,	,	O	,	_	0	SENT_123	[p9l492t133r558b219],
3	A	DT	O	a	det	9	SENT_123	[p9l582t131r680b219],
4	,	,	O	,	_	0	SENT_123	[p9l582t131r680b219],
5	shows	VBZ	O	show	dep	9	SENT_123	[p9l721t133r960b205],
6	that	IN	O	that	acomp	5	SENT_123	[p9l998t133r1157b205],
7	within	IN	O	within	_	0	SENT_123	[p9l1191t133r1446b208],
8	this	DT	O	this	prep_within	6	SENT_123	[p9l1482t133r1624b208],
9	time	NN	O	time	dep	1	SENT_123	[p9l1663t135r1844b208],
10	period	NN	O	period	dep	9	SENT_123	[p9l1880t133r2145b228],
11	most	JJS	O	most	advmod	12	SENT_123	[p9l13t258r208b322],
12	of	IN	O	of	dep	10	SENT_123	[p9l240t247r324b320],
13	the	DT	O	the	dep	16	SENT_123	[p9l348t247r474b320],
14	daunorubicin	NN	O	daunorubicin	nsubj	16	SENT_123	[p9l506t247r1048b322],
15	became	VBD	O	become	cop	16	SENT_123	[p9l1075t249r1388b322],
16	daunorubicinol	NN	O	daunorubicinol	dep	9	SENT_123	[p9l1420t249r2040b325],
17	in	IN	O	in	_	0	SENT_123	[p9l2070t249r2145b322],
18	hemolysates	NNS	O	hemolysate	prep_in	1	SENT_123	[p9l13t364r509b457],
19	that	WDT	O	that	nsubjpass	22	SENT_123	[p9l561t364r722b436],
20	had	VBD	O	have	aux	22	SENT_123	[p9l774t366r923b436],
21	been	VBN	O	be	auxpass	22	SENT_123	[p9l973t366r1171b436],
22	supplied	VBN	O	supply	rcmod	18	SENT_123	[p9l1223t366r1566b459],
23	directly	RB	O	directly	advmod	22	SENT_123	[p9l1621t366r1923b459],
24	with	IN	O	with	_	0	SENT_123	[p9l1970t366r2145b439],
25	NADPH	NN	O	nadph	prep_with	22	SENT_123	[p9l13t480r391b553],
26	.	.	O	.	_	0	SENT_123	[p9l13t480r391b553],

1	Conversion	NN	O	conversion	nsubj	5	SENT_124	[p9l432t480r895b553],
2	to	TO	O	to	_	0	SENT_124	[p9l932t490r1011b553],
3	daunorubicinol	NN	O	daunorubicinol	prep_to	1	SENT_124	[p9l1047t481r1668b556],
4	was	VBD	O	be	cop	5	SENT_124	[p9l1699t504r1848b555],
5	slower	JJR	O	slower	_	0	SENT_124	[p9l1885t483r2145b555],
6	in	IN	O	in	_	0	SENT_124	[p9l11t594r86b666],
7	hemolysates	NNS	O	hemolysate	prep_in	5	SENT_124	[p9l122t594r618b689],
8	supported	VBN	O	support	partmod	7	SENT_124	[p9l654t596r1064b691],
9	with	IN	O	with	_	0	SENT_124	[p9l1096t596r1272b669],
10	G6P	NN	O	g6p	prep_with	8	SENT_124	[p9l1311t596r1490b671],
11	and	CC	O	and	_	0	SENT_124	[p9l1528t598r1675b668],
12	NADP	NN	O	nadp	conj_and	10	SENT_124	[p9l1709t598r2010b669],
13	.	.	O	.	_	0	SENT_124	[p9l1709t598r2010b669],

1	Fig	NN	O	fig	_	0	SENT_125	[p9l106t709r255b802],
2	.	.	O	.	_	0	SENT_125	[p9l106t709r255b802],

1	2	CD	NUMBER	2	nsubj	5	SENT_126	[p9l302t711r366b795],
2	,	,	O	,	_	0	SENT_126	[p9l302t711r366b795],
3	B	NN	O	b	appos	1	SENT_126	[p9l404t711r491b795],
4	,	,	O	,	_	0	SENT_126	[p9l404t711r491b795],
5	shows	VBZ	O	show	_	0	SENT_126	[p9l536t709r773b784],
6	that	IN	O	that	complm	11	SENT_126	[p9l813t711r974b784],
7	the	DT	O	the	det	8	SENT_126	[p9l1015t711r1143b784],
8	amount	NN	O	amount	nsubj	11	SENT_126	[p9l1186t723r1497b786],
9	of	IN	O	of	_	0	SENT_126	[p9l1537t713r1622b786],
10	doxorubicin	NN	O	doxorubicin	prep_of	8	SENT_126	[p9l1660t711r2142b786],
11	converted	VBD	O	convert	ccomp	5	SENT_126	[p9l11t827r414b900],
12	into	IN	O	into	_	0	SENT_126	[p9l462t825r620b898],
13	doxorubicinol	NN	O	doxorubicinol	prep_into	11	SENT_126	[p9l670t827r1231b900],
14	within	IN	O	within	_	0	SENT_126	[p9l1276t827r1532b902],
15	24	CD	DURATION	24	num	16	SENT_126	[p9l1579t829r1673b900],
16	hours	NNS	NUMBER	hour	prep_within	11	SENT_126	[p9l1720t829r1948b902],
17	was	VBD	O	be	cop	19	SENT_126	[p9l1993t850r2142b900],
18	very	RB	O	very	advmod	19	SENT_126	[p9l6t963r178b1034],
19	small	JJ	O	small	rcmod	16	SENT_126	[p9l217t940r449b1027],
20	,	,	O	,	_	0	SENT_126	[p9l217t940r449b1027],
21	whether	IN	O	whether	complm	24	SENT_126	[p9l487t940r821b1015],
22	NADPH	NN	O	nadph	nsubjpass	24	SENT_126	[p9l857t943r1217b1013],
23	was	VBD	O	be	auxpass	24	SENT_126	[p9l1251t964r1402b1013],
24	provided	VBN	O	provide	ccomp	19	SENT_126	[p9l1440t943r1802b1038],
25	directly	RB	O	directly	advmod	24	SENT_126	[p9l1843t943r2145b1036],
26	or	CC	O	or	_	0	SENT_126	[p9l11t1082r97b1129],
27	indirectly	RB	O	indirectly	conj_or	25	SENT_126	[p9l131t1057r532b1152],
28	.	.	O	.	_	0	SENT_126	[p9l131t1057r532b1152],

1	Hence	RB	O	hence	advmod	5	SENT_127	[p9l571t1059r835b1132],
2	most	RBS	O	most	advmod	3	SENT_127	[p9l871t1068r1067b1132],
3	subsequent	JJ	O	subsequent	amod	4	SENT_127	[p9l1103t1059r1559b1152],
4	work	NN	O	work	nsubj	5	SENT_127	[p9l1591t1061r1798b1134],
5	focused	VBD	O	focus	_	0	SENT_127	[p9l1829t1061r2142b1132],
6	on	IN	O	on	_	0	SENT_127	[p9l11t1198r113b1248],
7	the	DT	O	the	det	8	SENT_127	[p9l147t1175r275b1248],
8	metabolism	NN	O	metabolism	prep_on	5	SENT_127	[p9l311t1173r784b1248],
9	of	IN	O	of	_	0	SENT_127	[p9l820t1175r905b1248],
10	daunorubicin	NN	O	daunorubicin	prep_of	8	SENT_127	[p9l938t1175r1499b1251],
11	.	.	O	.	_	0	SENT_127	[p9l938t1175r1499b1251],

1	Fig	NN	O	fig	_	0	SENT_128	[p9l103t1289r252b1383],
2	.	.	O	.	_	0	SENT_128	[p9l103t1289r252b1383],

1	3	CD	NUMBER	3	nsubj	2	SENT_129	[p9l293t1288r336b1361],
2	illustrates	VBZ	O	illustrate	_	0	SENT_129	[p9l374t1289r768b1364],
3	the	DT	O	the	det	5	SENT_129	[p9l804t1291r932b1361],
4	stoichiometric	JJ	O	stoichiometric	amod	5	SENT_129	[p9l968t1288r1550b1364],
5	conversion	NN	O	conversion	dobj	2	SENT_129	[p9l1584t1291r2024b1364],
6	of	IN	O	of	_	0	SENT_129	[p9l2060t1291r2147b1364],
7	daunorubicin	NN	O	daunorubicin	prep_of	5	SENT_129	[p9l8t1404r551b1477],
8	into	IN	O	into	_	0	SENT_129	[p9l610t1404r768b1480],
9	daunorubicinol	NN	O	daunorubicinol	prep_into	2	SENT_129	[p9l830t1404r1451b1480],
10	in	IN	O	in	_	0	SENT_129	[p9l1510t1407r1585b1480],
11	hemolysates	NNS	O	hemolysate	prep_in	9	SENT_129	[p9l1644t1407r2140b1500],
12	supplied	VBN	O	supply	partmod	11	SENT_129	[p9l8t1520r352b1616],
13	with	IN	O	with	_	0	SENT_129	[p9l381t1520r558b1593],
14	100	CD	NUMBER	100	num	16	SENT_129	[p9l596t1523r731b1596],
15	ng/ml	NN	O	ng/ml	nn	16	SENT_129	[p9l765t1523r993b1616],
16	daunorubicin	NN	O	daunorubicin	prep_with	12	SENT_129	[p9l1029t1523r1592b1612],
17	,	,	O	,	_	0	SENT_129	[p9l1029t1523r1592b1612],
18	a	DT	O	a	det	19	SENT_129	[p9l1630t1548r1673b1596],
19	concentration	NN	O	concentration	appos	16	SENT_129	[p9l1706t1535r2138b1596, p9l8t1638r167b1708],
20	within	IN	O	within	_	0	SENT_129	[p9l224t1638r479b1708],
21	therapeutic	JJ	O	therapeutic	amod	22	SENT_129	[p9l543t1635r1009b1733],
22	range	NN	O	range	prep_within	19	SENT_129	[p9l1070t1661r1317b1731],
23	.	.	O	.	_	0	SENT_129	[p9l1070t1661r1317b1731],

1	Biotransformation	NNP	O	Biotransformation	nsubj	2	SENT_130	[p9l1383t1640r2140b1711],
2	depended	VBD	O	depend	_	0	SENT_130	[p9l8t1752r410b1845],
3	on	IN	O	on	_	0	SENT_130	[p9l459t1775r562b1824],
4	the	DT	O	the	det	5	SENT_130	[p9l612t1752r738b1827],
5	amount	NN	O	amount	prep_on	2	SENT_130	[p9l790t1763r1101b1827],
6	of	IN	O	of	_	0	SENT_130	[p9l1151t1754r1236b1824],
7	hemolysate	NN	O	hemolysate	prep_of	5	SENT_130	[p9l1278t1754r1761b1847],
8	,	,	O	,	_	0	SENT_130	[p9l1278t1754r1761b1847],
9	and	CC	O	and	_	0	SENT_130	[p9l1815t1754r1962b1827],
10	the	DT	O	the	det	11	SENT_130	[p9l2012t1754r2138b1827],
11	rate	NN	O	rate	nsubj	13	SENT_130	[p9l8t1879r167b1940],
12	was	VBD	O	be	cop	13	SENT_130	[p9l193t1891r343b1940],
13	linear	JJ	O	linear	conj_and	2	SENT_130	[p9l374t1867r609b1940],
14	at	IN	O	at	_	0	SENT_130	[p9l640t1882r715b1943],
15	lower	JJR	O	lower	amod	17	SENT_130	[p9l744t1870r972b1940],
16	hemoglobin	NN	O	hemoglobin	nn	17	SENT_130	[p9l1001t1870r1485b1963],
17	concentrations	NNS	O	concentration	prep_at	13	SENT_130	[p9l1514t1870r2135b1943],
18	.	.	O	.	_	0	SENT_130	[p9l1514t1870r2135b1943],

1	Tables	NNS	O	table	nsubj	5	SENT_131	[p9l101t1983r370b2056],
2	I	CD	NUMBER	i	dep	1	SENT_131	[p9l402t1986r433b2056],
3	and	CC	O	and	_	0	SENT_131	[p9l466t1984r613b2056],
4	II	CD	NUMBER	ii	conj_and	2	SENT_131	[p9l645t1986r713b2059],
5	compare	VBP	O	compare	_	0	SENT_131	[p9l744t2009r1097b2079],
6	the	DT	O	the	det	7	SENT_131	[p9l1128t1986r1256b2056],
7	biotransformation	NN	O	biotransformation	dobj	5	SENT_131	[p9l1283t1983r2027b2059],
8	of	IN	O	of	_	0	SENT_131	[p9l2056t1986r2142b2059],
9	daunorubicin	NN	O	daunorubicin	prep_of	7	SENT_131	[p9l6t2100r548b2172],
10	at	IN	O	at	_	0	SENT_131	[p9l589t2111r664b2172],
11	15	CD	NUMBER	15	prep_at	5	SENT_131	[p9l707t2102r814b2188],
12	,	,	O	,	_	0	SENT_131	[p9l707t2102r814b2188],
13	30	CD	NUMBER	30	prep_at	5	SENT_131	[p9l857t2102r970b2188],
14	,	,	O	,	_	0	SENT_131	[p9l857t2102r970b2188],
15	and	CC	DURATION	and	_	0	SENT_131	[p9l1015t2102r1162b2172],
16	60	CD	DURATION	60	num	17	SENT_131	[p9l1202t2102r1293b2174],
17	minutes	NNS	NUMBER	minute	prep_at	5	SENT_131	[p9l1332t2102r1654b2175],
18	in	IN	O	in	_	0	SENT_131	[p9l1695t2102r1770b2175],
19	hemolysates	NNS	O	hemolysate	prep_in	17	SENT_131	[p9l1808t2102r2135b2195, p9l6t2227r201b2288],
20	from	IN	O	from	_	0	SENT_131	[p9l240t2218r435b2288],
21	persons	NNS	O	person	prep_from	19	SENT_131	[p9l471t2239r784b2309],
22	without	IN	O	without	_	0	SENT_131	[p9l818t2218r1131b2288],
23	or	CC	O	or	_	0	SENT_131	[p9l1167t2241r1254b2290],
24	with	IN	O	with	_	0	SENT_131	[p9l1288t2218r1465b2290],
25	the	DT	O	the	det	28	SENT_131	[p9l1503t2220r1629b2290],
26	GdA	NNP	O	GdA	nn	28	SENT_131	[p9l1669t2220r1920b2290],
27	_	NNP	O	_	nn	28	SENT_131	[p9l1669t2220r1920b2290],
28	type	NN	O	type	prep_with	21	SENT_131	[p9l1966t2229r2135b2312],
29	of	IN	O	of	_	0	SENT_131	[p9l6t2334r93b2407],
30	G6PD	NN	O	g6pd	nn	34	SENT_131	[p9l136t2335r389b2407],
31	deﬁciency	NN	O	deﬁciency	nn	34	SENT_131	[p9l441t2334r845b2428],
32	(	CD	NUMBER	(	num	34	SENT_131	[p9l894t2335r1182b2430],
33	G6PD	NN	O	g6pd	nn	34	SENT_131	[p9l894t2335r1182b2430],
34	activities	NNS	O	activity	prep_of	28	SENT_131	[p9l1234t2335r1608b2423],
35	,	,	O	,	_	0	SENT_131	[p9l1234t2335r1608b2423],
36	respectively	RB	O	respectively	advmod	28	SENT_131	[p9l1658t2337r2138b2430],
37	>	JJR	O	>	dep	28	SENT_131	[p9l13t2450r130b2520],
38	6	CD	NUMBER	6	amod	37	SENT_131	[p9l13t2450r130b2520],
39	or	CC	O	or	_	0	SENT_131	[p9l163t2471r248b2520],
40	<	JJR	O	<	amod	37	SENT_131	[p9l284t2450r403b2518],
41	2	CD	NUMBER	2	num	44	SENT_131	[p9l284t2450r403b2518],
42	IU/gm	NN	O	iu/gm	nn	44	SENT_131	[p9l434t2448r699b2539],
43	hemoblobin	NN	O	hemoblobin	nn	44	SENT_131	[p9l728t2448r1275b2544],
44	)	NN	O	)	prep_without	21	SENT_131	[p9l728t2448r1275b2544],
45	.	.	O	.	_	0	SENT_131	[p9l728t2448r1275b2544],

1	The	DT	O	the	det	7	SENT_132	[p9l1308t2448r1469b2523],
2	cell	NN	O	cell	nn	7	SENT_132	[p9l1503t2450r1640b2523],
3	lysates	NNS	O	lysate	nn	7	SENT_132	[p9l1669t2450r1934b2543],
4	supJ	NNP	O	supJ	nn	7	SENT_132	[p9l1966t2473r2135b2543, p9l7t2557r38b2617],
5	Lab	NNP	O	Lab	nn	7	SENT_132	[p9l73t2557r206b2619],
6	Clin	NNP	O	Clin	nn	7	SENT_132	[p9l234t2556r365b2619],
7	Med	NNP	O	Med	_	0	SENT_132	[p9l400t2557r563b2619],
8	Volume	NN	O	volume	dep	7	SENT_132	[p9l7t2657r288b2717],
9	127	CD	NUMBER	127	num	8	SENT_132	[p9l325t2654r456b2721],
10	,	,	O	,	_	0	SENT_132	[p9l325t2654r456b2721],
11	Number	NNP	O	Number	appos	8	SENT_132	[p9l494t2657r786b2719],
12	6	CD	NUMBER	6	num	11	SENT_132	[p9l812t2657r852b2719],

1	Relative	JJ	O	relative	amod	2	SENT_133	[p10l594t1952r652b2217],
2	fluorescence	NN	O	fluorescence	_	0	SENT_133	[p10l594t1511r649b1926],

1	—	SYM	O	—	dep	4	SENT_134	[p10l826t2680r1107b2705],
2	-	:	O	-	_	0	SENT_134	[p10l826t2680r1107b2705],
3	«	NN	O	«	nn	4	SENT_134	[p10l826t2680r1107b2705],
4	#e	NN	O	#e	_	0	SENT_134	[p10l826t2680r1107b2705],

1	TH118	NN	O	th118	_	0	SENT_135	[p10l1285t2873r1443b2928],
2	(	CD	NUMBER	(	num	4	SENT_135	[p10l1473t2871r1631b2944],
3	min	NN	DURATION	min	nn	4	SENT_135	[p10l1473t2871r1631b2944],
4	)	NN	O	)	dep	1	SENT_135	[p10l1473t2871r1631b2944],

1	Amifoi	NNP	PERSON	Amifoi	_	0	SENT_136	[p10l789t2981r1047b3052],
2	,	,	O	,	_	0	SENT_136	[p10l789t2981r1047b3052],
3	Bhoomct	NNP	O	Bhoomct	conj_and	1	SENT_136	[p10l1086t2984r1419b3054],
4	,	,	O	,	_	0	SENT_136	[p10l1086t2984r1419b3054],
5	and	CC	O	and	_	0	SENT_136	[p10l1456t2987r1605b3050],
6	Frischer	NNP	PERSON	Frischer	conj_and	1	SENT_136	[p10l1639t2986r1916b3050],

1	Relative	JJ	O	relative	amod	2	SENT_137	[p11l8t1993r71b2269],
2	fluorescence	NN	O	fluorescence	_	0	SENT_137	[p11l6t1535r69b1968],

1	Time	NNP	O	Time	_	0	SENT_138	[p11l737t2951r1101b3031],
2	(	JJ	O	(	amod	4	SENT_138	[p11l737t2951r1101b3031],
3	mIn	NN	DURATION	min	nn	4	SENT_138	[p11l737t2951r1101b3031],
4	)	NN	O	)	dep	1	SENT_138	[p11l737t2951r1101b3031],

1	Fig	NN	O	fig	_	0	SENT_139	[p11l333t3107r385b3139],
2	.	.	O	.	_	0	SENT_139	[p11l333t3107r385b3139],

1	1	LS	NUMBER	1	_	0	SENT_140	[p11l406t3107r428b3132],
2	.	.	O	.	_	0	SENT_140	[p11l406t3107r428b3132],

1	Distribution	NN	O	distribution	_	0	SENT_141	[p11l446t3106r618b3132],
2	of	IN	O	of	_	0	SENT_141	[p11l629t3107r659b3132],
3	anthracyclines	NNS	O	anthracycline	prep_of	1	SENT_141	[p11l667t3106r868b3139],
4	and	CC	O	and	_	0	SENT_141	[p11l878t3106r929b3132],
5	their	PRP$	O	they	poss	6	SENT_141	[p11l939t3106r1006b3132],
6	metabolites	NNS	O	metabolite	prep_of	1	SENT_141	[p11l1015t3106r1179b3132],
7	in	IN	O	in	_	0	SENT_141	[p11l1189t3106r1215b3131],
8	erythrocytes	NNS	O	erythrocyte	prep_in	1	SENT_141	[p11l1225t3106r1396b3140],
9	and	CC	O	and	_	0	SENT_141	[p11l1407t3107r1458b3132],
10	plasma	NN	O	plasma	conj_and	8	SENT_141	[p11l1468t3107r1573b3140],
11	.	.	O	.	_	0	SENT_141	[p11l1468t3107r1573b3140],

1	Whole	JJ	O	whole	amod	2	SENT_142	[p11l1584t3106r1677b3132],
2	blood	NN	O	blood	nsubjpass	4	SENT_142	[p11l1687t3106r1767b3132],
3	was	VBD	O	be	auxpass	4	SENT_142	[p11l1776t3115r1827b3132],
4	incubated	VBN	O	incubate	_	0	SENT_142	[p11l334t3148r471b3174],
5	with	IN	O	with	_	0	SENT_142	[p11l481t3149r541b3174],
6	doxorubicin	NN	O	doxorubicin	nn	7	SENT_142	[p11l552t3148r719b3174],
7	(	NN	O	(	prep_with	4	SENT_142	[p11l731t3147r791b3181],
8	100	CD	NUMBER	100	num	10	SENT_142	[p11l731t3147r791b3181],
9	ng/ml	NN	O	ng/ml	nn	10	SENT_142	[p11l801t3148r891b3182],
10	)	NN	O	)	dep	7	SENT_142	[p11l801t3148r891b3182],
11	and	CC	O	and	_	0	SENT_142	[p11l903t3148r953b3174],
12	daunorubicin	NN	O	daunorubicin	nn	13	SENT_142	[p11l964t3148r1152b3174],
13	(	NN	O	(	prep_with	4	SENT_142	[p11l1163t3147r1223b3181],
14	100	CD	NUMBER	100	num	16	SENT_142	[p11l1163t3147r1223b3181],
15	ng/ml	NN	O	ng/ml	nn	16	SENT_142	[p11l1232t3148r1323b3182],
16	)	NN	O	)	dep	13	SENT_142	[p11l1232t3148r1323b3182],
17	at	IN	O	at	_	0	SENT_142	[p11l1334t3152r1360b3174],
18	37	CD	NUMBER	37	number	19	SENT_142	[p11l1370t3148r1413b3174],
19	°	CD	NUMBER	°	num	20	SENT_142	[p11l1370t3148r1413b3174],
20	C	NN	O	c	prep_at	4	SENT_142	[p11l1423t3149r1445b3174],
21	for	IN	O	for	_	0	SENT_142	[p11l1455t3149r1496b3174],
22	40	CD	DURATION	40	num	23	SENT_142	[p11l1505t3148r1537b3174],
23	minutes	NNS	NUMBER	minute	prep_for	20	SENT_142	[p11l1547t3148r1665b3174],
24	.	.	O	.	_	0	SENT_142	[p11l1547t3148r1665b3174],

1	At	IN	O	at	_	0	SENT_143	[p11l1676t3149r1712b3174],
2	the	DT	O	the	det	3	SENT_143	[p11l1722t3148r1766b3174],
3	end	NN	O	end	prep_at	11	SENT_143	[p11l1777t3149r1827b3174],
4	of	IN	O	of	_	0	SENT_143	[p11l333t3190r362b3215],
5	incubation	NN	O	incubation	prep_of	3	SENT_143	[p11l370t3190r527b3221],
6	,	,	O	,	_	0	SENT_143	[p11l370t3190r527b3221],
7	erythrocytes	NNS	O	erythrocyte	nsubjpass	11	SENT_143	[p11l536t3190r709b3223],
8	and	CC	O	and	_	0	SENT_143	[p11l718t3189r768b3215],
9	plasma	NN	O	plasma	nsubjpass	11	SENT_143	[p11l777t3189r877b3223],
10	were	VBD	O	be	auxpass	11	SENT_143	[p11l883t3197r952b3215],
11	separated	VBN	O	separate	_	0	SENT_143	[p11l961t3190r1105b3223],
12	,	,	O	,	_	0	SENT_143	[p11l961t3190r1105b3223],
13	idarubicin	NN	O	idarubicin	dep	16	SENT_143	[p11l1114t3189r1256b3215],
14	(	CD	NUMBER	(	num	13	SENT_143	[p11l1265t3189r1308b3223],
15	25	CD	NUMBER	25	num	16	SENT_143	[p11l1265t3189r1308b3223],
16	ng/ml	NN	O	ng/ml	ccomp	11	SENT_143	[p11l1318t3189r1403b3223],
17	,	,	O	,	_	0	SENT_143	[p11l1318t3189r1403b3223],
18	internal	JJ	O	internal	amod	20	SENT_143	[p11l1414t3189r1522b3215],
19	standard	JJ	O	standard	amod	20	SENT_143	[p11l1531t3189r1664b3223],
20	)	NN	O	)	nsubjpass	22	SENT_143	[p11l1531t3189r1664b3223],
21	was	VBD	O	be	auxpass	22	SENT_143	[p11l1673t3197r1724b3215],
22	added	VBN	O	add	ccomp	11	SENT_143	[p11l1733t3190r1826b3221],
23	,	,	O	,	_	0	SENT_143	[p11l1733t3190r1826b3221],
24	and	CC	O	and	_	0	SENT_143	[p11l334t3232r384b3258],
25	the	DT	O	the	det	26	SENT_143	[p11l395t3232r439b3258],
26	drugs	NNS	O	drug	nsubjpass	28	SENT_143	[p11l449t3232r526b3265],
27	were	VBD	O	be	auxpass	28	SENT_143	[p11l535t3240r603b3258],
28	extracted	VBN	O	extract	conj_and	11	SENT_143	[p11l614t3231r751b3258],
29	.	.	O	.	_	0	SENT_143	[p11l614t3231r751b3258],

1	A	DT	O	a	det	4	SENT_144	[p11l761t3233r790b3262],
2	,	,	O	,	_	0	SENT_144	[p11l761t3233r790b3262],
3	Distribution	NN	O	distribution	dep	4	SENT_144	[p11l800t3231r973b3258],
4	of	IN	O	of	npadvmod	6	SENT_144	[p11l983t3232r1013b3258],
5	peaks	NNS	O	peak	pobj	4	SENT_144	[p11l1020t3232r1100b3266],
6	in	IN	O	in	_	0	SENT_144	[p11l1111t3231r1137b3257],
7	erythrocytes	NNS	O	erythrocyte	pobj	6	SENT_144	[p11l1147t3231r1325b3265],
8	.	.	O	.	_	0	SENT_144	[p11l1147t3231r1325b3265],

1	B	NN	O	b	_	0	SENT_145	[p11l1337t3233r1364b3263],
2	,	,	O	,	_	0	SENT_145	[p11l1337t3233r1364b3263],
3	Distribution	NN	O	distribution	appos	1	SENT_145	[p11l1375t3232r1547b3258],
4	of	IN	O	of	_	0	SENT_145	[p11l1557t3231r1587b3257],
5	peaks	NNS	O	peak	prep_of	3	SENT_145	[p11l1595t3232r1674b3265],
6	in	IN	O	in	_	0	SENT_145	[p11l1685t3232r1710b3257],
7	plasma	NN	O	plasma	prep_in	5	SENT_145	[p11l1720t3232r1826b3266],
8	.	.	O	.	_	0	SENT_145	[p11l1720t3232r1826b3266],

1	The	DT	O	the	det	3	SENT_146	[p11l332t3273r388b3299],
2	retention	NN	O	retention	nn	3	SENT_146	[p11l404t3274r533b3299],
3	times	NNS	O	time	nsubj	9	SENT_146	[p11l549t3274r624b3300],
4	of	IN	O	of	_	0	SENT_146	[p11l640t3274r670b3300],
5	the	DT	O	the	det	6	SENT_146	[p11l683t3273r727b3298],
6	anthracyclines	NNS	O	anthracycline	prep_of	3	SENT_146	[p11l743t3273r944b3306],
7	and	CC	O	and	_	0	SENT_146	[p11l959t3273r1010b3299],
8	metabolites	NNS	O	metabolite	prep_of	3	SENT_146	[p11l1025t3273r1189b3299],
9	are	VBP	O	be	_	0	SENT_146	[p11l1205t3281r1248b3299],
10	as	IN	O	as	dep	11	SENT_146	[p11l1265t3281r1292b3299],
11	follows	VBZ	O	follow	advcl	9	SENT_146	[p11l1306t3273r1413b3299],
12	:	:	O	:	_	0	SENT_146	[p11l1306t3273r1413b3299],
13	doxorubicinol	NN	O	doxorubicinol	nn	15	SENT_146	[p11l1430t3272r1624b3299],
14	(	CD	NUMBER	(	num	15	SENT_146	[p11l1640t3273r1720b3307],
15	peak	NN	O	peak	dep	11	SENT_146	[p11l1640t3273r1720b3307],
16	1	CD	NUMBER	1	num	17	SENT_146	[p11l1736t3273r1770b3307],
17	)	CD	NUMBER	)	dep	15	SENT_146	[p11l1736t3273r1770b3307],
18	:	:	O	:	_	0	SENT_146	[p11l1736t3273r1770b3307],
19	5.8	CD	DURATION	5.8	num	20	SENT_146	[p11l1787t3274r1827b3299],
20	minutes	NNS	NUMBER	minute	dep	15	SENT_146	[p11l333t3315r453b3346],
21	;	:	O	;	_	0	SENT_146	[p11l333t3315r453b3346],
22	doxorubicin	NN	O	doxorubicin	nn	24	SENT_146	[p11l464t3315r632b3341],
23	(	CD	NUMBER	(	num	24	SENT_146	[p11l643t3314r723b3349],
24	peak	NN	O	peak	dep	20	SENT_146	[p11l643t3314r723b3349],
25	2	CD	NUMBER	2	number	26	SENT_146	[p11l733t3314r768b3348],
26	)	CD	NUMBER	)	dep	24	SENT_146	[p11l733t3314r768b3348],
27	:	:	O	:	_	0	SENT_146	[p11l733t3314r768b3348],
28	6.5	CD	DURATION	6.5	num	29	SENT_146	[p11l780t3315r818b3340],
29	minutes	NNS	NUMBER	minute	dep	20	SENT_146	[p11l830t3314r950b3346],
30	;	:	O	;	_	0	SENT_146	[p11l830t3314r950b3346],
31	daunorubicinol	NN	O	daunorubicinol	nn	33	SENT_146	[p11l961t3314r1175b3341],
32	(	CD	NUMBER	(	num	33	SENT_146	[p11l1186t3314r1266b3348],
33	peak	NN	O	peak	dep	15	SENT_146	[p11l1186t3314r1266b3348],
34	3	CD	NUMBER	3	num	35	SENT_146	[p11l1275t3314r1310b3348],
35	)	NN	O	)	dep	33	SENT_146	[p11l1275t3314r1310b3348],
36	:	:	O	:	_	0	SENT_146	[p11l1275t3314r1310b3348],
37	7.4	CD	DURATION	7.4	num	38	SENT_146	[p11l1322t3315r1362b3340],
38	minutes	NNS	NUMBER	minute	dep	33	SENT_146	[p11l1373t3315r1491b3346],
39	;	:	O	;	_	0	SENT_146	[p11l1373t3315r1491b3346],
40	daunorubicin	NN	O	daunorubicin	dep	38	SENT_146	[p11l1503t3314r1690b3341],
41	(	CD	NUMBER	(	num	44	SENT_146	[p11l1701t3314r1781b3349],
42	peak	NN	O	peak	nn	44	SENT_146	[p11l1701t3314r1781b3349],
43	4	CD	NUMBER	4	num	44	SENT_146	[p11l1790t3314r1825b3348],
44	)	NN	O	)	nsubj	11	SENT_146	[p11l1790t3314r1825b3348],
45	:	:	O	:	_	0	SENT_146	[p11l1790t3314r1825b3348],

1	9.9	CD	DURATION	9.9	num	2	SENT_147	[p11l563t3370r654b3427],
2	minutes	NNS	DURATION	minute	_	0	SENT_147	[p11l683t3368r960b3438],
3	;	:	O	;	_	0	SENT_147	[p11l683t3368r960b3438],
4	idarubicin	NN	O	idarubicin	dep	6	SENT_147	[p11l992t3368r1321b3427],
5	(	CD	NUMBER	(	num	6	SENT_147	[p11l1353t3366r1537b3445],
6	peak	NN	O	peak	dep	2	SENT_147	[p11l1353t3366r1537b3445],
7	5	CD	NUMBER	5	num	8	SENT_147	[p11l1564t3365r1646b3446],
8	)	NN	O	)	dep	6	SENT_147	[p11l1564t3365r1646b3446],
9	:	:	O	:	_	0	SENT_147	[p11l1564t3365r1646b3446],
10	11.3	CD	DURATION	11.3	num	11	SENT_147	[p11l1682t3368r1808b3427],
11	minutes	NNS	NUMBER	minute	dep	6	SENT_147	[p11l1837t3368r2111b3427],
12	-	:	O	-	_	0	SENT_147	[p11l1837t3368r2111b3427],
13	.	.	O	.	_	0	SENT_147	[p11l1837t3368r2111b3427],

1	plied	VBN	O	ply	csubjpass	5	SENT_148	[p12l9t91r219b187],
2	with	IN	O	with	_	0	SENT_148	[p12l264t89r448b164],
3	anthracycline	NN	O	anthracycline	prep_with	1	SENT_148	[p12l498t88r1064b185],
4	were	VBD	O	be	auxpass	5	SENT_148	[p12l1110t112r1312b162],
5	incubated	VBN	O	incubate	_	0	SENT_148	[p12l1362t88r1780b162],
6	without	IN	O	without	_	0	SENT_148	[p12l1823t88r2148b162],
7	further	JJ	O	further	amod	9	SENT_148	[p12l12t208r312b282],
8	addition	NN	O	addition	nn	9	SENT_148	[p12l350t204r814b302],
9	(	NN	O	(	prep_without	5	SENT_148	[p12l350t204r814b302],
10	s	VBZ	O	s	auxpass	25	SENT_148	[p12l350t204r814b302],
11	)	CD	NUMBER	)	num	12	SENT_148	[p12l350t204r814b302],
12	(	NN	O	(	attr	25	SENT_148	[p12l859t206r1259b302],
13	control	NN	O	control	dep	12	SENT_148	[p12l859t206r1259b302],
14	)	CD	NUMBER	)	num	13	SENT_148	[p12l859t206r1259b302],
15	,	,	O	,	_	0	SENT_148	[p12l859t206r1259b302],
16	with	IN	O	with	dep	12	SENT_148	[p12l1295t203r1477b279],
17	1	CD	NUMBER	1	num	19	SENT_148	[p12l1520t206r1555b277],
18	mmol/L	NN	O	mmol/l	nn	19	SENT_148	[p12l1596t206r1931b286],
19	G6P	NN	O	g6p	pobj	16	SENT_148	[p12l1967t206r2148b279],
20	and	CC	O	and	_	0	SENT_148	[p12l14t323r166b396],
21	1	CD	NUMBER	1	num	23	SENT_148	[p12l206t325r240b396],
22	mmol/L	NN	O	mmol/l	nn	23	SENT_148	[p12l283t323r615b403],
23	NADP	NN	O	nadp	conj_and	13	SENT_148	[p12l649t323r935b394],
24	(	CD	NUMBER	(	dep	23	SENT_148	[p12l975t321r1344b419],
25	coupled	VBN	O	couple	rcmod	9	SENT_148	[p12l975t321r1344b419],
26	NADPH	NN	O	nadph	nn	27	SENT_148	[p12l1381t320r1810b417],
27	)	NN	O	)	dobj	25	SENT_148	[p12l1381t320r1810b417],
28	,	,	O	,	_	0	SENT_148	[p12l1381t320r1810b417],
29	or	CC	O	or	_	0	SENT_148	[p12l1848t344r1935b396],
30	with	IN	O	with	_	0	SENT_148	[p12l1967t323r2148b394],
31	1	CD	NUMBER	1	num	32	SENT_148	[p12l19t441r52b510],
32	mmol/L	NN	O	mmol/l	prep_with	36	SENT_148	[p12l88t439r423b521],
33	NADPH	NN	O	nadph	npadvmod	35	SENT_148	[p12l452t439r821b510],
34	(	CD	NUMBER	(	num	33	SENT_148	[p12l857t436r1136b535],
35	direct	JJ	O	direct	amod	32	SENT_148	[p12l857t436r1136b535],
36	uncoupled	VBD	O	uncouple	rcmod	9	SENT_148	[p12l1165t437r1611b531],
37	biotransformation	NN	O	biotransformation	nn	38	SENT_148	[p12l1642t436r2146b510, p12l12t555r367b653],
38	)	NN	O	)	dobj	36	SENT_148	[p12l1642t436r2146b510, p12l12t555r367b653],
39	.	.	O	.	_	0	SENT_148	[p12l1642t436r2146b510, p12l12t555r367b653],

1	The	DT	O	the	det	2	SENT_149	[p12l408t555r573b628],
2	data	NNS	O	datum	nsubj	3	SENT_149	[p12l614t555r793b628],
3	based	VBN	O	base	_	0	SENT_149	[p12l829t555r1071b628],
4	on	IN	O	on	_	0	SENT_149	[p12l1110t578r1213b628],
5	the	DT	O	the	det	6	SENT_149	[p12l1249t555r1382b628],
6	disappearance	NN	O	disappearance	prep_on	3	SENT_149	[p12l1420t553r2028b649],
7	of	IN	O	of	_	0	SENT_149	[p12l2066t555r2153b628],
8	daunorubicin	NN	O	daunorubicin	nn	10	SENT_149	[p12l14t668r578b744],
9	(	CD	NUMBER	(	num	10	SENT_149	[p12l616t668r893b765],
10	Table	NNP	O	Table	prep_of	6	SENT_149	[p12l616t668r893b765],
11	I	PRP	O	I	nsubj	12	SENT_149	[p12l931t669r997b764],
12	)	VBP	O	)	rcmod	10	SENT_149	[p12l931t669r997b764],
13	and	CC	O	and	_	0	SENT_149	[p12l1042t671r1192b741],
14	on	IN	O	on	_	0	SENT_149	[p12l1230t694r1333b744],
15	the	DT	O	the	det	16	SENT_149	[p12l1371t669r1502b741],
16	appearance	NN	O	appearance	prep_on	23	SENT_149	[p12l1543t692r2028b764],
17	of	IN	O	of	_	0	SENT_149	[p12l2066t671r2153b741],
18	daunorubicinol	NN	O	daunorubicinol	prep_of	16	SENT_149	[p12l12t787r659b862],
19	(	CD	NUMBER	(	num	18	SENT_149	[p12l702t785r976b883],
20	Table	NNP	O	Table	nn	21	SENT_149	[p12l702t785r976b883],
21	II	NNP	O	II	nsubj	23	SENT_149	[p12l1017t784r1124b883],
22	)	CD	NUMBER	)	num	21	SENT_149	[p12l1017t784r1124b883],
23	gave	VBD	O	give	conj_and	3	SENT_149	[p12l1165t810r1354b883],
24	concordant	JJ	O	concordant	amod	25	SENT_149	[p12l1394t787r1870b858],
25	information	NN	O	information	dobj	23	SENT_149	[p12l1911t787r2146b860, p12l12t903r328b978],
26	.	.	O	.	_	0	SENT_149	[p12l1911t787r2146b860, p12l12t903r328b978],

1	Signiﬁcantly	RB	O	signiﬁcantly	advmod	2	SENT_150	[p12l385t900r907b996],
2	less	JJR	O	less	amod	3	SENT_150	[p12l952t903r1101b976],
3	daunorubicin	NN	O	daunorubicin	nsubjpass	5	SENT_150	[p12l1154t900r1718b976],
4	was	VBD	O	be	auxpass	5	SENT_150	[p12l1763t924r1917b973],
5	converted	VBN	O	convert	_	0	SENT_150	[p12l1967t924r2146b976, p12l7t1019r277b1092],
6	into	IN	O	into	_	0	SENT_150	[p12l334t1019r497b1092],
7	daunorubicinol	NN	O	daunorubicinol	prep_into	5	SENT_150	[p12l558t1016r1205b1089],
8	in	IN	O	in	_	0	SENT_150	[p12l1263t1019r1340b1089],
9	hemolysates	NNS	O	hemolysate	prep_in	5	SENT_150	[p12l1399t1017r1914b1110],
10	supplied	VBN	O	supply	partmod	9	SENT_150	[p12l1971t1040r2146b1113, p12l12t1137r221b1231],
11	with	IN	O	with	_	0	SENT_150	[p12l250t1137r432b1211],
12	G6P	NN	O	g6p	prep_with	10	SENT_150	[p12l468t1135r650b1208],
13	and	CC	O	and	_	0	SENT_150	[p12l686t1135r835b1208],
14	NADP	NN	O	nadp	conj_and	12	SENT_150	[p12l869t1137r1155b1206],
15	than	IN	O	than	dep	10	SENT_150	[p12l1188t1135r1375b1208],
16	in	IN	O	in	_	0	SENT_150	[p12l1408t1132r1486b1206],
17	those	DT	O	those	prep_in	10	SENT_150	[p12l1517t1135r1743b1206],
18	provided	VBN	O	provide	partmod	17	SENT_150	[p12l1774t1135r2148b1229],
19	with	IN	O	with	_	0	SENT_150	[p12l7t1250r191b1323],
20	NADPH	NN	O	nadph	prep_with	18	SENT_150	[p12l243t1250r633b1323],
21	.	.	O	.	_	0	SENT_150	[p12l243t1250r633b1323],

1	The	DT	O	the	det	2	SENT_151	[p12l690t1248r854b1320],
2	diﬁerence	NN	O	diﬁerence	_	0	SENT_151	[p12l910t1248r1328b1322],
3	in	IN	O	in	_	0	SENT_151	[p12l1383t1248r1460b1318],
4	biotransformation	NN	O	biotransformation	prep_in	2	SENT_151	[p12l1513t1248r2148b1320, p12l14t1368r177b1439],

1	rates	NNS	O	rate	nsubjpass	11	SENT_152	[p12l222t1378r425b1439],
2	in	IN	O	in	_	0	SENT_152	[p12l470t1366r548b1436],
3	the	DT	O	the	det	4	SENT_152	[p12l593t1366r724b1436],
4	systems	NNS	O	system	prep_in	1	SENT_152	[p12l769t1375r1088b1459],
5	with	IN	O	with	_	0	SENT_152	[p12l1128t1366r1312b1439],
6	coupled	VBN	O	couple	prepc_with	4	SENT_152	[p12l1355t1363r1690b1459],
7	versus	CC	O	versus	prep	6	SENT_152	[p12l1730t1386r1993b1439],
8	direct	JJ	O	direct	amod	9	SENT_152	[p12l2041t1366r2148b1436, p12l12t1490r173b1554],
9	NADPH	NN	O	nadph	dep	7	SENT_152	[p12l232t1481r601b1554],
10	was	VBD	O	be	auxpass	11	SENT_152	[p12l656t1501r810b1551],
11	seen	VBN	O	see	conj_or	11	SENT_152	[p12l871t1502r1057b1551],
12	without	IN	O	without	_	0	SENT_152	[p12l1114t1479r1439b1553],
13	or	CC	O	or	_	0	SENT_152	[p12l1501t1499r1588b1551],
14	with	IN	O	with	_	0	SENT_152	[p12l1642t1479r1824b1551],
15	G6PD	NN	O	g6pd	prep_without	11	SENT_152	[p12l1888t1478r2146b1553],

1	deﬁciency	NN	O	deﬁciency	_	0	SENT_153	[p12l14t1598r455b1691],
2	.	.	O	.	_	0	SENT_153	[p12l14t1598r455b1691],

1	Thus	RB	O	thus	advmod	9	SENT_154	[p12l500t1596r710b1668],
2	even	RB	O	even	advmod	9	SENT_154	[p12l755t1619r949b1668],
3	in	IN	O	in	_	0	SENT_154	[p12l992t1596r1069b1669],
4	normal	JJ	O	normal	amod	5	SENT_154	[p12l1112t1596r1414b1668],
5	hemolysates	NNS	O	hemolysate	prep_in	9	SENT_154	[p12l1457t1596r1972b1689],
6	the	DT	O	the	det	8	SENT_154	[p12l2018t1596r2148b1668],
7	HMS	NNP	O	HMS	nn	8	SENT_154	[p12l12t1713r233b1786],
8	dehydrogenases	NNS	O	dehydrogenase	nsubj	9	SENT_154	[p12l285t1710r958b1807],
9	limit	VBP	O	limit	_	0	SENT_154	[p12l1005t1710r1201b1783],
10	the	DT	O	the	det	11	SENT_154	[p12l1249t1713r1379b1783],
11	rate	NN	O	rate	dobj	9	SENT_154	[p12l1427t1720r1592b1783],
12	of	IN	O	of	_	0	SENT_154	[p12l1640t1711r1729b1783],
13	biotrans	NNS	O	biotran	prep_of	11	SENT_154	[p12l1767t1711r2146b1783],
14	—	CD	NUMBER	—	num	15	SENT_154	[p12l1767t1711r2146b1783],
15	formation	NN	O	formation	tmod	9	SENT_154	[p12l9t1831r434b1901],
16	of	IN	O	of	_	0	SENT_154	[p12l470t1831r559b1899],
17	daunorubicin	NN	O	daunorubicin	prep_of	15	SENT_154	[p12l591t1831r1176b1902],
18	.	.	O	.	_	0	SENT_154	[p12l591t1831r1176b1902],

1	Within	IN	O	within	_	0	SENT_155	[p12l1216t1828r1507b1901],
2	the	DT	O	the	det	6	SENT_155	[p12l1545t1831r1676b1899],
3	GdA	NN	O	gda	nn	6	SENT_155	[p12l1716t1831r1972b1902],
4	"	''	O	"	punct	6	SENT_155	[p12l1716t1831r1972b1902],
5	‘	NN	O	‘	nn	6	SENT_155	[p12l1716t1831r1972b1902],
6	deﬁcient	NN	O	deﬁcient	pobj	1	SENT_155	[p12l2018t1831r2146b1901, p12l12t1945r270b2020],

1	samples	NNS	O	sample	nsubj	22	SENT_156	[p12l348t1945r703b2038],
2	,	,	O	,	_	0	SENT_156	[p12l348t1945r703b2038],
3	the	DT	O	the	det	5	SENT_156	[p12l783t1945r914b2018],
4	quantitative	JJ	O	quantitative	amod	5	SENT_156	[p12l991t1942r1500b2038],
5	difference	NN	O	difference	appos	1	SENT_156	[p12l1575t1945r1995b2018],
6	in	IN	O	in	_	0	SENT_156	[p12l2071t1945r2148b2018],
7	daunorubicin	NN	O	daunorubicin	nn	8	SENT_156	[p12l14t2060r578b2133],
8	metabolism	NN	O	metabolism	prep_in	5	SENT_156	[p12l626t2060r1120b2133],
9	between	IN	O	between	_	0	SENT_156	[p12l1163t2060r1518b2133],
10	the	DT	O	the	det	11	SENT_156	[p12l1566t2061r1697b2131],
11	G6P	NN	O	g6p	prep_between	8	SENT_156	[p12l1749t2061r1931b2131],
12	plus	CC	O	plus	_	0	SENT_156	[p12l1978t2061r2148b2154],
13	NADP	NN	O	nadp	nn	14	SENT_156	[p12l12t2179r298b2247],
14	system	NN	O	system	conj_plus	5	SENT_156	[p12l341t2186r620b2270],
15	and	CC	O	and	_	0	SENT_156	[p12l663t2176r814b2247],
16	the	DT	O	the	det	18	SENT_156	[p12l853t2176r983b2247],
17	NADPH	NN	O	nadph	nn	18	SENT_156	[p12l1024t2176r1393b2247],
18	system	NN	O	system	conj_plus	5	SENT_156	[p12l1434t2186r1713b2268],
19	was	VBD	O	be	cop	22	SENT_156	[p12l1749t2197r1901b2247],
20	magniﬁed	JJ	O	magniﬁed	amod	22	SENT_156	[p12l1941t2198r2148b2271, p12l12t2293r249b2366],
21	(	NN	O	(	nn	22	SENT_156	[p12l290t2291r369b2389],
22	p	NN	O	p	_	0	SENT_156	[p12l290t2291r369b2389],
23	<	JJR	O	<	dep	22	SENT_156	[p12l412t2302r481b2359],
24	0.001	CD	NUMBER	0.001	num	25	SENT_156	[p12l524t2291r805b2387],
25	)	NN	O	)	dep	23	SENT_156	[p12l524t2291r805b2387],
26	.	.	O	.	_	0	SENT_156	[p12l524t2291r805b2387],

1	When	WRB	O	when	advmod	4	SENT_157	[p12l846t2291r1097b2364],
2	NADPH	NN	O	nadph	nsubjpass	4	SENT_157	[p12l1135t2293r1502b2364],
3	was	VBD	O	be	auxpass	4	SENT_157	[p12l1536t2314r1690b2364],
4	generated	VBN	O	generate	advcl	18	SENT_157	[p12l1726t2293r2148b2385],
5	through	IN	O	through	_	0	SENT_157	[p12l12t2411r346b2503],
6	G6P	NN	O	g6p	prep_through	4	SENT_157	[p12l396t2409r580b2479],
7	and	CC	O	and	_	0	SENT_157	[p12l632t2409r782b2479],
8	NADP	NN	ORGANIZATION	nadp	prep_through	4	SENT_157	[p12l832t2411r1143b2495],
9	,	,	O	,	_	0	SENT_157	[p12l832t2411r1143b2495],
10	the	DT	O	the	det	11	SENT_157	[p12l1195t2409r1326b2481],
11	biotransformation	NN	O	biotransformation	nsubjpass	18	SENT_157	[p12l1374t2407r2148b2479],
12	of	IN	O	of	_	0	SENT_157	[p12l7t2525r94b2597],
13	daunorubicin	NN	O	daunorubicin	prep_of	11	SENT_157	[p12l135t2525r699b2599],
14	to	TO	O	to	_	0	SENT_157	[p12l742t2537r823b2599],
15	daunorubicinol	NN	O	daunorubicinol	prep_to	13	SENT_157	[p12l871t2525r1518b2599],
16	was	VBD	O	be	auxpass	18	SENT_157	[p12l1557t2549r1710b2601],
17	markedly	RB	O	markedly	advmod	18	SENT_157	[p12l1755t2526r2151b2623],
18	decreased	VBN	O	decrease	_	0	SENT_157	[p12l9t2640r433b2715],
19	in	IN	O	in	_	0	SENT_157	[p12l481t2642r557b2715],
20	the	DT	O	the	det	22	SENT_157	[p12l607t2642r739b2715],
21	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	22	SENT_157	[p12l787t2642r1455b2715],
22	hemolysates	NNS	O	hemolysate	prep_in	18	SENT_157	[p12l1503t2642r2020b2738],
23	as	IN	O	as	dep	29	SENT_157	[p12l2070t2665r2151b2715],
24	compared	VBN	O	compare	_	0	SENT_157	[p12l9t2758r431b2853],
25	with	IN	O	with	prepc_compared_with	29	SENT_157	[p12l488t2758r671b2829],
26	the	DT	O	the	det	28	SENT_157	[p12l733t2758r867b2832],
27	nondeﬁcient	JJ	O	nondeﬁcient	amod	28	SENT_157	[p12l929t2756r1460b2831],
28	controls	NNS	O	control	pobj	29	SENT_157	[p12l1524t2758r1864b2832],
29	(	VBP	O	(	dep	18	SENT_157	[p12l1930t2756r2008b2853],
30	p	NN	O	p	dep	31	SENT_157	[p12l1930t2756r2008b2853],
31	<	JJR	O	<	dobj	29	SENT_157	[p12l2079t2767r2146b2827],
32	0.001	CD	NUMBER	0.001	nsubj	29	SENT_157	[p12l9t2872r223b2946],
33	at	IN	O	at	_	0	SENT_157	[p12l282t2884r358b2946],
34	all	DT	O	all	det	36	SENT_157	[p12l408t2873r507b2946],
35	time	NN	O	time	nn	36	SENT_157	[p12l558t2873r743b2946],
36	points	NNS	O	point	prep_at	32	SENT_157	[p12l794t2873r1054b2969],
37	tested	VBN	O	test	partmod	36	SENT_157	[p12l1104t2873r1418b2969],
38	)	RB	O	)	advmod	37	SENT_157	[p12l1104t2873r1418b2969],
39	.	.	O	.	_	0	SENT_157	[p12l1104t2873r1418b2969],

1	However	RB	O	however	advmod	10	SENT_158	[p12l1473t2875r1878b2960],
2	,	,	O	,	_	0	SENT_158	[p12l1473t2875r1878b2960],
3	when	WRB	O	when	advmod	6	SENT_158	[p12l1926t2873r2150b2946],
4	NADPH	NN	PERSON	nadph	nsubjpass	6	SENT_158	[p12l7t2992r377b3063],
5	was	VBD	O	be	auxpass	6	SENT_158	[p12l415t3015r568b3065],
6	supplied	VBN	O	supply	advcl	10	SENT_158	[p12l614t2990r972b3089],
7	directly	RB	O	directly	advmod	6	SENT_158	[p12l1015t2989r1355b3086],
8	,	,	O	,	_	0	SENT_158	[p12l1015t2989r1355b3086],
9	there	EX	O	there	expl	10	SENT_158	[p12l1400t2992r1621b3065],
10	was	VBD	O	be	_	0	SENT_158	[p12l1662t3015r1815b3065],
11	no	DT	O	no	det	12	SENT_158	[p12l1858t3015r1962b3065],
12	difference	NN	O	difference	nsubj	10	SENT_158	[p12l2007t2992r2148b3065, p12l7t3108r321b3181],
13	between	IN	O	between	_	0	SENT_158	[p12l357t3107r713b3181],
14	normal	JJ	O	normal	amod	17	SENT_158	[p12l747t3108r1049b3181],
15	and	CC	O	and	_	0	SENT_158	[p12l1088t3108r1240b3181],
16	G6PD	NN	O	g6pd	conj_and	14	SENT_158	[p12l1279t3110r1539b3181],
17	GdA	NN	O	gda	prep_between	12	SENT_158	[p12l1580t3110r1840b3183],
18	‘	CD	NUMBER	‘	num	19	SENT_158	[p12l1580t3110r1840b3183],
19	hemolysates	NNS	O	hemolysate	dep	17	SENT_158	[p12l1881t3108r2148b3181, p13l7t27r284b123],

1	(	RB	O	(	advmod	2	SENT_159	[p13l331t27r468b125],
2	all	DT	O	all	amod	3	SENT_159	[p13l331t27r468b125],
3	p	NN	O	p	_	0	SENT_159	[p13l495t52r554b123],
4	>	JJR	O	>	dep	3	SENT_159	[p13l605t41r671b95],
5	0.1	CD	NUMBER	0.1	num	6	SENT_159	[p13l719t27r902b125],
6	)	NN	O	)	dep	4	SENT_159	[p13l719t27r902b125],
7	.	.	O	.	_	0	SENT_159	[p13l719t27r902b125],

1	Non-G6PD-deﬁcient	JJ	O	non-g6pd-deﬁcient	amod	2	SENT_160	[p13l948t29r1838b102],
2	hemolysates	NNS	O	hemolysate	nsubj	3	SENT_160	[p13l1881t27r2148b102, p13l7t143r284b237],
3	produced	VBN	O	produce	_	0	SENT_160	[p13l362t145r762b239],
4	so	RB	O	so	advmod	5	SENT_160	[p13l843t166r928b218],
5	little	JJ	O	little	amod	6	SENT_160	[p13l1006t142r1201b216],
6	doxorubicinol	NN	O	doxorubicinol	dobj	3	SENT_160	[p13l1281t142r1868b219],
7	from	IN	O	from	_	0	SENT_160	[p13l1946t142r2150b216],
8	doxorubicin	NN	O	doxorubicin	prep_from	3	SENT_160	[p13l9t258r515b335],
9	(	CD	NUMBER	(	num	8	SENT_160	[p13l579t261r809b358],
10	even	RB	O	even	advmod	14	SENT_160	[p13l579t261r809b358],
11	after	IN	O	after	dep	14	SENT_160	[p13l871t261r1070b335],
12	24	CD	DURATION	24	num	13	SENT_160	[p13l1132t263r1224b335],
13	hours	NNS	NUMBER	hour	nsubj	14	SENT_160	[p13l1286t261r1558b360],
14	)	VBP	O	)	dep	3	SENT_160	[p13l1286t261r1558b360],
15	that	IN	O	that	complm	24	SENT_160	[p13l1624t263r1789b337],
16	further	JJ	O	further	amod	17	SENT_160	[p13l1851t261r2151b337],
17	comparisons	NNS	O	comparison	nsubj	24	SENT_160	[p13l9t380r542b474],
18	with	IN	O	with	_	0	SENT_160	[p13l611t379r795b453],
19	G6PD	NN	O	g6pd	npadvmod	21	SENT_160	[p13l871t379r1539b453],
20	—	CD	NUMBER	—	num	19	SENT_160	[p13l871t379r1539b453],
21	deﬁcient	JJ	O	deﬁcient	amod	22	SENT_160	[p13l871t379r1539b453],
22	samples	NNS	O	sample	prep_with	17	SENT_160	[p13l1613t382r1947b477],
23	became	VBD	O	become	cop	24	SENT_160	[p13l2019t380r2151b451, p13l9t517r227b567],
24	pointless	JJ	O	pointless	ccomp	14	SENT_160	[p13l266t494r643b590],
25	(	NN	O	(	nn	26	SENT_160	[p13l686t494r904b590],
26	data	NNS	O	datum	tmod	24	SENT_160	[p13l686t494r904b590],
27	not	RB	O	not	neg	28	SENT_160	[p13l943t505r1082b567],
28	shown	VBN	O	show	partmod	26	SENT_160	[p13l1123t494r1448b592],
29	)	NN	O	)	dep	26	SENT_160	[p13l1123t494r1448b592],
30	.	.	O	.	_	0	SENT_160	[p13l1123t494r1448b592],

1	Fig	NN	O	fig	_	0	SENT_161	[p13l105t612r256b707],
2	.	.	O	.	_	0	SENT_161	[p13l105t612r256b707],

1	4	CD	NUMBER	4	num	3	SENT_162	[p13l306t612r349b684],
2	shows	NNS	O	show	nn	3	SENT_162	[p13l397t612r636b686],
3	studies	NNS	O	study	nsubjpass	8	SENT_162	[p13l684t612r963b687],
4	in	IN	O	in	_	0	SENT_162	[p13l1011t612r1086b684],
5	which	WDT	O	which	dep	6	SENT_162	[p13l1127t613r1369b686],
6	daunorubicin	NN	O	daunorubicin	prep_in	3	SENT_162	[p13l1414t612r1959b686],
7	was	VBD	O	be	auxpass	8	SENT_162	[p13l2000t636r2151b686],
8	added	VBN	O	add	conj_negcc	8	SENT_162	[p13l12t726r258b800],
9	without	IN	O	without	_	0	SENT_162	[p13l280t726r594b800],
10	doxorubicin	NN	O	doxorubicin	prep_without	8	SENT_162	[p13l621t727r1126b816],
11	,	,	O	,	_	0	SENT_162	[p13l621t727r1126b816],
12	G6P	NN	O	g6p	conj_or	10	SENT_162	[p13l1158t727r1357b816],
13	,	,	O	,	_	0	SENT_162	[p13l1158t727r1357b816],
14	or	CC	O	or	_	0	SENT_162	[p13l1386t752r1474b803],
15	NADP	NN	O	nadp	prep_without	8	SENT_162	[p13l1498t729r1777b803],
16	to	TO	O	to	_	0	SENT_162	[p13l1804t740r1882b802],
17	whole	JJ	O	whole	amod	18	SENT_162	[p13l1905t727r2150b803],
18	blood	NN	O	blood	prep_to	10	SENT_162	[p13l7t845r239b918],
19	rather	RB	O	rather	_	0	SENT_162	[p13l266t845r517b918],
20	than	IN	O	than	_	0	SENT_162	[p13l544t845r724b918],
21	to	TO	O	to	_	0	SENT_162	[p13l752t856r830b918],
22	hemolysate	NN	O	hemolysate	prep_to	8	SENT_162	[p13l859t844r1341b939],
23	.	.	O	.	_	0	SENT_162	[p13l859t844r1341b939],

1	The	DT	O	the	det	2	SENT_163	[p13l1370t847r1530b918],
2	data	NNS	O	datum	nsubj	3	SENT_163	[p13l1559t847r1735b921],
3	Show	NN	O	show	_	0	SENT_163	[p13l1762t847r1966b921],
4	that	IN	O	that	complm	12	SENT_163	[p13l1991t845r2151b918],
5	the	DT	O	the	det	6	SENT_163	[p13l7t960r136b1034],
6	difference	NN	O	difference	nsubj	12	SENT_163	[p13l173t960r575b1034],
7	in	IN	O	in	_	0	SENT_163	[p13l612t963r687b1034],
8	the	DT	O	the	det	9	SENT_163	[p13l719t963r848b1036],
9	bioconversion	NN	O	bioconversion	prep_in	6	SENT_163	[p13l882t960r1455b1037],
10	of	IN	O	of	_	0	SENT_163	[p13l1491t963r1577b1037],
11	daunorubicin	NN	O	daunorubicin	prep_of	9	SENT_163	[p13l1608t963r2150b1037],
12	found	VBN	O	find	ccomp	3	SENT_163	[p13l7t1082r248b1150],
13	in	IN	O	in	_	0	SENT_163	[p13l299t1082r372b1152],
14	GdA	NN	O	gda	prep_in	12	SENT_163	[p13l425t1082r678b1152],
15	"	''	O	"	punct	14	SENT_163	[p13l425t1082r678b1152],
16	and	CC	O	and	_	0	SENT_163	[p13l735t1084r883b1153],
17	non	JJ	O	non	conj_and	14	SENT_163	[p13l931t1081r1772b1155],
18	.	.	O	.	_	0	SENT_163	[p13l931t1081r1772b1155],

1	—	NN	O	—	_	0	SENT_164	[p13l931t1081r1772b1155],
2	.	.	O	.	_	0	SENT_164	[p13l931t1081r1772b1155],

1	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	4	SENT_165	[p13l931t1081r1772b1155],
2	hemoly	JJ	O	hemoly	amod	4	SENT_165	[p13l1820t1082r2148b1173],
3	—	NN	O	—	nn	4	SENT_165	[p13l1820t1082r2148b1173],
4	sates	NNS	O	sate	nsubj	5	SENT_165	[p13l7t1206r204b1270],
5	supplied	VBN	O	supply	_	0	SENT_165	[p13l259t1196r603b1291],
6	with	IN	O	with	_	0	SENT_165	[p13l654t1199r832b1270],
7	G6P	NN	O	g6p	prep_with	5	SENT_165	[p13l887t1197r1065b1270],
8	and	CC	O	and	_	0	SENT_165	[p13l1120t1197r1268b1270],
9	NADP	NN	O	nadp	nn	11	SENT_165	[p13l1323t1199r1604b1270],
10	(	CD	NUMBER	(	num	11	SENT_165	[p13l1662t1197r1845b1293],
11	Fig	NN	O	fig	prep_with	5	SENT_165	[p13l1662t1197r1845b1293],
12	.	.	O	.	_	0	SENT_165	[p13l1662t1197r1845b1293],

1	2	CD	NUMBER	2	nsubj	8	SENT_166	[p13l1902t1197r1948b1268],
2	and	CC	O	and	_	0	SENT_166	[p13l2003t1197r2151b1270],
3	Table	NNP	O	Table	conj_and	1	SENT_166	[p13l9t1314r242b1385],
4	I	PRP	O	I	nsubj	5	SENT_166	[p13l294t1314r358b1408],
5	)	VBP	O	)	rcmod	3	SENT_166	[p13l294t1314r358b1408],
6	was	VBD	O	be	cop	8	SENT_166	[p13l406t1337r554b1387],
7	also	RB	O	also	advmod	8	SENT_166	[p13l607t1314r762b1387],
8	demonstrable	JJ	O	demonstrable	_	0	SENT_166	[p13l815t1314r1373b1387],
9	in	IN	O	in	_	0	SENT_166	[p13l1421t1314r1499b1385],
10	intact	JJ	O	intact	amod	11	SENT_166	[p13l1547t1316r1775b1387],
11	erythrocytes	NNS	O	erythrocyte	prep_in	8	SENT_166	[p13l1823t1314r2151b1406, p13l9t1437r207b1522],
12	supported	VBN	O	support	partmod	11	SENT_166	[p13l268t1430r680b1525],
13	solely	RB	O	solely	advmod	12	SENT_166	[p13l740t1427r972b1522],
14	by	IN	O	by	_	0	SENT_166	[p13l1025t1427r1121b1522],
15	plasma	NN	O	plasma	nn	16	SENT_166	[p13l1176t1430r1467b1525],
16	glucose	NN	O	glucose	agent	12	SENT_166	[p13l1524t1430r1826b1524],
17	as	IN	O	as	_	0	SENT_166	[p13l1886t1451r1964b1501],
18	the	DT	O	the	det	19	SENT_166	[p13l2024t1430r2151b1501],
19	source	NN	O	source	prep_as	12	SENT_166	[p13l9t1568r274b1618],
20	of	IN	O	of	_	0	SENT_166	[p13l315t1547r400b1618],
21	energy	NN	O	energy	prep_of	19	SENT_166	[p13l432t1568r725b1641],
22	.	.	O	.	_	0	SENT_166	[p13l432t1568r725b1641],

1	The	DT	O	the	det	2	SENT_167	[p13l766t1547r925b1621],
2	biotransformation	NN	O	biotransformation	nsubj	8	SENT_167	[p13l962t1545r1710b1621],
3	of	IN	O	of	_	0	SENT_167	[p13l1748t1549r1833b1621],
4	dauno	NN	O	dauno	nn	6	SENT_167	[p13l1867t1547r2151b1618],
5	—	NN	O	—	nn	6	SENT_167	[p13l1867t1547r2151b1618],
6	rubicin	NN	O	rubicin	prep_of	2	SENT_167	[p13l9t1661r295b1735],
7	was	VBD	O	be	cop	8	SENT_167	[p13l339t1685r489b1735],
8	lower	JJR	O	lower	_	0	SENT_167	[p13l537t1664r764b1737],
9	in	IN	O	in	_	0	SENT_167	[p13l810t1664r886b1740],
10	GdA	NN	O	gda	prep_in	8	SENT_167	[p13l936t1664r1584b1737],
11	“	SYM	O	“	dep	8	SENT_167	[p13l936t1664r1584b1737],
12	-	:	O	-	_	0	SENT_167	[p13l936t1664r1584b1737],
13	deﬁcient	JJ	O	deﬁcient	amod	15	SENT_167	[p13l936t1664r1584b1737],
14	whole	JJ	O	whole	amod	15	SENT_167	[p13l1627t1666r1873b1737],
15	blood	NN	O	blood	dep	8	SENT_167	[p13l1918t1664r2153b1735],

1	592	CD	NUMBER	592	_	0	SENT_168	[p13l7t1792r132b1854],
2	Amifcii	NNP	O	Amifcii	dep	1	SENT_168	[p13l249t1792r497b1856],
3	,	,	O	,	_	0	SENT_168	[p13l249t1792r497b1856],
4	Bhoomo	NNP	PERSON	Bhoomo	dep	1	SENT_168	[p13l535t1794r856b1856],
5	,	,	O	,	_	0	SENT_168	[p13l535t1794r856b1856],
6	and	CC	O	and	_	0	SENT_168	[p13l892t1792r1037b1852],
7	Frischer	NNP	PERSON	Frischer	conj_and	2	SENT_168	[p13l1070t1792r1339b1852],

1	Nanomoles	NNP	O	Nanomoles	dep	5	SENT_169	[p13l672t2903r744b3366],
2	gm	NN	O	gm	npadvmod	5	SENT_169	[p13l647t2700r758b2874],
3	‘	CD	NUMBER	‘	num	4	SENT_169	[p13l647t2700r758b2874],
4	Hb	NN	O	hb	dep	2	SENT_169	[p13l670t2549r742b2660],
5	at	IN	O	at	_	0	SENT_169	[p13l673t2442r742b2518],
6	24	CD	DURATION	24	num	7	SENT_169	[p13l672t2316r740b2413],
7	hr	NN	DURATION	hr	pobj	5	SENT_169	[p13l670t2201r738b2278],
8	;	:	O	;	_	0	SENT_169	[p13l686t2030r774b2127],
9	,	,	O	,	_	0	SENT_169	[p13l686t2030r774b2127],

1	NADPH	NN	O	nadph	_	0	SENT_170	[p13l1402t3442r1693b3506],
2	:	:	O	:	_	0	SENT_170	[p13l1402t3442r1693b3506],

1	None	NN	O	none	_	0	SENT_171	[p13l1118t3550r1328b3620],
2	Coupled	JJ	O	coupled	amod	3	SENT_171	[p13l1372t3548r1705b3635],
3	Direct	JJ	O	direct	amod	1	SENT_171	[p13l1768t3548r1997b3620],

1	Nanomoles	NNP	O	Nanomoles	_	0	SENT_172	[p14l44t1613r119b2097],
2	gm	NN	O	gm	dep	1	SENT_172	[p14l20t1403r136b1583],
3	“	CD	NUMBER	“	num	2	SENT_172	[p14l20t1403r136b1583],
4	Hb	NN	O	hb	dep	10	SENT_172	[p14l47t1245r119b1359],
5	at	IN	O	at	_	0	SENT_172	[p14l49t1133r119b1213],
6	24	CD	DURATION	24	num	8	SENT_172	[p14l49t999r117b1103],
7	hr	NN	DURATION	hr	nn	8	SENT_172	[p14l47t877r117b962],
8	h	NN	O	h	prep_at	4	SENT_172	[p14l6t702r143b811],
9	-	:	O	-	_	0	SENT_172	[p14l6t702r143b811],
10	+	CC	O	+	rcmod	2	SENT_172	[p14l6t702r143b811],

1	oo	NN	O	oo	nn	3	SENT_173	[p14l202t825r244b900],
2	O1	NN	O	o1	nn	3	SENT_173	[p14l252t827r296b900],
3	oo	NN	O	oo	_	0	SENT_173	[p14l202t1009r244b1081],
4	CD	NNP	O	CD	nn	6	SENT_173	[p14l252t1011r296b1081],
5	[	CD	NUMBER	[	num	6	SENT_173	[p14l200t1190r246b1263],
6	o	NN	O	o	dep	3	SENT_173	[p14l200t1190r246b1263],
7	o	NN	O	o	dep	6	SENT_173	[p14l252t1190r296b1263],
8	'	''	O	'	_	0	SENT_173	[p14l252t1190r296b1263],
9	!	.	O	!	_	0	SENT_173	[p14l252t1190r296b1263],

1	DJ	NNP	O	DJ	nn	3	SENT_174	[p14l200t1367r244b1442],
2	C	NNP	O	C	nn	3	SENT_174	[p14l252t1370r296b1442],
3	)	NN	O	)	_	0	SENT_174	[p14l252t1370r296b1442],
4	...	:	O	...	_	0	SENT_174	[p14l204t1551r232b1621],
5	x	CC	O	x	cc	6	SENT_174	[p14l204t1551r232b1621],
6	U1	NN	O	u1	dep	3	SENT_174	[p14l252t1551r296b1621],
7	_	CD	NUMBER	_	dep	6	SENT_174	[p14l204t1731r229b1801],
8	x	CC	O	x	_	0	SENT_174	[p14l204t1731r229b1801],
9	O	NN	O	o	dep	6	SENT_174	[p14l250t1731r296b1803],

1	C	NN	O	c	_	0	SENT_175	[p14l250t2087r296b2157],
2	)	SYM	O	)	dep	1	SENT_175	[p14l250t2087r296b2157],

1	{	NN	O	{	_	0	SENT_176	[p14l1091t94r1302b172],
2	:1	CD	NUMBER	:1	dep	1	SENT_176	[p14l1091t94r1302b172],
3	Daunorubicin	NNP	O	Daunorubicin	nn	4	SENT_176	[p14l1358t96r1885b168],
4	Daunorubicinol	NNP	O	Daunorubicinol	dep	1	SENT_176	[p14l1358t244r1956b318],

1	J	NN	O	j	nn	2	SENT_177	[p14l1566t357r1601b421],
2	Lab	NN	O	lab	_	0	SENT_177	[p14l1638t357r1775b421],
3	Ciin	NNP	O	Ciin	nn	5	SENT_177	[p14l1805t354r1945b421],
4	Med	NNP	O	Med	nn	5	SENT_177	[p14l1980t355r2148b421],
5	June	NNP	PERCENT	June	dep	2	SENT_177	[p14l1765t457r1950b523],
6	19	CD	PERCENT	19	num	7	SENT_177	[p14l1987t456r2153b523],
7	%	NN	PERCENT	%	dep	2	SENT_177	[p14l1987t456r2153b523],

1	%	NN	O	%	_	0	SENT_178	[p14l1321t2059r1418b2120],
2	@	SYM	O	@	dep	4	SENT_178	[p14l1013t2092r1110b2120],
3	232	CD	NUMBER	232	num	4	SENT_178	[p14l1013t2092r1110b2120],
4	NADPH	NN	O	nadph	rcmod	1	SENT_178	[p14l811t2180r1116b2246],
5	:	:	O	:	_	0	SENT_178	[p14l811t2180r1116b2246],

1	None	NN	O	none	_	0	SENT_179	[p14l510t2276r731b2351],
2	Coupled	JJ	O	coupled	amod	3	SENT_179	[p14l814t2283r1161b2377],
3	Direct	JJ	O	direct	amod	1	SENT_179	[p14l1229t2278r1474b2356],
4	i	FW	O	i	dep	1	SENT_179	[p14l479t2557r703b2643],
5	:	:	O	:	_	0	SENT_179	[p14l479t2557r703b2643],
6	J	NNP	O	J	nn	7	SENT_179	[p14l479t2557r703b2643],
7	Doxorubicin	NNP	O	Doxorubicin	dep	4	SENT_179	[p14l759t2560r1250b2635],

1	`	``	O	`	_	0	SENT_180	[p14l492t2740r704b2811],
2	e	SYM	O	e	_	0	SENT_180	[p14l492t2740r704b2811],
3	-	:	O	-	_	0	SENT_180	[p14l492t2740r704b2811],
4	+	CC	O	+	dep	5	SENT_180	[p14l492t2740r704b2811],
5	Doxorubicinol	NNP	O	Doxorubicinol	dep	2	SENT_180	[p14l766t2737r1331b2815],

1	Fig	NN	O	fig	_	0	SENT_181	[p14l330t2873r382b2905],
2	.	.	O	.	_	0	SENT_181	[p14l330t2873r382b2905],

1	2	LS	NUMBER	2	_	0	SENT_182	[p14l400t2873r425b2898],
2	.	.	O	.	_	0	SENT_182	[p14l400t2873r425b2898],

1	Biotransformation	NN	O	biotransformation	nsubj	8	SENT_183	[p14l442t2872r704b2898],
2	of	IN	O	of	_	0	SENT_183	[p14l718t2872r748b2898],
3	daunorubicin	NN	O	daunorubicin	prep_of	1	SENT_183	[p14l759t2872r946b2898],
4	and	CC	O	and	_	0	SENT_183	[p14l960t2872r1011b2898],
5	of	IN	O	of	_	0	SENT_183	[p14l1024t2873r1054b2899],
6	doxorubicin	NN	O	doxorubicin	prep_of	7	SENT_183	[p14l1065t2872r1233b2898],
7	in	IN	O	in	conj_and	1	SENT_183	[p14l1246t2872r1272b2899],
8	destromatized	VBN	O	destromatize	_	0	SENT_183	[p14l1285t2872r1486b2899],
9	hemolysates	NNS	O	hemolysate	dobj	8	SENT_183	[p14l1498t2873r1670b2906],
10	from	IN	O	from	_	0	SENT_183	[p14l1684t2872r1751b2899],
11	nonG6PD-deﬁcient	JJ	O	nong6pd-deﬁcient	amod	12	SENT_183	[p14l1764t2881r1828b2899, p14l331t2913r553b2940],
12	persons	NNS	O	person	prep_from	8	SENT_183	[p14l570t2921r685b2947],
13	.	.	O	.	_	0	SENT_183	[p14l570t2921r685b2947],

1	A	DT	O	a	_	0	SENT_184	[p14l702t2914r731b2944],
2	,	,	O	,	_	0	SENT_184	[p14l702t2914r731b2944],
3	Biotransformation	NN	O	biotransformation	appos	1	SENT_184	[p14l748t2913r1010b2940],
4	of	IN	O	of	_	0	SENT_184	[p14l1027t2914r1057b2940],
5	daunorubicin	NN	O	daunorubicin	prep_of	3	SENT_184	[p14l1071t2913r1266b2940],
6	.	.	O	.	_	0	SENT_184	[p14l1071t2913r1266b2940],

1	B	NN	O	b	_	0	SENT_185	[p14l1284t2915r1312b2946],
2	,	,	O	,	_	0	SENT_185	[p14l1284t2915r1312b2946],
3	Biotransformation	NN	O	biotransformation	appos	1	SENT_185	[p14l1329t2914r1591b2940],
4	of	IN	O	of	_	0	SENT_185	[p14l1608t2914r1638b2940],
5	doxorubicin	NN	O	doxorubicin	prep_of	3	SENT_185	[p14l1652t2914r1828b2940],
6	.	.	O	.	_	0	SENT_185	[p14l1652t2914r1828b2940],

1	Daunorubicin	NN	O	daunorubicin	nn	2	SENT_186	[p14l330t2954r526b2981],
2	(	NN	O	(	nsubjpass	14	SENT_186	[p14l540t2953r601b2988],
3	200	CD	NUMBER	200	num	5	SENT_186	[p14l540t2953r601b2988],
4	ng/ml	NN	O	ng/ml	nn	5	SENT_186	[p14l613t2954r704b2988],
5	)	NN	O	)	dep	2	SENT_186	[p14l613t2954r704b2988],
6	and	CC	O	and	_	0	SENT_186	[p14l718t2954r769b2980],
7	doxorubicin	NN	O	doxorubicin	nn	8	SENT_186	[p14l781t2955r949b2981],
8	(	NN	O	(	nsubjpass	14	SENT_186	[p14l962t2954r1023b2989],
9	200	CD	NUMBER	200	num	11	SENT_186	[p14l962t2954r1023b2989],
10	ng/ml	NN	O	ng/ml	nn	11	SENT_186	[p14l1035t2955r1126b2989],
11	)	NN	O	)	dep	8	SENT_186	[p14l1035t2955r1126b2989],
12	were	VBD	O	be	auxpass	14	SENT_186	[p14l1138t2963r1207b2981],
13	each	DT	O	each	dep	14	SENT_186	[p14l1219t2955r1284b2981],
14	incubated	VBN	O	incubate	dep	45	SENT_186	[p14l1297t2955r1435b2981],
15	either	CC	O	either	preconj	14	SENT_186	[p14l1447t2955r1530b2981],
16	with	IN	O	with	_	0	SENT_186	[p14l1541t2955r1602b2981],
17	buffer	NN	O	buffer	prep_with	14	SENT_186	[p14l1613t2955r1697b2981],
18	alone	RB	O	alone	advmod	14	SENT_186	[p14l1709t2956r1786b2982],
19	or	CC	O	or	_	0	SENT_186	[p14l1799t2963r1829b2981],
20	with	IN	O	with	_	0	SENT_186	[p14l328t2996r390b3022],
21	1	CD	NUMBER	1	num	22	SENT_186	[p14l403t2996r415b3022],
22	mmol/L	NN	O	mmol/l	conj_or	17	SENT_186	[p14l429t2995r542b3024],
23	each	DT	O	each	dobj	14	SENT_186	[p14l553t2996r617b3022],
24	of	IN	O	of	_	0	SENT_186	[p14l630t2996r660b3022],
25	G6P	NN	O	g6p	prep_of	23	SENT_186	[p14l670t2996r732b3022],
26	and	CC	O	and	_	0	SENT_186	[p14l745t2997r795b3022],
27	NADP	NN	ORGANIZATION	nadp	prep_of	23	SENT_186	[p14l808t2997r913b3027],
28	,	,	O	,	_	0	SENT_186	[p14l808t2997r913b3027],
29	or	CC	O	or	_	0	SENT_186	[p14l926t3004r956b3022],
30	with	IN	O	with	conj_or	23	SENT_186	[p14l966t2996r1028b3022],
31	1	CD	NUMBER	1	num	33	SENT_186	[p14l1041t2998r1054b3022],
32	mmol/L	NN	O	mmol/l	nn	33	SENT_186	[p14l1067t2996r1180b3025],
33	NADPH	NN	O	nadph	pobj	30	SENT_186	[p14l1190t2997r1315b3023],
34	(	CD	NUMBER	(	num	36	SENT_186	[p14l1328t2996r1432b3031],
35	direct	JJ	O	direct	amod	36	SENT_186	[p14l1328t2996r1432b3031],
36	)	NN	O	)	dep	23	SENT_186	[p14l1328t2996r1432b3031],
37	for	IN	O	for	_	0	SENT_186	[p14l1446t2996r1487b3022],
38	24	CD	DURATION	24	num	39	SENT_186	[p14l1498t2997r1531b3023],
39	hours	NNS	NUMBER	hour	prep_for	36	SENT_186	[p14l1543t2997r1621b3023],
40	at	IN	O	at	_	0	SENT_186	[p14l1634t3000r1660b3022],
41	37	CD	NUMBER	37	num	42	SENT_186	[p14l1672t2996r1715b3023],
42	°	CD	NUMBER	°	prep_at	39	SENT_186	[p14l1672t2996r1715b3023],
43	C.	NNP	O	C.	nn	44	SENT_186	[p14l1725t2998r1754b3023],
44	Bars	NNP	O	Bars	nsubj	45	SENT_186	[p14l1765t2998r1828b3023],
45	represent	VBP	O	represent	_	0	SENT_186	[p14l330t3040r464b3071],
46	mean	JJ	O	mean	amod	47	SENT_186	[p14l474t3044r552b3062],
47	1	CD	NUMBER	1	nn	53	SENT_186	[p14l565t3041r586b3062],
48	SD	NN	O	sd	nn	50	SENT_186	[p14l600t3037r643b3063],
49	(	NN	O	(	nn	50	SENT_186	[p14l655t3037r683b3071],
50	n	NN	O	n	dep	47	SENT_186	[p14l655t3037r683b3071],
51	=	JJ	O	=	amod	53	SENT_186	[p14l697t3046r718b3055],
52	4	CD	NUMBER	4	tmod	51	SENT_186	[p14l731t3036r767b3071],
53	)	NN	O	)	dobj	45	SENT_186	[p14l731t3036r767b3071],
54	.	.	O	.	_	0	SENT_186	[p14l731t3036r767b3071],

1	Values	NNS	O	value	nsubjpass	3	SENT_187	[p14l778t3037r875b3063],
2	are	VBP	O	be	auxpass	3	SENT_187	[p14l886t3045r931b3063],
3	expressed	VBN	O	express	_	0	SENT_187	[p14l941t3038r1079b3071],
4	as	IN	O	as	_	0	SENT_187	[p14l1090t3045r1117b3063],
5	nanomoles	NNS	O	nanomole	prep_as	3	SENT_187	[p14l1128t3037r1282b3064],
6	per	IN	O	per	_	0	SENT_187	[p14l1291t3046r1339b3072],
7	gram	NN	O	gram	prep_per	5	SENT_187	[p14l1348t3046r1421b3071],
8	of	IN	O	of	_	0	SENT_187	[p14l1431t3037r1461b3063],
9	hemoglobin	NN	O	hemoglobin	prep_of	7	SENT_187	[p14l1469t3037r1637b3071],
10	at	IN	O	at	_	0	SENT_187	[p14l1648t3041r1673b3063],
11	the	DT	O	the	det	12	SENT_187	[p14l1683t3038r1728b3064],
12	end	NN	O	end	prep_at	3	SENT_187	[p14l1738t3038r1790b3064],
13	of	IN	O	of	prep	12	SENT_187	[p14l1802t3038r1831b3064],

1	24	CD	DURATION	24	num	2	SENT_188	[p14l572t3088r645b3148],
2	hours	NNS	DURATION	hour	_	0	SENT_188	[p14l674t3089r856b3147],
3	of	IN	O	of	_	0	SENT_188	[p14l885t3089r954b3147],
4	incubation	NN	O	incubation	prep_of	2	SENT_188	[p14l978t3089r1341b3147],
5	.	.	O	.	_	0	SENT_188	[p14l978t3089r1341b3147],

1	.	.	O	.	_	0	SENT_189	[p15l428t132r594b182],

1	—	NN	O	—	_	0	SENT_190	[p15l428t132r594b182],
2	.	.	O	.	_	0	SENT_190	[p15l428t132r594b182],

1	O	NN	O	o	nn	2	SENT_191	[p15l428t132r594b182],
2	Daunorubicin	NN	O	daunorubicin	_	0	SENT_191	[p15l637t129r1049b186],

1	—	NN	O	—	_	0	SENT_192	[p15l421t276r587b321],
2	l	NN	O	l	dep	1	SENT_192	[p15l421t276r587b321],
3	—	CD	NUMBER	—	num	4	SENT_192	[p15l421t276r587b321],
4	Daunorubicinol	NN	O	daunorubicinol	dep	1	SENT_192	[p15l630t271r1100b328],

1	Nanomoles	NNP	O	Nanomoles	_	0	SENT_193	[p15l43t925r98b1281],
2	/	:	O	/	punct	3	SENT_193	[p15l43t883r98b903],
3	hr	NN	DURATION	hr	dep	1	SENT_193	[p15l43t800r98b859],

1	Hemoglobin	NN	O	hemoglobin	nn	3	SENT_194	[p15l915t2160r1285b2232],
2	(	NN	O	(	nn	3	SENT_194	[p15l1317t2159r1431b2230],
3	gld	NN	O	gld	_	0	SENT_194	[p15l1317t2159r1431b2230],
4	I	PRP	O	I	nsubj	5	SENT_194	[p15l1440t2160r1471b2228],
5	)	VBP	O	)	rcmod	3	SENT_194	[p15l1440t2160r1471b2228],

1	Fig	NN	O	fig	_	0	SENT_195	[p15l6t2370r130b2441],
2	.	.	O	.	_	0	SENT_195	[p15l6t2370r130b2441],

1	3	LS	NUMBER	3	_	0	SENT_196	[p15l171t2368r228b2424],
2	.	.	O	.	_	0	SENT_196	[p15l171t2368r228b2424],

1	Daunorubicin	NN	O	daunorubicin	nn	2	SENT_197	[p15l270t2368r726b2425],
2	metabolism	NN	O	metabolism	_	0	SENT_197	[p15l748t2365r1130b2427],
3	at	IN	O	at	_	0	SENT_197	[p15l1152t2377r1211b2427],
4	varying	VBG	O	vary	amod	6	SENT_197	[p15l1229t2368r1469b2443],
5	hemoglobin	NN	O	hemoglobin	nn	6	SENT_197	[p15l1488t2368r1877b2445],
6	concentrations	NNS	O	concentration	prep_at	2	SENT_197	[p15l1899t2387r2153b2427, p15l8t2462r274b2521],
7	.	.	O	.	_	0	SENT_197	[p15l1899t2387r2153b2427, p15l8t2462r274b2521],

1	The	DT	O	the	det	3	SENT_198	[p15l310t2461r441b2518],
2	upper	JJ	O	upper	amod	3	SENT_198	[p15l470t2480r654b2540],
3	part	NN	O	part	nsubj	7	SENT_198	[p15l670t2473r807b2537],
4	of	IN	O	of	_	0	SENT_198	[p15l839t2462r907b2521],
5	the	DT	O	the	det	6	SENT_198	[p15l936t2462r1039b2518],
6	ﬁgure	NN	O	ﬁgure	prep_of	3	SENT_198	[p15l1071t2461r1260b2539],
7	shows	VBZ	O	show	_	0	SENT_198	[p15l1294t2464r1485b2521],
8	the	DT	O	the	det	9	SENT_198	[p15l1519t2462r1622b2521],
9	daunorubicinol	NN	O	daunorubicinol	dobj	7	SENT_198	[p15l1655t2464r2153b2523],
10	formed	VBN	O	form	partmod	9	SENT_198	[p15l8t2556r265b2627],
11	,	,	O	,	_	0	SENT_198	[p15l8t2556r265b2627],
12	and	CC	O	and	_	0	SENT_198	[p15l303t2556r422b2612],
13	the	DT	O	the	det	16	SENT_198	[p15l459t2555r562b2615],
14	lower	JJR	O	lower	amod	16	SENT_198	[p15l595t2558r770b2615],
15	pan	NN	O	pan	nn	16	SENT_198	[p15l790t2567r928b2633],
16	‘	NN	O	‘	nsubj	17	SENT_198	[p15l790t2567r928b2633],
17	shows	VBZ	O	show	conj_and	7	SENT_198	[p15l962t2556r1155b2617],
18	the	DT	O	the	det	19	SENT_198	[p15l1191t2558r1292b2615],
19	amount	NN	O	amount	nsubj	22	SENT_198	[p15l1333t2565r1582b2615],
20	of	IN	O	of	_	0	SENT_198	[p15l1618t2560r1687b2617],
21	daunorubicin	NN	O	daunorubicin	prep_of	19	SENT_198	[p15l1718t2558r2153b2617],
22	decreased	VBD	O	decrease	ccomp	17	SENT_198	[p15l11t2652r336b2712],
23	when	WRB	O	when	advmod	24	SENT_198	[p15l363t2650r538b2712],
24	incubated	VBN	O	incubate	advcl	22	SENT_198	[p15l567t2652r889b2712],
25	with	IN	O	with	_	0	SENT_198	[p15l915t2652r1056b2709],
26	1	CD	NUMBER	1	num	28	SENT_198	[p15l1090t2654r1116b2711],
27	mmol/L	NN	O	mmol/l	nn	28	SENT_198	[p15l1150t2652r1411b2719],
28	NADPH	NN	O	nadph	prep_with	24	SENT_198	[p15l1437t2652r1742b2714],
29	.	.	O	.	_	0	SENT_198	[p15l1437t2652r1742b2714],

1	than	IN	O	than	amod	8	SENT_199	[p15l8t2896r190b2967],
2	in	IN	O	in	_	0	SENT_199	[p15l219t2896r295b2967],
3	nondeﬁcient	JJ	O	nondeﬁcient	amod	4	SENT_199	[p15l324t2894r838b2967],
4	blood	NN	O	blood	prep_in	1	SENT_199	[p15l864t2896r1100b2969],
5	at	IN	O	at	_	0	SENT_199	[p15l1131t2908r1204b2969],
6	both	DT	O	both	det	7	SENT_199	[p15l1231t2896r1420b2969],
7	time	NN	O	time	prep_at	1	SENT_199	[p15l1449t2896r1629b2969],
8	points	NNS	O	point	nsubj	9	SENT_199	[p15l1658t2898r1907b2993],
9	monitored	VBD	O	monitor	_	0	SENT_199	[p15l1938t2919r2151b2969, p15l11t3009r255b3082],
10	(	RB	O	(	advmod	9	SENT_199	[p15l294t3007r420b3103],
11	20	CD	NUMBER	20	nn	14	SENT_199	[p15l294t3007r420b3103],
12	and	CC	O	and	_	0	SENT_199	[p15l458t3011r608b3082],
13	60	CD	DURATION	60	conj_and	11	SENT_199	[p15l644t3011r736b3082],
14	minutes	NNS	NUMBER	minute	tmod	9	SENT_199	[p15l772t3009r1153b3105],
15	)	CD	NUMBER	)	dep	14	SENT_199	[p15l772t3009r1153b3105],
16	.	.	O	.	_	0	SENT_199	[p15l772t3009r1153b3105],

1	Fig	NN	O	fig	_	0	SENT_200	[p15l104t3121r251b3214],
2	.	.	O	.	_	0	SENT_200	[p15l104t3121r251b3214],

1	5	CD	NUMBER	5	nsubj	2	SENT_201	[p15l294t3123r334b3191],
2	extends	VBZ	O	extend	_	0	SENT_201	[p15l377t3123r673b3193],
3	the	DT	O	the	det	5	SENT_201	[p15l711t3123r835b3193],
4	previous	JJ	O	previous	amod	5	SENT_201	[p15l874t3121r1209b3214],
5	results	NNS	O	result	dobj	2	SENT_201	[p15l1247t3123r1501b3193],
6	by	IN	O	by	_	0	SENT_201	[p15l1537t3123r1631b3214],
7	carrying	VBG	O	carry	prepc_by	2	SENT_201	[p15l1667t3123r1984b3216],
8	out	RP	O	out	prt	7	SENT_201	[p15l2022t3135r2151b3193],
9	the	DT	O	the	det	10	SENT_201	[p15l8t3235r132b3303],
10	incubations	NNS	O	incubation	dobj	7	SENT_201	[p15l164t3232r615b3305],
11	with	IN	O	with	_	0	SENT_201	[p15l642t3235r814b3306],
12	whole	JJ	O	whole	amod	13	SENT_201	[p15l841t3233r1079b3305],
13	blood	NN	O	blood	prep_with	7	SENT_201	[p15l1108t3235r1334b3305],
14	for	IN	O	for	_	0	SENT_201	[p15l1365t3235r1480b3305],
15	24	CD	DURATION	24	num	16	SENT_201	[p15l1509t3235r1601b3305],
16	hours	NNS	NUMBER	hour	prep_for	13	SENT_201	[p15l1632t3237r1854b3308],
17	and	CC	O	and	_	0	SENT_201	[p15l1885t3237r2030b3308],
18	by	IN	O	by	_	0	SENT_201	[p15l2059t3237r2153b3328],
19	comparing	VBG	O	compare	prepc_by	2	SENT_201	[p15l19t3349r436b3442],
20	the	DT	O	the	det	21	SENT_201	[p15l477t3349r600b3419],
21	biotransformation	NN	O	biotransformation	dobj	19	SENT_201	[p15l641t3347r1355b3422],
22	of	IN	O	of	_	0	SENT_201	[p15l1395t3349r1480b3422],
23	daunorubicin	NN	O	daunorubicin	prep_of	21	SENT_201	[p15l1518t3349r2037b3422],
24	in	IN	O	in	_	0	SENT_201	[p15l2078t3349r2153b3422],
25	blood	NN	O	blood	nn	26	SENT_201	[p15l16t3462r242b3535],
26	samples	NNS	O	sample	prep_in	23	SENT_201	[p15l287t3462r598b3558],
27	with	IN	O	with	_	0	SENT_201	[p15l639t3463r809b3535],
28	either	CC	O	either	preconj	29	SENT_201	[p15l854t3465r1082b3538],
29	GdA	NN	O	gda	prep_with	19	SENT_201	[p15l1127t3463r1376b3538],
30	“	CD	NUMBER	“	num	29	SENT_201	[p15l1127t3463r1376b3538],
31	or	CC	O	or	_	0	SENT_201	[p15l1428t3488r1512b3538],
32	Gd	JJ	MISC	gd	amod	35	SENT_201	[p15l1555t3465r1679b3538],
33	Mediterranean	JJ	MISC	mediterranean	amod	35	SENT_201	[p15l1724t3465r2151b3538, p15l19t3602r209b3651],
34	G6PD	NN	O	g6pd	nn	35	SENT_201	[p15l259t3581r508b3654],
35	deﬁciency	NN	O	deﬁciency	prep_with	19	SENT_201	[p15l558t3579r964b3674],
36	.	.	O	.	_	0	SENT_201	[p15l558t3579r964b3674],

1	The	DT	O	the	det	2	SENT_202	[p15l1014t3578r1172b3654],
2	difference	NN	O	difference	_	0	SENT_202	[p15l1219t3579r1605b3654],
3	between	IN	O	between	_	0	SENT_202	[p15l1650t3578r1982b3654],
4	the	DT	O	the	det	6	SENT_202	[p15l2027t3581r2151b3654],
5	G6PD	NN	O	g6pd	nn	6	SENT_202	[p15l19t3694r267b3766],
6	GdA	NN	O	gda	prep_between	2	SENT_202	[p15l294t3694r917b3768],
7	'	''	O	'	_	0	SENT_202	[p15l294t3694r917b3768],
8	.	.	O	.	_	0	SENT_202	[p15l294t3694r917b3768],

1	—	NN	O	—	_	0	SENT_203	[p15l294t3694r917b3768],
2	.	.	O	.	_	0	SENT_203	[p15l294t3694r917b3768],

1	deﬁcient	NN	O	deﬁcient	nn	5	SENT_204	[p15l294t3694r917b3768],
2	and	CC	O	and	_	0	SENT_204	[p15l942t3694r1086b3766],
3	control	NN	O	control	conj_and	1	SENT_204	[p15l1108t3696r1387b3768],
4	blood	NN	O	blood	nn	5	SENT_204	[p15l1407t3696r1635b3768],
5	samples	NNS	O	sample	nsubj	6	SENT_204	[p15l1657t3694r1968b3789],
6	persisted	VBD	O	persist	_	0	SENT_204	[p15l1990t3719r2148b3791, p16l16t14r235b89],

1	for	IN	O	for	_	0	SENT_205	[p16l282t16r397b89],
2	at	IN	DURATION	at	quantmod	4	SENT_205	[p16l447t25r519b89],
3	least	JJS	DURATION	least	mwe	2	SENT_205	[p16l567t16r746b89],
4	24	CD	DURATION	24	num	5	SENT_205	[p16l794t18r885b89],
5	hours	NNS	NUMBER	hour	pobj	1	SENT_205	[p16l933t16r1172b89],
6	.	.	O	.	_	0	SENT_205	[p16l933t16r1172b89],

1	GdA	NN	O	gda	nn	4	SENT_206	[p16l1226t16r1475b89],
2	‘	CD	NUMBER	‘	num	4	SENT_206	[p16l1226t16r1475b89],
3	G6PD	NN	O	g6pd	nn	4	SENT_206	[p16l1532t16r2151b92],
4	—	NN	O	—	nsubj	28	SENT_206	[p16l1532t16r2151b92],
5	deﬁcient	JJ	O	deﬁcient	amod	6	SENT_206	[p16l1532t16r2151b92],
6	erythrocytes	NNS	O	erythrocyte	dep	4	SENT_206	[p16l19t132r494b227],
7	supported	VBN	O	support	partmod	4	SENT_206	[p16l525t134r922b227],
8	at	IN	O	at	_	0	SENT_206	[p16l956t143r1026b206],
9	body	NN	O	body	nn	10	SENT_206	[p16l1057t134r1250b227],
10	temperature	NN	O	temperature	prep_at	7	SENT_206	[p16l1280t143r1769b229],
11	by	IN	O	by	_	0	SENT_206	[p16l1798t134r1891b227],
12	physiologic	JJ	O	physiologic	amod	14	SENT_206	[p16l1918t134r2148b229, p16l16t248r251b341],
13	plasma	NN	O	plasma	nn	14	SENT_206	[p16l273t250r552b343],
14	glucose	NN	O	glucose	agent	7	SENT_206	[p16l574t248r864b341],
15	needed	VBN	O	need	partmod	14	SENT_206	[p16l889t248r1177b320],
16	about	IN	DURATION	about	_	0	SENT_206	[p16l1201t248r1424b323],
17	24	CD	DURATION	24	num	18	SENT_206	[p16l1448t250r1538b320],
18	hours	NNS	NUMBER	hour	prep_about	15	SENT_206	[p16l1562t247r1783b320],
19	to	TO	O	to	aux	20	SENT_206	[p16l1807t259r1885b320],
20	match	VB	O	match	xcomp	15	SENT_206	[p16l1907t250r2150b323],
21	quantitatively	RB	O	quantitatively	advmod	20	SENT_206	[p16l19t363r552b459],
22	the	DT	O	the	det	23	SENT_206	[p16l590t365r714b438],
23	biotransformation	NN	O	biotransformation	dobj	20	SENT_206	[p16l752t365r1468b438],
24	of	IN	O	of	_	0	SENT_206	[p16l1509t365r1593b438],
25	daunorubicin	NN	O	daunorubicin	prep_of	23	SENT_206	[p16l1629t365r2151b438],
26	to	TO	O	to	_	0	SENT_206	[p16l14t490r91b551],
27	daunorubicinol	NN	O	daunorubicinol	prep_to	25	SENT_206	[p16l123t478r718b554],
28	achieved	VBD	O	achieve	_	0	SENT_206	[p16l750t481r1093b553],
29	within	IN	O	within	_	0	SENT_206	[p16l1115t479r1362b553],
30	2	CD	DURATION	2	num	31	SENT_206	[p16l1393t481r1438b553],
31	hours	NNS	NUMBER	hour	prep_within	28	SENT_206	[p16l1467t481r1686b554],
32	by	IN	O	by	_	0	SENT_206	[p16l1712t479r1806b574],
33	erythrocytes	NNS	O	erythrocyte	prep_by	28	SENT_206	[p16l1835t481r2146b577, p16l16t606r202b690],
34	without	IN	O	without	_	0	SENT_206	[p16l222t597r524b670],
35	G6PD	NN	O	g6pd	nn	36	SENT_206	[p16l551t596r799b669],
36	deﬁciency	NN	O	deﬁciency	prep_without	28	SENT_206	[p16l824t596r1230b690],
37	.	.	O	.	_	0	SENT_206	[p16l824t596r1230b690],

1	The	DT	O	the	det	2	SENT_207	[p16l1256t597r1413b669],
2	biotransformation	NN	O	biotransformation	nsubj	8	SENT_207	[p16l1435t596r2148b669],
3	of	IN	O	of	_	0	SENT_207	[p16l16t710r98b782],
4	daunorubicin	NN	O	daunorubicin	prep_of	2	SENT_207	[p16l120t709r640b784],
5	was	VBD	O	be	cop	8	SENT_207	[p16l662t732r806b782],
6	even	RB	O	even	advmod	8	SENT_207	[p16l833t735r1015b785],
7	more	RBR	O	more	advmod	8	SENT_207	[p16l1039t732r1244b784],
8	depressed	JJ	O	depressed	_	0	SENT_207	[p16l1273t710r1662b807],
9	in	IN	O	in	_	0	SENT_207	[p16l1689t710r1762b782],
10	the	DT	O	the	det	12	SENT_207	[p16l1786t710r1910b784],
11	Mediterranean	NNP	LOCATION	Mediterranean	nn	12	SENT_207	[p16l1937t712r2148b784, p16l16t826r422b899],
12	type	NN	O	type	prep_in	8	SENT_207	[p16l454t838r619b922],
13	of	IN	O	of	_	0	SENT_207	[p16l655t826r737b899],
14	G6PD	NN	O	g6pd	nn	15	SENT_207	[p16l766t826r1015b902],
15	deﬁciency	NN	O	deﬁciency	prep_of	12	SENT_207	[p16l1051t826r1443b923],
16	so	IN	O	so	mark	21	SENT_207	[p16l1474t850r1556b899],
17	that	IN	O	that	dep	21	SENT_207	[p16l1590t829r1743b899],
18	Gd	NNP	MISC	Gd	nn	20	SENT_207	[p16l1779t827r1903b899],
19	Mediterranean	NNP	MISC	Mediterranean	nn	20	SENT_207	[p16l1937t829r2146b899, p16l14t942r420b1017],
20	blood	NN	O	blood	nsubj	21	SENT_207	[p16l458t941r686b1017],
21	generated	VBD	O	generate	advcl	8	SENT_207	[p16l727t944r1119b1037],
22	only	RB	O	only	advmod	25	SENT_207	[p16l1159t944r1327b1037],
23	half	PDT	O	half	predet	25	SENT_207	[p16l1368t944r1521b1017],
24	the	DT	O	the	det	25	SENT_207	[p16l1557t944r1681b1017],
25	amount	NN	O	amount	dobj	21	SENT_207	[p16l1726t955r2028b1017],
26	of	IN	O	of	_	0	SENT_207	[p16l2069t944r2153b1017],
27	daunorubicinol	NN	O	daunorubicinol	prep_of	25	SENT_207	[p16l14t1059r610b1131],
28	found	VBN	O	find	partmod	27	SENT_207	[p16l641t1059r873b1131],
29	in	IN	O	in	_	0	SENT_207	[p16l905t1061r980b1131],
30	GdA	NN	O	gda	prep_in	28	SENT_207	[p16l1014t1058r1260b1131],
31	'	''	O	'	_	0	SENT_207	[p16l1014t1058r1260b1131],
32	"	``	O	"	punct	30	SENT_207	[p16l1014t1058r1260b1131],
33	blood	NN	O	blood	dep	30	SENT_207	[p16l1296t1059r1524b1133],
34	after	IN	O	after	_	0	SENT_207	[p16l1557t1061r1739b1131],
35	24	CD	DURATION	24	num	36	SENT_207	[p16l1770t1059r1861b1131],
36	hours	NNS	NUMBER	hour	prep_after	28	SENT_207	[p16l1893t1061r2132b1134],
37	.	.	O	.	_	0	SENT_207	[p16l1893t1061r2132b1134],

1	Table	NNP	O	Table	nn	2	SENT_208	[p16l109t1172r341b1246],
2	III	NNP	O	III	nsubj	3	SENT_208	[p16l373t1176r478b1246],
3	shows	VBZ	O	show	_	0	SENT_208	[p16l509t1174r749b1246],
4	that	IN	O	that	complm	5	SENT_208	[p16l780t1174r938b1246],
5	known	VBN	O	know	ccomp	3	SENT_208	[p16l967t1174r1239b1247],
6	inhibitors	NNS	O	inhibitor	dobj	5	SENT_208	[p16l1268t1172r1658b1246],
7	of	IN	O	of	_	0	SENT_208	[p16l1687t1174r1776b1246],
8	carbonyl	NN	O	carbonyl	nn	9	SENT_208	[p16l1798t1174r2146b1270],
9	reductase	NN	O	reductase	prep_of	6	SENT_208	[p16l14t1286r880b1382],
10	.	.	O	.	_	0	SENT_208	[p16l14t1286r880b1382],

1	—	NN	O	—	_	0	SENT_209	[p16l14t1286r880b1382],
2	.	.	O	.	_	0	SENT_209	[p16l14t1286r880b1382],

1	~	NN	O	~	_	0	SENT_210	[p16l14t1286r880b1382],
2	.	.	O	.	_	0	SENT_210	[p16l14t1286r880b1382],

1	—	NN	O	—	_	0	SENT_211	[p16l14t1286r880b1382],
2	.	.	O	.	_	0	SENT_211	[p16l14t1286r880b1382],

1	-	:	O	-	_	0	SENT_212	[p16l14t1286r880b1382],
2	including	VBG	O	include	_	0	SENT_212	[p16l14t1286r880b1382],
3	phenanthrene	NN	O	phenanthrene	nn	4	SENT_212	[p16l919t1287r1491b1384],
4	quinone	NN	O	quinone	prep_including	15	SENT_212	[p16l1532t1287r1885b1384],
5	,	,	O	,	_	0	SENT_212	[p16l1532t1287r1885b1384],
6	rutin	NN	O	rutin	conj_and	4	SENT_212	[p16l1927t1289r2144b1375],
7	,	,	O	,	_	0	SENT_212	[p16l1927t1289r2144b1375],
8	menadione	NN	O	menadione	conj_and	4	SENT_212	[p16l14t1404r489b1493],
9	,	,	O	,	_	0	SENT_212	[p16l14t1404r489b1493],
10	and	CC	O	and	_	0	SENT_212	[p16l535t1404r681b1477],
11	Cibacron	NNP	PERSON	Cibacron	nn	12	SENT_212	[p16l722t1402r1095b1477],
12	blue	NN	O	blue	conj_and	4	SENT_212	[p16l1132t1404r1306b1477],
13	A	DT	O	a	det	14	SENT_212	[p16l1342t1404r1868b1493],
14	—	NN	O	—	nsubj	15	SENT_212	[p16l1342t1404r1868b1493],
15	blocked	VBD	O	block	_	0	SENT_212	[p16l1342t1404r1868b1493],
16	,	,	O	,	_	0	SENT_212	[p16l1342t1404r1868b1493],
17	as	IN	O	as	mark	18	SENT_212	[p16l1911t1427r1991b1479],
18	expected	VBN	O	expect	parataxis	15	SENT_212	[p16l2032t1427r2146b1477, p16l9t1521r302b1615],
19	,	,	O	,	_	0	SENT_212	[p16l2032t1427r2146b1477, p16l9t1521r302b1615],
20	the	DT	O	the	det	21	SENT_212	[p16l359t1521r487b1594],
21	biotransformation	NN	O	biotransformation	dobj	15	SENT_212	[p16l539t1518r1283b1594],
22	of	IN	O	of	_	0	SENT_212	[p16l1335t1521r1422b1594],
23	daunorubicin	NN	O	daunorubicin	prep_of	21	SENT_212	[p16l1469t1521r2012b1594],
24	to	TO	O	to	_	0	SENT_212	[p16l2066t1530r2144b1593],
25	daunorubicinol	NN	O	daunorubicinol	prep_to	23	SENT_212	[p16l12t1635r654b1707],
26	.	.	O	.	_	0	SENT_212	[p16l12t1635r654b1707],

1	Primaquine	NNP	O	Primaquine	nn	2	SENT_213	[p16l738t1635r1211b1731],
2	aldehyde	NN	O	aldehyde	nsubj	3	SENT_213	[p16l1293t1634r1658b1730],
3	interfered	VBD	O	interfere	_	0	SENT_213	[p16l1740t1634r2146b1707],
4	with	IN	O	with	mark	9	SENT_213	[p16l7t1752r184b1823],
5	the	DT	O	the	det	8	SENT_213	[p16l211t1753r339b1826],
6	carbonyl	NN	O	carbonyl	nn	8	SENT_213	[p16l368t1752r716b1844],
7	reductase	NN	O	reductase	nn	8	SENT_213	[p16l743t1755r1567b1826],
8	—	NN	O	—	nsubj	9	SENT_213	[p16l743t1755r1567b1826],
9	mediated	VBD	O	mediate	advcl	3	SENT_213	[p16l743t1755r1567b1826],
10	conversion	NN	O	conversion	dobj	9	SENT_213	[p16l1597t1755r2037b1826],
11	of	IN	O	of	_	0	SENT_213	[p16l2066t1755r2151b1826],
12	daunorubicin	NN	O	daunorubicin	prep_of	10	SENT_213	[p16l14t1869r554b1942],
13	to	TO	O	to	_	0	SENT_213	[p16l597t1878r677b1940],
14	daunorubicinol	NN	O	daunorubicinol	prep_to	9	SENT_213	[p16l722t1866r1364b1958],
15	,	,	O	,	_	0	SENT_213	[p16l722t1866r1364b1958],
16	while	IN	O	while	mark	34	SENT_213	[p16l1405t1869r1623b1942],
17	BCN	NNP	ORGANIZATION	BCN	nn	18	SENT_213	[p16l1668t1869r1873b1940],
18	U	NNP	ORGANIZATION	U	nsubj	34	SENT_213	[p16l1877t1869r1972b1958],
19	,	,	O	,	_	0	SENT_213	[p16l1877t1869r1972b1958],
20	the	DT	O	the	det	21	SENT_213	[p16l2018t1869r2144b1942],
21	compound	NN	O	compound	appos	18	SENT_213	[p16l12t1986r445b2077],
22	used	VBN	O	use	partmod	21	SENT_213	[p16l491t1986r677b2056],
23	in	IN	O	in	_	0	SENT_213	[p16l724t1984r802b2056],
24	earlier	JJR	O	earlier	amod	25	SENT_213	[p16l847t1986r1112b2059],
25	studies	NNS	O	study	prep_in	22	SENT_213	[p16l1159t1983r1438b2059],
26	to	TO	O	to	aux	27	SENT_213	[p16l1486t1995r1565b2056],
27	dissect	VB	O	dissect	xcomp	22	SENT_213	[p16l1613t1986r1882b2056],
28	druginduced	JJ	O	druginduced	amod	29	SENT_213	[p16l1930t1986r2144b2077, p16l12t2100r337b2173],
29	activation	NN	O	activation	dobj	27	SENT_213	[p16l373t2101r769b2174],
30	of	IN	O	of	_	0	SENT_213	[p16l805t2103r892b2173],
31	the	DT	O	the	det	32	SENT_213	[p16l921t2101r1047b2173],
32	HMS	NNP	O	HMS	prep_of	29	SENT_213	[p16l1085t2101r1325b2187],
33	,	,	O	,	_	0	SENT_213	[p16l1085t2101r1325b2187],
34	did	VBD	O	do	advcl	9	SENT_213	[p16l1365t2103r1491b2173],
35	not	RB	O	not	neg	34	SENT_213	[p16l1527t2112r1681b2173],
36	.	.	O	.	_	0	SENT_213	[p16l1527t2112r1681b2173],

1	DISCUSSION	NN	O	discussion	_	0	SENT_214	[p16l14t2354r508b2425],

1	The	DT	O	the	det	2	SENT_215	[p16l107t2505r267b2573],
2	data	NNS	O	datum	nsubj	3	SENT_215	[p16l308t2505r480b2575],
3	presented	VBD	O	present	_	0	SENT_215	[p16l518t2505r920b2598],
4	reveal	VBP	O	reveal	dep	3	SENT_215	[p16l960t2505r1204b2575],
5	that	IN	O	that	complm	8	SENT_215	[p16l1245t2505r1403b2575],
6	G6PD	NN	O	g6pd	nn	7	SENT_215	[p16l1444t2507r1697b2575],
7	deﬁciency	NN	O	deﬁciency	nsubj	8	SENT_215	[p16l1740t2503r2146b2596],
8	interacts	VBZ	O	interact	ccomp	4	SENT_215	[p16l9t2618r358b2691],
9	with	IN	O	with	_	0	SENT_215	[p16l394t2618r568b2688],
10	the	DT	O	the	det	13	SENT_215	[p16l609t2618r735b2688],
11	main	JJ	O	main	amod	13	SENT_215	[p16l775t2618r977b2690],
12	carbonyl	NN	O	carbonyl	nn	13	SENT_215	[p16l1018t2615r1366b2709],
13	reductase	NN	O	reductase	prep_with	8	SENT_215	[p16l1405t2618r2139b2711],
14	—	CD	NUMBER	—	num	17	SENT_215	[p16l1405t2618r2139b2711],
15	depen	NN	O	depen	nn	17	SENT_215	[p16l1405t2618r2139b2711],
16	—	NN	O	—	nn	17	SENT_215	[p16l1405t2618r2139b2711],
17	dent	NN	O	dent	nsubj	4	SENT_215	[p16l9t2731r191b2801],
18	pathway	NN	O	pathway	dep	4	SENT_215	[p16l234t2733r573b2823],
19	for	IN	O	for	_	0	SENT_215	[p16l616t2731r735b2801],
20	anthracycline	NN	O	anthracycline	nn	21	SENT_215	[p16l780t2730r1322b2822],
21	metabolism	NN	O	metabolism	prep_for	4	SENT_215	[p16l1368t2731r1845b2804],
22	in	IN	O	in	_	0	SENT_215	[p16l1888t2733r1963b2804],
23	huJ	NN	O	huj	prep_in	21	SENT_215	[p16l2006t2733r2139b2801, p16l93t2898r106b2924],

1	LC1b	NN	O	lc1b	nn	3	SENT_216	[p16l123t2898r180b2925],
2	Clin	NNP	O	Clin	nn	3	SENT_216	[p16l194t2898r252b2925],
3	Med	NNP	O	Med	_	0	SENT_216	[p16l266t2898r338b2925],
4	Volume	NN	O	volume	dep	3	SENT_216	[p16l94t2939r218b2966],
5	127	CD	NUMBER	127	num	4	SENT_216	[p16l233t2939r291b2969],
6	,	,	O	,	_	0	SENT_216	[p16l233t2939r291b2969],
7	Number	NNP	O	Number	appos	4	SENT_216	[p16l307t2939r437b2966],
8	6	CD	NUMBER	6	num	7	SENT_216	[p16l448t2939r465b2967],
9	Amitoii	NNP	O	Amitoii	dep	7	SENT_216	[p16l1485t2941r1593b2970],
10	.	.	O	.	_	0	SENT_216	[p16l1485t2941r1593b2970],

1	Bhoomo	NNP	PERSON	Bhoomo	_	0	SENT_217	[p16l1610t2941r1750b2970],
2	,	,	O	,	_	0	SENT_217	[p16l1610t2941r1750b2970],
3	cind	NN	O	cind	nn	4	SENT_217	[p16l1765t2941r1829b2968],
4	Frischer	NN	PERSON	frischer	appos	1	SENT_217	[p16l1843t2941r1960b2968],
5	593	CD	NUMBER	593	dep	1	SENT_217	[p16l2010t2941r2065b2969],

1	Table	NNP	O	Table	nn	5	SENT_218	[p16l94t3045r191b3076],
2	l.	NNP	O	l.	nn	5	SENT_218	[p16l206t3045r223b3075],
3	Restricted	NNP	O	Restricted	nn	5	SENT_218	[p16l240t3045r416b3076],
4	daunorubicin	NN	O	daunorubicin	nn	5	SENT_218	[p16l432t3045r672b3076],
5	removal	NN	O	removal	_	0	SENT_218	[p16l689t3046r834b3076],
6	in	IN	O	in	_	0	SENT_218	[p16l851t3046r877b3076],
7	G6PD	NN	O	g6pd	nn	8	SENT_218	[p16l893t3045r994b3076],
8	deficiency	NN	O	deficiency	prep_in	5	SENT_218	[p16l1008t3045r1199b3084],
9	(	CD	NUMBER	(	num	10	SENT_218	[p16l1214t3046r1349b3084],
10	GdA	NN	O	gda	dep	5	SENT_218	[p16l1214t3046r1349b3084],
11	’	CD	NUMBER	’	num	12	SENT_218	[p16l1214t3046r1349b3084],
12	)	NN	O	)	dep	10	SENT_218	[p16l1214t3046r1349b3084],

1	Coupled	JJ	O	coupled	amod	3	SENT_219	[p16l610t3120r732b3149],
2	(	NN	O	(	nn	3	SENT_219	[p16l744t3120r925b3148],
3	G6P	NN	O	g6p	_	0	SENT_219	[p16l744t3120r925b3148],
4	+	CC	O	+	_	0	SENT_219	[p16l744t3120r925b3148],
5	NADP	NN	O	nadp	conj_+	3	SENT_219	[p16l744t3120r925b3148],
6	)	CD	NUMBER	)	num	9	SENT_219	[p16l744t3120r925b3148],
7	Direct	JJ	O	direct	amod	9	SENT_219	[p16l1529t3121r1611b3145],
8	(	NN	O	(	nn	9	SENT_219	[p16l1622t3121r1740b3149],
9	NADPH	NN	O	nadph	dep	3	SENT_219	[p16l1622t3121r1740b3149],
10	)	CD	NUMBER	)	dep	9	SENT_219	[p16l1622t3121r1740b3149],

1	Group	NNP	O	Group	_	0	SENT_220	[p16l169t3174r257b3203],
2	15	CD	DURATION	15	num	3	SENT_220	[p16l402t3174r431b3198],
3	minutes	NNS	NUMBER	minute	dep	1	SENT_220	[p16l442t3174r551b3198],
4	30	CD	DURATION	30	num	5	SENT_220	[p16l684t3174r716b3198],
5	minutes	NNS	NUMBER	minute	tmod	3	SENT_220	[p16l727t3175r836b3198],
6	60	CD	DURATION	60	num	7	SENT_220	[p16l977t3175r1009b3198],
7	minutes	NNS	NUMBER	minute	tmod	3	SENT_220	[p16l1020t3175r1128b3198],
8	15	CD	DURATION	15	num	9	SENT_220	[p16l1273t3175r1301b3198],
9	minutes	NNS	NUMBER	minute	tmod	3	SENT_220	[p16l1313t3175r1421b3199],
10	30	CD	DURATION	30	num	11	SENT_220	[p16l1556t3175r1588b3199],
11	minutes	NNS	NUMBER	minute	tmod	3	SENT_220	[p16l1599t3176r1707b3199],
12	60	CD	DURATION	60	num	13	SENT_220	[p16l1845t3176r1877b3199],
13	minutes	NNS	NUMBER	minute	tmod	3	SENT_220	[p16l1888t3176r1996b3199],

1	Control	NN	O	control	_	0	SENT_221	[p16l163t3247r265b3274],
2	5.3	CD	NUMBER	5.3	num	1	SENT_221	[p16l407t3248r452b3274],
3	i	FW	O	i	dep	8	SENT_221	[p16l465t3251r486b3273],
4	1.3	CD	NUMBER	1.3	number	5	SENT_221	[p16l501t3248r544b3274],
5	9.5	CD	NUMBER	9.5	dep	3	SENT_221	[p16l692t3248r736b3274],
6	i	FW	O	i	dep	5	SENT_221	[p16l750t3251r771b3273],
7	2.5	CD	NUMBER	2.5	dep	8	SENT_221	[p16l784t3248r828b3274],
8	15.4	CD	NUMBER	15.4	dep	1	SENT_221	[p16l971t3249r1032b3274],
9	1	CD	NUMBER	1	number	10	SENT_221	[p16l1046t3252r1067b3273],
10	2.6	CD	NUMBER	2.6	dep	8	SENT_221	[p16l1080t3249r1137b3275],
11	*	NN	O	*	dep	10	SENT_221	[p16l1080t3249r1137b3275],
12	7.2	CD	NUMBER	7.2	num	11	SENT_221	[p16l1277t3249r1320b3275],
13	:	:	O	:	_	0	SENT_221	[p16l1334t3252r1355b3274],
14	1.4	CD	NUMBER	1.4	number	15	SENT_221	[p16l1371t3249r1413b3274],
15	12.3	CD	NUMBER	12.3	dep	1	SENT_221	[p16l1555t3249r1616b3275],
16	I	PRP	O	I	dep	15	SENT_221	[p16l1630t3253r1650b3274],
17	3.6	CD	NUMBER	3.6	num	18	SENT_221	[p16l1664t3250r1709b3275],
18	19.7	CD	NUMBER	19.7	dep	15	SENT_221	[p16l1844t3250r1905b3276],
19	:	:	O	:	_	0	SENT_221	[p16l1919t3253r1940b3275],
20	2.9	CD	NUMBER	2.9	dep	15	SENT_221	[p16l1953t3250r1997b3276],

1	G6PD	NN	O	g6pd	dep	6	SENT_222	[p16l163t3340r248b3366],
2	1.0	CD	NUMBER	1.0	num	1	SENT_222	[p16l409t3341r452b3366],
3	i	FW	O	i	dep	1	SENT_222	[p16l465t3344r486b3365],
4	0.8	CD	NUMBER	0.8	dep	6	SENT_222	[p16l500t3341r545b3366],
5	2.5	CD	NUMBER	2.5	num	6	SENT_222	[p16l692t3341r736b3367],
6	t	NN	O	t	dep	11	SENT_222	[p16l750t3344r771b3365],
7	2.1	CD	NUMBER	2.1	number	8	SENT_222	[p16l784t3341r824b3366],
8	6.0	CD	NUMBER	6.0	dep	6	SENT_222	[p16l988t3341r1033b3367],
9	i	FW	O	i	dep	8	SENT_222	[p16l1046t3344r1067b3366],
10	5.0	CD	NUMBER	5.0	num	11	SENT_222	[p16l1080t3342r1125b3367],
11	6.2	CD	NUMBER	6.2	dep	20	SENT_222	[p16l1277t3342r1320b3367],
12	1	CD	NUMBER	1	number	13	SENT_222	[p16l1334t3345r1356b3366],
13	3.4	CD	NUMBER	3.4	dep	11	SENT_222	[p16l1368t3342r1413b3367],
14	8.7	CD	NUMBER	8.7	num	15	SENT_222	[p16l1572t3342r1616b3368],
15	t	NN	O	t	dep	13	SENT_222	[p16l1630t3345r1650b3367],
16	5.1	CD	NUMBER	5.1	number	17	SENT_222	[p16l1664t3343r1703b3368],
17	15.3	CD	NUMBER	15.3	dep	13	SENT_222	[p16l1845t3343r1905b3368],
18	i	FW	O	i	dep	17	SENT_222	[p16l1919t3346r1939b3367],
19	7.6	CD	NUMBER	7.6	num	20	SENT_222	[p16l1953t3343r1997b3369],
20	Gd/V	NN	O	gd/v	dep	29	SENT_222	[p16l163t3383r244b3409],
21	(	CD	NUMBER	(	number	22	SENT_222	[p16l460t3382r492b3415],
22	8	CD	NUMBER	8	num	23	SENT_222	[p16l460t3382r492b3415],
23	)	NN	O	)	dep	20	SENT_222	[p16l460t3382r492b3415],
24	(	CD	NUMBER	(	number	25	SENT_222	[p16l744t3383r777b3415],
25	9	CD	NUMBER	9	num	26	SENT_222	[p16l744t3383r777b3415],
26	)	NN	O	)	dep	23	SENT_222	[p16l744t3383r777b3415],
27	(	CD	NUMBER	(	number	28	SENT_222	[p16l1037t3383r1069b3415],
28	9	CD	NUMBER	9	num	26	SENT_222	[p16l1037t3383r1069b3415],
29	)	NN	O	)	dep	32	SENT_222	[p16l1037t3383r1069b3415],
30	(	CD	NUMBER	(	num	29	SENT_222	[p16l1329t3383r1361b3416],
31	5	CD	NUMBER	5	num	32	SENT_222	[p16l1329t3383r1361b3416],
32	)	NN	O	)	dep	42	SENT_222	[p16l1329t3383r1361b3416],
33	(	CD	NUMBER	(	number	34	SENT_222	[p16l1615t3384r1647b3416],
34	9	CD	NUMBER	9	num	35	SENT_222	[p16l1615t3384r1647b3416],
35	)	NN	O	)	dep	32	SENT_222	[p16l1615t3384r1647b3416],
36	(	CD	NUMBER	(	number	37	SENT_222	[p16l1904t3384r1935b3417],
37	5	CD	NUMBER	5	num	39	SENT_222	[p16l1904t3384r1935b3417],
38	)	NN	O	)	nn	39	SENT_222	[p16l1904t3384r1935b3417],
39	p	NN	O	p	npadvmod	40	SENT_222	[p16l160t3439r180b3465],
40	<	JJR	O	<	amod	35	SENT_222	[p16l422t3433r525b3459],
41	0.001	CD	NUMBER	0.001	num	42	SENT_222	[p16l422t3433r525b3459],
42	<	JJR	O	<	dep	46	SENT_222	[p16l707t3434r809b3459],
43	0.001	CD	NUMBER	0.001	num	44	SENT_222	[p16l707t3434r809b3459],
44	<	JJR	O	<	dep	42	SENT_222	[p16l1000t3434r1102b3459],
45	0.001	CD	NUMBER	0.001	num	46	SENT_222	[p16l1000t3434r1102b3459],
46	>	JJR	O	>	dep	49	SENT_222	[p16l1310t3434r1376b3460],
47	0.1	CD	NUMBER	0.1	num	48	SENT_222	[p16l1310t3434r1376b3460],
48	>	JJR	O	>	dep	46	SENT_222	[p16l1597t3435r1661b3460],
49	O.	NNP	O	O.	dep	51	SENT_222	[p16l1597t3435r1661b3460],
50	1	CD	NUMBER	1	num	51	SENT_222	[p16l1597t3435r1661b3460],
51	>	JJR	O	>	_	0	SENT_222	[p16l1885t3436r1950b3461],
52	O.	NNP	O	O.	dep	51	SENT_222	[p16l1885t3436r1950b3461],
53	1	CD	NUMBER	1	num	52	SENT_222	[p16l1885t3436r1950b3461],

1	Fiemoval	NN	O	fiemoval	nsubj	15	SENT_223	[p16l97t3509r203b3532],
2	of	IN	O	of	_	0	SENT_223	[p16l214t3509r239b3532],
3	daunorubicin	NN	O	daunorubicin	nn	4	SENT_223	[p16l248t3509r408b3532],
4	ng	NN	O	ng	prep_of	1	SENT_223	[p16l485t3514r515b3537],
5	in	IN	O	in	_	0	SENT_223	[p16l572t3509r591b3531],
6	destromatized	VBN	O	destromatize	dep	14	SENT_223	[p16l602t3509r779b3532],
7	hemolysates	NNS	O	hemolysate	nsubj	11	SENT_223	[p16l791t3509r946b3537],
8	from	IN	O	from	_	0	SENT_223	[p16l955t3509r1011b3532],
9	G6PD	NN	O	g6pd	nn	10	SENT_223	[p16l1022t3509r1212b3532],
10	—	NN	O	—	prep_from	7	SENT_223	[p16l1022t3509r1212b3532],
11	deficient	JJ	O	deficient	xcomp	6	SENT_223	[p16l1022t3509r1212b3532],
12	or	CC	O	or	_	0	SENT_223	[p16l1222t3515r1247b3532],
13	nondeficient	JJ	O	nondeficient	conj_or	6	SENT_223	[p16l1257t3510r1407b3533],
14	persons	NNS	O	person	prep_in	4	SENT_223	[p16l1418t3515r1517b3538],
15	incubated	VBN	O	incubate	_	0	SENT_223	[p16l1528t3510r1649b3533],
16	with	IN	O	with	_	0	SENT_223	[p16l1659t3510r1709b3533],
17	either	CC	O	either	preconj	20	SENT_223	[p16l1720t3511r1789b3533],
18	1	CD	NUMBER	1	num	20	SENT_223	[p16l1800t3511r1808b3533],
19	mmol/L	NN	O	mmol/l	nn	20	SENT_223	[p16l1824t3511r1919b3534],
20	GGP	NN	O	ggp	prep_with	15	SENT_223	[p16l1929t3510r1983b3534],
21	and	CC	O	and	_	0	SENT_223	[p16l1993t3511r2039b3534],
22	1	CD	NUMBER	1	num	24	SENT_223	[p16l2052t3512r2059b3534],
23	mmol/L	NN	O	mmol/l	nn	24	SENT_223	[p16l97t3546r191b3569],
24	NADP	NN	O	nadp	conj_and	20	SENT_223	[p16l200t3546r275b3568],
25	or	CC	O	or	_	0	SENT_223	[p16l283t3551r309b3569],
26	with	IN	O	with	_	0	SENT_223	[p16l315t3546r366b3569],
27	1	CD	NUMBER	1	num	29	SENT_223	[p16l376t3546r385b3568],
28	m	NN	O	m	nn	29	SENT_223	[p16l398t3551r420b3568],
29	o	NN	O	o	prep_with	15	SENT_223	[p16l446t3551r462b3569],
30	L	NN	O	l	nn	31	SENT_223	[p16l479t3546r494b3568],
31	PH.	NN	O	ph.	dep	15	SENT_223	[p16l560t3546r604b3569],
32	.	.	O	.	_	0	SENT_223	[p16l560t3546r604b3569],

1	Results	NNS	O	result	nsubj	2	SENT_224	[p16l615t3546r705b3569],
2	are	VBP	O	be	_	0	SENT_224	[p16l713t3551r752b3569],
3	in	IN	O	in	_	0	SENT_224	[p16l760t3546r779b3569],
4	nmoles	NNS	O	nmole	prep_in	2	SENT_224	[p16l788t3546r878b3569],
5	daunorubicin	NN	O	daunorubicin	nsubj	6	SENT_224	[p16l886t3546r1046b3569],
6	removed	VBD	O	remove	rcmod	4	SENT_224	[p16l1055t3546r1163b3569],
7	gram	NN	O	gram	dobj	6	SENT_224	[p16l1220t3552r1283b3575],
8	of	IN	O	of	_	0	SENT_224	[p16l1291t3547r1315b3569],
9	hemoglobin	NN	O	hemoglobin	prep_of	7	SENT_224	[p16l1322t3547r1466b3575],
10	at	IN	O	at	_	0	SENT_224	[p16l1475t3548r1498b3570],
11	the	DT	O	the	det	15	SENT_224	[p16l1505t3547r1545b3570],
12	indicated	JJ	O	indicated	amod	15	SENT_224	[p16l1553t3547r1664b3570],
13	times	NNS	O	time	nn	15	SENT_224	[p16l1672t3547r1739b3570],
14	t	NN	O	t	nn	15	SENT_224	[p16l1750t3550r1768b3569],
15	SD	NN	O	sd	prep_at	6	SENT_224	[p16l1778t3547r1816b3570],
16	(	CD	NUMBER	(	num	17	SENT_224	[p16l1824t3547r1927b3576],
17	number	NN	O	number	nsubj	21	SENT_224	[p16l1824t3547r1927b3576],
18	of	IN	O	of	_	0	SENT_224	[p16l1934t3548r1958b3571],
19	different	JJ	O	different	amod	20	SENT_224	[p16l1965t3548r2064b3571],
20	individuals	NNS	O	individual	prep_of	17	SENT_224	[p16l97t3582r237b3611],
21	)	VBP	O	)	rcmod	15	SENT_224	[p16l97t3582r237b3611],
22	.	.	O	.	_	0	SENT_224	[p16l97t3582r237b3611],

1	The	DT	O	the	det	3	SENT_225	[p16l246t3583r294b3606],
2	est	JJS	O	est	amod	3	SENT_225	[p16l301t3583r345b3606],
3	row	NN	O	row	nsubj	4	SENT_225	[p16l350t3588r398b3606],
4	provides	VBZ	O	provide	_	0	SENT_225	[p16l407t3583r512b3611],
5	the	DT	O	the	det	7	SENT_225	[p16l519t3583r558b3606],
6	statistical	JJ	O	statistical	amod	7	SENT_225	[p16l566t3583r680b3606],
7	comparisons	NNS	O	comparison	dobj	4	SENT_225	[p16l689t3583r850b3611],
8	between	IN	O	between	_	0	SENT_225	[p16l858t3583r964b3606],
9	G6PD-deficient	JJ	O	g6pd-deficient	amod	10	SENT_225	[p16l973t3583r1163b3606],
10	nondeﬁcient	JJ	O	nondeﬁcient	amod	11	SENT_225	[p16l1225t3584r1375b3607],
11	persons	NNS	O	person	prep_between	7	SENT_225	[p16l1384t3589r1489b3612],
12	.	.	O	.	_	0	SENT_225	[p16l1384t3589r1489b3612],

1	Drug	NN	O	drug	nn	2	SENT_226	[p16l1500t3584r1558b3612],
2	biotransformation	NN	O	biotransformation	nsubj	6	SENT_226	[p16l1567t3584r1783b3607],
3	was	VBD	O	be	cop	6	SENT_226	[p16l1791t3590r1841b3608],
4	also	RB	O	also	advmod	6	SENT_226	[p16l1849t3585r1899b3608],
5	com	NN	O	com	nn	6	SENT_226	[p16l1907t3590r1961b3608],
6	d	NN	O	d	_	0	SENT_226	[p16l2019t3585r2033b3608],
7	at	IN	O	at	_	0	SENT_226	[p16l2043t3586r2065b3608],
8	equivalent	JJ	O	equivalent	amod	9	SENT_226	[p16l97t3620r222b3648],
9	times	NNS	O	time	prep_at	6	SENT_226	[p16l229t3620r296b3643],
10	in	IN	O	in	mark	15	SENT_226	[p16l305t3620r323b3643],
11	coupled	VBN	O	couple	csubj	15	SENT_226	[p16l332t3620r431b3648],
12	versus	CC	O	versus	prep	11	SENT_226	[p16l440t3626r521b3643],
13	direct	JJ	O	direct	amod	14	SENT_226	[p16l529t3620r598b3643],
14	systems	NNS	O	system	dep	12	SENT_226	[p16l606t3621r708b3648],
15	(	VBP	O	(	advcl	6	SENT_226	[p16l717t3620r764b3648],
16	not	RB	O	not	neg	17	SENT_226	[p16l717t3620r764b3648],
17	shown	VBN	O	show	ccomp	15	SENT_226	[p16l771t3620r852b3643],
18	in	IN	O	in	_	0	SENT_226	[p16l862t3620r880b3643],
19	the	DT	O	the	det	21	SENT_226	[p16l888t3620r927b3643],
20	table	NN	O	table	nn	21	SENT_226	[p16l934t3620r1008b3649],
21	)	NN	O	)	prep_in	17	SENT_226	[p16l934t3620r1008b3649],
22	.	.	O	.	_	0	SENT_226	[p16l934t3620r1008b3649],

1	For	IN	O	for	_	0	SENT_227	[p16l1019t3620r1059b3643],
2	these	DT	O	these	det	3	SENT_227	[p16l1065t3620r1133b3643],
3	comparisons	NNS	O	comparison	prep_for	13	SENT_227	[p16l1141t3621r1308b3649],
4	,	,	O	,	_	0	SENT_227	[p16l1141t3621r1308b3649],
5	the	DT	O	the	det	7	SENT_227	[p16l1316t3621r1356b3644],
6	p	NN	O	p	nn	7	SENT_227	[p16l1361t3626r1379b3649],
7	values	NNS	O	value	nsubj	13	SENT_227	[p16l1387t3621r1464b3644],
8	in	IN	O	in	_	0	SENT_227	[p16l1473t3621r1492b3644],
9	the	DT	O	the	det	11	SENT_227	[p16l1499t3621r1538b3644],
10	non-G6PD-deficient	JJ	O	non-g6pd-deficient	amod	11	SENT_227	[p16l1547t3621r1794b3645],
11	controls	NNS	O	control	prep_in	7	SENT_227	[p16l1802t3622r1901b3645],
12	were	VBD	O	be	cop	13	SENT_227	[p16l1909t3627r1969b3645],
13	.01	CD	NUMBER	.01	_	0	SENT_227	[p16l2020t3622r2051b3645],
14	.	.	O	.	_	0	SENT_227	[p16l2059t3640r2063b3648],

1	<	JJR	O	<	_	0	SENT_228	[p16l98t3658r182b3684],
2	0.05	CD	NUMBER	0.05	dep	1	SENT_228	[p16l98t3658r182b3684],
3	,	,	O	,	_	0	SENT_228	[p16l98t3658r182b3684],
4	and	CC	O	and	_	0	SENT_228	[p16l194t3657r239b3680],
5	<	JJR	O	<	dep	1	SENT_228	[p16l251t3657r341b3680],
6	0.001	CD	NUMBER	0.001	dep	1	SENT_228	[p16l251t3657r341b3680],
7	at	IN	O	at	_	0	SENT_228	[p16l355t3658r378b3680],
8	15	CD	NUMBER	15	prep_at	6	SENT_228	[p16l388t3658r424b3683],
9	,	,	O	,	_	0	SENT_228	[p16l388t3658r424b3683],
10	30	CD	NUMBER	30	conj_and	1	SENT_228	[p16l435t3657r473b3683],
11	,	,	O	,	_	0	SENT_228	[p16l435t3657r473b3683],
12	and	CC	DURATION	and	_	0	SENT_228	[p16l484t3657r530b3680],
13	60	CD	DURATION	60	num	14	SENT_228	[p16l539t3657r571b3680],
14	minutes	NNS	NUMBER	minute	conj_and	1	SENT_228	[p16l581t3657r684b3683],
15	,	,	O	,	_	0	SENT_228	[p16l581t3657r684b3683],
16	respectively	RB	O	respectively	advmod	14	SENT_228	[p16l695t3657r847b3685],
17	.	.	O	.	_	0	SENT_228	[p16l695t3657r847b3685],

1	In	IN	O	in	_	0	SENT_229	[p16l859t3657r878b3680],
2	G-BPD	NN	O	g-bpd	nn	3	SENT_229	[p16l888t3657r963b3680],
3	deficiency	NN	O	deficiency	prep_in	10	SENT_229	[p16l972t3657r1096b3686],
4	the	DT	O	the	det	7	SENT_229	[p16l1103t3657r1143b3680],
5	corresponding	JJ	O	corresponding	amod	7	SENT_229	[p16l1151t3658r1331b3686],
6	p	NN	O	p	nn	7	SENT_229	[p16l1338t3663r1355b3686],
7	values	NNS	O	value	nsubj	10	SENT_229	[p16l1364t3658r1442b3681],
8	were	VBD	O	be	cop	10	SENT_229	[p16l1451t3663r1512b3681],
9	all	DT	O	all	advmod	10	SENT_229	[p16l1520t3658r1544b3681],
10	<	JJR	O	<	_	0	SENT_229	[p16l1556t3658r1656b3681],
11	0.001	CD	NUMBER	0.001	tmod	10	SENT_229	[p16l1556t3658r1656b3681],
12	.	.	O	.	_	0	SENT_229	[p16l1556t3658r1656b3681],

1	‘	NN	O	‘	_	0	SENT_230	[p16l97t3694r152b3717],
2	The	DT	O	the	det	3	SENT_230	[p16l97t3694r152b3717],
3	disappearance	NN	O	disappearance	nsubj	14	SENT_230	[p16l161t3694r345b3723],
4	of	IN	O	of	_	0	SENT_230	[p16l353t3694r378b3717],
5	daunorubicin	NN	O	daunorubicin	prep_of	3	SENT_230	[p16l385t3694r545b3717],
6	as	RB	O	as	_	0	SENT_230	[p16l554t3700r582b3717],
7	well	RB	O	well	_	0	SENT_230	[p16l590t3694r637b3717],
8	as	IN	O	as	_	0	SENT_230	[p16l646t3700r674b3717],
9	the	DT	O	the	det	10	SENT_230	[p16l681t3694r721b3717],
10	production	NN	O	production	prep_of	3	SENT_230	[p16l729t3694r862b3723],
11	of	IN	O	of	_	0	SENT_230	[p16l871t3694r895b3717],
12	daunorubicinol	NN	O	daunorubicinol	prep_of	10	SENT_230	[p16l902t3694r1084b3718],
13	were	VBD	O	be	cop	14	SENT_230	[p16l1092t3700r1153b3718],
14	similar	JJ	O	similar	rcmod	1	SENT_230	[p16l1161t3695r1239b3718],
15	to	TO	O	to	_	0	SENT_230	[p16l1245t3696r1270b3718],
16	those	DT	O	those	prep_to	14	SENT_230	[p16l1278t3695r1347b3718],
17	in	IN	O	in	_	0	SENT_230	[p16l1355t3695r1374b3718],
18	controls	NNS	O	control	prep_in	16	SENT_230	[p16l1383t3695r1482b3718],
19	in	IN	O	in	_	0	SENT_230	[p16l1490t3695r1509b3718],
20	a	DT	O	a	det	21	SENT_230	[p16l1518t3701r1533b3718],
21	hemolysate	NN	O	hemolysate	prep_in	14	SENT_230	[p16l1541t3695r1682b3723],
22	prepared	VBN	O	prepare	partmod	21	SENT_230	[p16l1691t3696r1802b3724],
23	from	IN	O	from	_	0	SENT_230	[p16l1810t3696r1866b3719],
24	a	DT	O	a	det	26	SENT_230	[p16l1875t3701r1890b3719],
25	blood	NN	O	blood	nn	26	SENT_230	[p16l1898t3696r1967b3719],
26	sample	NN	O	sample	prep_from	22	SENT_230	[p16l1976t3696r2065b3725],
27	with	IN	O	with	_	0	SENT_230	[p16l96t3732r145b3755],
28	reticulocytosis	NN	O	reticulocytosis	prep_with	22	SENT_230	[p16l157t3732r332b3760],
29	(	CD	NUMBER	(	number	30	SENT_230	[p16l342t3731r437b3760],
30	310,00	CD	NUMBER	310,00	num	32	SENT_230	[p16l342t3731r437b3760],
31	reticulocytes/mma	NN	O	reticulocytes/mma	nn	32	SENT_230	[p16l446t3728r680b3760],
32	)	NN	O	)	dep	1	SENT_230	[p16l446t3728r680b3760],
33	obtained	VBN	O	obtain	partmod	32	SENT_230	[p16l689t3731r797b3755],
34	from	IN	O	from	_	0	SENT_230	[p16l806t3732r863b3755],
35	a	DT	O	a	det	36	SENT_230	[p16l872t3737r887b3755],
36	patient	NN	O	patient	prep_from	33	SENT_230	[p16l896t3732r980b3760],
37	with	IN	O	with	_	0	SENT_230	[p16l988t3732r1038b3755],
38	idiopathic	JJ	O	idiopathic	amod	39	SENT_230	[p16l1048t3732r1166b3760],
39	congenital	JJ	O	congenital	amod	42	SENT_230	[p16l1175t3732r1302b3761],
40	nonspherocytic	JJ	O	nonspherocytic	amod	42	SENT_230	[p16l1312t3732r1502b3761],
41	hemolytic	JJ	O	hemolytic	amod	42	SENT_230	[p16l1511t3732r1628b3761],
42	anemia	NN	O	anemia	prep_with	36	SENT_230	[p16l1637t3733r1733b3756],
43	.	.	O	.	_	0	SENT_230	[p16l1637t3733r1733b3756],

1	Table	NNP	O	Table	_	0	SENT_231	[p17l96t45r194b76],
2	ll	NN	O	ll	dep	1	SENT_231	[p17l209t45r236b75],
3	.	.	O	.	_	0	SENT_231	[p17l209t45r236b75],

1	Restricted	JJ	O	restricted	amod	2	SENT_232	[p17l253t45r429b75],
2	dounorubicinol	NN	O	dounorubicinol	_	0	SENT_232	[p17l445t45r717b75],
3	formation	NN	O	formation	dep	2	SENT_232	[p17l731t45r905b75],
4	in	IN	O	in	_	0	SENT_232	[p17l921t45r948b75],
5	G6PD	NN	O	g6pd	nn	6	SENT_232	[p17l963t45r1064b76],
6	deficiency	NN	O	deficiency	prep_in	3	SENT_232	[p17l1078t45r1269b83],
7	(	CD	NUMBER	(	dep	6	SENT_232	[p17l1283t45r1418b83],
8	GdA	NN	O	gda	dep	7	SENT_232	[p17l1283t45r1418b83],
9	'	''	O	'	_	0	SENT_232	[p17l1283t45r1418b83],
10	)	SYM	O	)	dep	3	SENT_232	[p17l1283t45r1418b83],

1	Coupled	JJ	O	coupled	amod	3	SENT_233	[p17l585t117r707b147],
2	(	NN	O	(	nn	3	SENT_233	[p17l718t117r785b146],
3	G6P	NN	O	g6p	_	0	SENT_233	[p17l718t117r785b146],
4	plus	CC	O	plus	prep	3	SENT_233	[p17l795t118r851b147],
5	NADP	NN	O	nadp	nn	9	SENT_233	[p17l862t118r950b146],
6	)	CD	NUMBER	)	num	9	SENT_233	[p17l862t118r950b146],
7	Direct	JJ	O	direct	amod	9	SENT_233	[p17l1526t118r1608b142],
8	(	NN	O	(	nn	9	SENT_233	[p17l1619t118r1737b146],
9	NADPH	NN	O	nadph	dep	4	SENT_233	[p17l1619t118r1737b146],
10	)	CD	NUMBER	)	dep	3	SENT_233	[p17l1619t118r1737b146],

1	Group	NNP	O	Group	_	0	SENT_234	[p17l172t192r260b221],
2	15	CD	DURATION	15	num	3	SENT_234	[p17l406t192r435b216],
3	minutes	NNS	NUMBER	minute	dep	1	SENT_234	[p17l446t192r555b216],
4	30	CD	DURATION	30	num	5	SENT_234	[p17l689t192r722b216],
5	minutes	NNS	NUMBER	minute	tmod	3	SENT_234	[p17l733t192r841b216],
6	60	CD	DURATION	60	num	7	SENT_234	[p17l978t192r1010b216],
7	minutes	NNS	NUMBER	minute	tmod	3	SENT_234	[p17l1021t192r1129b216],
8	15	CD	DURATION	15	num	9	SENT_234	[p17l1269t192r1298b216],
9	minutes	NNS	NUMBER	minute	tmod	3	SENT_234	[p17l1309t192r1416b216],
10	30	CD	DURATION	30	num	11	SENT_234	[p17l1553t192r1585b216],
11	minutes	NNS	NUMBER	minute	tmod	3	SENT_234	[p17l1596t193r1704b216],
12	60	CD	DURATION	60	num	13	SENT_234	[p17l1844t193r1876b216],
13	minutes	NNS	NUMBER	minute	tmod	3	SENT_234	[p17l1887t193r1995b217],

1	Control	NN	O	control	_	0	SENT_235	[p17l164t266r267b293],
2	4.8	CD	NUMBER	4.8	number	3	SENT_235	[p17l410t266r455b292],
3	1	CD	NUMBER	1	num	5	SENT_235	[p17l469t269r489b291],
4	1.3	CD	NUMBER	1.3	number	5	SENT_235	[p17l505t266r548b292],
5	9.8	CD	NUMBER	9.8	dep	1	SENT_235	[p17l697t266r741b292],
6	1	CD	NUMBER	1	number	7	SENT_235	[p17l755t269r776b291],
7	2.4	CD	NUMBER	2.4	num	9	SENT_235	[p17l789t266r833b292],
8	14.9	CD	NUMBER	14.9	number	9	SENT_235	[p17l978t266r1039b292],
9	1	CD	NUMBER	1	dep	1	SENT_235	[p17l1052t269r1073b291],
10	2.5	CD	NUMBER	2.5	number	11	SENT_235	[p17l1087t267r1131b292],
11	7.6	CD	NUMBER	7.6	amod	9	SENT_235	[p17l1273t266r1317b292],
12	1	CD	NUMBER	1	number	13	SENT_235	[p17l1331t269r1352b291],
13	1.9	CD	NUMBER	1.9	num	15	SENT_235	[p17l1367t266r1409b292],
14	11.9	CD	NUMBER	11.9	number	15	SENT_235	[p17l1553t267r1614b292],
15	1	CD	NUMBER	1	dep	9	SENT_235	[p17l1628t270r1649b291],
16	3.5	CD	NUMBER	3.5	number	17	SENT_235	[p17l1662t267r1706b292],
17	19.1	CD	NUMBER	19.1	num	19	SENT_235	[p17l1844t267r1899b293],
18	1	CD	NUMBER	1	number	19	SENT_235	[p17l1919t270r1939b291],
19	2.6	CD	NUMBER	2.6	dep	15	SENT_235	[p17l1952t267r1997b293],

1	G6PD	NN	O	g6pd	dep	10	SENT_236	[p17l164t358r250b385],
2	1.0	CD	NUMBER	1.0	num	3	SENT_236	[p17l412t359r455b384],
3	1	CD	NUMBER	1	dep	1	SENT_236	[p17l469t362r489b383],
4	0.9	CD	NUMBER	0.9	number	5	SENT_236	[p17l503t359r548b384],
5	2.5	CD	NUMBER	2.5	num	7	SENT_236	[p17l697t359r741b384],
6	1	CD	NUMBER	1	number	7	SENT_236	[p17l755t361r776b383],
7	2.2	CD	NUMBER	2.2	dep	3	SENT_236	[p17l789t359r833b384],
8	5.0	CD	NUMBER	5.0	dep	10	SENT_236	[p17l995t359r1039b384],
9	1	CD	NUMBER	1	num	10	SENT_236	[p17l1052t362r1073b383],
10	4.3	CD	NUMBER	4.3	dep	21	SENT_236	[p17l1087t359r1131b384],
11	6.0	CD	NUMBER	6.0	number	12	SENT_236	[p17l1273t359r1317b384],
12	1	CD	NUMBER	1	num	14	SENT_236	[p17l1331t362r1352b383],
13	3.3	CD	NUMBER	3.3	number	14	SENT_236	[p17l1365t359r1409b384],
14	8.9	CD	NUMBER	8.9	dep	10	SENT_236	[p17l1570t359r1614b385],
15	1	CD	NUMBER	1	number	16	SENT_236	[p17l1628t362r1649b383],
16	4.4	CD	NUMBER	4.4	num	18	SENT_236	[p17l1662t359r1707b384],
17	14.4	CD	NUMBER	14.4	number	18	SENT_236	[p17l1844t359r1905b385],
18	1	CD	NUMBER	1	dep	14	SENT_236	[p17l1919t362r1939b384],
19	6.4	CD	NUMBER	6.4	num	21	SENT_236	[p17l1952t359r1997b385],
20	(	NN	O	(	nn	21	SENT_236	[p17l165t401r264b434],
21	Gd/V	NN	O	gd/v	dep	28	SENT_236	[p17l165t401r264b434],
22	)	CD	NUMBER	)	number	23	SENT_236	[p17l165t401r264b434],
23	(	CD	NUMBER	(	dep	21	SENT_236	[p17l463t400r495b433],
24	8	CD	NUMBER	8	num	25	SENT_236	[p17l463t400r495b433],
25	)	NN	O	)	dep	23	SENT_236	[p17l463t400r495b433],
26	(	CD	NUMBER	(	num	28	SENT_236	[p17l749t400r782b433],
27	9	CD	NUMBER	9	num	28	SENT_236	[p17l749t400r782b433],
28	)	NN	O	)	dep	34	SENT_236	[p17l749t400r782b433],
29	(	CD	NUMBER	(	number	30	SENT_236	[p17l1038t400r1070b433],
30	9	CD	NUMBER	9	dep	28	SENT_236	[p17l1038t400r1070b433],
31	)	NN	O	)	dep	30	SENT_236	[p17l1038t400r1070b433],
32	(	CD	NUMBER	(	num	31	SENT_236	[p17l1325t400r1358b433],
33	5	CD	NUMBER	5	num	34	SENT_236	[p17l1325t400r1358b433],
34	)	NN	O	)	dep	44	SENT_236	[p17l1325t400r1358b433],
35	(	CD	NUMBER	(	number	36	SENT_236	[p17l1613t401r1645b433],
36	9	CD	NUMBER	9	num	37	SENT_236	[p17l1613t401r1645b433],
37	)	NN	O	)	dep	34	SENT_236	[p17l1613t401r1645b433],
38	(	CD	NUMBER	(	number	39	SENT_236	[p17l1904t401r1935b434],
39	5	CD	NUMBER	5	num	41	SENT_236	[p17l1904t401r1935b434],
40	)	NN	O	)	nn	41	SENT_236	[p17l1904t401r1935b434],
41	p	NN	O	p	npadvmod	42	SENT_236	[p17l162t449r182b475],
42	<	JJR	O	<	amod	37	SENT_236	[p17l426t443r528b468],
43	0.001	CD	NUMBER	0.001	num	44	SENT_236	[p17l426t443r528b468],
44	<	JJR	O	<	dep	48	SENT_236	[p17l713t442r815b468],
45	0.001	CD	NUMBER	0.001	num	46	SENT_236	[p17l713t442r815b468],
46	<	JJR	O	<	dep	44	SENT_236	[p17l1001t442r1103b468],
47	0.001	CD	NUMBER	0.001	num	48	SENT_236	[p17l1001t442r1103b468],
48	>	JJR	O	>	dep	51	SENT_236	[p17l1307t443r1372b468],
49	O.	NNP	O	O.	dep	48	SENT_236	[p17l1307t443r1372b468],
50	1	CD	NUMBER	1	num	49	SENT_236	[p17l1307t443r1372b468],
51	>	JJR	O	>	dep	54	SENT_236	[p17l1596t443r1660b468],
52	O.	NNP	O	O.	dep	51	SENT_236	[p17l1596t443r1660b468],
53	1	CD	NUMBER	1	num	52	SENT_236	[p17l1596t443r1660b468],
54	>	JJR	O	>	_	0	SENT_236	[p17l1885t443r1950b469],
55	O.	NNP	O	O.	dep	54	SENT_236	[p17l1885t443r1950b469],
56	1	CD	NUMBER	1	num	55	SENT_236	[p17l1885t443r1950b469],

1	Appearance	NN	O	appearance	nsubj	5	SENT_237	[p17l96t519r249b547],
2	of	IN	O	of	_	0	SENT_237	[p17l257t519r281b542],
3	daunorubicinol	NN	O	daunorubicinol	prep_of	1	SENT_237	[p17l290t519r472b542],
4	in	IN	O	in	prep	3	SENT_237	[p17l482t519r501b541],
5	destromatized	VBN	O	destromatize	_	0	SENT_237	[p17l511t519r688b542],
6	hemolysates	NNS	O	hemolysate	dobj	5	SENT_237	[p17l698t519r853b547],
7	from	IN	O	from	_	0	SENT_237	[p17l861t519r918b542],
8	G6PD-deficient	JJ	O	g6pd-deficient	amod	11	SENT_237	[p17l928t518r1118b542],
9	or	CC	O	or	_	0	SENT_237	[p17l1126t524r1152b542],
10	nondeﬁcient	JJ	O	nondeﬁcient	amod	11	SENT_237	[p17l1160t519r1310b542],
11	ons	NNS	O	on	prep_from	5	SENT_237	[p17l1374t524r1425b542],
12	.	.	O	.	_	0	SENT_237	[p17l1374t524r1425b542],

1	Experimental	JJ	O	experimental	amod	2	SENT_238	[p17l1436t519r1595b547],
2	conditions	NNS	O	condition	nsubj	3	SENT_238	[p17l1605t519r1732b542],
3	are	VBP	O	be	_	0	SENT_238	[p17l1741t525r1780b542],
4	as	IN	O	as	mark	5	SENT_238	[p17l1788t525r1817b542],
5	described	VBN	O	describe	dep	3	SENT_238	[p17l1826t519r1947b542],
6	for	IN	O	for	_	0	SENT_238	[p17l1956t519r1990b542],
7	Table	NNP	O	Table	prep_for	5	SENT_238	[p17l1996t519r2065b543],
8	l	NN	O	l	tmod	5	SENT_238	[p17l98t556r101b579],
9	and	CC	O	and	_	0	SENT_238	[p17l112t556r157b579],
10	in	IN	O	in	dep	3	SENT_238	[p17l168t556r187b579],
11	Methods	NNS	O	method	pobj	10	SENT_238	[p17l197t556r312b583],
12	;	:	O	;	_	0	SENT_238	[p17l197t556r312b583],
13	results	NNS	O	result	nsubjpass	15	SENT_238	[p17l324t556r404b579],
14	are	VBP	O	be	auxpass	15	SENT_238	[p17l413t561r452b579],
15	expressed	VBN	O	express	parataxis	3	SENT_238	[p17l461t556r590b584],
16	in	IN	O	in	_	0	SENT_238	[p17l600t556r618b578],
17	nanomoles	NNS	O	nanomole	prep_in	15	SENT_238	[p17l629t556r765b579],
18	per	IN	O	per	_	0	SENT_238	[p17l774t561r815b584],
19	gram	NN	O	gram	prep_per	17	SENT_238	[p17l823t561r886b584],
20	of	IN	O	of	_	0	SENT_238	[p17l895t556r920b579],
21	hemoglobin	NN	O	hemoglobin	prep_of	19	SENT_238	[p17l928t556r1072b584],
22	1	CD	NUMBER	1	num	21	SENT_238	[p17l1084t559r1102b577],
23	1	CD	NUMBER	1	num	26	SENT_238	[p17l1115t556r1124b578],
24	SD	NN	O	sd	nn	26	SENT_238	[p17l1138t555r1175b579],
25	(	NN	O	(	nn	26	SENT_238	[p17l1184t556r1287b584],
26	number	NN	O	number	nsubj	31	SENT_238	[p17l1184t556r1287b584],
27	of	IN	O	of	_	0	SENT_238	[p17l1295t556r1319b579],
28	'	''	O	'	_	0	SENT_238	[p17l1344t556r1347b560],
29	erent	JJ	O	erent	amod	30	SENT_238	[p17l1364t557r1426b579],
30	individuals	NNS	O	individual	prep_of	26	SENT_238	[p17l1436t555r1576b584],
31	)	VBP	O	)	rcmod	21	SENT_238	[p17l1436t555r1576b584],
32	.	.	O	.	_	0	SENT_238	[p17l1436t555r1576b584],

1	The	DT	O	the	det	3	SENT_239	[p17l1586t556r1633b579],
2	last	JJ	O	last	amod	3	SENT_239	[p17l1640t556r1685b579],
3	row	NN	O	row	nsubj	4	SENT_239	[p17l1691t562r1739b579],
4	refers	VBZ	O	refer	_	0	SENT_239	[p17l1748t556r1816b579],
5	to	TO	O	to	_	0	SENT_239	[p17l1824t558r1848b579],
6	the	DT	O	the	det	7	SENT_239	[p17l1857t556r1896b579],
7	comparisons	NNS	O	comparison	prep_to	4	SENT_239	[p17l1905t556r2065b584],
8	between	IN	O	between	_	0	SENT_239	[p17l98t594r204b617],
9	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	12	SENT_239	[p17l212t593r403b617],
10	and	CC	O	and	_	0	SENT_239	[p17l411t593r457b616],
11	nondeficient	JJ	O	nondeficient	amod	12	SENT_239	[p17l466t593r617b616],
12	persons	NNS	O	person	prep_between	7	SENT_239	[p17l626t598r731b621],
13	.	.	O	.	_	0	SENT_239	[p17l626t598r731b621],

1	For	IN	O	for	_	0	SENT_240	[p17l742t593r782b616],
2	the	DT	O	the	det	4	SENT_240	[p17l788t593r828b616],
3	non-G6PD-deficient	JJ	O	non-g6pd-deficient	amod	4	SENT_240	[p17l836t592r1084b616],
4	controls	NNS	O	control	prep_for	9	SENT_240	[p17l1092t593r1197b619],
5	,	,	O	,	_	0	SENT_240	[p17l1092t593r1197b619],
6	the	DT	O	the	det	8	SENT_240	[p17l1206t593r1245b616],
7	p	NN	O	p	nn	8	SENT_240	[p17l1251t599r1269b621],
8	values	NNS	O	value	nsubj	9	SENT_240	[p17l1276t593r1355b616],
9	(	VBP	O	(	dep	27	SENT_240	[p17l1363t593r1409b621],
10	not	RB	O	not	neg	9	SENT_240	[p17l1363t593r1409b621],
11	shown	VBN	O	show	dep	9	SENT_240	[p17l1417t593r1498b616],
12	in	IN	O	in	_	0	SENT_240	[p17l1507t593r1526b616],
13	the	DT	O	the	det	15	SENT_240	[p17l1534t593r1573b616],
14	table	NN	O	table	nn	15	SENT_240	[p17l1580t593r1647b621],
15	)	NN	O	)	prep_in	11	SENT_240	[p17l1580t593r1647b621],
16	for	IN	O	for	_	0	SENT_240	[p17l1655t593r1689b616],
17	the	DT	O	the	det	18	SENT_240	[p17l1694t593r1734b616],
18	comparisons	NNS	O	comparison	prep_for	15	SENT_240	[p17l1742t593r1902b621],
19	at	IN	O	at	_	0	SENT_240	[p17l1910t595r1933b616],
20	equivalent	JJ	O	equivalent	amod	21	SENT_240	[p17l1940t593r2066b622],
21	times	NNS	O	time	prep_at	18	SENT_240	[p17l97t631r163b654],
22	in	IN	O	in	_	0	SENT_240	[p17l172t631r191b653],
23	coupled	VBN	O	couple	prepc_in	11	SENT_240	[p17l200t631r300b659],
24	versus	CC	O	versus	prep	23	SENT_240	[p17l308t636r389b653],
25	direct	JJ	O	direct	amod	26	SENT_240	[p17l398t630r467b653],
26	systems	NNS	O	system	dep	24	SENT_240	[p17l475t632r577b658],
27	are	VBP	O	be	_	0	SENT_240	[p17l586t636r630b653],
28	:	:	O	:	_	0	SENT_240	[p17l586t636r630b653],
29	<	JJR	O	<	dobj	27	SENT_240	[p17l642t630r727b656],
30	0.01	CD	NUMBER	0.01	dep	29	SENT_240	[p17l642t630r727b656],
31	,	,	O	,	_	0	SENT_240	[p17l642t630r727b656],
32	<	JJR	O	<	dobj	27	SENT_240	[p17l738t630r823b656],
33	0.05	CD	NUMBER	0.05	dep	32	SENT_240	[p17l738t630r823b656],
34	,	,	O	,	_	0	SENT_240	[p17l738t630r823b656],
35	and	CC	O	and	_	0	SENT_240	[p17l833t630r878b653],
36	<	JJR	O	<	conj_and	29	SENT_240	[p17l889t630r978b653],
37	0.001	CD	NUMBER	0.001	nsubj	27	SENT_240	[p17l889t630r978b653],
38	at	IN	O	at	_	0	SENT_240	[p17l992t631r1014b653],
39	15	CD	NUMBER	15	prep_at	37	SENT_240	[p17l1024t631r1060b656],
40	,	,	O	,	_	0	SENT_240	[p17l1024t631r1060b656],
41	30	CD	NUMBER	30	conj_and	37	SENT_240	[p17l1070t630r1108b656],
42	,	,	O	,	_	0	SENT_240	[p17l1070t630r1108b656],
43	and	CC	DURATION	and	_	0	SENT_240	[p17l1118t630r1163b653],
44	60	CD	DURATION	60	num	45	SENT_240	[p17l1172t630r1203b653],
45	minutes	NNS	NUMBER	minute	nsubj	27	SENT_240	[p17l1212t630r1315b656],
46	,	,	O	,	_	0	SENT_240	[p17l1212t630r1315b656],
47	respectively	RB	O	respectively	advmod	45	SENT_240	[p17l1325t630r1476b658],
48	.	.	O	.	_	0	SENT_240	[p17l1325t630r1476b658],

1	In	IN	O	in	_	0	SENT_241	[p17l1487t630r1507b653],
2	G6PD	NN	O	g6pd	nn	3	SENT_241	[p17l1516t630r1590b653],
3	deficiency	NN	O	deficiency	prep_in	10	SENT_241	[p17l1598t630r1722b658],
4	the	DT	O	the	det	7	SENT_241	[p17l1729t630r1768b653],
5	corresponding	JJ	O	corresponding	amod	7	SENT_241	[p17l1776t630r1955b659],
6	p	NN	O	p	nn	7	SENT_241	[p17l1962t636r1979b658],
7	values	NNS	O	value	nsubj	10	SENT_241	[p17l1987t631r2065b653],
8	are	VBP	O	be	cop	10	SENT_241	[p17l12t694r98b734],
9	all	DT	O	all	det	10	SENT_241	[p17l120t682r175b735],
10	<	JJR	O	<	_	0	SENT_241	[p17l204t683r436b734],
11	0.001	CD	NUMBER	0.001	attr	10	SENT_241	[p17l204t683r436b734],
12	.	.	O	.	_	0	SENT_241	[p17l204t683r436b734],

1	man	NN	O	man	nn	2	SENT_242	[p17l9t951r186b1001],
2	erythrocytes	NNS	O	erythrocyte	_	0	SENT_242	[p17l225t909r1058b1021],
3	.5	CD	NUMBER	.5	number	4	SENT_242	[p17l225t909r1058b1021],
4	‘	CD	NUMBER	‘	num	5	SENT_242	[p17l225t909r1058b1021],
5	13	CD	NUMBER	13	dep	2	SENT_242	[p17l225t909r1058b1021],
6	=	JJ	O	=	amod	5	SENT_242	[p17l225t909r1058b1021],
7	24	CD	NUMBER	24	tmod	6	SENT_242	[p17l225t909r1058b1021],
8	=	JJ	O	=	amod	5	SENT_242	[p17l225t909r1058b1021],
9	25	CD	NUMBER	25	tmod	8	SENT_242	[p17l225t909r1058b1021],
10	Moreover	RB	O	moreover	advmod	13	SENT_242	[p17l1099t928r1524b1014],
11	,	,	O	,	_	0	SENT_242	[p17l1099t928r1524b1014],
12	we	PRP	O	we	nsubj	13	SENT_242	[p17l1560t949r1672b998],
13	found	VBD	O	find	dep	2	SENT_242	[p17l1710t926r1949b998],
14	that	IN	O	that	complm	18	SENT_242	[p17l1985t926r2144b999],
15	this	DT	O	this	det	16	SENT_242	[p17l12t1042r154b1114],
16	pathway	NN	O	pathway	nsubjpass	18	SENT_242	[p17l229t1042r568b1138],
17	is	VBZ	O	be	auxpass	18	SENT_242	[p17l643t1040r700b1112],
18	limited	VBN	O	limit	ccomp	13	SENT_242	[p17l778t1040r1063b1112],
19	by	IN	O	by	_	0	SENT_242	[p17l1136t1039r1230b1133],
20	NADPH	NN	ORGANIZATION	nadph	agent	18	SENT_242	[p17l1303t1042r1665b1112],
21	generated	VBN	O	generate	partmod	20	SENT_242	[p17l1738t1040r2144b1133],
22	through	IN	O	through	_	0	SENT_242	[p17l9t1156r334b1251],
23	the	DT	O	the	det	25	SENT_242	[p17l393t1156r519b1228],
24	HMS	NNP	O	HMS	nn	25	SENT_242	[p17l579t1158r797b1228],
25	dehydrogenases	NNS	O	dehydrogenase	prep_through	21	SENT_242	[p17l858t1156r1531b1251],
26	,	,	O	,	_	0	SENT_242	[p17l858t1156r1531b1251],
27	even	RB	O	even	advmod	2	SENT_242	[p17l1592t1179r1780b1228],
28	without	IN	O	without	_	0	SENT_242	[p17l1833t1156r2146b1228],
29	G6PD	NN	O	g6pd	nn	30	SENT_242	[p17l12t1277r267b1350],
30	deﬁciency	NN	O	deﬁciency	prep_without	2	SENT_242	[p17l315t1274r737b1370],
31	.	.	O	.	_	0	SENT_242	[p17l315t1274r737b1370],

1	In	IN	O	in	_	0	SENT_243	[p17l785t1277r871b1347],
2	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	4	SENT_243	[p17l914t1274r1558b1347],
3	red	JJ	O	red	amod	4	SENT_243	[p17l1601t1274r1734b1347],
4	cells	NNS	O	cell	prep_in	12	SENT_243	[p17l1777t1274r1972b1361],
5	,	,	O	,	_	0	SENT_243	[p17l1777t1274r1972b1361],
6	the	DT	O	the	det	7	SENT_243	[p17l2018t1275r2144b1345],
7	conversion	NN	O	conversion	nsubj	12	SENT_243	[p17l12t1389r452b1464],
8	of	IN	O	of	_	0	SENT_243	[p17l479t1389r566b1462],
9	daunorubicin	NN	O	daunorubicin	prep_of	7	SENT_243	[p17l588t1389r1130b1462],
10	is	VBZ	O	be	cop	12	SENT_243	[p17l1159t1389r1218b1462],
11	markedly	RB	O	markedly	advmod	12	SENT_243	[p17l1245t1387r1628b1483],
12	restricted	JJ	O	restricted	_	0	SENT_243	[p17l1652t1387r2037b1462],
13	as	IN	O	as	prep	12	SENT_243	[p17l2066t1410r2144b1462],
14	compared	VBN	O	compare	_	0	SENT_243	[p17l12t1505r420b1600],
15	with	IN	O	with	prepc_compared_with	12	SENT_243	[p17l477t1505r654b1577],
16	non-G6PD-deﬁcient	JJ	O	non-g6pd-deﬁcient	amod	17	SENT_243	[p17l717t1502r1551b1577],
17	cells	NNS	O	cell	pobj	12	SENT_243	[p17l1615t1503r1808b1575],
18	.	.	O	.	_	0	SENT_243	[p17l1615t1503r1808b1575],

1	Persistence	NN	O	persistence	nsubj	10	SENT_244	[p17l1883t1503r2144b1575, p17l12t1632r228b1692],
2	of	IN	O	of	_	0	SENT_244	[p17l268t1620r353b1693],
3	unmetabolized	JJ	O	unmetabolized	amod	4	SENT_244	[p17l384t1617r991b1693],
4	daunorubicin	NN	O	daunorubicin	prep_of	1	SENT_244	[p17l1032t1617r1575b1690],
5	in	IN	O	in	_	0	SENT_244	[p17l1613t1618r1686b1690],
6	G6PDdeﬁcient	JJ	O	g6pddeﬁcient	amod	7	SENT_244	[p17l1726t1618r2144b1690, p17l12t1733r263b1808],
7	erythrocytes	NNS	O	erythrocyte	prep_in	4	SENT_244	[p17l294t1733r790b1829],
8	is	VBZ	O	be	cop	10	SENT_244	[p17l819t1733r878b1806],
9	strictly	RB	O	strictly	advmod	10	SENT_244	[p17l909t1733r1181b1826],
10	stoichiometric	JJ	O	stoichiometric	_	0	SENT_244	[p17l1208t1731r1790b1806],
11	with	IN	O	with	_	0	SENT_244	[p17l1814t1730r1989b1806],
12	defective	JJ	O	defective	amod	13	SENT_244	[p17l2020t1733r2144b1805, p17l12t1853r276b1925],
13	formation	NN	O	formation	prep_with	10	SENT_244	[p17l324t1851r732b1923],
14	of	IN	O	of	_	0	SENT_244	[p17l777t1850r864b1923],
15	daunorubicinol	NN	O	daunorubicinol	prep_of	13	SENT_244	[p17l905t1850r1544b1923],
16	.	.	O	.	_	0	SENT_244	[p17l905t1850r1544b1923],

1	The	DT	O	the	det	2	SENT_245	[p17l1594t1851r1755b1923],
2	effect	NN	O	effect	nsubjpass	7	SENT_245	[p17l1803t1851r2021b1923],
3	of	IN	O	of	_	0	SENT_245	[p17l2066t1850r2151b1923],
4	the	DT	O	the	det	5	SENT_245	[p17l12t1965r138b2037],
5	enzymopathy	NN	O	enzymopathy	prep_of	2	SENT_245	[p17l194t1965r737b2061],
6	is	VBZ	O	be	auxpass	7	SENT_245	[p17l789t1965r848b2037],
7	seen	VBN	O	see	_	0	SENT_245	[p17l905t1986r1084b2037],
8	at	IN	O	at	_	0	SENT_245	[p17l1141t1974r1214b2035],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_245	[p17l1268t1962r1734b2058],
10	levels	NNS	O	level	prep_at	7	SENT_245	[p17l1786t1963r2012b2035],
11	of	IN	O	of	_	0	SENT_245	[p17l2066t1963r2151b2035],
12	daunorubicin	NN	O	daunorubicin	prep_of	10	SENT_245	[p17l14t2079r577b2167],
13	,	,	O	,	_	0	SENT_245	[p17l14t2079r577b2167],
14	in	IN	O	in	_	0	SENT_245	[p17l634t2079r707b2151],
15	hemolysates	NNS	O	hemolysate	prep_in	7	SENT_245	[p17l761t2079r1258b2174],
16	as	RB	O	as	_	0	SENT_245	[p17l1314t2102r1392b2151],
17	well	RB	O	well	_	0	SENT_245	[p17l1439t2078r1607b2151],
18	as	IN	O	as	_	0	SENT_245	[p17l1659t2102r1739b2151],
19	in	IN	O	in	_	0	SENT_245	[p17l1791t2078r1866b2151],
20	intact	JJ	O	intact	amod	21	SENT_245	[p17l1918t2078r2146b2151],
21	erythrocytes	NNS	O	erythrocyte	prep_in	7	SENT_245	[p17l12t2197r531b2291],
22	.	.	O	.	_	0	SENT_245	[p17l12t2197r531b2291],

1	The	DT	O	the	det	3	SENT_246	[p17l588t2195r749b2267],
2	depressed	JJ	O	depressed	amod	3	SENT_246	[p17l808t2195r1213b2290],
3	biotransformation	NN	O	biotransformation	nsubj	16	SENT_246	[p17l1268t2194r2012b2267],
4	of	IN	O	of	_	0	SENT_246	[p17l2066t2194r2153b2267],
5	daunorubicin	NN	O	daunorubicin	prep_of	3	SENT_246	[p17l14t2313r554b2386],
6	in	IN	O	in	_	0	SENT_246	[p17l593t2313r670b2385],
7	G6PD	NN	O	g6pd	nn	8	SENT_246	[p17l710t2313r964b2386],
8	deﬁciency	NN	O	deﬁciency	prep_in	5	SENT_246	[p17l1004t2313r1412b2404],
9	is	VBZ	O	be	cop	11	SENT_246	[p17l1449t2313r1505b2383],
10	clearly	RB	O	clearly	advmod	11	SENT_246	[p17l1546t2313r1813b2407],
11	evident	JJ	O	evident	_	0	SENT_246	[p17l1849t2311r2146b2383],
12	within	IN	O	within	_	0	SENT_246	[p17l7t2432r262b2502],
13	15	CD	DURATION	15	num	14	SENT_246	[p17l301t2429r385b2502],
14	minutes	NNS	NUMBER	minute	prep_within	11	SENT_246	[p17l421t2430r744b2502],
15	and	CC	O	and	_	0	SENT_246	[p17l780t2430r927b2502],
16	persists	VBZ	O	persist	conj_and	11	SENT_246	[p17l958t2430r1260b2526],
17	for	IN	O	for	_	0	SENT_246	[p17l1293t2430r1413b2502],
18	at	IN	DURATION	at	quantmod	20	SENT_246	[p17l1446t2439r1519b2502],
19	least	JJS	DURATION	least	mwe	18	SENT_246	[p17l1553t2430r1739b2502],
20	24	CD	DURATION	24	num	21	SENT_246	[p17l1770t2430r1861b2500],
21	hours	NNS	NUMBER	hour	prep_for	16	SENT_246	[p17l1895t2430r2141b2500],
22	.	.	O	.	_	0	SENT_246	[p17l1895t2430r2141b2500],

1	Quantitatively	RB	O	quantitatively	advmod	13	SENT_247	[p17l14t2545r614b2638],
2	,	,	O	,	_	0	SENT_247	[p17l14t2545r614b2638],
3	the	DT	O	the	det	4	SENT_247	[p17l673t2545r802b2618],
4	removal	NN	O	removal	nsubj	13	SENT_247	[p17l856t2545r1186b2618],
5	of	IN	O	of	_	0	SENT_247	[p17l1243t2545r1329b2615],
6	daunorubicin	NN	O	daunorubicin	prep_of	4	SENT_247	[p17l1379t2542r1921b2615],
7	with	IN	O	with	_	0	SENT_247	[p17l1969t2542r2148b2615],
8	generation	NN	O	generation	prep_with	6	SENT_247	[p17l12t2662r450b2757],
9	of	IN	O	of	_	0	SENT_247	[p17l509t2662r594b2734],
10	daunorubicinol	NN	O	daunorubicinol	prep_of	8	SENT_247	[p17l648t2661r1269b2735],
11	is	VBZ	O	be	cop	13	SENT_247	[p17l1328t2662r1385b2734],
12	very	RB	O	very	advmod	13	SENT_247	[p17l1439t2685r1614b2755],
13	inadequate	JJ	O	inadequate	_	0	SENT_247	[p17l1668t2662r2144b2755],
14	,	,	O	,	_	0	SENT_247	[p17l1668t2662r2144b2755],
15	even	RB	O	even	advmod	13	SENT_247	[p17l14t2800r200b2850],
16	in	IN	O	in	_	0	SENT_247	[p17l252t2777r330b2850],
17	the	DT	O	the	det	21	SENT_247	[p17l380t2777r508b2850],
18	milder	JJ	O	milder	amod	21	SENT_247	[p17l562t2777r830b2847],
19	GdA	NN	O	gda	nn	21	SENT_247	[p17l884t2775r1135b2847],
20	‘	NN	O	‘	nn	21	SENT_247	[p17l884t2775r1135b2847],
21	variety	NN	O	variety	prep_in	13	SENT_247	[p17l1192t2775r1470b2868],
22	of	IN	O	of	_	0	SENT_247	[p17l1523t2775r1607b2847],
23	G6PD	NN	O	g6pd	nn	24	SENT_247	[p17l1657t2777r1910b2847],
24	deﬁciency	NN	O	deﬁciency	prep_of	21	SENT_247	[p17l1967t2774r2144b2847, p17l12t2891r283b2987],
25	.	.	O	.	_	0	SENT_247	[p17l1967t2774r2144b2847, p17l12t2891r283b2987],

1	In	IN	O	in	_	0	SENT_248	[p17l329t2894r415b2964],
2	the	DT	O	the	det	5	SENT_248	[p17l456t2891r584b2964],
3	Gd	NNP	MISC	Gd	nn	5	SENT_248	[p17l629t2892r753b2964],
4	Mediterranean	NNP	MISC	Mediterranean	nn	5	SENT_248	[p17l796t2892r1412b2964],
5	variety	NN	O	variety	prep_in	16	SENT_248	[p17l1449t2892r1727b2985],
6	of	IN	O	of	_	0	SENT_248	[p17l1768t2892r1852b2964],
7	G6PD	NN	O	g6pd	nn	8	SENT_248	[p17l1890t2891r2144b2964],
8	deﬁciency	NN	O	deﬁciency	prep_of	5	SENT_248	[p17l14t3011r438b3102],
9	,	,	O	,	_	0	SENT_248	[p17l14t3011r438b3102],
10	the	DT	O	the	det	12	SENT_248	[p17l491t3011r619b3082],
11	bioconversion	NN	O	bioconversion	nn	12	SENT_248	[p17l666t3009r1239b3081],
12	defect	NN	O	defect	nsubj	16	SENT_248	[p17l1291t3009r1540b3081],
13	is	VBZ	O	be	cop	16	SENT_248	[p17l1587t3008r1648b3081],
14	even	RB	O	even	advmod	16	SENT_248	[p17l1698t3032r1880b3079],
15	more	RBR	O	more	advmod	16	SENT_248	[p17l1934t3032r2146b3079],
16	severe	JJ	O	severe	_	0	SENT_248	[p17l14t3148r288b3197],
17	.	.	O	.	_	0	SENT_248	[p17l14t3148r288b3197],

1	Daunorubicin	NNP	O	Daunorubicin	nsubjpass	3	SENT_249	[p17l324t3124r892b3198],
2	is	VBZ	O	be	auxpass	3	SENT_249	[p17l921t3125r980b3197],
3	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_249	[p17l1011t3124r1426b3198],
4	to	TO	O	to	aux	9	SENT_249	[p17l1455t3134r1533b3197],
5	be	VB	O	be	cop	9	SENT_249	[p17l1562t3124r1658b3195],
6	a	DT	O	a	det	9	SENT_249	[p17l1691t3148r1734b3195],
7	far	RB	O	far	advmod	8	SENT_249	[p17l1761t3124r1878b3195],
8	better	JJR	O	better	amod	9	SENT_249	[p17l1902t3125r2148b3195],
9	substrate	NN	O	substrate	xcomp	3	SENT_249	[p17l14t3243r381b3316],
10	for	IN	O	for	_	0	SENT_249	[p17l424t3243r543b3313],
11	carbonyl	NN	O	carbonyl	nn	12	SENT_249	[p17l585t3241r934b3334],
12	reductase	NN	O	reductase	prep_for	9	SENT_249	[p17l979t3240r1371b3314],
13	than	IN	O	than	_	0	SENT_249	[p17l1414t3240r1595b3314],
14	doxorubicin	NN	O	doxorubicin	prep_than	12	SENT_249	[p17l1641t3240r2144b3313],
15	.	.	O	.	_	0	SENT_249	[p17l1641t3240r2144b3313],

1	Correspondingly	RB	O	correspondingly	advmod	5	SENT_250	[p17l14t3357r714b3453],
2	,	,	O	,	_	0	SENT_250	[p17l14t3357r714b3453],
3	G6PD	NN	O	g6pd	nn	4	SENT_250	[p17l754t3360r1010b3430],
4	deﬁciency	NN	O	deﬁciency	nsubj	5	SENT_250	[p17l1046t3358r1452b3451],
5	impacts	VBZ	O	impact	_	0	SENT_250	[p17l1483t3358r1797b3451],
6	the	DT	O	the	det	7	SENT_250	[p17l1830t3358r1956b3428],
7	metabolism	NN	O	metabolism	dobj	5	SENT_250	[p17l1992t3378r2146b3428, p17l12t3472r360b3546],
8	of	IN	O	of	_	0	SENT_250	[p17l391t3473r478b3545],
9	daunorubicin	NN	O	daunorubicin	prep_of	7	SENT_250	[p17l505t3472r1047b3545],
10	in	IN	O	in	_	0	SENT_250	[p17l1078t3473r1156b3543],
11	the	DT	O	the	det	13	SENT_250	[p17l1185t3473r1313b3543],
12	red	JJ	O	red	amod	13	SENT_250	[p17l1347t3473r1480b3546],
13	cell	NN	O	cell	prep_in	9	SENT_250	[p17l1511t3473r1648b3543],
14	much	RB	O	much	advmod	15	SENT_250	[p17l1680t3473r1905b3543],
15	more	RBR	O	more	advmod	5	SENT_250	[p17l1934t3494r2146b3543],
16	than	IN	O	than	_	0	SENT_250	[p17l12t3588r193b3660],
17	that	DT	O	that	prep_than	15	SENT_250	[p17l229t3588r388b3658],
18	of	IN	O	of	_	0	SENT_250	[p17l426t3588r510b3658],
19	doxorubicin	NN	O	doxorubicin	prep_of	17	SENT_250	[p17l542t3585r1047b3658],
20	.	.	O	.	_	0	SENT_250	[p17l542t3585r1047b3658],

1	The	DT	O	the	det	2	SENT_251	[p18l105t30r266b101],
2	observation	NN	O	observation	nsubj	28	SENT_251	[p18l307t30r801b104],
3	that	IN	O	that	complm	7	SENT_251	[p18l840t30r1006b103],
4	G6PD	NN	O	g6pd	nn	5	SENT_251	[p18l1047t30r1306b103],
5	deﬁciency	NN	O	deﬁciency	nsubj	7	SENT_251	[p18l1347t27r1769b124],
6	severely	RB	O	severely	advmod	7	SENT_251	[p18l1808t30r2148b124],
7	restricts	VBZ	O	restrict	dep	2	SENT_251	[p18l9t145r348b220],
8	the	DT	O	the	det	13	SENT_251	[p18l402t147r534b220],
9	carbonyl	NN	O	carbonyl	nn	13	SENT_251	[p18l591t147r950b241],
10	reductase	NN	O	reductase	nn	13	SENT_251	[p18l1007t145r1932b243],
11	—	NN	O	—	nn	13	SENT_251	[p18l1007t145r1932b243],
12	dependent	JJ	O	dependent	amod	13	SENT_251	[p18l1007t145r1932b243],
13	metabolism	NN	O	metabolism	dobj	7	SENT_251	[p18l1987t170r2144b220, p18l9t260r371b337],
14	of	IN	O	of	_	0	SENT_251	[p18l412t263r501b336],
15	daunorubicin	NN	O	daunorubicin	prep_of	13	SENT_251	[p18l537t260r1101b337],
16	in	IN	O	in	_	0	SENT_251	[p18l1145t263r1222b334],
17	a	DT	O	a	det	20	SENT_251	[p18l1268t286r1309b334],
18	relatively	RB	O	relatively	advmod	19	SENT_251	[p18l1352t260r1744b357],
19	selective	JJ	O	selective	amod	20	SENT_251	[p18l1784t261r2144b336],
20	manner	NN	O	manner	prep_in	15	SENT_251	[p18l9t401r334b451],
21	as	IN	O	as	_	0	SENT_251	[p18l363t401r443b451],
22	compared	VBN	O	compare	prepc_as	7	SENT_251	[p18l472t380r892b474],
23	with	IN	O	with	pcomp	22	SENT_251	[p18l917t377r1101b451],
24	its	PRP$	O	its	poss	25	SENT_251	[p18l1128t378r1222b451],
25	effect	NN	O	effect	pobj	23	SENT_251	[p18l1252t377r1481b451],
26	on	IN	O	on	_	0	SENT_251	[p18l1510t401r1613b451],
27	doxorubicin	NN	O	doxorubicin	prep_on	25	SENT_251	[p18l1642t378r2146b451],
28	rekindles	VBZ	O	rekindle	_	0	SENT_251	[p18l9t495r397b570],
29	long-standing	JJ	O	long-standing	amod	30	SENT_251	[p18l442t494r1020b591],
30	interest	NN	O	interest	dobj	28	SENT_251	[p18l1066t495r1385b570],
31	in	IN	O	in	_	0	SENT_251	[p18l1431t494r1506b568],
32	how	WRB	O	how	advmod	34	SENT_251	[p18l1552t495r1725b568],
33	biotransformation	NN	O	biotransformation	nsubj	34	SENT_251	[p18l1763t495r2144b570, p18l9t612r432b685],
34	affects	VBZ	O	affect	prepc_in	28	SENT_251	[p18l482t611r746b685],
35	the	DT	O	the	det	36	SENT_251	[p18l793t612r925b685],
36	pharmacology	NN	O	pharmacology	dobj	34	SENT_251	[p18l972t611r1571b709],
37	of	IN	O	of	_	0	SENT_251	[p18l1617t612r1706b685],
38	these	DT	O	these	det	39	SENT_251	[p18l1745t612r1967b685],
39	anthracyclines	NNS	O	anthracycline	prep_of	36	SENT_251	[p18l2017t632r2144b685, p18l9t732r536b826],
40	.	.	O	.	_	0	SENT_251	[p18l2017t632r2144b685, p18l9t732r536b826],

1	The	DT	O	the	det	3	SENT_252	[p18l600t732r764b805],
2	pioneering	JJ	O	pioneering	amod	3	SENT_252	[p18l824t732r1283b828],
3	studies	NNS	O	study	nsubj	8	SENT_252	[p18l1345t732r1637b805],
4	of	IN	O	of	_	0	SENT_252	[p18l1698t732r1785b805],
5	Bachur	NN	LOCATION	bachur	prep_of	3	SENT_252	[p18l1842t732r2148b805],
6	and	CC	O	and	_	0	SENT_252	[p18l12t848r162b922],
7	Huffman7	NN	O	huffman7	prep_of	3	SENT_252	[p18l207t832r617b922],
8	led	VBD	O	lead	_	0	SENT_252	[p18l661t848r787b921],
9	them	PRP	O	they	dobj	8	SENT_252	[p18l828t848r1043b922],
10	to	TO	O	to	_	0	SENT_252	[p18l1086t857r1167b921],
11	state	NN	O	state	prep_to	8	SENT_252	[p18l1212t857r1409b922],
12	as	RB	O	as	advmod	13	SENT_252	[p18l1454t871r1534b922],
13	early	RB	O	early	advmod	50	SENT_252	[p18l1580t848r1785b942],
14	as	IN	O	as	dep	50	SENT_252	[p18l1829t871r1909b921],
15	1971	CD	DATE	1971	nsubj	50	SENT_252	[p18l1957t848r2141b921],
16	that	WDT	O	that	nsubj	17	SENT_252	[p18l9t965r175b1036],
17	“	VBD	O	“	rcmod	15	SENT_252	[p18l209t965r278b1036],
18	. . .	CD	NUMBER	. . .	dobj	17	SENT_252	[p18l368t1023r380b1036],[p18l209t965r278b1036],
19	since	IN	O	since	mark	24	SENT_252	[p18l419t962r627b1038],
20	blood	NN	O	blood	nn	21	SENT_252	[p18l658t965r899b1038],
21	cells	NNS	O	cell	nsubj	24	SENT_252	[p18l933t965r1115b1039],
22	are	VBP	O	be	cop	24	SENT_252	[p18l1152t988r1280b1036],
23	the	DT	O	the	det	24	SENT_252	[p18l1312t965r1446b1039],
24	site	NN	O	site	advcl	17	SENT_252	[p18l1480t965r1622b1038],
25	of	IN	O	of	_	0	SENT_252	[p18l1656t965r1744b1039],
26	action	NN	O	action	prep_of	24	SENT_252	[p18l1773t965r2032b1039],
27	of	IN	O	of	_	0	SENT_252	[p18l2066t965r2153b1038],
28	the	DT	O	the	det	29	SENT_252	[p18l9t1079r141b1153],
29	drug	NN	O	drug	prep_of	26	SENT_252	[p18l216t1080r406b1176],
30	in	IN	O	in	_	0	SENT_252	[p18l477t1080r552b1153],
31	leukaemias	NNS	O	leukaemia	prep_in	29	SENT_252	[p18l626t1080r1125b1170],
32	,	,	O	,	_	0	SENT_252	[p18l626t1080r1125b1170],
33	the	DT	O	the	det	34	SENT_252	[p18l1201t1079r1332b1153],
34	concentration	NN	O	concentration	appos	31	SENT_252	[p18l1403t1080r1992b1153],
35	of	IN	O	of	_	0	SENT_252	[p18l2066t1079r2153b1153],
36	daunorubicin	NN	O	daunorubicin	nn	37	SENT_252	[p18l12t1196r576b1270],
37	reductase	NN	O	reductase	prep_of	34	SENT_252	[p18l605t1197r1013b1270],
38	in	IN	O	in	_	0	SENT_252	[p18l1045t1196r1122b1270],
39	these	DT	O	these	det	40	SENT_252	[p18l1152t1197r1374b1270],
40	cells	NNS	O	cell	prep_in	37	SENT_252	[p18l1403t1196r1611b1287],
41	,	,	O	,	_	0	SENT_252	[p18l1403t1196r1611b1287],
42	as	RB	O	as	_	0	SENT_252	[p18l1647t1220r1725b1270],
43	well	RB	O	well	_	0	SENT_252	[p18l1754t1197r1925b1270],
44	as	IN	O	as	_	0	SENT_252	[p18l1959t1220r2037b1270],
45	in	IN	O	in	_	0	SENT_252	[p18l2070t1196r2148b1273],
46	other	JJ	O	other	amod	47	SENT_252	[p18l12t1316r236b1390],
47	tissues	NNS	O	tissue	conj_and	40	SENT_252	[p18l270t1317r566b1404],
48	,	,	O	,	_	0	SENT_252	[p18l270t1317r566b1404],
49	may	MD	O	may	aux	50	SENT_252	[p18l603t1340r776b1411],
50	bear	VB	O	bear	dep	8	SENT_252	[p18l803t1317r992b1390],
51	a	DT	O	a	det	52	SENT_252	[p18l1026t1340r1069b1390],
52	relationship	NN	O	relationship	dobj	50	SENT_252	[p18l1100t1317r1606b1413],
53	to	TO	O	to	_	0	SENT_252	[p18l1640t1326r1723b1390],
54	the	DT	O	the	det	55	SENT_252	[p18l1756t1317r1888b1390],
55	pharmacodynamics	NNS	O	pharmacodynamic	prep_to	50	SENT_252	[p18l1919t1317r2146b1413, p18l9t1433r629b1527],
56	of	IN	O	of	_	0	SENT_252	[p18l665t1435r753b1506],
57	daunorubicin	NN	O	daunorubicin	nn	58	SENT_252	[p18l786t1432r1348b1506],
58	therapy	NN	O	therapy	prep_of	55	SENT_252	[p18l1384t1435r1778b1530],
59	.	.	O	.	_	0	SENT_252	[p18l1384t1435r1778b1530],

1	”	NN	O	”	nsubjpass	6	SENT_253	[p18l1384t1435r1778b1530],
2	This	DT	O	this	det	3	SENT_253	[p18l1817t1435r1999b1506],
3	insight	NN	O	insight	dep	1	SENT_253	[p18l2036t1435r2146b1506, p18l12t1550r208b1645],
4	has	VBZ	O	have	aux	6	SENT_253	[p18l272t1550r406b1621],
5	been	VBN	O	be	auxpass	6	SENT_253	[p18l468t1550r671b1621],
6	supported	VBN	O	support	_	0	SENT_253	[p18l735t1550r1162b1645],
7	by	IN	O	by	_	0	SENT_253	[p18l1224t1550r1320b1642],
8	much	JJ	O	much	amod	10	SENT_253	[p18l1380t1550r1611b1621],
9	subsequent	JJ	O	subsequent	amod	10	SENT_253	[p18l1673t1548r2148b1645],
10	work	NN	O	work	agent	6	SENT_253	[p18l7t1667r238b1741],
11	.	.	O	.	_	0	SENT_253	[p18l7t1667r238b1741],

1	For	IN	O	for	_	0	SENT_254	[p18l286t1670r438b1741],
2	example	NN	O	example	prep_for	21	SENT_254	[p18l482t1668r855b1764],
3	,	,	O	,	_	0	SENT_254	[p18l482t1668r855b1764],
4	in	IN	O	in	_	0	SENT_254	[p18l900t1668r978b1741],
5	a	DT	O	a	det	7	SENT_254	[p18l1026t1691r1066b1741],
6	recent	JJ	O	recent	amod	7	SENT_254	[p18l1110t1677r1376b1741],
7	study	NN	O	study	prep_in	21	SENT_254	[p18l1419t1668r1643b1762],
8	of	IN	O	of	_	0	SENT_254	[p18l1684t1668r1771b1741],
9	patients	NNS	O	patient	prep_of	7	SENT_254	[p18l1810t1668r2146b1764],
10	with	IN	O	with	_	0	SENT_254	[p18l7t1784r187b1855],
11	acute	JJ	O	acute	amod	12	SENT_254	[p18l240t1793r462b1855],
12	leukemia	NN	O	leukemia	prep_with	9	SENT_254	[p18l510t1782r899b1855],
13	induced	VBN	O	induce	partmod	12	SENT_254	[p18l947t1782r1283b1855],
14	with	IN	O	with	_	0	SENT_254	[p18l1326t1784r1508b1855],
15	daunorubicin	NN	O	daunorubicin	prep_with	13	SENT_254	[p18l1556t1782r2144b1871],
16	,	,	O	,	_	0	SENT_254	[p18l1556t1782r2144b1871],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_254	[p18l9t1902r497b1999],
18	efﬁcacy	NN	O	efﬁcacy	nsubj	21	SENT_254	[p18l535t1902r843b1996],
19	did	VBD	O	do	aux	21	SENT_254	[p18l879t1902r1008b1973],
20	not	RB	O	not	neg	21	SENT_254	[p18l1045t1911r1183b1975],
21	correlate	VB	O	correlate	_	0	SENT_254	[p18l1221t1902r1599b1975],
22	with	IN	O	with	_	0	SENT_254	[p18l1633t1902r1816b1975],
23	plasma	NN	O	plasma	nn	24	SENT_254	[p18l1849t1902r2148b1999],
24	levels	NNS	O	level	prep_with	21	SENT_254	[p18l12t2018r243b2091],
25	or	CC	O	or	_	0	SENT_254	[p18l312t2039r401b2091],
26	with	IN	O	with	_	0	SENT_254	[p18l463t2016r645b2089],
27	multiple	JJ	O	multiple	amod	30	SENT_254	[p18l712t2015r1064b2113],
28	drug	NN	O	drug	nn	30	SENT_254	[p18l1133t2016r1325b2112],
29	resistance	NN	O	resistance	nn	30	SENT_254	[p18l1391t2016r1811b2092],
30	status	NN	O	status	prep_with	21	SENT_254	[p18l1880t2027r2144b2105],
31	,	,	O	,	_	0	SENT_254	[p18l1880t2027r2144b2105],
32	While	IN	O	while	mark	40	SENT_254	[p18l7t2135r231b2206],
33	the	DT	O	the	det	34	SENT_254	[p18l305t2135r436b2205],
34	levels	NNS	O	level	nsubj	40	SENT_254	[p18l509t2135r743b2206],
35	of	IN	O	of	_	0	SENT_254	[p18l817t2134r904b2205],
36	cellular	JJ	O	cellular	amod	37	SENT_254	[p18l970t2134r1285b2206],
37	daunorubicin	NN	O	daunorubicin	prep_of	34	SENT_254	[p18l1359t2134r1923b2206],
38	and	CC	O	and	_	0	SENT_254	[p18l1996t2134r2148b2206],
39	daunorubicinol	NN	O	daunorubicinol	prep_of	34	SENT_254	[p18l14t2249r657b2322],
40	discriminated	VBD	O	discriminate	advcl	63	SENT_254	[p18l754t2249r1329b2322],
41	signiﬁcantly	RB	O	signiﬁcantly	advmod	40	SENT_254	[p18l1422t2249r1927b2346],
42	between	IN	O	between	_	0	SENT_254	[p18l2015t2251r2146b2322, p18l12t2377r259b2439],
43	responders	NNS	O	responder	prep_between	40	SENT_254	[p18l300t2368r766b2463],
44	and	CC	O	and	_	0	SENT_254	[p18l810t2368r962b2439],
45	failures	NNS	O	failure	conj_and	43	SENT_254	[p18l1000t2352r1418b2442],
46	.26	CD	NUMBER	.26	dobj	40	SENT_254	[p18l1000t2352r1418b2442],
47	The	DT	O	the	det	49	SENT_254	[p18l1459t2368r1623b2439],
48	clinical	JJ	O	clinical	amod	49	SENT_254	[p18l1663t2368r1962b2442],
49	relevance	NN	O	relevance	nsubj	53	SENT_254	[p18l2003t2368r2146b2439, p18l12t2506r299b2555],
50	of	IN	O	of	_	0	SENT_254	[p18l361t2485r448b2555],
51	our	PRP$	O	we	poss	52	SENT_254	[p18l503t2505r648b2555],
52	observation	NN	O	observation	prep_of	49	SENT_254	[p18l707t2485r1202b2555],
53	depends	VBZ	O	depend	rcmod	46	SENT_254	[p18l1263t2484r1613b2579],
54	in	IN	O	in	_	0	SENT_254	[p18l1675t2485r1753b2555],
55	part	NN	O	part	prep_in	53	SENT_254	[p18l1812t2494r1985b2578],
56	on	IN	O	on	_	0	SENT_254	[p18l2045t2508r2148b2555],
57	whether	IN	O	whether	complm	60	SENT_254	[p18l7t2601r355b2672],
58	G6PD	NN	O	g6pd	nn	59	SENT_254	[p18l405t2601r664b2675],
59	deﬁciency	NN	O	deﬁciency	nsubj	60	SENT_254	[p18l717t2599r1139b2695],
60	modiﬁes	VBZ	O	modiﬁes	prepc_on	40	SENT_254	[p18l1184t2598r1541b2675],
61	the	DT	O	the	det	62	SENT_254	[p18l1591t2601r1720b2672],
62	biotrans	NNS	O	biotran	nsubj	63	SENT_254	[p18l1768t2601r2148b2672],
63	—	VBP	O	—	ccomp	21	SENT_254	[p18l1768t2601r2148b2672],
64	formation	NN	O	formation	dobj	63	SENT_254	[p18l12t2718r434b2788],
65	of	IN	O	of	_	0	SENT_254	[p18l486t2718r573b2788],
66	daunorubicin	NN	O	daunorubicin	prep_of	64	SENT_254	[p18l619t2717r1183b2788],
67	in	IN	O	in	_	0	SENT_254	[p18l1233t2718r1311b2788],
68	tissues	NNS	O	tissue	prep_in	63	SENT_254	[p18l1361t2718r1637b2790],
69	other	JJ	O	other	advmod	70	SENT_254	[p18l1689t2718r1913b2788],
70	than	IN	O	than	advmod	63	SENT_254	[p18l1961t2718r2150b2788],

1	594	CD	NUMBER	594	_	0	SENT_255	[p18l7t2847r134b2908],
2	Amitcii	NNP	O	Amitcii	dep	1	SENT_255	[p18l250t2847r500b2912],
3	.	.	O	.	_	0	SENT_255	[p18l250t2847r500b2912],

1	Bhoomo	NNP	PERSON	Bhoomo	_	0	SENT_256	[p18l538t2847r860b2912],
2	,	,	O	,	_	0	SENT_256	[p18l538t2847r860b2912],
3	and	CC	O	and	dep	1	SENT_256	[p18l896t2847r1039b2908],
4	Frischer	NNP	PERSON	Frischer	dep	3	SENT_256	[p18l1075t2844r1345b2908],

1	Nanomoles	NNS	O	nanomole	_	0	SENT_257	[p19l556t858r630b1329],
2	I	PRP	O	I	nsubj	3	SENT_257	[p19l556t802r626b831],
3	dl	VBP	O	dl	rcmod	1	SENT_257	[p19l556t706r626b776],
4	whoie	JJ	O	whoie	amod	5	SENT_257	[p19l554t433r624b677],
5	blood	NN	O	blood	dobj	3	SENT_257	[p19l549t175r621b399],

1	Control	NNP	O	Control	nn	2	SENT_258	[p19l1215t152r1498b229],
2	L.C.	NNP	O	L.C.	_	0	SENT_258	[p19l1536t155r1691b229],

1	Minutes	NNPS	DURATION	Minutes	_	0	SENT_259	[p19l1318t1626r1634b1703],

1	Nanomoles	NNS	O	nanomole	_	0	SENT_260	[p20l6t1077r109b1703],
2	I	PRP	O	I	nsubj	3	SENT_260	[p20l15t1003r105b1041],
3	dl	VBP	O	dl	rcmod	1	SENT_260	[p20l15t875r109b967],
4	whole	JJ	O	whole	amod	5	SENT_260	[p20l18t510r112b839],
5	blood	NN	O	blood	dobj	3	SENT_260	[p20l18t171r115b465],

1	-5	CD	NUMBER	-5	num	2	SENT_261	[p20l193t90r255b184],
2	C	NN	O	c	_	0	SENT_261	[p20l266t90r323b184],
3	)	CD	NUMBER	)	num	5	SENT_261	[p20l266t90r323b184],
4	CO	NN	O	co	nn	5	SENT_261	[p20l196t494r255b589],
5	C	NN	O	c	dep	2	SENT_261	[p20l263t492r320b588],
6	)	CD	NUMBER	)	num	9	SENT_261	[p20l263t492r320b588],
7	[	NN	O	[	nn	9	SENT_261	[p20l190t902r249b995],
8	o	NN	O	o	nn	9	SENT_261	[p20l190t902r249b995],
9	D	NN	O	d	dep	2	SENT_261	[p20l260t902r320b996],

1	_	NN	O	_	nn	2	SENT_262	[p20l193t1306r228b1400],
2	L	NN	O	l	_	0	SENT_262	[p20l193t1306r228b1400],

1	C	NN	O	c	_	0	SENT_263	[p20l254t1306r313b1400],

1	C	NN	O	c	_	0	SENT_264	[p20l251t1713r311b1803],
2	)	CD	NUMBER	)	num	3	SENT_264	[p20l251t1713r311b1803],
3	o	NN	O	o	dep	1	SENT_264	[p20l410t1906r467b1996],

1	G6PD	NN	O	g6pd	_	0	SENT_265	[p20l707t183r1030b285],
2	Deﬁcient	JJ	O	deﬁcient	amod	3	SENT_265	[p20l1077t185r1541b289],
3	P.R.	NN	O	p.r.	dep	1	SENT_265	[p20l1579t188r1792b285],

1	°	NN	O	°	_	0	SENT_266	[p20l532t321r1930b487],
2	\	NN	O	\	nn	3	SENT_266	[p20l532t321r1930b487],
3	o	NN	O	o	dep	1	SENT_266	[p20l532t321r1930b487],
4	.	.	O	.	_	0	SENT_266	[p20l532t321r1930b487],

1	—	NN	O	—	_	0	SENT_267	[p20l532t321r1930b487],
2	.	.	O	.	_	0	SENT_267	[p20l532t321r1930b487],

1	.	.	O	.	_	0	SENT_268	[p20l532t321r1930b487],

1	—	NN	O	—	_	0	SENT_269	[p20l532t321r1930b487],
2	.	.	O	.	_	0	SENT_269	[p20l532t321r1930b487],

1	.	.	O	.	_	0	SENT_270	[p20l532t321r1930b487],

1	—	NN	O	—	_	0	SENT_271	[p20l532t321r1930b487],
2	.	.	O	.	_	0	SENT_271	[p20l532t321r1930b487],

1	:	:	O	:	_	0	SENT_272	[p20l532t321r1930b487],
2	.	.	O	.	_	0	SENT_272	[p20l532t321r1930b487],

1	—	NN	O	—	_	0	SENT_273	[p20l532t321r1930b487],
2	.	.	O	.	_	0	SENT_273	[p20l532t321r1930b487],

1	o	NN	O	o	_	0	SENT_274	[p20l532t321r1930b487],

1	Minutes	NNPS	DURATION	Minutes	_	0	SENT_275	[p20l1037t2174r1455b2272],

1	J	NN	O	j	nn	2	SENT_276	[p20l1634t2434r1662b2489],
2	Lab	NN	O	lab	_	0	SENT_276	[p20l1695t2432r1817b2490],
3	Clin	NNP	O	Clin	nn	4	SENT_276	[p20l1846t2432r1968b2489],
4	Med	NNP	O	Med	dep	2	SENT_276	[p20l1999t2434r2151b2489],
5	June	NNP	DATE	June	tmod	4	SENT_276	[p20l1808t2522r1972b2579],
6	1996	CD	DATE	1996	num	5	SENT_276	[p20l2005t2522r2153b2579],

1	35	CD	NUMBER	35	num	2	SENT_277	[p21l256t142r320b232],
2	Control	NN	O	control	_	0	SENT_277	[p21l893t127r1157b196],
3	P.T.	NNP	O	P.T.	nn	4	SENT_277	[p21l1192t127r1333b196],
4	.9	NNP	NUMBER	.9	dep	2	SENT_277	[p21l255t237r318b300],
5	.	.	O	.	_	0	SENT_277	[p21l256t305r320b347],

1	o	NN	O	o	_	0	SENT_278	[p21l256t305r320b347],
2	.9	CD	NUMBER	.9	num	1	SENT_278	[p21l256t382r320b440],
3	30	CD	NUMBER	30	num	4	SENT_278	[p21l434t371r518b436],
4	O	NN	O	o	dep	1	SENT_278	[p21l270t448r320b493],
5	.	.	O	.	_	0	SENT_278	[p21l256t499r318b538],

1	i	FW	O	i	_	0	SENT_279	[p21l256t499r318b538],
2	''	''	O	''	_	0	SENT_279	[p21l256t499r318b538],
3	_	NN	O	_	dep	1	SENT_279	[p21l256t499r318b538],
4	'	''	O	'	_	0	SENT_279	[p21l256t499r318b538],
5	3	CD	NUMBER	3	dep	8	SENT_279	[p21l270t543r318b608],
6	5	CD	NUMBER	5	dep	5	SENT_279	[p21l256t635r320b699],
7	20	CD	NUMBER	20	num	8	SENT_279	[p21l432t656r518b721],
8	I3	NN	O	i3	dep	1	SENT_279	[p21l256t724r320b814],
9	.92	CD	NUMBER	.92	number	10	SENT_279	[p21l256t819r320b882],
10	O	NN	O	o	amod	11	SENT_279	[p21l270t887r320b933],
11	E	NN	O	e	dep	1	SENT_279	[p21l270t938r318b1003],
12	10	CD	NUMBER	10	num	13	SENT_279	[p21l436t938r518b1003],
13	O	NN	O	o	dep	1	SENT_279	[p21l270t1008r320b1054],
14	C	NN	O	c	dep	13	SENT_279	[p21l270t1062r318b1101],
15	(	CD	NUMBER	(	dobj	14	SENT_279	[p21l270t1106r320b1150],
16	U	NNP	O	U	dep	15	SENT_279	[p21l270t1106r320b1150],
17	z	SYM	O	z	dep	15	SENT_279	[p21l253t1159r316b1209],

1	Minutes	NNPS	DURATION	Minutes	_	0	SENT_280	[p21l1001t1480r1293b1549],

1	Daunorubicin	NN	O	daunorubicin	_	0	SENT_281	[p21l7t1583r488b1651],

1	Daunorubicinol	NN	O	daunorubicinol	_	0	SENT_282	[p21l6t1696r708b1785],

1	13	CD	NUMBER	13	number	2	SENT_283	[p21l309t2030r389b2084],
2	4	CD	NUMBER	4	num	6	SENT_283	[p21l532t1971r643b2051],
3	°	NN	O	°	nn	6	SENT_283	[p21l532t1971r643b2051],
4	G6PDDf	NN	O	g6pddf	nn	6	SENT_283	[p21l974t2019r1556b2108],
5	'	''	O	'	_	0	SENT_283	[p21l974t2019r1556b2108],
6	tBJ	NN	O	tbj	_	0	SENT_283	[p21l1680t2020r1889b2105],
7	o	NN	O	o	dep	6	SENT_283	[p21l328t2088r389b2146],
8	encren	NN	O	encren	dep	7	SENT_283	[p21l1372t2039r1676b2109],
9	.	.	O	.	_	0	SENT_283	[p21l1819t2088r1916b2103],

1	.	.	O	.	_	0	SENT_284	[p21l1819t2088r1916b2103],

1	.9	NN	NUMBER	.9	_	0	SENT_285	[p21l309t2154r389b2231],
2	.	.	O	.	_	0	SENT_285	[p21l309t2238r389b2294],

1	o	NN	O	o	_	0	SENT_286	[p21l309t2238r389b2294],

1	9	CD	NUMBER	9	num	2	SENT_287	[p21l309t2334r389b2411],
2	30	CD	NUMBER	30	_	0	SENT_287	[p21l535t2328r643b2411],
3	O	NN	O	o	dep	2	SENT_287	[p21l328t2418r389b2476],
4	.	.	O	.	_	0	SENT_287	[p21l309t2483r389b2536],

1	:	:	O	:	_	0	SENT_288	[p21l309t2483r389b2536],
2	3	CD	NUMBER	3	_	0	SENT_288	[p21l328t2541r389b2623],

1	E	NN	O	e	_	0	SENT_289	[p21l306t2685r389b2803],
2	20	CD	NUMBER	20	num	1	SENT_289	[p21l532t2691r643b2773],

1	an	DT	O	a	_	0	SENT_290	[p21l328t2835r389b2886],
2	.	.	O	.	_	0	SENT_290	[p21l303t2892r389b2972],

1	o.	SYM	O	o.	_	0	SENT_291	[p21l303t2892r389b2972],
2	-	:	O	-	_	0	SENT_291	[p21l303t2892r389b2972],
3	‘	NN	O	‘	nn	4	SENT_291	[p21l303t2892r389b2972],
4	O	NN	O	o	dep	5	SENT_291	[p21l322t2980r386b3038],
5	E	NN	O	e	dep	9	SENT_291	[p21l322t3045r386b3125],
6	10	CD	NUMBER	10	num	7	SENT_291	[p21l538t3051r640b3130],
7	o	NN	O	o	dep	9	SENT_291	[p21l322t3135r386b3190],
8	:	:	O	:	_	0	SENT_291	[p21l322t3200r386b3253],
9	to	TO	O	to	dep	1	SENT_291	[p21l322t3260r386b3316],
10	Z	NN	O	z	dep	9	SENT_291	[p21l303t3329r384b3393],

1	Minutes	NNPS	DURATION	Minutes	_	0	SENT_292	[p22l1238t87r1610b172],

1	4	LS	NUMBER	4	_	0	SENT_293	[p22l403t232r426b257],
2	.	.	O	.	_	0	SENT_293	[p22l403t232r426b257],

1	Biotransformation	NN	O	biotransformation	_	0	SENT_294	[p22l444t231r706b257],
2	of	IN	O	of	_	0	SENT_294	[p22l717t232r747b257],
3	daunorubicin	NN	O	daunorubicin	prep_of	1	SENT_294	[p22l755t231r943b257],
4	from	IN	O	from	_	0	SENT_294	[p22l953t231r1022b257],
5	o	NN	O	o	prep_from	1	SENT_294	[p22l1031t231r1047b257],
6	to	TO	O	to	_	0	SENT_294	[p22l1057t234r1085b257],
7	1	CD	DURATION	1	num	8	SENT_294	[p22l1097t231r1109b256],
8	hour	NN	NUMBER	hour	prep_to	1	SENT_294	[p22l1121t231r1188b258],
9	in	IN	O	in	_	0	SENT_294	[p22l1197t232r1224b257],
10	whole	JJ	O	whole	amod	11	SENT_294	[p22l1233t231r1317b257],
11	blood	NN	O	blood	prep_in	8	SENT_294	[p22l1327t231r1407b257],
12	from	IN	O	from	_	0	SENT_294	[p22l1417t231r1485b257],
13	persons	NNS	O	person	conj_or	13	SENT_294	[p22l1495t238r1604b264],
14	without	IN	O	without	_	0	SENT_294	[p22l1613t231r1721b257],
15	or	CC	O	or	_	0	SENT_294	[p22l1731t239r1761b257],
16	with	IN	O	with	_	0	SENT_294	[p22l1770t231r1830b257],
17	PD	NN	O	pd	nn	18	SENT_294	[p22l375t273r420b299],
18	GdA	NN	O	gda	prep_with	13	SENT_294	[p22l436t272r524b299],
19	“	CD	NUMBER	“	num	20	SENT_294	[p22l436t272r524b299],
20	deﬁciency	NN	O	deﬁciency	prep_without	13	SENT_294	[p22l541t272r688b305],
21	.	.	O	.	_	0	SENT_294	[p22l541t272r688b305],

1	Whole	JJ	O	whole	amod	2	SENT_295	[p22l703t273r797b299],
2	blood	NN	O	blood	nsubjpass	4	SENT_295	[p22l811t273r892b299],
3	was	VBD	O	be	auxpass	4	SENT_295	[p22l905t280r957b298],
4	incubated	VBN	O	incubate	_	0	SENT_295	[p22l971t272r1110b298],
5	with	IN	O	with	_	0	SENT_295	[p22l1123t273r1185b299],
6	daunorubicin	NN	O	daunorubicin	nn	7	SENT_295	[p22l1199t272r1387b299],
7	(	NN	O	(	prep_with	4	SENT_295	[p22l1402t272r1463b306],
8	200	CD	NUMBER	200	num	10	SENT_295	[p22l1402t272r1463b306],
9	ng/ml	NN	O	ng/ml	nn	10	SENT_295	[p22l1477t271r1568b305],
10	)	NN	O	)	dobj	4	SENT_295	[p22l1477t271r1568b305],
11	for	IN	O	for	_	0	SENT_295	[p22l1583t273r1625b298],
12	5	CD	NUMBER	5	prep_for	10	SENT_295	[p22l1638t273r1661b304],
13	,	,	O	,	_	0	SENT_295	[p22l1638t273r1661b304],
14	20	CD	NUMBER	20	conj_and	12	SENT_295	[p22l1677t273r1716b303],
15	,	,	O	,	_	0	SENT_295	[p22l1677t273r1716b303],
16	and	CC	NUMBER	and	_	0	SENT_295	[p22l1733t272r1784b298],
17	60	CD	NUMBER	60	num	18	SENT_295	[p22l1799t272r1830b298],
18	utes	NNS	O	ute	prep_for	10	SENT_295	[p22l385t319r449b340],
19	.	.	O	.	_	0	SENT_295	[p22l385t319r449b340],

1	Daunorubicin	NN	PERSON	daunorubicin	nsubjpass	5	SENT_296	[p22l469t313r666b340],
2	and	CC	O	and	_	0	SENT_296	[p22l685t314r736b340],
3	daunorubicinol	NN	O	daunorubicinol	nsubjpass	5	SENT_296	[p22l755t314r970b340],
4	were	VBD	O	be	auxpass	5	SENT_296	[p22l987t321r1055b339],
5	determined	VBN	O	determine	_	0	SENT_296	[p22l1074t313r1237b340],
6	separately	RB	O	separately	advmod	5	SENT_296	[p22l1255t313r1399b348],
7	in	IN	O	in	_	0	SENT_296	[p22l1417t313r1443b339],
8	plasma	NN	O	plasma	prep_in	5	SENT_296	[p22l1462t313r1561b347],
9	and	CC	O	and	_	0	SENT_296	[p22l1579t314r1630b340],
10	erythrocytes	NNS	O	erythrocyte	conj_and	8	SENT_296	[p22l1648t314r1828b347],
11	.	.	O	.	_	0	SENT_296	[p22l1648t314r1828b347],

1	alues	NNS	O	alue	nsubjpass	3	SENT_297	[p22l357t356r428b381],
2	were	VBD	O	be	auxpass	3	SENT_297	[p22l439t363r507b381],
3	calculated	VBN	O	calculate	_	0	SENT_297	[p22l520t355r670b386],
4	,	,	O	,	_	0	SENT_297	[p22l520t355r670b386],
5	taking	VBG	O	take	xcomp	3	SENT_297	[p22l683t356r770b389],
6	into	IN	O	into	_	0	SENT_297	[p22l782t356r838b381],
7	account	NN	O	account	prep_into	5	SENT_297	[p22l850t359r961b381],
8	the	DT	O	the	dep	7	SENT_297	[p22l972t355r1017b381],
9	measured	VBN	O	measure	partmod	7	SENT_297	[p22l1029t355r1167b381],
10	whole	JJ	O	whole	amod	12	SENT_297	[p22l1177t355r1262b381],
11	blood	NN	O	blood	nn	12	SENT_297	[p22l1273t355r1354b381],
12	hematocrits	NNS	O	hematocrit	dobj	9	SENT_297	[p22l1367t354r1540b381],
13	.	.	O	.	_	0	SENT_297	[p22l1367t354r1540b381],

1	erythrocytes	NNS	O	erythrocyte	_	0	SENT_298	[p22l13t564r555b657],
2	.	.	O	.	_	0	SENT_298	[p22l13t564r555b657],

1	Currently	RB	DATE	currently	advmod	6	SENT_299	[p22l625t564r1035b657],
2	this	DT	O	this	det	3	SENT_299	[p22l1099t564r1248b634],
3	information	NN	O	information	nsubj	6	SENT_299	[p22l1315t564r1823b636],
4	is	VBZ	O	be	cop	6	SENT_299	[p22l1890t564r1949b636],
5	not	RB	O	not	neg	6	SENT_299	[p22l2015t573r2153b634],
6	available	JJ	O	available	_	0	SENT_299	[p22l13t678r408b750],
7	.	.	O	.	_	0	SENT_299	[p22l13t678r408b750],

1	It	PRP	O	it	nsubjpass	3	SENT_300	[p22l451t680r518b750],
2	is	VBZ	O	be	auxpass	3	SENT_300	[p22l556t678r617b750],
3	known	VBN	O	know	_	0	SENT_300	[p22l653t678r958b764],
4	,	,	O	,	_	0	SENT_300	[p22l653t678r958b764],
5	however	RB	O	however	advmod	3	SENT_300	[p22l999t678r1376b765],
6	,	,	O	,	_	0	SENT_300	[p22l999t678r1376b765],
7	that	IN	O	that	complm	11	SENT_300	[p22l1416t678r1585b750],
8	G6PD	NN	O	g6pd	nn	9	SENT_300	[p22l1623t678r1884b750],
9	activity	NN	O	activity	nsubjpass	11	SENT_300	[p22l1927t676r2151b751, p22l11t790r114b884],
10	is	VBZ	O	be	auxpass	11	SENT_300	[p22l161t790r221b863],
11	diminished	VBN	O	diminish	ccomp	3	SENT_300	[p22l273t790r740b865],
12	in	IN	O	in	prep	11	SENT_300	[p22l790t790r868b863],
13	leukocytes	NNS	O	leukocyte	dep	30	SENT_300	[p22l915t774r1464b884],
14	,	,	O	,	_	0	SENT_300	[p22l915t774r1464b884],
15	”	NN	O	”	nn	16	SENT_300	[p22l915t774r1464b884],
16	platelets	NNS	O	platelet	appos	13	SENT_300	[p22l1512t774r1974b886],
17	,	,	O	,	_	0	SENT_300	[p22l1512t774r1974b886],
18	”	NN	O	”	nn	19	SENT_300	[p22l1512t774r1974b886],
19	liver	NN	O	liver	appos	13	SENT_300	[p22l2022t790r2151b863, p22l11t891r195b994],
20	,	,	O	,	_	0	SENT_300	[p22l2022t790r2151b863, p22l11t891r195b994],
21	”	CD	NUMBER	”	num	22	SENT_300	[p22l2022t790r2151b863, p22l11t891r195b994],
22	skin	NN	O	skin	appos	13	SENT_300	[p22l231t889r501b994],
23	,3	CD	NUMBER	,3	num	24	SENT_300	[p22l231t889r501b994],
24	°	NN	O	°	dep	30	SENT_300	[p22l231t889r501b994],
25	muscle	NN	O	muscle	nn	30	SENT_300	[p22l535t891r926b994],
26	,	,	O	,	_	0	SENT_300	[p22l535t891r926b994],
27	“	NN	O	“	conj_and	25	SENT_300	[p22l535t891r926b994],
28	and	CC	O	and	_	0	SENT_300	[p22l966t907r1118b981],
29	saliva	NN	O	saliva	nn	30	SENT_300	[p22l1152t889r1464b978],
30	”	NN	O	”	dep	39	SENT_300	[p22l1152t889r1464b978],
31	in	IN	O	in	_	0	SENT_300	[p22l1498t907r1575b981],
32	the	DT	O	the	det	37	SENT_300	[p22l1609t907r1740b981],
33	Mediterranean	JJ	LOCATION	mediterranean	amod	37	SENT_300	[p22l1779t905r2151b978, p22l11t1046r304b1096],
34	deﬁciency	NN	O	deﬁciency	nn	37	SENT_300	[p22l368t1023r791b1119],
35	Variant	JJ	O	variant	amod	37	SENT_300	[p22l850t1023r1148b1096],
36	(	NN	O	(	nn	37	SENT_300	[p22l1217t1021r1383b1119],
37	Gd	NN	MISC	gd	prep_in	30	SENT_300	[p22l1217t1021r1383b1119],
38	Mediterranean	JJ	MISC	mediterranean	amod	39	SENT_300	[p22l1449t1021r2148b1119],
39	)	NN	O	)	dep	12	SENT_300	[p22l1449t1021r2148b1119],
40	.	.	O	.	_	0	SENT_300	[p22l1449t1021r2148b1119],

1	Likewise	RB	O	likewise	advmod	11	SENT_301	[p22l8t1134r404b1223],
2	,	,	O	,	_	0	SENT_301	[p22l8t1134r404b1223],
3	in	IN	O	in	_	0	SENT_301	[p22l463t1137r541b1210],
4	Chinese	JJ	MISC	chinese	amod	7	SENT_301	[p22l598t1137r935b1210],
5	G6PD	NN	O	g6pd	nn	7	SENT_301	[p22l994t1137r1255b1209],
6	deﬁciency	NN	O	deﬁciency	nn	7	SENT_301	[p22l1314t1134r1738b1231],
7	variants	NNS	O	variant	prep_in	11	SENT_301	[p22l1785t1134r2148b1223],
8	,	,	O	,	_	0	SENT_301	[p22l1785t1134r2148b1223],
9	enzyme	NN	O	enzyme	nn	10	SENT_301	[p22l8t1275r325b1343],
10	activity	NN	O	activity	nsubj	11	SENT_301	[p22l359t1254r664b1345],
11	is	VBZ	O	be	_	0	SENT_301	[p22l690t1252r752b1324],
12	markedly	RB	O	markedly	advmod	11	SENT_301	[p22l783t1252r1179b1343],
13	reduced	VBN	O	reduce	dep	12	SENT_301	[p22l1208t1252r1550b1324],
14	in	IN	O	in	_	0	SENT_301	[p22l1581t1252r1659b1324],
15	liver	NN	O	liver	prep_in	13	SENT_301	[p22l1688t1252r1895b1339],
16	,	,	O	,	_	0	SENT_301	[p22l1688t1252r1895b1339],
17	adrenals	NNS	O	adrenal	prep_in	13	SENT_301	[p22l1931t1252r2148b1322, p22l6t1366r172b1438],
18	and	CC	O	and	_	0	SENT_301	[p22l250t1366r402b1438],
19	kidneys	NNS	O	kidney	prep_in	13	SENT_301	[p22l477t1352r896b1461],
20	.	.	O	.	_	0	SENT_301	[p22l477t1352r896b1461],

1	”	NN	O	”	npadvmod	2	SENT_302	[p22l477t1352r896b1461],
2	Thus	RB	O	thus	advmod	32	SENT_302	[p22l971t1366r1204b1452],
3	,	,	O	,	_	0	SENT_302	[p22l971t1366r1204b1452],
4	although	IN	O	although	mark	15	SENT_302	[p22l1284t1366r1656b1462],
5	in	IN	O	in	_	0	SENT_302	[p22l1730t1366r1807b1438],
6	GdA	NNP	O	GdA	prep_in	15	SENT_302	[p22l1885t1366r2146b1438],
7	_	CD	NUMBER	_	num	6	SENT_302	[p22l1885t1366r2146b1438],
8	G6PD	NN	O	g6pd	nn	9	SENT_302	[p22l8t1481r269b1551],
9	deﬁciency	NN	O	deﬁciency	nsubjpass	15	SENT_302	[p22l324t1478r747b1574],
10	the	DT	O	the	det	13	SENT_302	[p22l795t1481r928b1554],
11	lowered	JJ	O	lowered	amod	13	SENT_302	[p22l978t1479r1315b1551],
12	enzyme	NN	O	enzyme	nn	13	SENT_302	[p22l1368t1502r1687b1574],
13	activity	NN	O	activity	dep	9	SENT_302	[p22l1737t1478r2042b1572],
14	is	VBZ	O	be	auxpass	15	SENT_302	[p22l2089t1479r2151b1551],
15	limited	VBN	O	limit	dep	32	SENT_302	[p22l6t1596r306b1668],
16	to	TO	O	to	_	0	SENT_302	[p22l352t1607r434b1668],
17	erythrocytes	NNS	O	erythrocyte	prep_to	15	SENT_302	[p22l484t1598r1002b1691],
18	(	CD	NUMBER	(	nsubj	26	SENT_302	[p22l1055t1596r1269b1692],
19	With	IN	O	with	_	0	SENT_302	[p22l1055t1596r1269b1692],
20	the	DT	O	the	det	22	SENT_302	[p22l1312t1596r1445b1666],
21	possible	JJ	O	possible	amod	22	SENT_302	[p22l1491t1595r1833b1691],
22	exception	NN	O	exception	prep_with	18	SENT_302	[p22l1880t1619r2148b1689, p22l8t1713r174b1783],
23	of	IN	O	of	_	0	SENT_302	[p22l213t1711r299b1783],
24	liver	NN	O	liver	nn	25	SENT_302	[p22l331t1711r517b1783],
25	cells	NNS	O	cell	prep_of	22	SENT_302	[p22l556t1697r882b1806],
26	)	VBP	O	)	rcmod	17	SENT_302	[p22l556t1697r882b1806],
27	,34	CD	NUMBER	,34	dobj	26	SENT_302	[p22l556t1697r882b1806],
28	this	DT	O	this	nsubj	32	SENT_302	[p22l918t1711r1067b1783],
29	is	VBZ	O	be	cop	32	SENT_302	[p22l1106t1711r1167b1783],
30	not	RB	O	not	neg	32	SENT_302	[p22l1205t1720r1343b1783],
31	the	DT	O	the	det	32	SENT_302	[p22l1382t1711r1513b1783],
32	case	NN	O	case	_	0	SENT_302	[p22l1551t1733r1728b1783],
33	for	IN	O	for	_	0	SENT_302	[p22l1764t1710r1888b1783],
34	other	JJ	O	other	amod	36	SENT_302	[p22l1925t1711r2153b1783],
35	common	JJ	O	common	amod	36	SENT_302	[p22l8t1846r374b1895],
36	types	NNS	O	type	prep_for	32	SENT_302	[p22l412t1834r629b1919],
37	of	IN	O	of	_	0	SENT_302	[p22l669t1825r759b1897],
38	G6PD	NN	O	g6pd	nn	39	SENT_302	[p22l795t1825r1053b1895],
39	deﬁciency	NN	O	deﬁciency	prep_of	36	SENT_302	[p22l1096t1822r1541b1918],
40	.	.	O	.	_	0	SENT_302	[p22l1096t1822r1541b1918],

1	Restricted	JJ	O	restricted	amod	2	SENT_303	[p22l106t1939r531b2011],
2	biotransformation	NN	O	biotransformation	_	0	SENT_303	[p22l572t1938r1318b2012],
3	of	IN	O	of	dep	2	SENT_303	[p22l1361t1939r1450b2011],
4	daunorubicin	NN	O	daunorubicin	pobj	3	SENT_303	[p22l1486t1938r2032b2012],
5	in	IN	O	in	dep	2	SENT_303	[p22l2075t1939r2153b2009],

1	G6PD	NN	O	g6pd	nn	2	SENT_304	[p22l8t2056r265b2124],
2	deﬁciency	NN	O	deﬁciency	nsubj	4	SENT_304	[p22l308t2053r717b2149],
3	may	MD	O	may	aux	4	SENT_304	[p22l753t2077r921b2147],
4	affect	VB	O	affect	_	0	SENT_304	[p22l962t2056r1183b2124],
5	antitumor	JJ	O	antitumor	amod	6	SENT_304	[p22l1224t2054r1631b2127],
6	activity	NN	O	activity	dobj	4	SENT_304	[p22l1672t2056r1963b2147],
7	and	CC	O	and	_	0	SENT_304	[p22l2001t2054r2151b2124],
8	toxicity	NN	O	toxicity	dobj	4	SENT_304	[p22l8t2166r323b2259],
9	.	.	O	.	_	0	SENT_304	[p22l8t2166r323b2259],

1	Both	DT	O	both	preconj	2	SENT_305	[p22l361t2168r561b2241],
2	doxorubicin	NN	O	doxorubicin	nsubj	5	SENT_305	[p22l598t2165r1084b2241],
3	and	CC	O	and	_	0	SENT_305	[p22l1122t2166r1269b2238],
4	daunorubicin	NN	O	daunorubicin	conj_and	2	SENT_305	[p22l1307t2166r1849b2241],
5	inhibit	VBP	O	inhibit	_	0	SENT_305	[p22l1885t2166r2151b2239],
6	DNA	NN	MISC	dna	nn	9	SENT_305	[p22l8t2285r234b2353],
7	and	CC	O	and	_	0	SENT_305	[p22l294t2283r441b2353],
8	RNA	NN	O	rna	nn	9	SENT_305	[p22l500t2285r724b2355],
9	syntheses	NNS	O	synthesis	npadvmod	13	SENT_305	[p22l781t2283r1162b2376],
10	and	CC	O	and	_	0	SENT_305	[p22l1224t2283r1371b2353],
11	cell	NN	O	cell	nn	12	SENT_305	[p22l1433t2283r1571b2356],
12	proliferation	NN	O	proliferation	conj_and	9	SENT_305	[p22l1630t2282r2151b2377],
13	more	RBR	O	more	advmod	5	SENT_305	[p22l14t2421r226b2471],
14	eifectively	RB	O	eifectively	advmod	5	SENT_305	[p22l278t2398r684b2489],
15	than	IN	O	than	_	0	SENT_305	[p22l731t2396r913b2468],
16	doxorubicinol	NN	O	doxorubicinol	prep_than	5	SENT_305	[p22l963t2398r1526b2471],
17	and	CC	O	and	_	0	SENT_305	[p22l1576t2396r1725b2469],
18	daunorubicinol	NN	O	daunorubicinol	conj_and	16	SENT_305	[p22l1775t2396r2148b2471, p22l12t2513r288b2586],
19	even	RB	O	even	advmod	23	SENT_305	[p22l345t2534r531b2586],
20	though	IN	O	though	dep	23	SENT_305	[p22l588t2510r873b2604],
21	the	DT	O	the	det	22	SENT_305	[p22l928t2510r1056b2586],
22	metabolites	NNS	O	metabolite	nsubj	23	SENT_305	[p22l1113t2510r1586b2586],
23	retain	VBP	O	retain	ccomp	5	SENT_305	[p22l1643t2511r1882b2584],
24	some	DT	O	some	det	26	SENT_305	[p22l1939t2534r2148b2586],
25	antitumor	NN	O	antitumor	nn	26	SENT_305	[p22l16t2627r422b2700],
26	activity	NN	O	activity	dobj	23	SENT_305	[p22l481t2608r862b2720],
27	.	.	O	.	_	0	SENT_305	[p22l481t2608r862b2720],

1	”	NN	O	”	nsubj	4	SENT_306	[p22l481t2608r862b2720],
2	Thus	RB	O	thus	advmod	4	SENT_306	[p22l921t2627r1123b2700],
3	metabolism	NN	O	metabolism	nsubj	4	SENT_306	[p22l1182t2627r1658b2700],
4	diminishes	VBZ	O	diminish	_	0	SENT_306	[p22l1717t2625r2148b2700],
5	the	DT	O	the	det	7	SENT_306	[p22l14t2742r142b2815],
6	antitumor	NN	O	antitumor	nn	7	SENT_306	[p22l194t2742r600b2815],
7	efﬁcacy	NN	O	efﬁcacy	dobj	4	SENT_306	[p22l650t2740r945b2833],
8	of	IN	O	of	_	0	SENT_306	[p22l995t2742r1079b2815],
9	anthracyclines	NNS	O	anthracycline	prep_of	7	SENT_306	[p22l1127t2739r1727b2833],
10	.	.	O	.	_	0	SENT_306	[p22l1127t2739r1727b2833],

1	Hence	RB	O	hence	advmod	5	SENT_307	[p22l1779t2742r2044b2812],
2	it	PRP	O	it	nsubj	5	SENT_307	[p22l2096t2742r2148b2812],
3	has	VBZ	O	have	aux	5	SENT_307	[p22l14t2858r147b2929],
4	been	VBN	O	be	cop	5	SENT_307	[p22l171t2856r369b2929],
5	tempting	JJ	O	tempting	_	0	SENT_307	[p22l396t2854r760b2949],
6	to	TO	O	to	_	0	SENT_307	[p22l784t2865r864b2926],
7	View	NNP	O	View	nn	10	SENT_307	[p22l886t2853r1070b2929],
8	active	JJ	O	active	amod	10	SENT_307	[p22l1099t2856r1329b2929],
9	drug	NN	O	drug	nn	10	SENT_307	[p22l1358t2856r1544b2949],
10	metabolism	NN	O	metabolism	prep_to	5	SENT_307	[p22l1569t2854r2042b2926],
11	as	IN	O	as	_	0	SENT_307	[p22l2071t2879r2148b2928],
12	contributing	VBG	O	contribute	prepc_as	5	SENT_307	[p22l12t2968r513b3065],
13	to	TO	O	to	_	0	SENT_307	[p22l553t2980r633b3041],
14	an	DT	O	a	det	17	SENT_307	[p22l678t2992r772b3041],
15	impaired	JJ	O	impaired	amod	17	SENT_307	[p22l815t2968r1179b3062],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_307	[p22l1222t2968r1688b3064],
17	range	NN	O	range	prep_to	12	SENT_307	[p22l1728t2989r1956b3062],
18	and	CC	O	and	_	0	SENT_307	[p22l1999t2968r2146b3041],
19	loss	NN	O	loss	conj_and	17	SENT_307	[p22l12t3085r161b3158],
20	of	IN	O	of	_	0	SENT_307	[p22l215t3085r300b3158],
21	therapeutic	JJ	O	therapeutic	amod	22	SENT_307	[p22l347t3083r816b3176],
22	activity	NN	O	activity	prep_of	19	SENT_307	[p22l870t3085r1177b3176],
23	.	.	O	.	_	0	SENT_307	[p22l870t3085r1177b3176],

1	Indeed	RB	O	indeed	advmod	20	SENT_308	[p22l1236t3085r1542b3169],
2	,	,	O	,	_	0	SENT_308	[p22l1236t3085r1542b3169],
3	a	DT	O	a	det	4	SENT_308	[p22l1601t3106r1644b3155],
4	number	NN	O	number	nsubj	20	SENT_308	[p22l1696t3083r2012b3156],
5	of	IN	O	of	_	0	SENT_308	[p22l2066t3085r2153b3155],
6	years	NNS	DATE	year	prep_of	4	SENT_308	[p22l7t3223r221b3293],
7	ago	IN	DATE	ago	advmod	10	SENT_308	[p22l259t3223r399b3293],
8	Loveless	JJ	O	loveless	amod	10	SENT_308	[p22l437t3200r786b3272],
9	et	FW	O	et	nn	10	SENT_308	[p22l824t3209r896b3270],
10	al.	FW	O	al.	dep	6	SENT_308	[p22l937t3184r1089b3286],
11	,8	CD	NUMBER	,8	dep	6	SENT_308	[p22l937t3184r1089b3286],
12	in	IN	O	in	_	0	SENT_308	[p22l1125t3200r1200b3273],
13	considering	VBG	O	consider	prepc_in	11	SENT_308	[p22l1236t3200r1706b3291],
14	the	DT	O	the	det	15	SENT_308	[p22l1742t3198r1871b3270],
15	implications	NNS	O	implication	dobj	13	SENT_308	[p22l1909t3198r2146b3293, p22l12t3316r297b3386],
16	of	IN	O	of	_	0	SENT_308	[p22l329t3316r415b3386],
17	anthracycline	NN	O	anthracycline	nn	18	SENT_308	[p22l442t3314r985b3407],
18	metabolism	NN	O	metabolism	prep_of	15	SENT_308	[p22l1016t3314r1510b3400],
19	,	,	O	,	_	0	SENT_308	[p22l1016t3314r1510b3400],
20	raised	VBD	O	raise	_	0	SENT_308	[p22l1543t3314r1787b3384],
21	the	DT	O	the	det	22	SENT_308	[p22l1817t3311r1945b3384],
22	possibility	NN	O	possibility	dobj	20	SENT_308	[p22l1976t3337r2144b3409, p22l12t3428r279b3522],
23	that	IN	O	that	complm	35	SENT_308	[p22l324t3428r482b3502],
24	“	NN	O	“	nn	27	SENT_308	[p22l532t3431r596b3501],
25	. . .	CD	NUMBER	. . .	num	24	SENT_308	[p22l678t3487r693b3499],[p22l532t3431r596b3501],
26	simultaneous	JJ	O	simultaneous	amod	27	SENT_308	[p22l743t3428r1283b3502],
27	administration	NN	O	administration	nsubj	35	SENT_308	[p22l1333t3428r1926b3499],
28	of	IN	O	of	_	0	SENT_308	[p22l1974t3429r2060b3501],
29	a	DT	O	a	det	33	SENT_308	[p22l2103t3452r2146b3499],
30	pharmacologically	RB	O	pharmacologically	advmod	31	SENT_308	[p22l12t3543r758b3639],
31	acceptable	JJ	O	acceptable	amod	33	SENT_308	[p22l831t3543r1260b3639],
32	reductase	NN	O	reductase	nn	33	SENT_308	[p22l1333t3543r1723b3613],
33	inhibitor	NN	O	inhibitor	prep_of	27	SENT_308	[p22l1793t3540r2146b3615],
34	could	MD	O	could	aux	35	SENT_308	[p22l12t3659r235b3729],
35	increase	VB	O	increase	ccomp	20	SENT_308	[p22l301t3657r633b3730],
36	the	DT	O	the	det	38	SENT_308	[p22l701t3657r827b3729],
37	therapeutic	JJ	O	therapeutic	amod	38	SENT_308	[p22l896t3655r1362b3752],
38	eiﬁcacy	NN	O	eiﬁcacy	dobj	35	SENT_308	[p22l1428t3657r1725b3748],
39	of	IN	O	of	_	0	SENT_308	[p22l1789t3655r1873b3727],
40	these	DT	O	these	det	41	SENT_308	[p22l1934t3657r2144b3729],
41	drugs	NNS	O	drug	prep_of	38	SENT_308	[p23l14t18r304b111],
42	.	.	O	.	_	0	SENT_308	[p23l14t18r304b111],

1	”	NN	O	”	nsubj	5	SENT_309	[p23l14t18r304b111],
2	We	PRP	O	we	nsubj	5	SENT_309	[p23l354t20r494b90],
3	have	VBP	O	have	aux	5	SENT_309	[p23l541t18r728b88],
4	now	RB	DATE	now	advmod	5	SENT_309	[p23l777t39r945b89],
5	shown	VBN	O	show	_	0	SENT_309	[p23l993t18r1248b91],
6	that	IN	O	that	complm	14	SENT_309	[p23l1296t18r1457b91],
7	the	DT	O	the	det	8	SENT_309	[p23l1502t18r1630b88],
8	function	NN	O	function	nsubj	14	SENT_309	[p23l1678t16r2016b91],
9	of	IN	O	of	_	0	SENT_309	[p23l2064t18r2151b90],
10	carbonyl	NN	O	carbonyl	nn	11	SENT_309	[p23l9t136r357b227],
11	reductase	NN	O	reductase	prep_of	8	SENT_309	[p23l398t136r790b204],
12	is	VBZ	O	be	cop	14	SENT_309	[p23l831t134r890b204],
13	severely	RB	O	severely	advmod	14	SENT_309	[p23l933t136r1260b227],
14	restricted	JJ	O	restricted	ccomp	5	SENT_309	[p23l1296t134r1683b204],
15	in	IN	O	in	_	0	SENT_309	[p23l1724t134r1799b202],
16	the	DT	O	the	det	18	SENT_309	[p23l1840t134r1968b202],
17	red	JJ	O	red	amod	18	SENT_309	[p23l2009t136r2141b204],
18	cells	NNS	O	cell	prep_in	14	SENT_309	[p23l9t247r184b320],
19	of	IN	O	of	_	0	SENT_309	[p23l215t247r302b320],
20	the	DT	O	the	det	22	SENT_309	[p23l324t247r452b320],
21	many	JJ	O	many	amod	22	SENT_309	[p23l481t270r702b340],
22	persons	NNS	O	person	prep_of	18	SENT_309	[p23l729t270r1040b341],
23	throughout	IN	O	throughout	_	0	SENT_309	[p23l1071t247r1531b340],
24	the	DT	O	the	det	25	SENT_309	[p23l1560t247r1686b317],
25	world	NN	O	world	prep_throughout	14	SENT_309	[p23l1712t244r1947b317],
26	who	WP	O	who	nsubj	29	SENT_309	[p23l1971t247r2141b320],
27	are	VBP	O	be	cop	29	SENT_309	[p23l12t385r138b435],
28	G6PD	NN	O	g6pd	nn	29	SENT_309	[p23l176t364r429b435],
29	deﬁcient	NN	O	deﬁcient	rcmod	25	SENT_309	[p23l470t362r839b433],
30	.	.	O	.	_	0	SENT_309	[p23l470t362r839b433],

1	Does	VBZ	O	do	_	0	SENT_310	[p23l879t362r1091b435],
2	this	DT	O	this	det	3	SENT_310	[p23l1127t362r1269b433],
3	mean	NN	O	mean	dobj	1	SENT_310	[p23l1307t383r1531b433],
4	that	WDT	O	that	dep	8	SENT_310	[p23l1567t362r1727b433],
5	anthracyJ	NNP	O	anthracyJ	nn	8	SENT_310	[p23l1765t360r2141b455, p23l7t469r40b528],
6	Lob	NNP	O	Lob	nn	8	SENT_310	[p23l75t469r204b530],
7	Clin	NNP	O	Clin	nn	8	SENT_310	[p23l235t469r364b530],
8	Med	NNP	O	Med	rcmod	3	SENT_310	[p23l399t471r558b530],
9	Volume	NN	O	volume	nsubj	1	SENT_310	[p23l9t565r287b624],
10	127	CD	NUMBER	127	num	9	SENT_310	[p23l325t565r452b628],
11	,	,	O	,	_	0	SENT_310	[p23l325t565r452b628],
12	Number	NNP	O	Number	appos	9	SENT_310	[p23l491t567r781b624],
13	6	CD	NUMBER	6	num	12	SENT_310	[p23l807t567r846b626],

1	ng	NN	O	ng	_	0	SENT_311	[p23l591t1594r652b1676],
2	I	CD	NUMBER	i	num	3	SENT_311	[p23l577t1540r637b1565],
3	ml	NN	O	ml	dep	1	SENT_311	[p23l577t1436r637b1516],
4	whole	JJ	O	whole	amod	5	SENT_311	[p23l577t1200r639b1410],
5	blood	NN	O	blood	dep	1	SENT_311	[p23l575t979r637b1171],

1	Time	NNP	O	Time	_	0	SENT_312	[p23l1291t2094r1464b2158],
2	(	CD	NUMBER	(	num	4	SENT_312	[p23l1492t2094r1608b2174],
3	hr	NN	DURATION	hr	nn	4	SENT_312	[p23l1492t2094r1608b2174],
4	)	NN	O	)	dep	1	SENT_312	[p23l1492t2094r1608b2174],

1	Amitoi	NNP	PERSON	Amitoi	nn	3	SENT_313	[p23l875t2511r1112b2573],
2	,	,	O	,	_	0	SENT_313	[p23l875t2511r1112b2573],
3	Bhoomo	NNP	PERSON	Bhoomo	_	0	SENT_313	[p23l1151t2513r1460b2573],
4	,	,	O	,	_	0	SENT_313	[p23l1151t2513r1460b2573],
5	ond	JJ	O	ond	amod	6	SENT_313	[p23l1494t2513r1630b2571],
6	Frischer	NN	PERSON	frischer	appos	3	SENT_313	[p23l1664t2513r1921b2571],
7	595	CD	NUMBER	595	num	6	SENT_313	[p23l2032t2513r2152b2571],

1	‘	NN	O	‘	nn	2	SENT_314	[p23l379t2815r497b2875],
2	I80	NN	O	i80	_	0	SENT_314	[p23l379t2815r497b2875],
3	150	CD	NUMBER	150	number	4	SENT_314	[p23l379t2969r497b3027],
4	120	CD	NUMBER	120	dep	2	SENT_314	[p23l377t3123r495b3183],
5	(	NN	O	(	nn	7	SENT_314	[p23l415t3277r451b3335],
6	O	NN	O	o	nn	7	SENT_314	[p23l415t3277r451b3335],
7	o	NN	O	o	dep	4	SENT_314	[p23l457t3277r493b3335],

1	ng	NN	O	ng	_	0	SENT_315	[p23l260t3517r321b3598],
2	I	CD	NUMBER	i	num	3	SENT_315	[p23l247t3467r306b3492],
3	ml	NN	O	ml	dep	1	SENT_315	[p23l247t3363r306b3441],
4	whole	JJ	O	whole	amod	5	SENT_315	[p23l247t3129r308b3340],
5	blood	NN	O	blood	dep	1	SENT_315	[p23l247t2916r308b3104],

1	oo	NN	O	oo	nn	2	SENT_316	[p23l415t3586r451b3646],
2	O	NN	O	o	_	0	SENT_316	[p23l415t3432r451b3492],
3	)	CD	NUMBER	)	num	4	SENT_316	[p23l415t3432r451b3492],
4	O	NN	O	o	dep	2	SENT_316	[p23l457t3588r493b3646],
5	O	NN	O	o	nn	7	SENT_316	[p23l457t3432r493b3492],
6	(	NN	O	(	nn	7	SENT_316	[p23l457t3742r493b3800],
7	D	NN	O	d	dep	2	SENT_316	[p23l457t3742r493b3800],

1	Time	NNP	O	Time	_	0	SENT_317	[p24l915t186r1088b250],
2	(	CD	NUMBER	(	num	4	SENT_317	[p24l1115t186r1227b265],
3	hr	NN	DURATION	hr	nn	4	SENT_317	[p24l1115t186r1227b265],
4	)	NN	O	)	dep	1	SENT_317	[p24l1115t186r1227b265],

1	Control	NN	O	control	_	0	SENT_318	[p24l7t292r250b356],

1	GdA	NN	O	gda	_	0	SENT_319	[p24l7t480r176b542],
2	"	''	O	"	punct	1	SENT_319	[p24l7t480r176b542],
3	Gd	NNP	MISC	Gd	nn	4	SENT_319	[p24l14t602r109b665],
4	Mediterranean	NNP	MISC	Mediterranean	dep	1	SENT_319	[p24l139t605r627b670],

1	Fig	NN	O	fig	_	0	SENT_320	[p24l333t736r387b768],
2	.	.	O	.	_	0	SENT_320	[p24l333t736r387b768],

1	5	CD	NUMBER	5	_	0	SENT_321	[p24l405t736r428b761],
2	.	.	O	.	_	0	SENT_321	[p24l405t736r428b761],

1	Biotransformation	NN	O	biotransformation	conj_or	1	SENT_322	[p24l446t735r708b761],
2	of	IN	O	of	_	0	SENT_322	[p24l721t736r751b761],
3	daunorubiczin	NN	O	daunorubiczin	prep_of	1	SENT_322	[p24l762t736r950b762],
4	from	IN	O	from	_	0	SENT_322	[p24l963t736r1031b762],
5	O	NN	O	o	prep_from	1	SENT_322	[p24l1044t736r1059b762],
6	to	TO	O	to	_	0	SENT_322	[p24l1072t740r1100b762],
7	24	CD	DURATION	24	num	8	SENT_322	[p24l1113t737r1145b762],
8	hours	NNS	NUMBER	hour	prep_to	1	SENT_322	[p24l1158t737r1236b763],
9	in	IN	O	in	_	0	SENT_322	[p24l1250t737r1275b763],
10	whole	JJ	O	whole	amod	11	SENT_322	[p24l1287t737r1371b763],
11	blood	NN	O	blood	prep_in	1	SENT_322	[p24l1384t737r1464b763],
12	from	IN	O	from	_	0	SENT_322	[p24l1477t737r1545b763],
13	persons	NNS	O	person	prep_from	1	SENT_322	[p24l1557t746r1665b771],
14	without	IN	O	without	_	0	SENT_322	[p24l1678t738r1785b764],
15	or	CC	O	or	_	0	SENT_322	[p24l1798t746r1828b764],
16	with	IN	O	with	_	0	SENT_322	[p24l332t776r392b802],
17	G6PD	NN	O	g6pd	nn	18	SENT_322	[p24l405t777r494b803],
18	deﬁciency	NN	O	deﬁciency	prep_with	1	SENT_322	[p24l506t776r647b810],
19	of	IN	O	of	_	0	SENT_322	[p24l657t777r687b803],
20	the	DT	O	the	det	22	SENT_322	[p24l696t777r741b803],
21	GdA	NN	O	gda	nn	22	SENT_322	[p24l753t777r841b803],
22	‘	NN	O	‘	prep_of	1	SENT_322	[p24l753t777r841b803],
23	or	CC	O	or	_	0	SENT_322	[p24l855t785r885b803],
24	Gd	JJ	MISC	gd	amod	26	SENT_322	[p24l896t777r940b803],
25	Mediterranean	JJ	MISC	mediterranean	amod	26	SENT_322	[p24l951t778r1163b804],
26	types	NNS	O	type	prep_of	1	SENT_322	[p24l1174t782r1254b812],
27	.	.	O	.	_	0	SENT_322	[p24l1174t782r1254b812],

1	A	DT	O	a	det	6	SENT_323	[p24l1265t779r1294b809],
2	,	,	O	,	_	0	SENT_323	[p24l1265t779r1294b809],
3	Disappearance	NNP	O	Disappearance	dep	4	SENT_323	[p24l1306t778r1516b812],
4	of	IN	O	of	dep	6	SENT_323	[p24l1528t779r1558b805],
5	daunorubicin	NN	O	daunorubicin	nn	6	SENT_323	[p24l1568t779r1755b805],
6	(	NN	O	(	_	0	SENT_323	[p24l1767t779r1828b813],
7	200	CD	NUMBER	200	num	8	SENT_323	[p24l1767t779r1828b813],
8	ng/ml	NN	O	ng/ml	dep	6	SENT_323	[p24l333t817r432b852],
9	)	NN	O	)	dep	8	SENT_323	[p24l333t817r432b852],
10	.	.	O	.	_	0	SENT_323	[p24l333t817r432b852],

1	B	NN	O	b	_	0	SENT_324	[p24l445t819r474b849],
2	,	,	O	,	_	0	SENT_324	[p24l445t819r474b849],
3	Formation	NN	O	formation	appos	1	SENT_324	[p24l487t818r637b844],
4	of	IN	O	of	_	0	SENT_324	[p24l650t818r680b844],
5	daunorubicinol	NN	O	daunorubicinol	prep_of	3	SENT_324	[p24l690t819r912b845],
6	.	.	O	.	_	0	SENT_324	[p24l690t819r912b845],

1	Table	NNP	O	Table	nn	2	SENT_325	[p24l95t927r193b957],
2	III	NNP	O	III	_	0	SENT_325	[p24l208t927r246b956],
3	.	.	O	.	_	0	SENT_325	[p24l208t927r246b956],

1	inhibitors	NNS	O	inhibitor	_	0	SENT_326	[p24l263t927r418b957],
2	of	IN	O	of	_	0	SENT_326	[p24l432t927r468b957],
3	dounorubicin	NN	O	dounorubicin	nn	4	SENT_326	[p24l481t928r721b957],
4	metabolism	NN	O	metabolism	prep_of	1	SENT_326	[p24l737t928r946b958],

1	Duunorubicin	NN	PERSON	duunorubicin	nsubj	2	SENT_327	[p24l957t1000r1144b1025],
2	removed	VBD	O	remove	_	0	SENT_327	[p24l1156t1001r1282b1025],

1	Substrate	NN	O	substrate	nn	2	SENT_328	[p24l234t1056r363b1079],
2	Conc	NN	O	conc	_	0	SENT_328	[p24l546t1056r623b1080],
3	(	CD	NUMBER	(	num	4	SENT_328	[p24l635t1056r760b1084],
4	mmol/L	NN	O	mmol/l	dep	2	SENT_328	[p24l635t1056r760b1084],
5	)	CD	NUMBER	)	num	6	SENT_328	[p24l635t1056r760b1084],
6	nmol/hr/gm	NN	O	nmol/hr/gm	dep	4	SENT_328	[p24l847t1057r1015b1086],
7	Hb	NN	O	hb	nn	9	SENT_328	[p24l1028t1057r1065b1080],
8	Percent	NN	O	percent	nn	9	SENT_328	[p24l1150t1057r1257b1081],
9	inhibition	NN	O	inhibition	dep	2	SENT_328	[p24l1267t1057r1391b1081],

1	None	NN	O	none	_	0	SENT_329	[p24l8t1158r183b1218],
2	Phenanthrene	NN	O	phenanthrene	nn	3	SENT_329	[p24l8t1258r471b1319],
3	quinone	NN	O	quinone	dep	1	SENT_329	[p24l497t1258r761b1333],

1	Rutin	NN	O	rutin	_	0	SENT_330	[p24l8t1453r173b1514],

1	Menadione	NN	O	menadione	_	0	SENT_331	[p24l8t1649r375b1709],

1	Cibaoron	NNP	MISC	Cibaoron	_	0	SENT_332	[p24l6t1846r304b1906],
2	blue	NN	O	blue	nn	3	SENT_332	[p24l334t1846r471b1906],
3	A	NN	O	a	dep	1	SENT_332	[p24l493t1846r543b1906],

1	Primaquine	NN	O	primaquine	_	0	SENT_333	[p24l6t2045r379b2120],
2	aldehyde	NN	O	aldehyde	nn	3	SENT_333	[p24l404t2045r705b2120],
3	BCNU	NN	O	bcnu	dep	1	SENT_333	[p24l6t2142r213b2202],

1	nmol/hr/gm	NN	O	nmol/hr/gm	nn	2	SENT_334	[p24l1477t1058r1645b1088],
2	Hb	NN	O	hb	_	0	SENT_334	[p24l1658t1058r1695b1082],

1	Daunorubicinol	NN	O	daunorubicinol	nsubj	2	SENT_335	[p24l1588t1002r1800b1026],
2	formed	VBD	O	form	_	0	SENT_335	[p24l1811t1002r1911b1026],

1	Percent	NN	O	percent	nn	2	SENT_336	[p24l1780t1058r1887b1082],
2	inhibition	NN	O	inhibition	_	0	SENT_336	[p24l1897t1059r2021b1082],

1	O	NN	O	o	_	0	SENT_337	[p25l62t30r116b107],
2	10.5	CD	NUMBER	10.5	num	3	SENT_337	[p25l989t34r1176b110],
3	o	NN	O	o	dep	1	SENT_337	[p25l2015t34r2069b114],

1	Daunorubicin	NN	O	daunorubicin	nn	2	SENT_338	[p25l96t161r259b184],
2	(	NN	O	(	nsubjpass	7	SENT_338	[p25l269t161r323b190],
3	100	CD	NUMBER	100	num	5	SENT_338	[p25l269t161r323b190],
4	ng/ml	NN	O	ng/ml	nn	5	SENT_338	[p25l332t161r408b190],
5	)	NN	O	)	dep	2	SENT_338	[p25l332t161r408b190],
6	was	VBD	O	be	auxpass	7	SENT_338	[p25l416t167r467b185],
7	incubated	VBN	O	incubate	_	0	SENT_338	[p25l476t162r597b185],
8	for	IN	O	for	_	0	SENT_338	[p25l605t162r639b185],
9	1	CD	DURATION	1	num	10	SENT_338	[p25l648t163r657b185],
10	hour	NN	NUMBER	hour	prep_for	7	SENT_338	[p25l671t162r727b185],
11	at	IN	O	at	_	0	SENT_338	[p25l734t163r757b185],
12	37	CD	NUMBER	37	number	13	SENT_338	[p25l765t162r807b185],
13	°	CD	NUMBER	°	num	14	SENT_338	[p25l765t162r807b185],
14	C	NN	O	c	prep_at	10	SENT_338	[p25l817t162r837b185],
15	in	IN	O	in	prep	7	SENT_338	[p25l845t162r864b185],
16	deslromatized	VBN	O	deslromatize	dep	15	SENT_338	[p25l873t162r1050b185],
17	hemolysate	NN	O	hemolysate	dobj	16	SENT_338	[p25l1059t163r1200b191],
18	with	IN	O	with	_	0	SENT_338	[p25l1208t163r1258b185],
19	1	CD	NUMBER	1	num	21	SENT_338	[p25l1268t163r1277b185],
20	mmol/L	NN	O	mmol/l	nn	21	SENT_338	[p25l1290t163r1385b186],
21	NADPH	NN	O	nadph	prep_with	16	SENT_338	[p25l1393t163r1488b186],
22	and	CC	O	and	_	0	SENT_338	[p25l1497t163r1542b186],
23	with	IN	O	with	_	0	SENT_338	[p25l1551t163r1600b186],
24	or	CC	O	or	_	0	SENT_338	[p25l1609t169r1635b186],
25	without	IN	O	without	dep	15	SENT_338	[p25l1641t164r1732b187],
26	the	DT	O	the	det	28	SENT_338	[p25l1740t164r1779b186],
27	indicated	JJ	O	indicated	amod	28	SENT_338	[p25l1788t164r1899b187],
28	compounds	NNS	O	compound	pobj	25	SENT_338	[p25l1908t164r2063b192],
29	.	.	O	.	_	0	SENT_338	[p25l1908t164r2063b192],

1	Cone	NNP	O	Cone	_	0	SENT_339	[p25l8t209r176b270],
2	,	,	O	,	_	0	SENT_339	[p25l8t209r176b270],
3	Concentration	NN	O	concentration	appos	1	SENT_339	[p25l203t209r624b261],
4	.	.	O	.	_	0	SENT_339	[p25l203t209r624b261],

1	clines	NNS	O	cline	_	0	SENT_340	[p25l8t446r237b518],
2	that	WDT	O	that	nsubjpass	5	SENT_340	[p25l282t446r443b518],
3	are	VBP	O	be	auxpass	5	SENT_340	[p25l491t469r617b519],
4	effectively	RB	O	effectively	advmod	5	SENT_340	[p25l665t445r1074b541],
5	metabolized	VBN	O	metabolize	rcmod	1	SENT_340	[p25l1117t445r1619b519],
6	by	IN	O	by	_	0	SENT_340	[p25l1665t446r1758b541],
7	carbonyl	NN	O	carbonyl	nn	8	SENT_340	[p25l1802t446r2150b541],
8	reductase	NN	O	reductase	agent	5	SENT_340	[p25l8t560r684b633],
9	—	CD	NUMBER	—	num	8	SENT_340	[p25l8t560r684b633],
10	such	JJ	O	such	_	0	SENT_340	[p25l8t560r684b633],
11	as	IN	O	as	_	0	SENT_340	[p25l714t584r791b633],
12	daunorubicin	NN	O	daunorubicin	prep_such_as	1	SENT_340	[p25l820t563r1366b633],
13	or	CC	O	or	_	0	SENT_340	[p25l1393t584r1480b633],
14	its	PRP$	O	its	poss	17	SENT_340	[p25l1507t563r1596b636],
15	4-demethoxy	JJ	O	4-demethoxy	amod	17	SENT_340	[p25l1625t563r2153b656],
16	derivative	JJ	O	derivative	amod	17	SENT_340	[p25l11t676r408b749],
17	idarubicin35	NN	O	idarubicin35	conj_or	12	SENT_340	[p25l449t659r1459b749],
18	'	''	DATE	'	_	0	SENT_340	[p25l449t659r1459b749],
19	37	CD	DATE	37	number	20	SENT_340	[p25l449t659r1459b749],
20	—	CD	NUMBER	—	dep	1	SENT_340	[p25l449t659r1459b749],
21	become	VBN	O	become	cop	24	SENT_340	[p25l449t659r1459b749],
22	better	RBR	O	better	advmod	23	SENT_340	[p25l1500t676r1745b751],
23	oncolytic	JJ	O	oncolytic	amod	24	SENT_340	[p25l1785t678r2151b772],
24	agents	NNS	O	agent	partmod	20	SENT_340	[p25l11t806r267b886],
25	in	IN	O	in	_	0	SENT_340	[p25l324t795r399b865],
26	a	DT	O	a	det	27	SENT_340	[p25l456t816r497b865],
27	patient	NN	O	patient	prep_in	24	SENT_340	[p25l551t795r838b889],
28	with	IN	O	with	_	0	SENT_340	[p25l888t795r1067b865],
29	a	DT	O	a	det	31	SENT_340	[p25l1122t818r1165b865],
30	severe	JJ	O	severe	amod	31	SENT_340	[p25l1219t818r1475b867],
31	type	NN	O	type	prep_with	27	SENT_340	[p25l1530t806r1701b888],
32	of	IN	O	of	_	0	SENT_340	[p25l1757t797r1842b867],
33	G6PD	NN	O	g6pd	nn	34	SENT_340	[p25l1894t797r2148b867],
34	deﬁciency	NN	O	deﬁciency	prep_of	31	SENT_340	[p25l11t908r457b1005],
35	‘	CD	NUMBER	‘	num	34	SENT_340	[p25l11t908r457b1005],
36	?	.	O	?	_	0	SENT_340	[p25l11t908r457b1005],

1	Although	IN	O	although	mark	4	SENT_341	[p25l510t911r900b1005],
2	this	DT	O	this	nsubj	4	SENT_341	[p25l948t911r1093b984],
3	is	VBZ	O	be	cop	4	SENT_341	[p25l1143t911r1202b984],
4	possible	JJ	O	possible	advcl	21	SENT_341	[p25l1250t911r1578b1007],
5	and	CC	O	and	_	0	SENT_341	[p25l1632t913r1777b984],
6	there	EX	O	there	expl	7	SENT_341	[p25l1827t913r2042b984],
7	is	VBZ	O	be	conj_and	4	SENT_341	[p25l2089t913r2148b986],
8	evidence	NN	O	evidence	nsubj	7	SENT_341	[p25l11t1025r364b1098],
9	that	IN	O	that	complm	13	SENT_341	[p25l424t1024r582b1098],
10	daunorubicin-resistant	JJ	O	daunorubicin-resistant	amod	12	SENT_341	[p25l642t1024r1568b1101],
11	murine	JJ	O	murine	amod	12	SENT_341	[p25l1623t1027r1916b1101],
12	cells	NNS	O	cell	nsubj	13	SENT_341	[p25l1973t1027r2148b1101],
13	have	VBP	O	have	ccomp	7	SENT_341	[p25l8t1143r195b1216],
14	an	DT	O	a	det	17	SENT_341	[p25l247t1166r344b1216],
15	elevated	JJ	O	elevated	amod	17	SENT_341	[p25l396t1143r735b1215],
16	HMS	NNP	O	HMS	nn	17	SENT_341	[p25l786t1143r1005b1216],
17	activity	NN	O	activity	dobj	13	SENT_341	[p25l1059t1127r1443b1236],
18	,	,	O	,	_	0	SENT_341	[p25l1059t1127r1443b1236],
19	“	CD	NUMBER	“	appos	17	SENT_341	[p25l1059t1127r1443b1236],
20	we	PRP	O	we	nsubj	32	SENT_341	[p25l1489t1166r1601b1215],
21	believe	VBP	O	believe	_	0	SENT_341	[p25l1651t1143r1939b1215],
22	that	IN	O	that	complm	28	SENT_341	[p25l1990t1145r2151b1218],
23	such	PDT	O	such	predet	25	SENT_341	[p25l8t1258r190b1330],
24	an	DT	O	a	det	25	SENT_341	[p25l219t1281r316b1330],
25	interpretation	NN	O	interpretation	nsubj	28	SENT_341	[p25l345t1257r916b1353],
26	would	MD	O	would	aux	28	SENT_341	[p25l941t1260r1193b1331],
27	be	VB	O	be	cop	28	SENT_341	[p25l1219t1260r1316b1330],
28	premature	JJ	O	premature	ccomp	21	SENT_341	[p25l1345t1269r1775b1353],
29	and	CC	O	and	_	0	SENT_341	[p25l1806t1260r1953b1333],
30	may	MD	O	may	aux	32	SENT_341	[p25l1983t1283r2151b1353],
31	be	VB	O	be	cop	32	SENT_341	[p25l6t1376r102b1446],
32	misleading	JJ	O	misleading	conj_and	21	SENT_341	[p25l141t1374r601b1469],
33	.	.	O	.	_	0	SENT_341	[p25l141t1374r601b1469],

1	The	DT	O	the	det	2	SENT_342	[p25l642t1376r803b1448],
2	difﬁculty	NN	O	difﬁculty	nsubj	3	SENT_342	[p25l843t1374r1195b1469],
3	stems	VBZ	O	stem	_	0	SENT_342	[p25l1229t1385r1457b1449],
4	from	IN	O	from	_	0	SENT_342	[p25l1495t1376r1694b1449],
5	uncertainties	NNS	O	uncertainty	prep_from	3	SENT_342	[p25l1730t1376r2148b1449, p25l8t1492r144b1562],
6	concerning	VBG	O	concern	_	0	SENT_342	[p25l178t1491r629b1583],
7	the	DT	O	the	det	9	SENT_342	[p25l660t1492r787b1562],
8	key	JJ	O	key	amod	9	SENT_342	[p25l820t1492r961b1583],
9	differences	NNS	O	difference	prep_concerning	5	SENT_342	[p25l992t1492r1432b1562],
10	between	IN	O	between	_	0	SENT_342	[p25l1463t1492r1805b1565],
11	nonmalignant	JJ	O	nonmalignant	amod	14	SENT_342	[p25l1837t1515r2148b1565, p25l6t1608r288b1702],
12	and	CC	O	and	_	0	SENT_342	[p25l326t1609r473b1679],
13	malignant	JJ	O	malignant	conj_and	11	SENT_342	[p25l512t1608r919b1702],
14	cells	NNS	O	cell	prep_between	9	SENT_342	[p25l957t1608r1130b1681],
15	that	WDT	O	that	nsubj	17	SENT_342	[p25l1168t1609r1329b1681],
16	are	VBP	O	be	cop	17	SENT_342	[p25l1368t1632r1492b1681],
17	responsible	JJ	O	responsible	rcmod	9	SENT_342	[p25l1530t1611r1995b1704],
18	for	IN	O	for	_	0	SENT_342	[p25l2031t1611r2151b1681],
19	the	DT	O	the	det	22	SENT_342	[p25l6t1722r135b1795],
20	relative	JJ	O	relative	amod	22	SENT_342	[p25l171t1722r473b1795],
21	antitumor	NN	O	antitumor	nn	22	SENT_342	[p25l512t1723r921b1795],
22	selectivity	NN	O	selectivity	prep_for	17	SENT_342	[p25l957t1723r1359b1818],
23	of	IN	O	of	_	0	SENT_342	[p25l1393t1725r1478b1795],
24	anthracyclines	NNS	O	anthracycline	prep_of	22	SENT_342	[p25l1512t1725r2113b1816],
25	.	.	O	.	_	0	SENT_342	[p25l1512t1725r2113b1816],

1	In	IN	O	in	_	0	SENT_343	[p25l103t1840r188b1911],
2	leukemic	JJ	O	leukemic	amod	3	SENT_343	[p25l238t1838r610b1911],
3	tissue	NN	O	tissue	prep_in	5	SENT_343	[p25l658t1838r884b1911],
4	there	EX	O	there	expl	5	SENT_343	[p25l934t1840r1148b1911],
5	is	VBZ	O	be	ccomp	28	SENT_343	[p25l1199t1840r1257b1911],
6	evidence	NN	O	evidence	nsubj	5	SENT_343	[p25l1307t1840r1663b1911],
7	that	IN	O	that	complm	9	SENT_343	[p25l1714t1840r1874b1911],
8	blasts	NNS	O	blast	nsubj	9	SENT_343	[p25l1925t1840r2148b1914],
9	have	VBP	O	have	ccomp	5	SENT_343	[p25l6t1958r193b2028],
10	lower	JJR	O	lower	amod	13	SENT_343	[p25l227t1958r455b2030],
11	carbonyl	NN	O	carbonyl	nn	13	SENT_343	[p25l489t1958r838b2051],
12	reductase	NN	O	reductase	nn	13	SENT_343	[p25l871t1960r1264b2030],
13	activity	NN	O	activity	dobj	9	SENT_343	[p25l1300t1960r1591b2053],
14	than	IN	O	than	_	0	SENT_343	[p25l1621t1960r1803b2030],
15	nonleukemic	JJ	O	nonleukemic	amod	16	SENT_343	[p25l1836t1960r2146b2030, p25l6t2072r251b2145],
16	cells	NNS	O	cell	prep_than	13	SENT_343	[p25l310t2056r766b2145],
17	.25	CD	NUMBER	.25	number	18	SENT_343	[p25l310t2056r766b2145],
18	’	CD	NUMBER	’	num	20	SENT_343	[p25l310t2056r766b2145],
19	39	CD	NUMBER	39	number	20	SENT_343	[p25l310t2056r766b2145],
20	'41	CD	NUMBER	'41	dep	16	SENT_343	[p25l310t2056r766b2145],
21	Consequently	RB	O	consequently	advmod	16	SENT_343	[p25l832t2074r1413b2168],
22	,	,	O	,	_	0	SENT_343	[p25l832t2074r1413b2168],
23	the	DT	O	the	det	25	SENT_343	[p25l1477t2074r1603b2145],
24	tumor	NN	O	tumor	nn	25	SENT_343	[p25l1665t2084r1914b2145],
25	cells	NNS	O	cell	nsubjpass	28	SENT_343	[p25l1973t2074r2148b2148],
26	might	MD	O	might	aux	28	SENT_343	[p25l12t2185r245b2280],
27	be	VB	O	be	auxpass	28	SENT_343	[p25l298t2186r392b2259],
28	exposed	VBN	O	expose	_	0	SENT_343	[p25l449t2185r776b2282],
29	for	IN	O	for	_	0	SENT_343	[p25l831t2188r950b2261],
30	a	DT	O	a	det	32	SENT_343	[p25l1005t2211r1046b2259],
31	longer	JJR	O	longer	amod	32	SENT_343	[p25l1100t2188r1360b2282],
32	period	NN	O	period	prep_for	28	SENT_343	[p25l1412t2188r1699b2284],
33	,	,	O	,	_	0	SENT_343	[p25l1412t2188r1699b2284],
34	to	TO	O	to	_	0	SENT_343	[p25l1757t2200r1837b2261],
35	higher	JJR	O	higher	amod	36	SENT_343	[p25l1891t2188r2151b2284],
36	levels	NNS	O	level	prep_to	28	SENT_343	[p25l12t2302r236b2372],
37	of	IN	O	of	_	0	SENT_343	[p25l295t2302r380b2372],
38	therapeutically	RB	O	therapeutically	advmod	39	SENT_343	[p25l433t2301r1046b2398],
39	more	JJR	O	more	amod	40	SENT_343	[p25l1100t2304r1583b2377],
40	—	NN	O	—	prep_of	36	SENT_343	[p25l1100t2304r1583b2377],
41	active	JJ	O	active	amod	43	SENT_343	[p25l1100t2304r1583b2377],
42	parent	NN	O	parent	nn	43	SENT_343	[p25l1640t2316r1906b2400],
43	drug	NN	O	drug	dep	40	SENT_343	[p25l1966t2304r2151b2400],
44	when	WRB	O	when	advmod	43	SENT_343	[p25l7t2413r227b2486],
45	compared	VBN	O	compare	_	0	SENT_343	[p25l272t2415r680b2509],
46	with	IN	O	with	_	0	SENT_343	[p25l719t2413r897b2488],
47	their	PRP$	O	they	poss	49	SENT_343	[p25l942t2415r1134b2488],
48	nonleukemic	JJ	O	nonleukemic	amod	49	SENT_343	[p25l1177t2415r1706b2490],
49	neighbors	NNS	O	neighbor	prep_compared_with	43	SENT_343	[p25l1752t2417r2151b2511],
50	in	IN	O	in	_	0	SENT_343	[p25l12t2531r87b2602],
51	the	DT	O	the	det	53	SENT_343	[p25l135t2531r262b2602],
52	bone	NN	O	bone	nn	53	SENT_343	[p25l307t2531r511b2604],
53	marrow	NN	O	marrow	prep_in	43	SENT_343	[p25l558t2554r894b2604],
54	.	.	O	.	_	0	SENT_343	[p25l558t2554r894b2604],

1	A	DT	O	a	det	3	SENT_344	[p25l942t2535r1018b2604],
2	relative	JJ	O	relative	amod	3	SENT_344	[p25l1063t2533r1367b2604],
3	deﬁciency	NN	O	deﬁciency	nsubj	17	SENT_344	[p25l1417t2533r1822b2627],
4	of	IN	O	of	_	0	SENT_344	[p25l1868t2535r1955b2606],
5	carbonyl	NN	O	carbonyl	nn	6	SENT_344	[p25l1996t2556r2151b2607, p25l9t2647r234b2741],
6	reductase	NN	O	reductase	prep_of	3	SENT_344	[p25l289t2649r680b2720],
7	in	IN	O	in	_	0	SENT_344	[p25l733t2649r808b2720],
8	malignant	JJ	O	malignant	amod	9	SENT_344	[p25l861t2649r1269b2743],
9	cells	NNS	O	cell	prep_in	6	SENT_344	[p25l1321t2649r1497b2722],
10	may	MD	O	may	aux	12	SENT_344	[p25l1549t2672r1718b2745],
11	therefore	RB	O	therefore	advmod	12	SENT_344	[p25l1770t2651r2150b2724],
12	contribute	VB	O	contribute	_	0	SENT_344	[p25l12t2758r434b2834],
13	to	TO	O	to	prep	12	SENT_344	[p25l470t2772r548b2834],
14	or	CC	O	or	_	0	SENT_344	[p25l586t2784r673b2834],
15	even	RB	O	even	advmod	12	SENT_344	[p25l707t2784r897b2834],
16	be	VB	O	be	cop	17	SENT_344	[p25l931t2761r1027b2834],
17	responsible	JJ	O	responsible	conj_or	12	SENT_344	[p25l1061t2761r1525b2857],
18	for	IN	O	for	_	0	SENT_344	[p25l1563t2763r1681b2837],
19	the	DT	O	the	det	21	SENT_344	[p25l1717t2763r1844b2837],
20	antimmor	JJ	O	antimmor	amod	21	SENT_344	[p25l1882t2763r2151b2837, p25l12t2900r178b2950],
21	selectivity	NN	O	selectivity	prep_for	17	SENT_344	[p25l212t2876r613b2971],
22	of	IN	O	of	_	0	SENT_344	[p25l644t2879r732b2952],
23	the	DT	O	the	det	24	SENT_344	[p25l761t2879r887b2953],
24	drug	NN	O	drug	prep_of	21	SENT_344	[p25l924t2879r1129b2974],
25	.	.	O	.	_	0	SENT_344	[p25l924t2879r1129b2974],

1	Taking	VBG	O	take	partmod	10	SENT_345	[p25l1168t2879r1453b2973],
2	this	DT	O	this	dobj	1	SENT_345	[p25l1487t2879r1630b2953],
3	into	IN	O	into	_	0	SENT_345	[p25l1663t2879r1823b2953],
4	consid	NN	O	consid	prep_into	1	SENT_345	[p25l1859t2881r2151b2955, p25l14t2994r324b3080],
5	:	:	O	:	_	0	SENT_345	[p25l1859t2881r2151b2955, p25l14t2994r324b3080],
6	eration	NN	O	eration	dep	4	SENT_345	[p25l1859t2881r2151b2955, p25l14t2994r324b3080],
7	,	,	O	,	_	0	SENT_345	[p25l1859t2881r2151b2955, p25l14t2994r324b3080],
8	it	PRP	O	it	nsubj	10	SENT_345	[p25l354t2994r408b3064],
9	is	VBZ	O	be	cop	10	SENT_345	[p25l433t2994r492b3066],
10	possible	JJ	O	possible	_	0	SENT_345	[p25l517t2993r845b3087],
11	that	IN	O	that	complm	21	SENT_345	[p25l870t2996r1032b3066],
12	restriction	NN	O	restriction	nsubj	24	SENT_345	[p25l1056t2994r1476b3066],
13	of	IN	O	of	_	0	SENT_345	[p25l1501t2996r1585b3066],
14	daunorubicin	NN	O	daunorubicin	nn	15	SENT_345	[p25l1608t2996r2151b3069],
15	metabolism	NN	O	metabolism	prep_of	12	SENT_345	[p25l12t3108r487b3181],
16	in	IN	O	in	_	0	SENT_345	[p25l519t3108r594b3181],
17	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	18	SENT_345	[p25l628t3107r1271b3183],
18	hematopoietic	JJ	O	hematopoietic	amod	19	SENT_345	[p25l1303t3110r1892b3204],
19	tissue	NN	O	tissue	prep_in	15	SENT_345	[p25l1922t3110r2151b3186],
20	would	MD	O	would	aux	21	SENT_345	[p25l7t3227r259b3298],
21	decrease	VB	O	decrease	ccomp	10	SENT_345	[p25l289t3227r643b3300],
22	rather	RB	O	rather	_	0	SENT_345	[p25l672t3229r922b3300],
23	than	IN	O	than	_	0	SENT_345	[p25l951t3229r1134b3300],
24	increase	VB	O	increase	ccomp	10	SENT_345	[p25l1163t3229r1497b3300],
25	the	DT	O	the	det	27	SENT_345	[p25l1528t3231r1655b3300],
26	therapeutic	JJ	O	therapeutic	amod	27	SENT_345	[p25l1684t3231r2153b3323],
27	index	NN	O	index	dobj	24	SENT_345	[p25l12t3340r234b3413],
28	of	IN	O	of	_	0	SENT_345	[p25l261t3342r348b3413],
29	the	DT	O	the	det	30	SENT_345	[p25l370t3340r499b3413],
30	drug	NN	O	drug	prep_of	27	SENT_345	[p25l531t3342r718b3436],
31	by	IN	O	by	_	0	SENT_345	[p25l744t3342r839b3437],
32	impairing	VBG	O	impair	prepc_by	24	SENT_345	[p25l868t3342r1260b3437],
33	anthracycline	NN	O	anthracycline	nn	36	SENT_345	[p25l1291t3342r1837b3436],
34	metab	NN	O	metab	nn	36	SENT_345	[p25l1866t3344r2151b3415],
35	»	NN	O	»	nn	36	SENT_345	[p25l1866t3344r2151b3415],
36	olism	NN	O	olism	dobj	32	SENT_345	[p25l12t3456r229b3529],
37	preferentially	RB	O	preferentially	advmod	32	SENT_345	[p25l261t3456r815b3550],
38	in	IN	O	in	_	0	SENT_345	[p25l847t3458r922b3529],
39	the	DT	O	the	det	41	SENT_345	[p25l954t3458r1083b3532],
40	nonmalignant	JJ	O	nonmalignant	amod	41	SENT_345	[p25l1114t3458r1683b3552],
41	cells	NNS	O	cell	prep_in	32	SENT_345	[p25l1712t3460r1909b3531],
42	.	.	O	.	_	0	SENT_345	[p25l1712t3460r1909b3531],

1	If	IN	O	if	mark	7	SENT_346	[p25l1947t3460r2016b3531],
2	so	RB	O	so	advmod	7	SENT_346	[p25l2043t3481r2148b3548],
3	,	,	O	,	_	0	SENT_346	[p25l2043t3481r2148b3548],
4	the	DT	O	the	det	5	SENT_346	[p25l12t3574r141b3646],
5	enzymopathy	NN	O	enzymopathy	nsubj	7	SENT_346	[p25l175t3575r718b3669],
6	would	MD	O	would	aux	7	SENT_346	[p25l745t3575r994b3646],
7	narrow	VB	O	narrow	_	0	SENT_346	[p25l1028t3598r1320b3648],
8	a	DT	O	a	det	14	SENT_346	[p25l1354t3598r1397b3646],
9	useful	JJ	O	useful	amod	14	SENT_346	[p25l1429t3577r1674b3648],
10	or	CC	O	or	_	0	SENT_346	[p25l1710t3598r1797b3648],
11	perhaps	RB	O	perhaps	advmod	12	SENT_346	[p25l1826t3577r2151b3671],
12	critical	JJ	O	critical	amod	14	SENT_346	[p25l12t3687r287b3761],
13	metabolic	JJ	O	metabolic	amod	14	SENT_346	[p25l321t3688r722b3761],
14	difference	NN	O	difference	nsubj	20	SENT_346	[p25l756t3690r1160b3761],
15	between	IN	O	between	_	0	SENT_346	[p25l1189t3690r1534b3764],
16	the	DT	O	the	det	19	SENT_346	[p25l1566t3690r1692b3764],
17	tumor	NN	O	tumor	nn	19	SENT_346	[p25l1726t3701r1976b3763],
18	tar	NN	O	tar	nn	19	SENT_346	[p25l2008t3702r2151b3763, p26l12t38r134b121],
19	»	NN	O	»	prep_between	14	SENT_346	[p25l2008t3702r2151b3763, p26l12t38r134b121],
20	get	VB	O	get	ccomp	7	SENT_346	[p25l2008t3702r2151b3763, p26l12t38r134b121],

1	and	CC	O	and	_	0	SENT_347	[p26l186t26r334b100],
2	the	DT	O	the	det	4	SENT_347	[p26l384t27r511b100],
3	surrounding	JJ	O	surrounding	amod	4	SENT_347	[p26l563t29r1062b123],
4	cells	NNS	O	cell	dep	1	SENT_347	[p26l1112t29r1306b102],
5	.	.	O	.	_	0	SENT_347	[p26l1112t29r1306b102],

1	Currently	RB	DATE	currently	advmod	6	SENT_348	[p26l1363t29r1755b123],
2	it	PRP	O	it	nsubj	6	SENT_348	[p26l1805t29r1860b103],
3	is	VBZ	O	be	cop	6	SENT_348	[p26l1910t31r1969b102],
4	not	RB	O	not	neg	6	SENT_348	[p26l2019t40r2153b103],
5	596	CD	NUMBER	596	num	6	SENT_348	[p26l13t161r139b222],
6	Amitoi	NNP	O	Amitoi	_	0	SENT_348	[p26l258t160r509b226],
7	,	,	O	,	_	0	SENT_348	[p26l258t160r509b226],
8	Bhoomol	NNP	PERSON	Bhoomol	appos	6	SENT_348	[p26l547t160r875b226],
9	,	,	O	,	_	0	SENT_348	[p26l547t160r875b226],
10	and	CC	O	and	_	0	SENT_348	[p26l911t161r1055b222],
11	Frischer	NNP	PERSON	Frischer	dep	12	SENT_348	[p26l1089t161r1360b222],
12	possible	JJ	O	possible	conj_and	6	SENT_348	[p26l11t404r338b499],
13	to	TO	O	to	aux	14	SENT_348	[p26l367t413r444b476],
14	decide	VB	O	decide	xcomp	12	SENT_348	[p26l476t404r740b476],
15	whether	IN	O	whether	complm	29	SENT_348	[p26l765t404r1101b477],
16	antitumor	NN	O	antitumor	nn	17	SENT_348	[p26l1130t404r1536b477],
17	chemotherapy	NN	O	chemotherapy	nsubj	33	SENT_348	[p26l1565t401r2149b497],
18	with	IN	O	with	_	0	SENT_348	[p26l8t521r183b594],
19	an	DT	O	a	det	20	SENT_348	[p26l228t544r322b594],
20	anthracycline	NN	O	anthracycline	prep_with	17	SENT_348	[p26l367t519r912b615],
21	that	WDT	O	that	nsubj	25	SENT_348	[p26l955t521r1113b593],
22	is	VBZ	O	be	cop	25	SENT_348	[p26l1156t519r1215b594],
23	an	DT	O	a	det	25	SENT_348	[p26l1260t542r1356b591],
24	elfective	JJ	O	elfective	amod	25	SENT_348	[p26l1399t519r1735b591],
25	substrate	NN	O	substrate	rcmod	20	SENT_348	[p26l1778t518r2145b593],
26	for	IN	O	for	_	0	SENT_348	[p26l11t638r130b711],
27	carbonyl	NN	O	carbonyl	nn	28	SENT_348	[p26l180t638r528b731],
28	reductase	NN	O	reductase	prep_for	25	SENT_348	[p26l580t635r972b711],
29	is	VBZ	O	be	ccomp	14	SENT_348	[p26l1022t636r1083b711],
30	or	CC	O	or	_	0	SENT_348	[p26l1133t658r1219b711],
31	is	VBZ	O	be	cop	33	SENT_348	[p26l1272t636r1328b708],
32	not	RB	O	not	neg	33	SENT_348	[p26l1380t647r1513b708],
33	deleterious	JJ	O	deleterious	ccomp	14	SENT_348	[p26l1568t636r2020b708],
34	in	IN	O	in	_	0	SENT_348	[p26l2072t636r2147b709],
35	G6PD-deﬁcient	JJ	O	g6pd-deﬁcient	amod	36	SENT_348	[p26l13t752r680b827],
36	persons	NNS	O	person	prep_in	33	SENT_348	[p26l735t774r1083b849],
37	,	,	O	,	_	0	SENT_348	[p26l735t774r1083b849],
38	particularly	RB	O	particularly	advmod	36	SENT_348	[p26l1142t752r1631b847],
39	those	DT	O	those	dep	36	SENT_348	[p26l1688t752r1911b824],
40	with	IN	O	with	_	0	SENT_348	[p26l1963t752r2147b824],
41	the	DT	O	the	det	43	SENT_348	[p26l11t870r141b943],
42	more	RBR	O	more	advmod	43	SENT_348	[p26l184t893r403b943],
43	severe	JJ	O	severe	prep_with	36	SENT_348	[p26l446t891r710b943],
44	common	JJ	O	common	amod	43	SENT_348	[p26l756t891r1120b943],
45	Mediterranean	NNP	MISC	Mediterranean	dep	36	SENT_348	[p26l1161t868r1800b943],
46	or	CC	O	or	_	0	SENT_348	[p26l1843t891r1930b940],
47	Oriental	JJ	O	oriental	conj_or	45	SENT_348	[p26l1972t868r2145b940, p26l13t986r220b1058],

1	subtypes	NNS	O	subtype	_	0	SENT_349	[p26l256t986r641b1081],
2	.	.	O	.	_	0	SENT_349	[p26l256t986r641b1081],

1	Resolution	NN	O	resolution	nsubj	7	SENT_350	[p26l682t984r1148b1058],
2	of	IN	O	of	_	0	SENT_350	[p26l1181t984r1270b1058],
3	this	DT	O	this	det	5	SENT_350	[p26l1299t984r1448b1056],
4	important	JJ	O	important	amod	5	SENT_350	[p26l1484t984r1909b1079],
5	issue	NN	O	issue	prep_of	1	SENT_350	[p26l1942t984r2147b1056],
6	will	MD	O	will	aux	7	SENT_350	[p26l6t1102r157b1175],
7	require	VB	O	require	_	0	SENT_350	[p26l196t1102r502b1197],
8	future	JJ	DATE	future	amod	9	SENT_350	[p26l541t1102r800b1175],
9	studies	NNS	O	study	dobj	7	SENT_350	[p26l839t1099r1131b1174],
10	to	TO	O	to	aux	11	SENT_350	[p26l1170t1111r1249b1172],
11	compare	VB	O	compare	dep	7	SENT_350	[p26l1290t1123r1656b1195],
12	the	DT	O	the	det	14	SENT_350	[p26l1695t1100r1825b1172],
13	antitumor	NN	O	antitumor	nn	14	SENT_350	[p26l1868t1100r2145b1172, p26l11t1241r181b1293],
14	efﬁcacy	NN	O	efﬁcacy	dobj	11	SENT_350	[p26l228t1218r535b1313],
15	and	CC	O	and	_	0	SENT_350	[p26l582t1218r733b1290],
16	safety	NN	O	safety	conj_and	14	SENT_350	[p26l779t1218r1025b1311],
17	of	IN	O	of	_	0	SENT_350	[p26l1070t1218r1159b1290],
18	anthracyclines	NNS	O	anthracycline	prep_of	14	SENT_350	[p26l1200t1218r1805b1311],
19	in	IN	O	in	_	0	SENT_350	[p26l1852t1216r1929b1288],
20	per	FW	O	per	nn	22	SENT_350	[p26l1975t1239r2145b1311, p26l13t1358r192b1410],
21	—	FW	O	—	nn	22	SENT_350	[p26l1975t1239r2145b1311, p26l13t1358r192b1410],
22	sons	NNS	O	son	prep_in	18	SENT_350	[p26l1975t1239r2145b1311, p26l13t1358r192b1410],
23	with	IN	O	with	_	0	SENT_350	[p26l251t1335r433b1408],
24	and	CC	O	and	_	0	SENT_350	[p26l496t1335r648b1408],
25	without	IN	O	without	_	0	SENT_350	[p26l705t1335r1032b1408],
26	various	JJ	O	various	amod	27	SENT_350	[p26l1089t1333r1397b1408],
27	types	NNS	O	type	prep_without	11	SENT_350	[p26l1459t1344r1675b1428],
28	of	IN	O	of	_	0	SENT_350	[p26l1739t1333r1825b1408],
29	G6PD	NN	O	g6pd	nn	30	SENT_350	[p26l1885t1333r2145b1408],
30	deﬁciency	NN	O	deﬁciency	prep_of	27	SENT_350	[p26l13t1452r433b1545],
31	and	CC	O	and	_	0	SENT_350	[p26l469t1452r620b1525],
32	to	TO	O	to	aux	33	SENT_350	[p26l654t1461r736b1525],
33	quantify	VB	O	quantify	conj_and	11	SENT_350	[p26l774t1450r1122b1545],
34	the	DT	O	the	det	35	SENT_350	[p26l1153t1449r1284b1522],
35	impact	NN	O	impact	dobj	33	SENT_350	[p26l1320t1450r1606b1545],
36	of	IN	O	of	_	0	SENT_350	[p26l1642t1450r1731b1522],
37	the	DT	O	the	det	38	SENT_350	[p26l1757t1450r1890b1522],
38	enzymopathy	NN	O	enzymopathy	prep_of	35	SENT_350	[p26l1926t1473r2145b1543, p26l11t1569r380b1663],
39	on	IN	O	on	_	0	SENT_350	[p26l409t1590r514b1639],
40	drug	NN	O	drug	nn	41	SENT_350	[p26l545t1567r736b1660],
41	metabolism	NN	O	metabolism	prep_on	38	SENT_350	[p26l765t1567r1259b1639],
42	in	IN	O	in	_	0	SENT_350	[p26l1290t1567r1367b1639],
43	tissues	NNS	O	tissue	prep_in	33	SENT_350	[p26l1396t1567r1673b1639],
44	other	JJ	O	other	dep	43	SENT_350	[p26l1704t1567r1930b1639],
45	than	IN	O	than	_	0	SENT_350	[p26l1961t1565r2147b1640],
46	red	JJ	O	red	amod	47	SENT_350	[p26l11t1684r148b1757],
47	cells	NNS	O	cell	prep_than	43	SENT_350	[p26l193t1684r398b1772],
48	,	,	O	,	_	0	SENT_350	[p26l193t1684r398b1772],
49	particularly	RB	O	particularly	advmod	33	SENT_350	[p26l443t1684r937b1779],
50	in	IN	O	in	_	0	SENT_350	[p26l978t1682r1055b1754],
51	leukemic	JJ	O	leukemic	amod	54	SENT_350	[p26l1098t1682r1481b1754],
52	and	CC	O	and	_	0	SENT_350	[p26l1526t1682r1677b1754],
53	nonleukemic	JJ	O	nonleukemic	amod	54	SENT_350	[p26l1723t1682r2145b1754, p26l11t1801r162b1874],
54	cells	NNS	O	cell	prep_in	33	SENT_350	[p26l198t1800r403b1874],
55	.	.	O	.	_	0	SENT_350	[p26l198t1800r403b1874],

1	Additional	JJ	O	additional	amod	2	SENT_351	[p26l106t1915r565b1990],
2	considerations	NNS	O	consideration	nsubj	9	SENT_351	[p26l619t1915r1233b1987],
3	that	WDT	O	that	nsubj	4	SENT_351	[p26l1288t1915r1453b1987],
4	arise	VBP	O	arise	rcmod	2	SENT_351	[p26l1507t1915r1705b1987],
5	from	IN	O	from	_	0	SENT_351	[p26l1757t1914r1962b1987],
6	the	DT	O	the	det	8	SENT_351	[p26l2014t1914r2147b1987],
7	present	JJ	DATE	present	amod	8	SENT_351	[p26l11t2043r326b2127],
8	ﬁndings	NNS	O	ﬁndings	prep_from	4	SENT_351	[p26l388t2032r717b2127],
9	concern	NN	O	concern	_	0	SENT_351	[p26l781t2055r1115b2104],
10	the	DT	O	the	det	12	SENT_351	[p26l1177t2032r1307b2104],
11	possible	JJ	O	possible	amod	12	SENT_351	[p26l1369t2032r1710b2127],
12	effect	NN	O	effect	dobj	9	SENT_351	[p26l1773t2032r2003b2104],
13	of	IN	O	of	_	0	SENT_351	[p26l2065t2032r2154b2104],
14	G6PD	NN	O	g6pd	nn	15	SENT_351	[p26l13t2153r273b2226],
15	deﬁciency	NN	O	deﬁciency	prep_of	12	SENT_351	[p26l309t2151r731b2245],
16	on	IN	O	on	_	0	SENT_351	[p26l763t2174r865b2224],
17	the	DT	O	the	det	18	SENT_351	[p26l897t2151r1027b2224],
18	toxicity	NN	O	toxicity	prep_on	9	SENT_351	[p26l1061t2151r1367b2245],
19	of	IN	O	of	_	0	SENT_351	[p26l1399t2151r1488b2223],
20	anthracyclines	NNS	O	anthracycline	prep_of	18	SENT_351	[p26l1514t2149r2142b2244],
21	.	.	O	.	_	0	SENT_351	[p26l1514t2149r2142b2244],

1	Much	JJ	O	much	amod	2	SENT_352	[p26l13t2266r252b2338],
2	effort	NN	O	effort	nsubj	4	SENT_352	[p26l300t2266r528b2338],
3	has	VBZ	O	have	aux	4	SENT_352	[p26l575t2266r713b2338],
4	focused	VBN	O	focus	dep	68	SENT_352	[p26l758t2266r1083b2338],
5	on	IN	O	on	_	0	SENT_352	[p26l1130t2289r1236b2339],
6	developing	VBG	O	develop	prepc_on	4	SENT_352	[p26l1283t2264r1744b2361],
7	less	JJR	O	less	amod	9	SENT_352	[p26l1790t2266r1939b2338],
8	cardiotoxic	JJ	O	cardiotoxic	amod	9	SENT_352	[p26l1986t2287r2145b2338, p26l13t2381r350b2456],
9	anthracyclines	NNS	O	anthracycline	dobj	6	SENT_352	[p26l427t2381r1057b2476],
10	,	,	O	,	_	0	SENT_352	[p26l427t2381r1057b2476],
11	on	IN	O	on	_	0	SENT_352	[p26l1137t2404r1240b2453],
12	minimizing	VBG	O	minimize	prepc_on	4	SENT_352	[p26l1318t2379r1791b2474],
13	abrupt	JJ	O	abrupt	amod	16	SENT_352	[p26l1871t2379r2147b2476],
14	blood	NN	O	blood	nn	16	SENT_352	[p26l8t2498r250b2572],
15	level	NN	O	level	nn	16	SENT_352	[p26l281t2498r477b2570],
16	peaks	NNS	O	peak	dobj	12	SENT_352	[p26l508t2498r747b2593],
17	of	IN	O	of	_	0	SENT_352	[p26l779t2498r868b2570],
18	available	JJ	O	available	amod	19	SENT_352	[p26l894t2498r1268b2570],
19	agents	NNS	O	agent	prep_of	16	SENT_352	[p26l1302t2507r1569b2591],
20	through	IN	O	through	_	0	SENT_352	[p26l1600t2498r1934b2591],
21	continuous	JJ	O	continuous	amod	23	SENT_352	[p26l1965t2521r2145b2570, p26l11t2617r324b2690],
22	infusion	NN	O	infusion	nn	23	SENT_352	[p26l362t2617r703b2690],
23	protocols	NNS	O	protocol	prep_through	12	SENT_352	[p26l742t2617r1138b2710],
24	or	CC	O	or	_	0	SENT_352	[p26l1177t2638r1266b2690],
25	drug	NN	O	drug	nn	26	SENT_352	[p26l1304t2615r1495b2710],
26	encapsulation	NN	O	encapsulation	prep_through	12	SENT_352	[p26l1533t2615r2145b2710],
27	,	,	O	,	_	0	SENT_352	[p26l1533t2615r2145b2710],
28	and	CC	O	and	_	0	SENT_352	[p26l13t2734r164b2807],
29	on	IN	O	on	_	0	SENT_352	[p26l196t2755r298b2806],
30	increasing	VBG	O	increase	prepc_on	49	SENT_352	[p26l332t2732r764b2827],
31	our	PRP$	O	we	poss	32	SENT_352	[p26l795t2755r937b2804],
32	understanding	NN	O	understanding	nn	43	SENT_352	[p26l968t2731r1580b2827],
33	of	IN	O	of	_	0	SENT_352	[p26l1612t2731r1701b2804],
34	the	DT	O	the	det	35	SENT_352	[p26l1725t2732r1856b2804],
35	mechanisms	NNS	O	mechanism	prep_of	32	SENT_352	[p26l1889t2732r2145b2804, p26l13t2849r294b2921],
36	responsible	JJ	O	responsible	amod	43	SENT_352	[p26l332t2849r814b2945],
37	for	IN	O	for	_	0	SENT_352	[p26l850t2849r974b2921],
38	anthracycline	NN	O	anthracycline	nn	39	SENT_352	[p26l1010t2848r1578b2942],
39	cardiomyopathy	NN	O	cardiomyopathy	prep_for	36	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
40	.14	CD	NUMBER	.14	number	41	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
41	’	CD	NUMBER	’	dep	39	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
42	25	CD	NUMBER	25	tmod	36	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
43	’	NN	O	’	iobj	30	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
44	35	CD	NUMBER	35	num	45	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
45	’	CD	NUMBER	’	dobj	30	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
46	42	CD	NUMBER	42	num	47	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
47	'45	CD	NUMBER	'45	dobj	30	SENT_352	[p26l1614t2849r2145b2944, p26l13t2952r673b3064],
48	There	EX	O	there	expl	49	SENT_352	[p26l726t2969r979b3041],
49	is	VBZ	O	be	dep	68	SENT_352	[p26l1031t2969r1092b3041],
50	mounting	VBG	O	mount	amod	51	SENT_352	[p26l1144t2969r1550b3062],
51	evidence	NN	O	evidence	nsubj	49	SENT_352	[p26l1605t2969r1971b3041],
52	for	IN	O	for	_	0	SENT_352	[p26l2023t2969r2147b3041],
53	the	DT	O	the	det	55	SENT_352	[p26l11t3084r141b3156],
54	pathogenic	JJ	O	pathogenic	amod	55	SENT_352	[p26l191t3084r662b3180],
55	role	NN	O	role	prep_for	51	SENT_352	[p26l709t3081r875b3156],
56	of	IN	O	of	_	0	SENT_352	[p26l924t3084r1013b3156],
57	reduced	VBN	O	reduce	amod	59	SENT_352	[p26l1056t3081r1397b3154],
58	oxygen	NN	O	oxygen	nn	59	SENT_352	[p26l1447t3104r1740b3177],
59	moieties	NNS	O	moiety	prep_of	55	SENT_352	[p26l1790t3082r2145b3154],
60	created	VBN	O	create	partmod	59	SENT_352	[p26l11t3199r324b3271],
61	by	IN	O	by	_	0	SENT_352	[p26l381t3201r479b3294],
62	semiquinones	NNS	O	semiquinone	agent	60	SENT_352	[p26l536t3199r1118b3294],
63	or	CC	O	or	_	0	SENT_352	[p26l1179t3222r1266b3271],
64	by	IN	O	by	_	0	SENT_352	[p26l1322t3199r1418b3292],
65	a	DT	O	a	det	67	SENT_352	[p26l1480t3222r1520b3271],
66	drug	NN	O	drug	nn	67	SENT_352	[p26l1581t3198r2147b3292],
67	—	NN	O	—	conj_or	62	SENT_352	[p26l1581t3198r2147b3292],
68	induced	VBD	O	induce	_	0	SENT_352	[p26l1581t3198r2147b3292],
69	elevation	NN	O	elevation	dobj	68	SENT_352	[p26l11t3317r398b3390],
70	of	IN	O	of	_	0	SENT_352	[p26l436t3317r523b3389],
71	cellular	JJ	O	cellular	amod	73	SENT_352	[p26l557t3314r872b3390],
72	Fe	NNP	O	Fe	nn	73	SENT_352	[p26l908t3315r1192b3412],
73	(	NN	O	(	prep_of	69	SENT_352	[p26l908t3315r1192b3412],
74	II	CD	NUMBER	ii	num	75	SENT_352	[p26l908t3315r1192b3412],
75	)	NN	O	)	nsubj	68	SENT_352	[p26l908t3315r1192b3412],
76	.	.	O	.	_	0	SENT_352	[p26l908t3315r1192b3412],

1	The	DT	O	the	det	4	SENT_353	[p26l1232t3317r1397b3387],
2	unequal	JJ	O	unequal	amod	4	SENT_353	[p26l1433t3315r1774b3410],
3	biologic	JJ	O	biologic	amod	4	SENT_353	[p26l1810t3314r2147b3410],
4	eﬁects	NNS	O	eﬁects	nsubj	7	SENT_353	[p26l11t3434r278b3507],
5	of	IN	O	of	_	0	SENT_353	[p26l312t3434r400b3506],
6	anthracyclines	NNS	O	anthracycline	prep_of	4	SENT_353	[p26l429t3432r1034b3527],
7	depend	VBP	O	depend	conj_negcc	7	SENT_353	[p26l1070t3431r1381b3527],
8	on	IN	O	on	_	0	SENT_353	[p26l1415t3455r1520b3504],
9	their	PRP$	O	they	poss	11	SENT_353	[p26l1554t3432r1751b3504],
10	different	JJ	O	different	amod	11	SENT_353	[p26l1785t3432r2147b3504],
11	availability	NN	O	availability	conj_and	11	SENT_353	[p26l13t3548r472b3644],
12	as	IN	O	as	_	0	SENT_353	[p26l520t3572r597b3621],
13	a	DT	O	a	det	14	SENT_353	[p26l647t3572r689b3621],
14	substrate	NN	O	substrate	prep_as	11	SENT_353	[p26l735t3549r1118b3621],
15	for	IN	O	for	_	0	SENT_353	[p26l1163t3549r1286b3621],
16	carbonyl	NN	O	carbonyl	nn	17	SENT_353	[p26l1332t3549r1694b3645],
17	reductase	NN	O	reductase	prep_for	14	SENT_353	[p26l1739t3548r2145b3621],
18	and	CC	O	and	_	0	SENT_353	[p26l13t3666r162b3738],
19	also	RB	O	also	advmod	11	SENT_353	[p26l196t3665r359b3741],
20	on	IN	O	on	_	0	SENT_353	[p26l392t3689r495b3740],
21	their	PRP$	O	they	poss	22	SENT_353	[p26l529t3665r729b3738],
22	ability	NN	O	ability	prep_on	11	SENT_353	[p26l760t3666r1020b3761],
23	to	TO	O	to	aux	24	SENT_353	[p26l1049t3675r1131b3738],
24	generate	VB	O	generate	dep	22	SENT_353	[p26l1163t3675r1532b3761],
25	semiquinones	NNS	O	semiquinone	dobj	24	SENT_353	[p26l1565t3666r2145b3761],
26	through	IN	O	through	_	0	SENT_353	[p27l8t18r345b113],
27	ﬁavoenzymes	NNS	O	ﬁavoenzymes	prep_through	24	SENT_353	[p27l376t18r939b113],
28	and	CC	O	and	_	0	SENT_353	[p27l975t18r1127b90],
29	to	TO	O	to	aux	30	SENT_353	[p27l1158t29r1240b90],
30	mobilize	VB	O	mobilize	conj_and	24	SENT_353	[p27l1274t18r1659b106],
31	,	,	O	,	_	0	SENT_353	[p27l1274t18r1659b106],
32	chelate	VB	O	chelate	conj_or	30	SENT_353	[p27l1695t17r2022b106],
33	,	,	O	,	_	0	SENT_353	[p27l1695t17r2022b106],
34	or	CC	O	or	_	0	SENT_353	[p27l2058t41r2147b90],
35	reduce	VB	O	reduce	conj_or	30	SENT_353	[p27l8t136r294b211],
36	Fe	NNP	O	Fe	dobj	35	SENT_353	[p27l353t136r648b231],
37	(	CD	NUMBER	(	num	36	SENT_353	[p27l353t136r648b231],
38	III	NNP	O	III	dep	44	SENT_353	[p27l353t136r648b231],
39	)	CD	NUMBER	)	num	38	SENT_353	[p27l353t136r648b231],
40	to	TO	O	to	_	0	SENT_353	[p27l712t147r794b208],
41	Fe	NNP	O	Fe	prep_to	38	SENT_353	[p27l853t119r1506b231],
42	(	NN	O	(	dep	44	SENT_353	[p27l853t119r1506b231],
43	II	CD	NUMBER	ii	num	42	SENT_353	[p27l853t119r1506b231],
44	)	NN	O	)	dep	47	SENT_353	[p27l853t119r1506b231],
45	.35	CD	NUMBER	.35	dep	44	SENT_353	[p27l853t119r1506b231],
46	’	CD	NUMBER	’	num	47	SENT_353	[p27l853t119r1506b231],
47	42	CD	NUMBER	42	dep	35	SENT_353	[p27l853t119r1506b231],
48	'	''	DATE	'	_	0	SENT_353	[p27l853t119r1506b231],
49	44	CD	DATE	44	number	50	SENT_353	[p27l853t119r1506b231],
50	’46	CD	NUMBER	’46	dep	11	SENT_353	[p27l853t119r1506b231],
51	For	IN	O	for	_	0	SENT_353	[p27l1563t138r1714b208],
52	instance	NN	O	instance	prep_for	57	SENT_353	[p27l1771t136r2142b224],
53	,	,	O	,	_	0	SENT_353	[p27l1771t136r2142b224],
54	three	CD	NUMBER	three	num	56	SENT_353	[p27l8t253r229b325],
55	drug	NN	O	drug	nn	56	SENT_353	[p27l265t253r458b348],
56	molecules	NNS	O	molecule	nsubj	57	SENT_353	[p27l492t253r914b325],
57	chelate	VBP	O	chelate	rcmod	50	SENT_353	[p27l952t253r1254b325],
58	one	CD	NUMBER	one	num	59	SENT_353	[p27l1290t276r1444b325],
59	atom	NN	O	atom	dobj	57	SENT_353	[p27l1480t262r1693b325],
60	of	IN	O	of	_	0	SENT_353	[p27l1727t253r1816b325],
61	Fe	NNP	O	Fe	prep_of	59	SENT_353	[p27l1845t251r2140b349],
62	(	CD	NUMBER	(	num	61	SENT_353	[p27l1845t251r2140b349],
63	III	CD	NUMBER	iii	num	64	SENT_353	[p27l1845t251r2140b349],
64	)	NN	O	)	dep	50	SENT_353	[p27l1845t251r2140b349],
65	that	WDT	O	that	nsubjpass	67	SENT_353	[p27l8t370r174b442],
66	remains	VBZ	O	remain	auxpass	67	SENT_353	[p27l217t370r551b443],
67	oxidized	VBN	O	oxidize	rcmod	64	SENT_353	[p27l596t370r946b443],
68	with	IN	O	with	_	0	SENT_353	[p27l985t370r1168b443],
69	daunorubicin	NN	O	daunorubicin	nn	73	SENT_353	[p27l1211t370r1777b443],
70	(	CD	NUMBER	(	num	73	SENT_353	[p27l1820t368r2145b465],
71	ketone	NN	O	ketone	nn	73	SENT_353	[p27l1820t368r2145b465],
72	side	NN	O	side	nn	73	SENT_353	[p27l8t488r174b561],
73	chain	NN	O	chain	prep_with	67	SENT_353	[p27l219t488r467b561],
74	:	:	O	:	_	0	SENT_353	[p27l219t488r467b561],
75	R-C130-CMH3	NN	O	r-c130-cmh3	nn	76	SENT_353	[p27l520t486r1180b581],
76	)	NN	O	)	dobj	67	SENT_353	[p27l520t486r1180b581],
77	but	CC	O	but	_	0	SENT_353	[p27l1227t486r1365b560],
78	not	RB	O	not	_	0	SENT_353	[p27l1410t497r1548b561],
79	with	IN	O	with	_	0	SENT_353	[p27l1588t486r1770b561],
80	doxorubicin	NN	O	doxorubicin	nn	83	SENT_353	[p27l1815t486r2142b561, p27l6t604r213b679],
81	(	NN	O	(	nn	83	SENT_353	[p27l281t604r551b702],
82	ketolz	NN	O	ketolz	nn	83	SENT_353	[p27l281t604r551b702],
83	R	NN	O	r	prep_with	7	SENT_353	[p27l624t606r1131b700],
84	.	.	O	.	_	0	SENT_353	[p27l624t606r1131b700],

1	—	NN	O	—	_	0	SENT_354	[p27l624t606r1131b700],
2	.	.	O	.	_	0	SENT_354	[p27l624t606r1131b700],

1	C13O	NN	O	c13o	_	0	SENT_355	[p27l624t606r1131b700],
2	.	.	O	.	_	0	SENT_355	[p27l624t606r1131b700],

1	—	NN	O	—	_	0	SENT_356	[p27l624t606r1131b700],
2	.	.	O	.	_	0	SENT_356	[p27l624t606r1131b700],

1	C14	NN	O	c14	dep	113	SENT_357	[p27l624t606r1131b700],
2	H2OH	NN	O	h2oh	dep	113	SENT_357	[p27l1195t588r1800b700],
3	)	CD	NUMBER	)	dep	113	SENT_357	[p27l1195t588r1800b700],
4	.42	CD	NUMBER	.42	dep	113	SENT_357	[p27l1195t588r1800b700],
5	’	NN	O	’	dep	113	SENT_357	[p27l1195t588r1800b700],
6	46	CD	NUMBER	46	dep	113	SENT_357	[p27l1195t588r1800b700],
7	’47	CD	NUMBER	’47	dep	113	SENT_357	[p27l1195t588r1800b700],
8	Excess	JJ	O	excess	dep	113	SENT_357	[p27l1864t606r2142b677],
9	production	NN	O	production	dep	113	SENT_357	[p27l8t722r474b818],
10	of	IN	O	of	dep	113	SENT_357	[p27l510t723r599b795],
11	O2	CD	NUMBER	o2	dep	113	SENT_357	[p27l631t723r796b816],
12	"	''	O	"	dep	113	SENT_357	[p27l631t723r796b816],
13	and	CC	O	and	dep	113	SENT_357	[p27l839t723r990b795],
14	more	RBR	O	more	dep	113	SENT_357	[p27l1024t746r1242b795],
15	reactive	JJ	O	reactive	dep	113	SENT_357	[p27l1278t723r1610b795],
16	oxygen	NN	O	oxygen	dep	113	SENT_357	[p27l1646t746r1939b816],
17	radicals	NNS	O	radical	dep	113	SENT_357	[p27l1972t723r2142b795, p27l8t840r190b912],
18	generated	VBN	O	generate	dep	113	SENT_357	[p27l233t840r657b935],
19	by	IN	O	by	dep	113	SENT_357	[p27l698t840r794b933],
20	Fe	NNP	O	Fe	dep	113	SENT_357	[p27l834t838r1092b935],
21	(	NNP	O	(	dep	113	SENT_357	[p27l834t838r1092b935],
22	II	NNP	O	II	dep	113	SENT_357	[p27l834t838r1092b935],
23	)	NN	O	)	dep	113	SENT_357	[p27l834t838r1092b935],
24	but	CC	O	but	dep	113	SENT_357	[p27l1137t840r1275b912],
25	not	RB	O	not	dep	113	SENT_357	[p27l1318t849r1453b913],
26	by	IN	O	by	dep	113	SENT_357	[p27l1494t840r1592b933],
27	Fe	NNP	O	Fe	dep	113	SENT_357	[p27l1632t837r1927b935],
28	(	CD	NUMBER	(	dep	113	SENT_357	[p27l1632t837r1927b935],
29	III	CD	NUMBER	iii	dep	113	SENT_357	[p27l1632t837r1927b935],
30	)	NN	O	)	dep	113	SENT_357	[p27l1632t837r1927b935],
31	may	MD	O	may	dep	113	SENT_357	[p27l1972t863r2145b933],
32	inﬂuence	VB	O	inﬂuence	dep	113	SENT_357	[p27l8t958r393b1031],
33	doxorubicin	NN	O	doxorubicin	dep	113	SENT_357	[p27l455t956r1023b1031],
34	’s	POS	O	’s	dep	113	SENT_357	[p27l455t956r1023b1031],
35	therapeutic	JJ	O	therapeutic	dep	113	SENT_357	[p27l1082t956r1569b1051],
36	range	NN	O	range	dep	113	SENT_357	[p27l1626t979r1860b1051],
37	while	IN	O	while	dep	113	SENT_357	[p27l1917t956r2142b1028],
38	increasing	VBG	O	increase	dep	113	SENT_357	[p27l8t1075r437b1168],
39	cardiotoxicity	NN	O	cardiotoxicity	dep	113	SENT_357	[p27l478t1073r1055b1168],
40	and	CC	O	and	dep	113	SENT_357	[p27l1093t1072r1245b1145],
41	the	DT	O	the	dep	113	SENT_357	[p27l1283t1073r1416b1145],
42	risk	NN	O	risk	dep	113	SENT_357	[p27l1454t1073r1610b1145],
43	of	IN	O	of	dep	113	SENT_357	[p27l1646t1073r1735b1145],
44	necrotiz	NN	O	necrotiz	dep	113	SENT_357	[p27l1767t1073r2140b1145],
45	—	CD	NUMBER	—	dep	113	SENT_357	[p27l1767t1073r2140b1145],
46	ing	NN	O	ing	dep	113	SENT_357	[p27l8t1192r134b1285],
47	enteroco1itis	NN	O	enteroco1itis	dep	113	SENT_357	[p27l168t1176r988b1265],
48	.36	CD	NUMBER	.36	dep	113	SENT_357	[p27l168t1176r988b1265],
49	’	CD	NUMBER	’	dep	113	SENT_357	[p27l168t1176r988b1265],
50	43	CD	NUMBER	43	dep	113	SENT_357	[p27l168t1176r988b1265],
51	’44	CD	NUMBER	’44	dep	113	SENT_357	[p27l168t1176r988b1265],
52	In	IN	O	in	dep	113	SENT_357	[p27l1022t1194r1108b1262],
53	the	DT	O	the	dep	113	SENT_357	[p27l1140t1192r1272b1265],
54	present	JJ	DATE	present	dep	113	SENT_357	[p27l1304t1201r1620b1285],
55	context	NN	O	context	dep	113	SENT_357	[p27l1653t1201r1960b1264],
56	it	PRP	O	it	dep	113	SENT_357	[p27l1993t1190r2050b1264],
57	is	VBZ	O	be	dep	113	SENT_357	[p27l2081t1190r2142b1264],
58	particularly	RB	O	particularly	dep	113	SENT_357	[p27l6t1306r497b1403],
59	relevant	JJ	O	relevant	dep	113	SENT_357	[p27l543t1306r889b1378],
60	to	TO	O	to	dep	113	SENT_357	[p27l936t1317r1016b1378],
61	note	VB	O	note	dep	113	SENT_357	[p27l1068t1317r1254b1378],
62	that	IN	O	that	dep	113	SENT_357	[p27l1304t1306r1469b1378],
63	antitumor	NN	O	antitumor	dep	113	SENT_357	[p27l1519t1306r1941b1378],
64	and	CC	O	and	dep	113	SENT_357	[p27l1991t1306r2142b1399],
65	antimyocardial	JJ	O	antimyocardial	dep	113	SENT_357	[p27l8t1423r641b1518],
66	mechanisms	NNS	O	mechanism	dep	113	SENT_357	[p27l728t1423r1242b1495],
67	can	MD	O	can	dep	113	SENT_357	[p27l1332t1446r1474b1495],
68	be	VB	O	be	dep	113	SENT_357	[p27l1558t1422r1656b1495],
69	dissociated	VBN	O	dissociate	dep	113	SENT_357	[p27l1746t1422r2140b1495, p27l8t1525r396b1628],
70	,25	CD	NUMBER	,25	dep	113	SENT_357	[p27l1746t1422r2140b1495, p27l8t1525r396b1628],
71	’	CD	NUMBER	’	dep	113	SENT_357	[p27l1746t1422r2140b1495, p27l8t1525r396b1628],
72	42	CD	NUMBER	42	dep	113	SENT_357	[p27l1746t1422r2140b1495, p27l8t1525r396b1628],
73	’45	CD	NUMBER	’45	dep	113	SENT_357	[p27l1746t1422r2140b1495, p27l8t1525r396b1628],
74	that	IN	O	that	dep	113	SENT_357	[p27l429t1542r597b1615],
75	the	DT	O	the	dep	113	SENT_357	[p27l631t1542r761b1614],
76	cardiotoxicity	NN	O	cardiotoxicity	dep	113	SENT_357	[p27l797t1540r1374b1633],
77	of	IN	O	of	dep	113	SENT_357	[p27l1408t1542r1495b1612],
78	parent	NN	O	parent	dep	113	SENT_357	[p27l1524t1551r1800b1635],
79	anthracyclines	NNS	O	anthracycline	dep	113	SENT_357	[p27l1836t1542r2140b1612, p27l6t1659r333b1755],
80	and	CC	O	and	dep	113	SENT_357	[p27l395t1660r546b1732],
81	their	PRP$	O	they	dep	113	SENT_357	[p27l605t1660r805b1733],
82	alcohol	NN	O	alcohol	dep	113	SENT_357	[p27l864t1660r1171b1732],
83	metabolites	NNS	O	metabolite	dep	113	SENT_357	[p27l1230t1660r1721b1732],
84	differ	VBP	O	differ	dep	113	SENT_357	[p27l1783t1660r2006b1732],
85	in	IN	O	in	dep	113	SENT_357	[p27l2065t1660r2142b1732],
86	some	DT	O	some	dep	113	SENT_357	[p27l6t1797r224b1848],
87	experimental	JJ	O	experimental	dep	113	SENT_357	[p27l272t1774r828b1869],
88	systems25	CD	NUMBER	systems25	dep	113	SENT_357	[p27l876t1758r1363b1867],
89	’45	CD	NUMBER	’45	dep	113	SENT_357	[p27l876t1758r1363b1867],
90	as	RB	O	as	dep	113	SENT_357	[p27l1413t1797r1495b1846],
91	well	RB	O	well	dep	113	SENT_357	[p27l1535t1776r1707b1846],
92	as	IN	O	as	dep	113	SENT_357	[p27l1757t1797r1837b1847],
93	in	IN	O	in	dep	113	SENT_357	[p27l1887t1774r1964b1846],
94	the	DT	O	the	dep	113	SENT_357	[p27l2009t1774r2140b1846],
95	human	JJ	O	human	dep	113	SENT_357	[p27l6t1893r294b1966],
96	myocardium	NN	O	myocardium	dep	113	SENT_357	[p27l341t1876r967b1987],
97	,45	CD	NUMBER	,45	dep	113	SENT_357	[p27l341t1876r967b1987],
98	and	CC	O	and	dep	113	SENT_357	[p27l1015t1893r1166b1963],
99	that	DT	O	that	dep	113	SENT_357	[p27l1211t1891r1379b1963],
100	anthracyclineinduced	JJ	O	anthracyclineinduced	dep	113	SENT_357	[p27l1424t1890r2140b1984, p27l8t2010r257b2083],
101	iron	NN	O	iron	dep	113	SENT_357	[p27l298t2010r470b2080],
102	mobilization	NN	O	mobilization	dep	113	SENT_357	[p27l508t2007r1041b2080],
103	in	IN	O	in	dep	113	SENT_357	[p27l1082t2008r1159b2080],
104	human	JJ	O	human	dep	113	SENT_357	[p27l1197t2008r1485b2080],
105	myocardial	JJ	O	myocardial	dep	113	SENT_357	[p27l1526t2008r1992b2103],
106	biopsy	NN	O	biopsy	dep	113	SENT_357	[p27l2030t2010r2140b2080, p27l6t2148r194b2220],
107	samples	NNS	O	sample	dep	113	SENT_357	[p27l247t2127r581b2221],
108	depends	VBZ	O	depend	dep	113	SENT_357	[p27l635t2126r986b2221],
109	critically	RB	O	critically	dep	113	SENT_357	[p27l1040t2126r1404b2218],
110	on	IN	O	on	dep	113	SENT_357	[p27l1454t2148r1557b2197],
111	carbonyl	NN	O	carbonyl	dep	113	SENT_357	[p27l1612t2127r1971b2220],
112	reductase	NN	O	reductase	dep	113	SENT_357	[p27l2026t2148r2140b2197, p27l6t2244r324b2317],
113	activity	NN	O	activity	_	0	SENT_357	[p27l390t2227r789b2337],
114	.	.	O	.	_	0	SENT_357	[p27l390t2227r789b2337],

1	”	NN	O	”	nsubj	13	SENT_358	[p27l390t2227r789b2337],
2	Thus	RB	O	thus	advmod	13	SENT_358	[p27l850t2244r1060b2316],
3	the	DT	O	the	det	6	SENT_358	[p27l1121t2244r1252b2314],
4	restricted	JJ	O	restricted	amod	6	SENT_358	[p27l1315t2244r1719b2316],
5	carbonyl	NN	O	carbonyl	nn	6	SENT_358	[p27l1780t2244r2140b2337],
6	reductase	NN	O	reductase	nsubj	13	SENT_358	[p27l6t2361r412b2434],
7	in	IN	O	in	_	0	SENT_358	[p27l443t2361r521b2433],
8	G6PD	NN	O	g6pd	nn	9	SENT_358	[p27l550t2361r810b2433],
9	deﬁciency	NN	O	deﬁciency	prep_in	6	SENT_358	[p27l841t2360r1263b2454],
10	may	MD	O	may	aux	13	SENT_358	[p27l1288t2384r1460b2455],
11	not	RB	O	not	neg	13	SENT_358	[p27l1487t2370r1624b2431],
12	only	RB	O	only	advmod	13	SENT_358	[p27l1653t2361r1830b2454],
13	impact	VB	O	impact	_	0	SENT_358	[p27l1857t2361r2140b2454],
14	the	DT	O	the	det	15	SENT_358	[p27l6t2478r139b2551],
15	drug	NN	O	drug	poss	18	SENT_358	[p27l177t2478r433b2571],
16	’s	POS	O	’s	_	0	SENT_358	[p27l177t2478r433b2571],
17	therapeutic	JJ	O	therapeutic	amod	18	SENT_358	[p27l471t2478r958b2571],
18	value	NN	O	value	dobj	13	SENT_358	[p27l989t2478r1215b2551],
19	but	CC	O	but	_	0	SENT_358	[p27l1251t2478r1388b2548],
20	also	RB	O	also	advmod	18	SENT_358	[p27l1429t2478r1590b2550],
21	its	PRP$	O	its	poss	22	SENT_358	[p27l1630t2476r1724b2550],
22	tendency	NN	O	tendency	dobj	13	SENT_358	[p27l1762t2478r2145b2569],
23	to	TO	O	to	aux	24	SENT_358	[p27l6t2607r86b2666],
24	injure	VB	O	injure	infmod	22	SENT_358	[p27l129t2598r377b2689],
25	the	DT	O	the	det	26	SENT_358	[p27l416t2598r548b2666],
26	heart	NN	O	heart	dobj	24	SENT_358	[p27l589t2598r833b2666],
27	.	.	O	.	_	0	SENT_358	[p27l589t2598r833b2666],

1	Daunorubicin	NN	O	daunorubicin	nsubj	4	SENT_359	[p27l105t2713r694b2786],
2	and	CC	O	and	_	0	SENT_359	[p27l744t2713r893b2785],
3	doxorubicin	NN	O	doxorubicin	conj_and	1	SENT_359	[p27l943t2712r1446b2786],
4	have	VBP	O	have	_	0	SENT_359	[p27l1494t2713r1684b2786],
5	dissimilar	JJ	O	dissimilar	amod	6	SENT_359	[p27l1734t2712r2142b2786],
6	toxic	JJ	O	toxic	amod	7	SENT_359	[p27l8t2830r208b2902],
7	effects	NNS	O	effect	dobj	4	SENT_359	[p27l244t2829r511b2902],
8	on	IN	O	on	_	0	SENT_359	[p27l550t2853r653b2902],
9	human	JJ	O	human	amod	10	SENT_359	[p27l688t2830r979b2903],
10	erythrocytes	NNS	O	erythrocyte	prep_on	4	SENT_359	[p27l1015t2830r1534b2923],
11	in	IN	O	in	prep	10	SENT_359	[p27l1570t2830r1647b2902],
12	which	WDT	O	which	dep	17	SENT_359	[p27l1681t2830r1927b2902],
13	they	PRP	O	they	dep	17	SENT_359	[p27l1963t2830r2142b2923],
14	J	NNP	O	J	nn	17	SENT_359	[p27l1580t2936r1611b2997],
15	Lab	NNP	O	Lab	nn	17	SENT_359	[p27l1649t2936r1780b2998],
16	Clin	NNP	O	Clin	nn	17	SENT_359	[p27l1811t2936r1945b2997],
17	Med	NNP	O	Med	rcmod	10	SENT_359	[p27l1980t2936r2144b2997],

1	June	NNP	DATE	June	_	0	SENT_360	[p27l1772t3035r1951b3096],
2	1996	CD	DATE	1996	dep	1	SENT_360	[p27l1987t3033r2148b3096],

1	have	VBP	O	have	aux	3	SENT_361	[p27l16t3271r207b3345],
2	been	VBN	O	be	auxpass	3	SENT_361	[p27l236t3274r439b3345],
3	encapsulated	VBN	O	encapsulate	_	0	SENT_361	[p27l470t3271r1048b3367],
4	,	,	O	,	_	0	SENT_361	[p27l470t3271r1048b3367],
5	so	IN	O	so	dep	3	SENT_361	[p27l1082t3295r1166b3344],
6	that	IN	O	that	dep	11	SENT_361	[p27l1198t3272r1363b3345],
7	entrapped	JJ	O	entrapped	amod	10	SENT_361	[p27l1394t3272r1826b3367],
8	dauno	NN	O	dauno	nn	10	SENT_361	[p27l1855t3271r2148b3344],
9	—	NN	O	—	nn	10	SENT_361	[p27l1855t3271r2148b3344],
10	rubicin	NN	O	rubicin	nsubj	11	SENT_361	[p27l16t3390r314b3462],
11	perturbs	VBZ	O	perturb	csubj	18	SENT_361	[p27l371t3390r728b3485],
12	the	DT	O	the	det	14	SENT_361	[p27l788t3390r918b3462],
13	loaded	JJ	O	loaded	amod	14	SENT_361	[p27l980t3390r1266b3462],
14	cells48	NN	O	cells48	dobj	11	SENT_361	[p27l1325t3371r1583b3462],
15	much	RB	O	much	advmod	17	SENT_361	[p27l1645t3390r1873b3462],
16	more	RBR	O	more	advmod	17	SENT_361	[p27l1932t3410r2151b3462],
17	than	IN	O	than	advmod	11	SENT_361	[p27l14t3507r203b3581],
18	does	VBZ	O	do	ccomp	3	SENT_361	[p27l239t3507r430b3580],
19	doxorubicin	NN	O	doxorubicin	dobj	18	SENT_361	[p27l466t3489r1071b3581],
20	.	.	O	.	_	0	SENT_361	[p27l466t3489r1071b3581],

1	”	NN	O	”	ccomp	5	SENT_362	[p27l466t3489r1071b3581],
2	Moreover	RB	O	moreover	advmod	1	SENT_362	[p27l1107t3507r1548b3595],
3	,	,	O	,	_	0	SENT_362	[p27l1107t3507r1548b3595],
4	daunorubicin	NN	O	daunorubicin	nsubj	5	SENT_362	[p27l1589t3505r2151b3581],
5	differs	VBZ	O	differ	dep	35	SENT_362	[p27l16t3625r277b3698],
6	from	IN	O	from	_	0	SENT_362	[p27l320t3625r525b3698],
7	doxorubicin	NN	O	doxorubicin	prep_from	5	SENT_362	[p27l568t3622r1071b3698],
8	in	IN	O	in	_	0	SENT_362	[p27l1114t3623r1192b3695],
9	boosting	VBG	O	boost	prepc_in	5	SENT_362	[p27l1232t3622r1597b3718],
10	the	DT	O	the	det	11	SENT_362	[p27l1638t3622r1768b3695],
11	demand	NN	O	demand	dobj	9	SENT_362	[p27l1814t3623r2151b3695],
12	for	IN	O	for	_	0	SENT_362	[p28l14t20r138b93],
13	erythrocyte	NN	O	erythrocyte	nn	14	SENT_362	[p28l178t18r657b116],
14	NADPH	NN	O	nadph	prep_for	11	SENT_362	[p28l697t20r1064b93],
15	by	IN	O	by	_	0	SENT_362	[p28l1100t18r1199b114],
16	detoxifying	VBG	O	detoxify	prepc_by	9	SENT_362	[p28l1237t18r1706b114],
17	peroxides	NNS	O	peroxide	dobj	16	SENT_362	[p28l1742t18r2151b114],
18	through	IN	O	through	_	0	SENT_362	[p28l14t138r351b232],
19	GSH-peroxidase	NN	O	gsh-peroxidase	prep_through	16	SENT_362	[p28l387t136r1090b234],
20	and	CC	O	and	_	0	SENT_362	[p28l1128t138r1280b209],
21	GSSG-R	NN	O	gssg-r	prep_through	16	SENT_362	[p28l1318t138r1711b225],
22	,	,	O	,	_	0	SENT_362	[p28l1318t138r1711b225],
23	as	RB	O	as	_	0	SENT_362	[p28l1751t159r1831b211],
24	well	RB	O	well	_	0	SENT_362	[p28l1862t136r2035b209],
25	as	IN	O	as	_	0	SENT_362	[p28l2071t159r2151b211],
26	by	IN	O	by	_	0	SENT_362	[p28l14t255r110b348],
27	serving	VBG	O	serve	conj_and	16	SENT_362	[p28l158t255r457b348],
28	as	IN	O	as	_	0	SENT_362	[p28l507t278r587b327],
29	a	DT	O	a	det	30	SENT_362	[p28l639t278r682b328],
30	substrate	NN	O	substrate	prep_as	27	SENT_362	[p28l730t255r1113b328],
31	for	IN	O	for	_	0	SENT_362	[p28l1163t255r1284b328],
32	carbonyl	NN	O	carbonyl	nn	33	SENT_362	[p28l1334t253r1694b348],
33	reductase	NN	O	reductase	prep_for	30	SENT_362	[p28l1744t255r2151b325],
34	(	CD	NUMBER	(	num	33	SENT_362	[p28l19t368r186b467],
35	see	VBP	O	see	_	0	SENT_362	[p28l19t368r186b467],
36	Results	NNS	O	result	dobj	35	SENT_362	[p28l222t368r569b466],
37	)	CD	NUMBER	)	num	36	SENT_362	[p28l222t368r569b466],
38	in	IN	O	in	_	0	SENT_362	[p28l609t370r687b443],
39	a	DT	O	a	det	43	SENT_362	[p28l723t393r765b443],
40	BCNU-insensitive	JJ	O	bcnu-insensitive	amod	43	SENT_362	[p28l799t370r1569b443],
41	manner	NN	O	manner	nn	43	SENT_362	[p28l1605t393r1928b443],
42	(	CD	NUMBER	(	num	43	SENT_362	[p28l1967t367r2148b467, p28l16t511r295b561],
43	reference	NN	O	reference	prep_in	36	SENT_362	[p28l1967t367r2148b467, p28l16t511r295b561],
44	1	CD	NUMBER	1	nsubj	35	SENT_362	[p28l343t490r404b577],
45	,	,	O	,	_	0	SENT_362	[p28l343t490r404b577],
46	Table	NNP	O	Table	nn	47	SENT_362	[p28l447t488r687b561],
47	III	NNP	O	III	appos	44	SENT_362	[p28l730t485r900b584],
48	)	NN	O	)	dep	47	SENT_362	[p28l730t485r900b584],
49	.	.	O	.	_	0	SENT_362	[p28l730t485r900b584],

1	To	TO	O	to	aux	2	SENT_363	[p28l945t490r1057b561],
2	mitigate	VB	O	mitigate	dep	19	SENT_363	[p28l1100t488r1446b585],
3	oxygen	NN	O	oxygen	nn	4	SENT_363	[p28l1487t511r1780b584],
4	toxicity	NN	O	toxicity	dobj	2	SENT_363	[p28l1821t488r2148b582],
5	,	,	O	,	_	0	SENT_363	[p28l1821t488r2148b582],
6	hydrogen	NN	O	hydrogen	nn	7	SENT_363	[p28l16t609r411b702],
7	peroxide	NN	O	peroxide	appos	4	SENT_363	[p28l450t608r819b705],
8	formed	VBN	O	form	partmod	7	SENT_363	[p28l857t609r1164b681],
9	from	IN	O	from	_	0	SENT_363	[p28l1202t609r1405b681],
10	02	CD	NUMBER	02	prep_from	8	SENT_363	[p28l1445t609r1613b702],
11	-	:	O	-	_	0	SENT_363	[p28l1445t609r1613b702],
12	by	IN	O	by	_	0	SENT_363	[p28l1654t608r1750b702],
13	superox	NN	O	superox	nn	16	SENT_363	[p28l1788t629r2148b702],
14	—	CD	NUMBER	—	num	16	SENT_363	[p28l1788t629r2148b702],
15	ide	NN	O	ide	nn	16	SENT_363	[p28l16t722r142b795],
16	dismutase	NN	O	dismutase	agent	19	SENT_363	[p28l188t722r608b795],
17	is	VBZ	O	be	auxpass	19	SENT_363	[p28l653t723r714b795],
18	rapidly	RB	O	rapidly	advmod	19	SENT_363	[p28l757t722r1053b818],
19	removed	VBN	O	remove	_	0	SENT_363	[p28l1093t723r1460b795],
20	through	IN	O	through	_	0	SENT_363	[p28l1503t722r1840b819],
21	defensive	JJ	O	defensive	amod	22	SENT_363	[p28l1883t723r2148b795, p28l16t840r173b912],
22	recycling	NN	O	recycling	prep_through	19	SENT_363	[p28l220t840r596b935],
23	of	IN	O	of	_	0	SENT_363	[p28l644t840r733b912],
24	glutathione	NN	O	glutathione	prep_of	22	SENT_363	[p28l771t840r1257b935],
25	by	IN	O	by	_	0	SENT_363	[p28l1304t840r1400b933],
26	GSH-peroxidase	NN	O	gsh-peroxidase	agent	19	SENT_363	[p28l1448t840r2151b935],
27	supported	VBN	O	support	partmod	26	SENT_363	[p28l16t960r443b1055],
28	by	IN	O	by	_	0	SENT_363	[p28l514t960r610b1053],
29	increased	VBN	O	increase	amod	32	SENT_363	[p28l679t960r1080b1032],
30	GSSG-R	NN	O	gssg-r	nn	32	SENT_363	[p28l1154t960r1528b1032],
31	actiVity	NN	O	activity	nn	32	SENT_363	[p28l1598t944r2153b1053],
32	.3	NN	NUMBER	.3	agent	27	SENT_363	[p28l1598t944r2153b1053],
33	’	CD	NUMBER	’	number	34	SENT_363	[p28l1598t944r2153b1053],
34	21	CD	NUMBER	21	num	35	SENT_363	[p28l1598t944r2153b1053],
35	’22	CD	NUMBER	’22	nsubjpass	19	SENT_363	[p28l1598t944r2153b1053],
36	The	DT	O	the	det	38	SENT_363	[p28l14t1076r180b1149],
37	disulﬁde	NN	O	disulﬁde	nn	38	SENT_363	[p28l211t1074r569b1149],
38	reductase	NN	O	reductase	nsubj	39	SENT_363	[p28l598t1076r1004b1149],
39	depends	VBZ	O	depend	dep	35	SENT_363	[p28l1035t1073r1386b1169],
40	in	IN	O	in	_	0	SENT_363	[p28l1415t1076r1493b1146],
41	turn	NN	O	turn	prep_in	39	SENT_363	[p28l1522t1085r1699b1149],
42	on	IN	O	on	_	0	SENT_363	[p28l1730t1097r1833b1149],
43	G6PD	NN	O	g6pd	prep_on	41	SENT_363	[p28l1865t1076r2148b1162],
44	,	,	O	,	_	0	SENT_363	[p28l1865t1076r2148b1162],
45	which	WDT	O	which	dobj	47	SENT_363	[p28l12t1191r260b1266],
46	it	PRP	O	it	nsubj	47	SENT_363	[p28l361t1191r418b1265],
47	stimulates	VBZ	O	stimulate	rcmod	43	SENT_363	[p28l519t1190r946b1266],
48	by	IN	O	by	_	0	SENT_363	[p28l1047t1191r1143b1286],
49	removing	VBG	O	remove	prepc_by	47	SENT_363	[p28l1242t1190r1639b1286],
50	inhibitory	JJ	O	inhibitory	amod	51	SENT_363	[p28l1737t1190r2153b1286],
51	NADPH	NN	O	nadph	dobj	49	SENT_363	[p28l16t1310r383b1380],
52	While	IN	O	while	mark	53	SENT_363	[p28l422t1308r647b1383],
53	providing	VBG	O	provide	dep	39	SENT_363	[p28l688t1308r1092b1403],
54	NADP	NNP	O	NADP	dobj	53	SENT_363	[p28l1135t1310r1444b1380],
55	.	.	O	.	_	0	SENT_363	[p28l1135t1310r1444b1380],

1	Thus	RB	O	thus	advmod	15	SENT_364	[p28l1489t1308r1697b1383],
2	doxorubicin	NN	O	doxorubicin	nsubj	15	SENT_364	[p28l1742t1308r2151b1383, p28l16t1426r138b1501],
3	that	WDT	O	that	nsubj	4	SENT_364	[p28l178t1425r344b1501],
4	produces	VBZ	O	produce	rcmod	2	SENT_364	[p28l380t1425r766b1524],
5	more	JJR	O	more	amod	6	SENT_364	[p28l806t1449r1023b1501],
6	semiquinone	NN	O	semiquinone	dobj	4	SENT_364	[p28l1063t1425r1629b1525],
7	,	,	O	,	_	0	SENT_364	[p28l1063t1425r1629b1525],
8	Fe	NNP	O	Fe	nn	11	SENT_364	[p28l1672t1425r1956b1525],
9	(	NNP	O	(	nn	11	SENT_364	[p28l1672t1425r1956b1525],
10	II	NNP	O	II	nn	11	SENT_364	[p28l1672t1425r1956b1525],
11	)	NN	O	)	dobj	4	SENT_364	[p28l1672t1425r1956b1525],
12	,	,	O	,	_	0	SENT_364	[p28l1672t1425r1956b1525],
13	and	CC	O	and	_	0	SENT_364	[p28l2001t1428r2153b1501],
14	peroxide	NN	O	peroxide	conj_and	6	SENT_364	[p28l14t1543r383b1642],
15	activates	VBZ	O	activate	_	0	SENT_364	[p28l431t1544r793b1619],
16	the	DT	O	the	det	17	SENT_364	[p28l839t1543r972b1619],
17	HMS	NNP	O	HMS	dobj	15	SENT_364	[p28l1015t1546r1236b1619],
18	powerfully	RB	O	powerfully	advmod	15	SENT_364	[p28l1283t1544r1736b1643],
19	in	IN	O	in	_	0	SENT_364	[p28l1777t1543r1854b1619],
20	an	DT	O	a	det	23	SENT_364	[p28l1899t1569r1995b1619],
21	indirect	JJ	O	indirect	amod	23	SENT_364	[p28l2041t1544r2151b1619, p28l16t1662r258b1734],
22	BCNU-sensitive	JJ	MISC	bcnu-sensitive	amod	23	SENT_364	[p28l292t1662r981b1734],
23	manner	NN	O	manner	prep_in	15	SENT_364	[p28l1015t1685r1361b1734],
24	.	.	O	.	_	0	SENT_364	[p28l1015t1685r1361b1734],

1	Daunorubicin	NNP	O	Daunorubicin	nsubj	16	SENT_365	[p28l1399t1661r2012b1750],
2	,	,	O	,	_	0	SENT_365	[p28l1399t1661r2012b1750],
3	on	IN	O	on	_	0	SENT_365	[p28l2048t1685r2153b1734],
4	the	DT	O	the	det	6	SENT_365	[p28l16t1778r147b1850],
5	other	JJ	O	other	amod	6	SENT_365	[p28l199t1777r425b1853],
6	hand	NN	O	hand	prep_on	1	SENT_365	[p28l475t1778r708b1866],
7	,	,	O	,	_	0	SENT_365	[p28l475t1778r708b1866],
8	being	VBG	O	be	cop	11	SENT_365	[p28l758t1778r990b1873],
9	an	DT	O	a	det	11	SENT_365	[p28l1042t1801r1141b1850],
10	effective	JJ	O	effective	amod	11	SENT_365	[p28l1191t1777r1544b1853],
11	substrate	NN	O	substrate	partmod	16	SENT_365	[p28l1596t1780r1979b1853],
12	for	IN	O	for	_	0	SENT_365	[p28l2029t1780r2153b1852],
13	carbonyl	NN	O	carbonyl	nn	14	SENT_365	[p28l16t1894r376b1990],
14	reductase	NN	O	reductase	prep_for	11	SENT_365	[p28l422t1895r854b1983],
15	,	,	O	,	_	0	SENT_365	[p28l422t1895r854b1983],
16	stimulates	VBZ	O	stimulate	_	0	SENT_365	[p28l899t1894r1328b1967],
17	the	DT	O	the	det	27	SENT_365	[p28l1371t1894r1502b1967],
18	HMS	NNP	O	HMS	nn	27	SENT_365	[p28l1547t1897r1768b1970],
19	strongly	RB	O	strongly	advmod	25	SENT_365	[p28l1814t1897r2153b1990],
20	with	IN	O	with	_	0	SENT_365	[p28l12t2014r193b2087],
21	a	DT	O	a	det	24	SENT_365	[p28l246t2037r288b2087],
22	direct	JJ	O	direct	amod	24	SENT_365	[p28l338t2014r582b2087],
23	BCNU	NN	O	bcnu	nn	24	SENT_365	[p28l630t2014r1405b2087],
24	—	NN	O	—	prep_with	19	SENT_365	[p28l630t2014r1405b2087],
25	insensitive	JJ	O	insensitive	amod	27	SENT_365	[p28l630t2014r1405b2087],
26	component	NN	O	component	nn	27	SENT_365	[p28l1455t2026r1931b2111],
27	(	NN	O	(	nsubj	28	SENT_365	[p28l1983t2012r2151b2110],
28	see	VBP	O	see	ccomp	16	SENT_365	[p28l1983t2012r2151b2110],
29	Introduction	NN	O	introduction	nn	30	SENT_365	[p28l16t2131r615b2230],
30	)	NN	O	)	dobj	28	SENT_365	[p28l16t2131r615b2230],
31	.	.	O	.	_	0	SENT_365	[p28l16t2131r615b2230],

1	Thus	RB	O	thus	advmod	4	SENT_366	[p28l665t2133r874b2206],
2	daunorubicin	NN	O	daunorubicin	nsubj	4	SENT_366	[p28l922t2133r1486b2206],
3	resembles	VBZ	O	resemble	cop	4	SENT_366	[p28l1533t2133r1954b2206],
4	primaquine	NN	O	primaquine	conj_and	4	SENT_366	[p28l1999t2133r2148b2229, p28l14t2248r381b2343],
5	rather	RB	O	rather	advmod	4	SENT_366	[p28l415t2248r675b2320],
6	than	IN	O	than	_	0	SENT_366	[p28l707t2247r893b2320],
7	doxorubicin	NN	O	doxorubicin	prep_than	4	SENT_366	[p28l927t2247r1430b2323],
8	in	IN	O	in	_	0	SENT_366	[p28l1464t2248r1541b2320],
9	its	PRP$	O	its	poss	11	SENT_366	[p28l1575t2248r1669b2323],
10	dual	JJ	O	dual	amod	11	SENT_366	[p28l1703t2250r1884b2323],
11	mode	NN	O	mode	prep_in	7	SENT_366	[p28l1916t2247r2148b2323],
12	of	IN	O	of	_	0	SENT_366	[p28l16t2365r103b2437],
13	consuming	JJ	O	consuming	amod	14	SENT_366	[p28l132t2365r587b2460],
14	NADPH	NN	ORGANIZATION	nadph	prep_of	11	SENT_366	[p28l621t2367r990b2437],
15	as	RB	O	as	_	0	SENT_366	[p28l1026t2388r1106b2437],
16	well	RB	O	well	_	0	SENT_366	[p28l1137t2364r1310b2437],
17	as	IN	O	as	_	0	SENT_366	[p28l1346t2388r1426b2437],
18	in	IN	O	in	_	0	SENT_366	[p28l1462t2365r1541b2437],
19	its	PRP$	O	its	poss	20	SENT_366	[p28l1575t2365r1669b2437],
20	propensity	NN	O	propensity	prep_in	4	SENT_366	[p28l1703t2365r2153b2460],
21	to	TO	O	to	aux	22	SENT_366	[p28l14t2494r96b2558],
22	damage	VB	O	damage	xcomp	4	SENT_366	[p28l181t2485r506b2579],
23	erythrocytes	NNS	O	erythrocyte	dobj	22	SENT_366	[p28l593t2483r1134b2579],
24	.	.	O	.	_	0	SENT_366	[p28l593t2483r1134b2579],

1	Consequently	RB	O	consequently	advmod	15	SENT_367	[p28l1223t2485r1806b2582],
2	G6PD	NN	O	g6pd	nn	3	SENT_367	[p28l1888t2485r2148b2558],
3	deﬁciency	NN	O	deﬁciency	nsubj	15	SENT_367	[p28l16t2600r457b2697],
4	,	,	O	,	_	0	SENT_367	[p28l16t2600r457b2697],
5	which	WDT	O	which	nsubj	7	SENT_367	[p28l507t2601r756b2674],
6	is	VBZ	O	be	cop	7	SENT_367	[p28l809t2600r867b2676],
7	responsible	JJ	O	responsible	rcmod	3	SENT_367	[p28l920t2601r1402b2697],
8	for	IN	O	for	_	0	SENT_367	[p28l1455t2603r1579b2676],
9	primaquinesensitivity	NN	O	primaquinesensitivity	prep_for	7	SENT_367	[p28l1626t2601r2148b2699, p28l14t2718r434b2814],
10	in	IN	O	in	_	0	SENT_367	[p28l470t2718r548b2790],
11	erythrocytes	NNS	O	erythrocyte	prep_in	9	SENT_367	[p28l588t2718r1127b2813],
12	,	,	O	,	_	0	SENT_367	[p28l588t2718r1127b2813],
13	may	MD	O	may	aux	15	SENT_367	[p28l1168t2741r1342b2813],
14	also	RB	O	also	advmod	15	SENT_367	[p28l1378t2718r1541b2790],
15	inﬂuence	VB	O	inﬂuence	_	0	SENT_367	[p28l1580t2717r1965b2793],
16	differentially	RB	O	differentially	advmod	15	SENT_367	[p28l2006t2718r2148b2790, p28l14t2834r450b2931],
17	how	WRB	O	how	advmod	20	SENT_367	[p28l487t2835r659b2907],
18	these	DT	O	these	det	19	SENT_367	[p28l695t2835r916b2910],
19	cells	NNS	O	cell	nsubj	20	SENT_367	[p28l957t2835r1138b2907],
20	interact	VBP	O	interact	ccomp	15	SENT_367	[p28l1179t2835r1504b2907],
21	with	IN	O	with	_	0	SENT_367	[p28l1538t2834r1722b2910],
22	daunorubicin	NN	O	daunorubicin	prep_with	20	SENT_367	[p28l1763t2834r2148b2910, p28l12t2953r240b3042],
23	,	,	O	,	_	0	SENT_367	[p28l1763t2834r2148b2910, p28l12t2953r240b3042],
24	idarubicin	NN	O	idarubicin	conj_and	22	SENT_367	[p28l273t2952r726b3042],
25	,	,	O	,	_	0	SENT_367	[p28l273t2952r726b3042],
26	and	CC	O	and	_	0	SENT_367	[p28l762t2953r911b3026],
27	other	JJ	O	other	amod	29	SENT_367	[p28l943t2953r1169b3028],
28	quinone	NN	O	quinone	nn	29	SENT_367	[p28l1200t2953r1544b3051],
29	substrates	NNS	O	substrate	conj_and	22	SENT_367	[p28l1575t2955r1995b3028],
30	for	IN	O	for	_	0	SENT_367	[p28l2027t2952r2151b3028],
31	carbonyl	NN	O	carbonyl	nn	32	SENT_367	[p28l14t3070r376b3165],
32	reductase	NN	O	reductase	prep_for	29	SENT_367	[p28l415t3070r844b3145],
33	.	.	O	.	_	0	SENT_367	[p28l415t3070r844b3145],

1	These	DT	O	these	det	2	SENT_368	[p28l109t3187r360b3259],
2	studies	NNS	O	study	nsubj	8	SENT_368	[p28l389t3187r680b3259],
3	and	CC	O	and	_	0	SENT_368	[p28l711t3187r863b3259],
4	the	DT	O	the	det	6	SENT_368	[p28l890t3186r1023b3259],
5	preceding	VBG	O	precede	amod	6	SENT_368	[p28l1049t3186r1470b3283],
6	discussion	NN	O	discussion	conj_and	2	SENT_368	[p28l1499t3186r1928b3262],
7	have	VBP	O	have	aux	8	SENT_368	[p28l1955t3187r2148b3262],
8	dealt	VBN	O	deal	_	0	SENT_368	[p28l14t3304r224b3376],
9	primarily	RB	O	primarily	advmod	8	SENT_368	[p28l255t3304r645b3399],
10	with	IN	O	with	_	0	SENT_368	[p28l672t3303r854b3376],
11	the	DT	O	the	det	12	SENT_368	[p28l887t3304r1018b3376],
12	effect	NN	O	effect	prep_with	8	SENT_368	[p28l1054t3303r1282b3376],
13	of	IN	O	of	_	0	SENT_368	[p28l1316t3304r1403b3376],
14	G6PD	NN	O	g6pd	nn	15	SENT_368	[p28l1432t3306r1694b3379],
15	deﬁciency	NN	O	deﬁciency	prep_of	12	SENT_368	[p28l1730t3304r2151b3399],
16	on	IN	O	on	_	0	SENT_368	[p29l14t42r117b91],
17	anthracycline	NN	O	anthracycline	nn	18	SENT_368	[p29l167t19r735b112],
18	metabolism	NN	O	metabolism	prep_on	15	SENT_368	[p29l783t18r1275b92],
19	by	IN	O	by	_	0	SENT_368	[p29l1323t19r1419b112],
20	carbonyl	NN	O	carbonyl	nn	21	SENT_368	[p29l1466t18r1829b113],
21	reductase	NN	O	reductase	prep_by	8	SENT_368	[p29l1879t18r2146b91, p29l12t145r200b206],
22	.	.	O	.	_	0	SENT_368	[p29l1879t18r2146b91, p29l12t145r200b206],

1	Nonetheless	RB	O	nonetheless	advmod	4	SENT_369	[p29l236t133r779b222],
2	,	,	O	,	_	0	SENT_369	[p29l236t133r779b222],
3	we	PRP	O	we	nsubj	4	SENT_369	[p29l811t157r925b206],
4	found	VBD	O	find	_	0	SENT_369	[p29l957t134r1203b208],
5	that	IN	O	that	complm	9	SENT_369	[p29l1235t136r1402b209],
6	drug	NN	O	drug	nn	7	SENT_369	[p29l1434t136r1625b229],
7	metabolism	NN	O	metabolism	nsubjpass	9	SENT_369	[p29l1656t134r2148b209],
8	was	VBD	O	be	auxpass	9	SENT_369	[p29l7t274r161b323],
9	limited	VBN	O	limit	ccomp	4	SENT_369	[p29l222t251r522b323],
10	by	IN	O	by	_	0	SENT_369	[p29l581t251r680b346],
11	the	DT	O	the	det	13	SENT_369	[p29l737t251r870b323],
12	HMS	NNP	O	HMS	nn	13	SENT_369	[p29l931t251r1152b325],
13	dehydrogenases	NNS	O	dehydrogenase	agent	9	SENT_369	[p29l1216t250r1891b346],
14	even	RB	O	even	advmod	9	SENT_369	[p29l1955t274r2148b326],
15	without	IN	O	without	_	0	SENT_369	[p29l7t368r332b441],
16	G6PD	NN	O	g6pd	nn	17	SENT_369	[p29l389t368r650b440],
17	deﬁciency	NN	O	deﬁciency	prep_without	9	SENT_369	[p29l709t367r1148b461],
18	.	.	O	.	_	0	SENT_369	[p29l709t367r1148b461],

1	Further	RB	O	further	advmod	5	SENT_370	[p29l1207t368r1558b456],
2	,	,	O	,	_	0	SENT_370	[p29l1207t368r1558b456],
3	carbonyl	NN	O	carbonyl	nn	4	SENT_370	[p29l1615t367r1977b463],
4	reductase	NN	O	reductase	nsubj	5	SENT_370	[p29l2031t391r2146b440, p29l14t484r330b558],
5	metabolizes	VBZ	O	metabolize	dep	53	SENT_370	[p29l375t483r879b558],
6	substances	NNS	O	substance	npadvmod	7	SENT_370	[p29l924t486r1372b559],
7	other	JJ	O	other	advmod	13	SENT_370	[p29l1418t486r1643b559],
8	than	IN	O	than	_	0	SENT_370	[p29l1686t486r1873b559],
9	xenobiotics	NNS	O	xenobiotic	prep_than	7	SENT_370	[p29l1911t509r2146b559, p29l9t584r488b690],
10	,1	CD	NUMBER	,1	number	11	SENT_370	[p29l1911t509r2146b559, p29l9t584r488b690],
11	°	CD	NUMBER	°	num	13	SENT_370	[p29l1911t509r2146b559, p29l9t584r488b690],
12	”	CD	NUMBER	”	number	13	SENT_370	[p29l1911t509r2146b559, p29l9t584r488b690],
13	13	CD	NUMBER	13	dobj	5	SENT_370	[p29l1911t509r2146b559, p29l9t584r488b690],
14	including	VBG	O	include	_	0	SENT_370	[p29l521t601r914b694],
15	9-keto	JJ	O	9-keto	amod	16	SENT_370	[p29l950t601r1215b676],
16	prostaglandins	NNS	O	prostaglandin	prep_including	13	SENT_370	[p29l1249t584r1972b697],
17	,49	CD	NUMBER	,49	num	19	SENT_370	[p29l1249t584r1972b697],
18	C21	NN	O	c21	nn	19	SENT_370	[p29l2008t603r2144b697],
19	steroids	NNS	O	steroid	dep	16	SENT_370	[p29l12t720r342b793],
20	of	IN	O	of	_	0	SENT_370	[p29l382t720r471b793],
21	the	DT	O	the	det	23	SENT_370	[p29l507t720r638b793],
22	progesterone	NN	O	progesterone	nn	23	SENT_370	[p29l679t729r1238b813],
23	family	NN	O	family	prep_of	19	SENT_370	[p29l1281t702r1643b813],
24	,	,	O	,	_	0	SENT_370	[p29l1281t702r1643b813],
25	”	JJ	O	”	amod	27	SENT_370	[p29l1281t702r1643b813],
26	cellular	JJ	O	cellular	amod	27	SENT_370	[p29l1684t720r2000b793],
27	alky1glyoxals	NNS	O	alky1glyoxal	appos	13	SENT_370	[p29l2043t720r2146b793, p29l12t818r569b931],
28	,5	CD	NUMBER	,5	num	29	SENT_370	[p29l2043t720r2146b793, p29l12t818r569b931],
29	°	NN	O	°	dep	27	SENT_370	[p29l2043t720r2146b793, p29l12t818r569b931],
30	and	CC	O	and	_	0	SENT_370	[p29l637t835r789b907],
31	naturally	RB	O	naturally	advmod	32	SENT_370	[p29l853t835r1231b930],
32	occurring	VBG	O	occur	conj_and	29	SENT_370	[p29l1295t835r1699b930],
33	quinones	NNS	O	quinone	dobj	32	SENT_370	[p29l1765t835r2146b930],
34	with	IN	O	with	_	0	SENT_370	[p29l7t952r189b1025],
35	the	DT	O	the	det	36	SENT_370	[p29l225t952r356b1024],
36	potential	NN	O	potential	prep_with	33	SENT_370	[p29l392t952r772b1047],
37	of	IN	O	of	_	0	SENT_370	[p29l811t952r898b1024],
38	generating	VBG	O	generate	amod	43	SENT_370	[p29l927t952r1379b1048],
39	reactive	JJ	O	reactive	amod	43	SENT_370	[p29l1415t952r1748b1024],
40	semiqui	NN	O	semiquus	nn	43	SENT_370	[p29l1786t952r2146b1047],
41	—	NN	O	—	nn	43	SENT_370	[p29l1786t952r2146b1047],
42	none	NN	O	none	nn	43	SENT_370	[p29l12t1092r219b1143],
43	radicals	NNS	O	radical	prep_of	36	SENT_370	[p29l292t1070r617b1143],
44	as	RB	O	as	_	0	SENT_370	[p29l693t1092r772b1143],
45	well	RB	O	well	_	0	SENT_370	[p29l841t1071r1013b1143],
46	as	IN	O	as	_	0	SENT_370	[p29l1089t1094r1166b1143],
47	detoxiﬁed	JJ	O	detoxiﬁed	amod	48	SENT_370	[p29l1242t1070r1662b1143],
48	hydroquinones	NNS	O	hydroquinone	conj_and	13	SENT_370	[p29l1733t1071r2146b1165, p29l12t1170r457b1259],
49	.11	CD	NUMBER	.11	number	50	SENT_370	[p29l1733t1071r2146b1165, p29l12t1170r457b1259],
50	'13	CD	NUMBER	'13	dep	48	SENT_370	[p29l1733t1071r2146b1165, p29l12t1170r457b1259],
51	Our	PRP$	O	we	poss	52	SENT_370	[p29l519t1187r687b1259],
52	observations	NNS	O	observation	nsubj	53	SENT_370	[p29l744t1187r1277b1259],
53	suggest	VBP	O	suggest	_	0	SENT_370	[p29l1337t1199r1643b1281],
54	that	IN	O	that	complm	66	SENT_370	[p29l1703t1187r1868b1259],
55	these	DT	O	these	det	59	SENT_370	[p29l1925t1187r2146b1259],
56	seemingly	RB	O	seemingly	advmod	57	SENT_370	[p29l12t1303r430b1396],
57	unrelated	JJ	O	unrelated	amod	59	SENT_370	[p29l480t1305r888b1375],
58	non-xenobiotic	JJ	O	non-xenobiotic	amod	59	SENT_370	[p29l938t1305r1576b1375],
59	reactions	NNS	O	reaction	nsubjpass	78	SENT_370	[p29l1626t1305r2012b1375],
60	of	IN	O	of	_	0	SENT_370	[p29l2064t1305r2153b1375],
61	uncertain	JJ	O	uncertain	amod	63	SENT_370	[p29l9t1422r413b1492],
62	physiologic	JJ	O	physiologic	amod	63	SENT_370	[p29l456t1422r932b1515],
63	signiﬁcance	NN	O	signiﬁcance	prep_of	59	SENT_370	[p29l978t1422r1467b1516],
64	may	MD	O	may	aux	66	SENT_370	[p29l1513t1445r1687b1516],
65	be	VB	O	be	auxpass	66	SENT_370	[p29l1728t1422r1826b1492],
66	modulated	VBN	O	modulate	ccomp	53	SENT_370	[p29l1872t1422r2144b1492, p29l9t1539r219b1609],
67	by	IN	O	by	_	0	SENT_370	[p29l257t1539r353b1632],
68	an	DT	O	a	det	70	SENT_370	[p29l392t1560r490b1609],
69	enhanced	VBN	O	enhance	amod	70	SENT_370	[p29l531t1539r935b1609],
70	ﬂux	NN	O	ﬂux	agent	66	SENT_370	[p29l973t1539r1127b1611],
71	of	IN	O	of	_	0	SENT_370	[p29l1165t1539r1252b1611],
72	glucose	NN	O	glucose	prep_of	70	SENT_370	[p29l1286t1538r1599b1632],
73	through	IN	O	through	_	0	SENT_370	[p29l1640t1539r1974b1632],
74	the	DT	O	the	det	75	SENT_370	[p29l2013t1539r2144b1609],
75	HMS	NNP	O	HMS	prep_through	72	SENT_370	[p29l9t1655r230b1728],
76	and	CC	O	and	_	0	SENT_370	[p29l276t1656r427b1728],
77	be	VB	O	be	auxpass	78	SENT_370	[p29l466t1656r564b1728],
78	altered	VBN	O	alter	ccomp	53	SENT_370	[p29l609t1656r904b1728],
79	in	IN	O	in	_	0	SENT_370	[p29l947t1656r1025b1726],
80	persons	NNS	O	person	prep_in	78	SENT_370	[p29l1063t1679r1389b1749],
81	with	IN	O	with	_	0	SENT_370	[p29l1427t1656r1611b1729],
82	G6PD	NN	O	g6pd	nn	83	SENT_370	[p29l1654t1656r1912b1728],
83	deﬁciency	NN	O	deﬁciency	prep_with	80	SENT_370	[p29l1957t1656r2141b1729, p29l12t1773r291b1866],
84	.	.	O	.	_	0	SENT_370	[p29l1957t1656r2141b1729, p29l12t1773r291b1866],

1	The	DT	O	the	det	3	SENT_371	[p29l104t1889r263b1960],
2	present	JJ	DATE	present	amod	3	SENT_371	[p29l285t1901r578b1983],
3	studies	NNS	O	study	nsubj	5	SENT_371	[p29l602t1890r870b1962],
4	have	VBP	O	have	aux	5	SENT_371	[p29l894t1890r1076b1962],
5	shown	VBN	O	show	_	0	SENT_371	[p29l1103t1890r1349b1963],
6	that	IN	O	that	complm	10	SENT_371	[p29l1374t1890r1528b1962],
7	HMS	NNP	O	HMS	nn	9	SENT_371	[p29l1552t1890r1764b1963],
8	dehydrogenase	NN	O	dehydrogenase	nn	9	SENT_371	[p29l1793t1889r2141b1983, p29l9t2028r274b2098],
9	activity	NN	O	activity	nsubj	10	SENT_371	[p29l299t2007r576b2100],
10	controls	VBZ	O	control	ccomp	5	SENT_371	[p29l595t2006r909b2080],
11	carbonyl	NN	O	carbonyl	nn	12	SENT_371	[p29l931t2006r1266b2100],
12	reductase	NN	O	reductase	dobj	10	SENT_371	[p29l1288t2007r1715b2079],
13	-	:	O	-	_	0	SENT_371	[p29l1288t2007r1715b2079],
14	dependent	JJ	O	dependent	amod	15	SENT_371	[p29l1726t2007r2141b2100],
15	biotransformation	NN	O	biotransformation	dep	12	SENT_371	[p29l7t2126r738b2197],
16	.	.	O	.	_	0	SENT_371	[p29l7t2126r738b2197],

1	New	JJ	O	new	amod	2	SENT_372	[p29l792t2129r974b2197],
2	issues	NNS	O	issue	nsubj	3	SENT_372	[p29l1024t2126r1247b2198],
3	arise	VBP	O	arise	_	0	SENT_372	[p29l1299t2126r1481b2197],
4	concerning	VBG	O	concern	xcomp	3	SENT_372	[p29l1536t2127r1968b2218],
5	the	DT	O	the	det	7	SENT_372	[p29l2018t2127r2141b2197],
6	possible	JJ	O	possible	amod	7	SENT_372	[p29l7t2240r321b2333],
7	effects	NNS	O	effect	dobj	4	SENT_372	[p29l361t2242r606b2312],
8	of	IN	O	of	_	0	SENT_372	[p29l646t2242r731b2312],
9	G6PD	NN	O	g6pd	nn	10	SENT_372	[p29l767t2242r1016b2312],
10	deﬁciency	NN	O	deﬁciency	prep_of	7	SENT_372	[p29l1059t2240r1451b2333],
11	on	IN	O	on	_	0	SENT_372	[p29l1487t2265r1585b2312],
12	the	DT	O	the	det	16	SENT_372	[p29l1626t2242r1750b2312],
13	oncolytic	JJ	O	oncolytic	amod	16	SENT_372	[p29l1791t2242r2141b2333],
14	and	CC	O	and	_	0	SENT_372	[p29l12t2358r154b2431],
15	toxic	JJ	O	toxic	conj_and	13	SENT_372	[p29l179t2358r363b2431],
16	properties	NNS	O	property	prep_on	4	SENT_372	[p29l385t2359r786b2452],
17	of	IN	O	of	_	0	SENT_372	[p29l811t2359r893b2432],
18	anthracyclines	NNS	O	anthracycline	prep_of	16	SENT_372	[p29l915t2358r1472b2453],
19	that	WDT	O	that	nsubj	25	SENT_372	[p29l1494t2358r1650b2431],
20	are	VBP	O	be	cop	25	SENT_372	[p29l1675t2382r1798b2431],
21	eﬁective	JJ	O	eﬁective	amod	25	SENT_372	[p29l1821t2359r2144b2431],
22	J	NN	O	j	nn	25	SENT_372	[p29l7t2468r38b2528],
23	Lob	NN	O	lob	nn	25	SENT_372	[p29l76t2466r208b2529],
24	Clin	NNP	O	Clin	nn	25	SENT_372	[p29l237t2466r371b2528],
25	Med	NNP	O	Med	rcmod	18	SENT_372	[p29l404t2466r568b2528],
26	Volume	NN	O	volume	dep	25	SENT_372	[p29l9t2564r293b2627],
27	127	CD	NUMBER	127	num	26	SENT_372	[p29l331t2564r463b2631],
28	,	,	O	,	_	0	SENT_372	[p29l331t2564r463b2631],
29	Number	NNP	O	Number	appos	26	SENT_372	[p29l501t2564r796b2627],
30	6	CD	NUMBER	6	num	29	SENT_372	[p29l822t2566r862b2627],

1	substrates	NNS	O	substrate	nsubj	9	SENT_373	[p29l12t2805r396b2879],
2	for	IN	O	for	_	0	SENT_373	[p29l430t2805r545b2879],
3	carbonyl	NN	O	carbonyl	nn	4	SENT_373	[p29l579t2805r910b2899],
4	reductase	NN	O	reductase	prep_for	1	SENT_373	[p29l944t2807r1319b2881],
5	and	CC	O	and	_	0	SENT_373	[p29l1355t2807r1498b2879],
6	on	IN	O	on	_	0	SENT_373	[p29l1532t2830r1632b2881],
7	nonxenobiotic	JJ	O	nonxenobiotic	amod	8	SENT_373	[p29l1665t2807r2132b2881, p29l12t2920r155b2994],
8	reactions	NNS	O	reaction	prep_on	1	SENT_373	[p29l186t2920r539b2997],
9	catalyzed	VBN	O	catalyze	_	0	SENT_373	[p29l570t2922r929b3017],
10	by	IN	O	by	_	0	SENT_373	[p29l960t2924r1051b3017],
11	this	DT	O	this	det	12	SENT_373	[p29l1082t2922r1216b2997],
12	enzyme	NN	O	enzyme	prep_by	9	SENT_373	[p29l1252t2945r1565b3018],
13	.	.	O	.	_	0	SENT_373	[p29l1252t2945r1565b3018],

1	REFERENCES	NNS	O	reference	_	0	SENT_374	[p29l16t3190r398b3245],

1	1	LS	NUMBER	1	_	0	SENT_375	[p29l60t3323r105b3379],
2	.	.	O	.	_	0	SENT_375	[p29l60t3323r105b3379],

1	Hohl	NNP	PERSON	Hohl	nn	2	SENT_376	[p29l150t3321r313b3379],
2	RJ	NN	PERSON	rj	_	0	SENT_376	[p29l347t3321r454b3388],
3	,	,	O	,	_	0	SENT_376	[p29l347t3321r454b3388],
4	Kennedy	NNP	PERSON	Kennedy	nn	5	SENT_376	[p29l487t3320r777b3395],
5	EJ	NNP	PERSON	EJ	appos	2	SENT_376	[p29l806t3321r908b3391],
6	,	,	O	,	_	0	SENT_376	[p29l806t3321r908b3391],
7	Frischer	NNP	PERSON	Frischer	nn	9	SENT_376	[p29l942t3320r1209b3379],
8	H.	NNP	O	H.	nn	9	SENT_376	[p29l1240t3323r1317b3379],
9	Defenses	NNP	O	Defenses	appos	2	SENT_376	[p29l1350t3320r1648b3379],
10	against	IN	O	against	_	0	SENT_376	[p29l1681t3323r1900b3395],
11	oxidation	NN	O	oxidation	prep_against	9	SENT_376	[p29l1938t3321r2135b3379, p29l152t3416r277b3474],
12	in	IN	O	in	_	0	SENT_376	[p29l306t3416r364b3476],
13	human	JJ	O	human	amod	14	SENT_376	[p29l393t3416r616b3474],
14	erythrocytes	NNS	O	erythrocyte	prep_in	11	SENT_376	[p29l648t3415r1060b3492],
15	:	:	O	:	_	0	SENT_376	[p29l648t3415r1060b3492],
16	role	NN	O	role	dep	2	SENT_376	[p29l1093t3416r1218b3474],
17	of	IN	O	of	_	0	SENT_376	[p29l1247t3416r1317b3476],
18	glutathione	NN	O	glutathione	nn	19	SENT_376	[p29l1339t3416r1707b3490],
19	reductase	NN	O	reductase	prep_of	16	SENT_376	[p29l1736t3418r2047b3476],
20	in	IN	O	in	_	0	SENT_376	[p29l2076t3418r2134b3476],
21	the	DT	O	the	det	22	SENT_376	[p29l150t3513r249b3569],
22	activation	NN	O	activation	prep_in	19	SENT_376	[p29l276t3511r591b3572],
23	of	IN	O	of	_	0	SENT_376	[p29l616t3513r683b3571],
24	glucose	NN	O	glucose	nn	25	SENT_376	[p29l703t3510r943b3588],
25	decarboxylation	NN	O	decarboxylation	prep_of	22	SENT_376	[p29l967t3513r1482b3587],
26	by	IN	O	by	_	0	SENT_376	[p29l1504t3513r1579b3587],
27	hemolytic	JJ	O	hemolytic	prep_by	25	SENT_376	[p29l1601t3513r1916b3587],
28	:	:	O	:	_	0	SENT_376	[p29l1601t3513r1916b3587],
29	drugs	NNS	O	drug	dep	16	SENT_376	[p29l1941t3511r2132b3587],
30	.	.	O	.	_	0	SENT_376	[p29l1941t3511r2132b3587],

1	J	NN	O	j	nn	4	SENT_377	[p29l147t3608r180b3664],
2	Lab	NN	O	lab	nn	4	SENT_377	[p29l209t3608r332b3664],
3	Clin	NNP	O	Clin	nn	4	SENT_377	[p29l363t3605r495b3664],
4	Med	NNP	O	Med	_	0	SENT_377	[p29l524t3608r674b3664],
5	1991	CD	DATE	1991	num	4	SENT_377	[p29l707t3606r1241b3675],
6	;	:	O	;	_	0	SENT_377	[p29l707t3606r1241b3675],
7	117:325	CD	NUMBER	117:325	number	8	SENT_377	[p29l707t3606r1241b3675],
8	-31	CD	NUMBER	-31	dep	4	SENT_377	[p29l707t3606r1241b3675],
9	.	.	O	.	_	0	SENT_377	[p29l707t3606r1241b3675],

1	.	.	O	.	_	0	SENT_378	[p30l97t68r107b78],

1	Frischer	NN	PERSON	frischer	nn	2	SENT_379	[p30l150t22r417b80],
2	H	NN	O	h	_	0	SENT_379	[p30l439t22r518b89],
3	,	,	O	,	_	0	SENT_379	[p30l439t22r518b89],
4	Ahmad	NNP	PERSON	Ahmad	nn	5	SENT_379	[p30l542t20r784b80],
5	T.	NNP	PERSON	T.	appos	2	SENT_379	[p30l806t22r872b81],
6	Severe	JJ	PERSON	severe	amod	2	SENT_379	[p30l900t22r1117b80],
7	generalized	VBN	O	generalize	partmod	2	SENT_379	[p30l1139t19r1512b96],
8	glutathione	NN	O	glutathione	nn	10	SENT_379	[p30l1539t22r1903b96],
9	reductase	NN	O	reductase	nn	10	SENT_379	[p30l1931t22r2137b78, p30l152t123r277b172],
10	deﬁciency	NN	O	deﬁciency	dobj	7	SENT_379	[p30l317t112r642b190],
11	after	IN	O	after	_	0	SENT_379	[p30l680t114r832b172],
12	antitumor	NN	O	antitumor	nn	13	SENT_379	[p30l873t116r1195b174],
13	chemotherapy	NN	O	chemotherapy	prep_after	10	SENT_379	[p30l1233t114r1698b188],
14	with	IN	O	with	_	0	SENT_379	[p30l1732t114r1870b172],
15	BCNU	NN	O	bcnu	prep_with	7	SENT_379	[p30l1911t114r2137b172],
16	(	CD	NUMBER	(	num	19	SENT_379	[p30l154t209r1315b288],
17	1,3-bis	JJ	O	1,3-bis	amod	19	SENT_379	[p30l154t209r1315b288],
18	[	NN	O	[	nn	19	SENT_379	[p30l154t209r1315b288],
19	chloroethy1	NN	O	chloroethy1	dep	2	SENT_379	[p30l154t209r1315b288],
20	]	CD	NUMBER	]	num	21	SENT_379	[p30l154t209r1315b288],
21	-1	CD	NUMBER	-1	dep	19	SENT_379	[p30l154t209r1315b288],
22	-	:	O	-	_	0	SENT_379	[p30l154t209r1315b288],
23	nitrosourea	NN	O	nitrosourea	dep	2	SENT_379	[p30l154t209r1315b288],
24	)	NN	O	)	dep	23	SENT_379	[p30l154t209r1315b288],
25	.	.	O	.	_	0	SENT_379	[p30l154t209r1315b288],

1	J	NNP	O	J	nn	3	SENT_380	[p30l1339t212r1370b268],
2	Lab	NNP	O	Lab	nn	3	SENT_380	[p30l1394t212r1517b268],
3	Clin	NNP	O	Clin	_	0	SENT_380	[p30l1541t210r1675b270],
4	.	.	O	.	_	0	SENT_380	[p30l1541t210r1675b270],

1	Med	VBN	O	med	_	0	SENT_381	[p30l1697t212r1845b268],
2	1977	CD	DATE	1977	dobj	1	SENT_381	[p30l1872t212r2132b279],
3	;	:	O	;	_	0	SENT_381	[p30l1872t212r2132b279],
4	89	CD	NUMBER	89	num	6	SENT_381	[p30l1872t212r2132b279],
5	:	:	O	:	_	0	SENT_381	[p30l1872t212r2132b279],
6	1080-91	CD	NUMBER	1080-91	dep	2	SENT_381	[p30l154t305r419b364],
7	.	.	O	.	_	0	SENT_381	[p30l154t305r419b364],

1	.	.	O	.	_	0	SENT_382	[p30l97t449r107b459],

1	Frischer	NN	PERSON	frischer	_	0	SENT_383	[p30l152t403r419b461],
2	H	NN	O	h	dep	1	SENT_383	[p30l441t403r518b470],
3	,	,	O	,	_	0	SENT_383	[p30l441t403r518b470],
4	Ahmad	NNP	PERSON	Ahmad	nn	6	SENT_383	[p30l542t401r784b461],
5	T.	NNP	O	T.	nn	6	SENT_383	[p30l808t403r872b459],
6	Consequences	NNP	O	Consequences	appos	2	SENT_383	[p30l900t403r1363b477],
7	of	IN	O	of	_	0	SENT_383	[p30l1389t403r1457b459],
8	erythrocyte	NN	O	erythrocyte	nn	10	SENT_383	[p30l1477t403r1841b477],
9	glutathi	NN	O	glutathus	nn	10	SENT_383	[p30l1865t403r2135b477],
10	—	NN	O	—	prep_of	6	SENT_383	[p30l1865t403r2135b477],

1	one	CD	NUMBER	one	num	2	SENT_384	[p30l152t516r268b556],
2	reductase	NN	O	reductase	_	0	SENT_384	[p30l299t498r610b557],
3	deﬁciency	NN	O	deﬁciency	dep	2	SENT_384	[p30l639t496r975b573],
4	.	.	O	.	_	0	SENT_384	[p30l639t496r975b573],

1	J	NN	O	j	nn	4	SENT_385	[p30l1006t498r1039b554],
2	Lab	NN	O	lab	nn	4	SENT_385	[p30l1066t498r1188b556],
3	Clin	NNP	O	Clin	nn	4	SENT_385	[p30l1222t498r1354b556],
4	Med	NNP	O	Med	_	0	SENT_385	[p30l1383t498r1531b554],
5	1987	CD	DATE	1987	num	4	SENT_385	[p30l1564t498r2059b568],
6	;	:	O	;	_	0	SENT_385	[p30l1564t498r2059b568],
7	109:5838	CD	NUMBER	109:5838	dep	4	SENT_385	[p30l1564t498r2059b568],

1	.	.	O	.	_	0	SENT_386	[p30l97t639r109b649],

1	Frischer	NN	PERSON	frischer	nn	2	SENT_387	[p30l150t591r419b651],
2	H	NN	O	h	dep	26	SENT_387	[p30l448t593r527b662],
3	,	,	O	,	_	0	SENT_387	[p30l448t593r527b662],
4	Kennedy	NNP	PERSON	Kennedy	nn	5	SENT_387	[p30l558t591r853b667],
5	EJ	NNP	PERSON	EJ	conj_and	2	SENT_387	[p30l880t593r982b662],
6	,	,	O	,	_	0	SENT_387	[p30l880t593r982b662],
7	Chigurupati	NNP	ORGANIZATION	Chigurupati	nn	8	SENT_387	[p30l1017t590r1404b670],
8	R	NNP	ORGANIZATION	R	conj_and	2	SENT_387	[p30l1436t593r1510b662],
9	,	,	O	,	_	0	SENT_387	[p30l1436t593r1510b662],
10	Sivarajan	NNP	PERSON	Sivarajan	nn	12	SENT_387	[p30l1543t590r1841b667],
11	M.	NNP	PERSON	M.	nn	12	SENT_387	[p30l1872t591r1958b651],
12	Glutathione	NNP	PERSON	Glutathione	conj_and	2	SENT_387	[p30l1993t591r2137b649, p30l152t685r438b754],
13	,	,	O	,	_	0	SENT_387	[p30l1993t591r2137b649, p30l152t685r438b754],
14	cell	NN	O	cell	nn	15	SENT_387	[p30l476t685r584b743],
15	proliferation	NN	O	proliferation	conj_and	2	SENT_387	[p30l620t685r1048b761],
16	,	,	O	,	_	0	SENT_387	[p30l620t685r1048b761],
17	and	CC	O	and	_	0	SENT_387	[p30l1089t685r1205b743],
18	1,3	CD	NUMBER	1,3	num	19	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
19	bis	NN	O	bi	conj_and	2	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
20	‘	CD	NUMBER	‘	number	21	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
21	(	CD	NUMBER	(	num	26	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
22	2chloroethyl	NN	O	2chloroethyl	nn	26	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
23	)	NN	O	)	nn	26	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
24	1	CD	NUMBER	1	num	26	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
25	—	NN	O	—	nn	26	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
26	nitrosourea	NN	O	nitrosourea	_	0	SENT_387	[p30l1247t683r2137b762, p30l152t790r463b841],
27	in	IN	O	in	_	0	SENT_387	[p30l492t783r550b841],
28	K562	NN	O	k562	nn	29	SENT_387	[p30l579t780r750b841],
29	leukemia	NN	O	leukemia	prep_in	26	SENT_387	[p30l776t781r1090b841],
30	.	.	O	.	_	0	SENT_387	[p30l776t781r1090b841],

1	J	NNP	O	J	nn	3	SENT_388	[p30l1119t783r1152b839],
2	Clin	NNP	O	Clin	nn	3	SENT_388	[p30l1183t781r1315b841],
3	Invest	NNP	O	Invest	_	0	SENT_388	[p30l1344t780r1537b839],
4	1993	CD	DATE	1993	num	3	SENT_388	[p30l1571t780r2066b850],
5	;	:	O	;	_	0	SENT_388	[p30l1571t780r2066b850],
6	92:2761	CD	NUMBER	92:2761	number	7	SENT_388	[p30l1571t780r2066b850],
7	-7	CD	NUMBER	-7	dep	3	SENT_388	[p30l1571t780r2066b850],
8	.	.	O	.	_	0	SENT_388	[p30l1571t780r2066b850],

1	.	.	O	.	_	0	SENT_389	[p30l97t924r107b934],

1	Bachur	NNP	O	Bachur	nn	2	SENT_390	[p30l152t878r385b936],
2	NR	NNP	O	NR	_	0	SENT_390	[p30l416t878r548b937],
3	.	.	O	.	_	0	SENT_390	[p30l416t878r548b937],

1	Daunorubicinol	NNP	O	Daunorubicinol	_	0	SENT_391	[p30l583t878r1115b945],
2	,	,	O	,	_	0	SENT_391	[p30l583t878r1115b945],
3	a	DT	O	a	det	5	SENT_391	[p30l1151t896r1184b934],
4	major	JJ	O	major	amod	5	SENT_391	[p30l1215t876r1404b953],
5	metabolite	NN	O	metabolite	appos	1	SENT_391	[p30l1435t875r1783b936],
6	of	IN	O	of	_	0	SENT_391	[p30l1814t878r1882b934],
7	daunorubicin	NN	O	daunorubicin	prep_of	5	SENT_391	[p30l1915t876r2135b936, p30l154t973r396b1032],
8	:	:	O	:	_	0	SENT_391	[p30l1915t876r2135b936, p30l154t973r396b1032],
9	isolation	NN	O	isolation	dep	1	SENT_391	[p30l423t973r699b1031],
10	from	IN	O	from	_	0	SENT_391	[p30l721t973r878b1031],
11	human	JJ	O	human	amod	12	SENT_391	[p30l900t973r1124b1031],
12	urine	NN	O	urine	prep_from	9	SENT_391	[p30l1146t973r1317b1031],
13	and	CC	O	and	_	0	SENT_391	[p30l1341t973r1457b1029],
14	enzymatic	JJ	O	enzymatic	amod	15	SENT_391	[p30l1481t973r1806b1047],
15	reactions	NNS	O	reaction	conj_and	12	SENT_391	[p30l1826t970r2137b1031],
16	.	.	O	.	_	0	SENT_391	[p30l1826t970r2137b1031],

1	J	NNP	O	J	nn	4	SENT_392	[p30l152t1068r183b1124],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_392	[p30l212t1066r559b1126],
3	Exp	NNP	O	Exp	nn	4	SENT_392	[p30l588t1068r713b1142],
4	Ther	NNP	O	Ther	_	0	SENT_392	[p30l742t1066r901b1124],
5	1971	CD	DATE	1971	num	4	SENT_392	[p30l932t1066r1430b1135],
6	;	:	O	;	_	0	SENT_392	[p30l932t1066r1430b1135],
7	177:573	CD	NUMBER	177:573	number	8	SENT_392	[p30l932t1066r1430b1135],
8	-8	CD	NUMBER	-8	dep	4	SENT_392	[p30l932t1066r1430b1135],
9	.	.	O	.	_	0	SENT_392	[p30l932t1066r1430b1135],

1	.	.	O	.	_	0	SENT_393	[p30l97t1210r107b1220],

1	Bachur	NNP	O	Bachur	nn	2	SENT_394	[p30l152t1164r387b1223],
2	NR	NNP	O	NR	_	0	SENT_394	[p30l414t1164r548b1232],
3	,	,	O	,	_	0	SENT_394	[p30l414t1164r548b1232],
4	Gee	NNP	PERSON	Gee	nn	7	SENT_394	[p30l579t1164r711b1223],
5	M.	NNP	PERSON	M.	nn	7	SENT_394	[p30l740t1162r823b1220],
6	Daunorubicin	NNP	PERSON	Daunorubicin	nn	7	SENT_394	[p30l857t1162r1308b1220],
7	metabolism	NN	O	metabolism	appos	2	SENT_394	[p30l1337t1161r1712b1220],
8	by	IN	O	by	_	0	SENT_394	[p30l1739t1162r1813b1236],
9	rat	NN	O	rat	nn	11	SENT_394	[p30l1840t1178r1930b1220],
10	tissue	NN	O	tissue	nn	11	SENT_394	[p30l1957t1162r2137b1220],
11	preparations	NNS	O	preparation	prep_by	7	SENT_394	[p30l154t1259r582b1336],
12	.	.	O	.	_	0	SENT_394	[p30l154t1259r582b1336],

1	J	NNP	O	J	nn	4	SENT_395	[p30l611t1259r644b1317],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_395	[p30l673t1256r1021b1317],
3	Exp	NNP	O	Exp	nn	4	SENT_395	[p30l1050t1259r1175b1333],
4	Ther	NNP	O	Ther	_	0	SENT_395	[p30l1203t1259r1361b1317],
5	1971	CD	DATE	1971	num	4	SENT_395	[p30l1394t1256r1926b1326],
6	;	:	O	;	_	0	SENT_395	[p30l1394t1256r1926b1326],
7	177:567	CD	NUMBER	177:567	number	8	SENT_395	[p30l1394t1256r1926b1326],
8	-72	CD	NUMBER	-72	dep	4	SENT_395	[p30l1394t1256r1926b1326],
9	.	.	O	.	_	0	SENT_395	[p30l1394t1256r1926b1326],

1	.	.	O	.	_	0	SENT_396	[p30l99t1401r109b1411],

1	Bachur	NNP	O	Bachur	nn	2	SENT_397	[p30l154t1353r389b1413],
2	NR	NNP	O	NR	_	0	SENT_397	[p30l423t1353r555b1423],
3	,	,	O	,	_	0	SENT_397	[p30l423t1353r555b1423],
4	Huffman	NNP	PERSON	Huffman	nn	5	SENT_397	[p30l590t1353r878b1413],
5	DH	NNP	O	DH	appos	2	SENT_397	[p30l912t1353r1051b1411],
6	.	.	O	.	_	0	SENT_397	[p30l912t1353r1051b1411],

1	Daunorubicin	NN	O	daunorubicin	nn	2	SENT_398	[p30l1086t1350r1540b1411],
2	metabolism	NN	O	metabolism	_	0	SENT_398	[p30l1573t1353r1967b1411],
3	:	:	O	:	_	0	SENT_398	[p30l1573t1353r1967b1411],
4	estimation	NN	O	estimation	dep	2	SENT_398	[p30l2005t1353r2139b1409, p30l154t1449r380b1509],
5	of	IN	O	of	_	0	SENT_398	[p30l411t1449r479b1507],
6	daunorubicin	NN	O	daunorubicin	nn	7	SENT_398	[p30l505t1446r936b1507],
7	reductase	NN	O	reductase	prep_of	4	SENT_398	[p30l965t1447r1292b1507],
8	.	.	O	.	_	0	SENT_398	[p30l965t1447r1292b1507],

1	Br	NN	O	br	nn	3	SENT_399	[p30l1325t1449r1404b1505],
2	J	NN	O	j	nn	3	SENT_399	[p30l1433t1449r1464b1505],
3	Pharmacol	NN	O	pharmacol	_	0	SENT_399	[p30l1493t1447r1843b1507],
4	1971	CD	DATE	1971	dep	3	SENT_399	[p30l1876t1446r2135b1516],
5	;	:	O	;	_	0	SENT_399	[p30l1876t1446r2135b1516],
6	43	CD	NUMBER	43	num	8	SENT_399	[p30l1876t1446r2135b1516],
7	:	:	O	:	_	0	SENT_399	[p30l1876t1446r2135b1516],
8	828-33	CD	NUMBER	828-33	dep	3	SENT_399	[p30l156t1544r385b1603],
9	.	.	O	.	_	0	SENT_399	[p30l156t1544r385b1603],

1	.	.	O	.	_	0	SENT_400	[p30l101t1686r109b1696],

1	Loveless	JJ	O	loveless	amod	2	SENT_401	[p30l156t1640r433b1698],
2	H	NN	O	h	_	0	SENT_401	[p30l460t1640r534b1710],
3	,	,	O	,	_	0	SENT_401	[p30l460t1640r534b1710],
4	Arena	NN	PERSON	arena	nn	5	SENT_401	[p30l561t1640r766b1698],
5	E	NN	PERSON	e	appos	2	SENT_401	[p30l792t1640r860b1707],
6	,	,	O	,	_	0	SENT_401	[p30l792t1640r860b1707],
7	Felsted	NNP	ORGANIZATION	Felsted	nn	8	SENT_401	[p30l889t1638r1124b1698],
8	RL	NNP	ORGANIZATION	RL	appos	2	SENT_401	[p30l1153t1640r1273b1710],
9	,	,	O	,	_	0	SENT_401	[p30l1153t1640r1273b1710],
10	Bachur	NNP	O	Bachur	nn	11	SENT_401	[p30l1302t1638r1535b1696],
11	NR	NNP	O	NR	appos	2	SENT_401	[p30l1562t1638r1691b1696],
12	.	.	O	.	_	0	SENT_401	[p30l1562t1638r1691b1696],

1	Comparative	JJ	O	comparative	amod	3	SENT_402	[p30l1722t1638r2139b1714],
2	mammalian	JJ	O	mammalian	amod	3	SENT_402	[p30l154t1733r536b1794],
3	metabolism	NN	O	metabolism	_	0	SENT_402	[p30l584t1733r961b1791],
4	of	IN	O	of	_	0	SENT_402	[p30l1008t1731r1078b1789],
5	adriamycin	NN	O	adriamycin	prep_of	3	SENT_402	[p30l1121t1733r1478b1807],
6	and	CC	O	and	_	0	SENT_402	[p30l1527t1731r1641b1791],
7	daunorubicin	NN	O	daunorubicin	prep_of	3	SENT_402	[p30l1690t1730r2137b1791],
8	.	.	O	.	_	0	SENT_402	[p30l1690t1730r2137b1791],

1	Cancer	NNP	O	Cancer	nn	2	SENT_403	[p30l159t1830r389b1888],
2	Res	NNP	O	Res	_	0	SENT_403	[p30l416t1830r539b1888],
3	1978	CD	DATE	1978	num	2	SENT_403	[p30l572t1828r1030b1897],
4	;	:	O	;	_	0	SENT_403	[p30l572t1828r1030b1897],
5	158:593	CD	NUMBER	158:593	number	6	SENT_403	[p30l572t1828r1030b1897],
6	-8	CD	NUMBER	-8	dep	2	SENT_403	[p30l572t1828r1030b1897],
7	.	.	O	.	_	0	SENT_403	[p30l572t1828r1030b1897],

1	.	.	O	.	_	0	SENT_404	[p30l101t1973r111b1983],

1	Bachur	NNP	O	Bachur	nn	2	SENT_405	[p30l156t1927r389b1986],
2	NR	NNP	O	NR	_	0	SENT_405	[p30l416t1925r548b1983],
3	.	.	O	.	_	0	SENT_405	[p30l416t1925r548b1983],

1	Anthracycline	JJ	O	anthracycline	amod	3	SENT_406	[p30l574t1923r1032b1999],
2	antibiotic	JJ	O	antibiotic	amod	3	SENT_406	[p30l1061t1925r1365b1983],
3	pharmacology	NN	O	pharmacology	_	0	SENT_406	[p30l1390t1923r1850b1999],
4	and	CC	O	and	_	0	SENT_406	[p30l1876t1923r1992b1983],
5	metabolism	NN	O	metabolism	conj_and	3	SENT_406	[p30l2021t1941r2139b1981, p30l154t2020r447b2078],
6	.	.	O	.	_	0	SENT_406	[p30l2021t1941r2139b1981, p30l154t2020r447b2078],

1	Cancer	NNP	O	Cancer	nn	4	SENT_407	[p30l480t2020r711b2078],
2	Treat	NNP	O	Treat	nn	4	SENT_407	[p30l737t2020r918b2078],
3	Res	NNP	O	Res	nn	4	SENT_407	[p30l946t2020r1067b2078],
4	l979	NN	O	l979	_	0	SENT_407	[p30l1100t2017r1597b2089],
5	;	:	O	;	_	0	SENT_407	[p30l1100t2017r1597b2089],
6	63:817	CD	NUMBER	63:817	number	7	SENT_407	[p30l1100t2017r1597b2089],
7	—	CD	NUMBER	—	dep	4	SENT_407	[p30l1100t2017r1597b2089],
8	20	CD	NUMBER	20	dep	7	SENT_407	[p30l1100t2017r1597b2089],
9	.	.	O	.	_	0	SENT_407	[p30l1100t2017r1597b2089],

1	Felsted	NNP	O	Felsted	nn	2	SENT_408	[p30l156t2115r394b2174],
2	RL	NNP	O	RL	_	0	SENT_408	[p30l432t2115r555b2185],
3	,	,	O	,	_	0	SENT_408	[p30l432t2115r555b2185],
4	Bachur	NNP	O	Bachur	nn	5	SENT_408	[p30l595t2113r830b2174],
5	NR	NNP	O	NR	appos	2	SENT_408	[p30l868t2113r998b2171],
6	.	.	O	.	_	0	SENT_408	[p30l868t2113r998b2171],

1	Mammalian	JJ	O	mammalian	amod	2	SENT_409	[p30l1041t2111r1432b2172],
2	carbonyl	NN	O	carbonyl	_	0	SENT_409	[p30l1470t2111r1746b2188],
3	reductases	NNS	O	reductase	dep	2	SENT_409	[p30l1785t2111r2139b2169],
4	.	.	O	.	_	0	SENT_409	[p30l1785t2111r2139b2169],

1	Drug	NN	O	drug	_	0	SENT_410	[p30l156t2212r325b2286],
2	Metab	NNP	O	Metab	nn	3	SENT_410	[p30l354t2210r562b2268],
3	Rev	NN	O	rev	dep	1	SENT_410	[p30l593t2212r722b2268],
4	1980	CD	DATE	1980	num	3	SENT_410	[p30l753t2207r1175b2279],
5	;	:	O	;	_	0	SENT_410	[p30l753t2207r1175b2279],
6	11:1	CD	NUMBER	11:1	number	7	SENT_410	[p30l753t2207r1175b2279],
7	—	CD	NUMBER	—	dep	1	SENT_410	[p30l753t2207r1175b2279],
8	60	CD	NUMBER	60	dep	7	SENT_410	[p30l753t2207r1175b2279],
9	.	.	O	.	_	0	SENT_410	[p30l753t2207r1175b2279],

1	Wermuth	NNP	PERSON	Wermuth	nn	2	SENT_411	[p30l156t2305r467b2363],
2	B	NNP	O	B	_	0	SENT_411	[p30l496t2305r562b2374],
3	,	,	O	,	_	0	SENT_411	[p30l496t2305r562b2374],
4	Bohren	NNP	PERSON	Bohren	nn	5	SENT_411	[p30l595t2305r837b2363],
5	KM	NNP	O	KM	appos	2	SENT_411	[p30l866t2305r1009b2374],
6	,	,	O	,	_	0	SENT_411	[p30l866t2305r1009b2374],
7	Heinemann	NNP	PERSON	Heinemann	nn	8	SENT_411	[p30l1041t2303r1423b2361],
8	G	NNP	PERSON	G	appos	2	SENT_411	[p30l1454t2303r1528b2372],
9	,	,	O	,	_	0	SENT_411	[p30l1454t2303r1528b2372],
10	von	NNP	O	von	nn	12	SENT_411	[p30l1557t2319r1675b2361],
11	Wartburg	NNP	ORGANIZATION	Wartburg	nn	12	SENT_411	[p30l1704t2302r2017b2374],
12	JP	NNP	ORGANIZATION	JP	appos	2	SENT_411	[p30l2044t2302r2139b2372],
13	,	,	O	,	_	0	SENT_411	[p30l2044t2302r2139b2372],
14	Gabbay	NNP	PERSON	Gabbay	nn	15	SENT_411	[p30l156t2400r408b2477],
15	KH	NNP	O	KH	appos	2	SENT_411	[p30l457t2400r589b2459],
16	.	.	O	.	_	0	SENT_411	[p30l457t2400r589b2459],

1	Human	JJ	O	human	amod	2	SENT_412	[p30l643t2403r885b2459],
2	carbonyl	NN	O	carbonyl	_	0	SENT_412	[p30l937t2398r1214b2475],
3	reductase	NN	O	reductase	dep	2	SENT_412	[p30l1265t2398r1593b2459],
4	.	.	O	.	_	0	SENT_412	[p30l1265t2398r1593b2459],

1	Nucleotide	NN	MISC	nucleotide	nn	3	SENT_413	[p30l1647t2395r2001b2457],
2	sequence	NN	O	sequence	nn	3	SENT_413	[p30l2053t2416r2141b2457, p30l159t2517r389b2572],
3	analysis	NN	O	analysis	nsubj	13	SENT_413	[p30l420t2496r667b2573],
4	of	IN	O	of	_	0	SENT_413	[p30l696t2496r764b2557],
5	a	DT	O	a	det	6	SENT_413	[p30l788t2514r821b2554],
6	CDNA	NN	ORGANIZATION	cdna	prep_of	3	SENT_413	[p30l850t2496r1062b2554],
7	and	CC	O	and	_	0	SENT_413	[p30l1089t2496r1207b2554],
8	amino	NN	O	amino	nn	10	SENT_413	[p30l1236t2494r1436b2554],
9	acid	NN	O	acid	nn	10	SENT_413	[p30l1468t2496r1597b2554],
10	sequence	NN	O	sequence	prep_of	3	SENT_413	[p30l1626t2512r1921b2570],
11	of	IN	O	of	_	0	SENT_413	[p30l1950t2494r2020b2552],
12	the	DT	O	the	prep_of	6	SENT_413	[p30l2042t2494r2144b2552],
13	encoded	VBN	O	encode	_	0	SENT_413	[p30l159t2588r431b2649],
14	protein	NN	O	protein	dobj	13	SENT_413	[p30l459t2590r711b2665],
15	.	.	O	.	_	0	SENT_413	[p30l459t2590r711b2665],

1	J	NNP	O	J	nn	3	SENT_414	[p30l742t2590r773b2646],
2	Biol	NNP	O	Biol	nn	3	SENT_414	[p30l802t2590r936b2646],
3	Chem	NNP	O	Chem	_	0	SENT_414	[p30l965t2588r1156b2649],
4	1988	CD	DATE	1988	num	3	SENT_414	[p30l1190t2585r1763b2657],
5	;	:	O	;	_	0	SENT_414	[p30l1190t2585r1763b2657],
6	263:16185	CD	NUMBER	263:16185	number	7	SENT_414	[p30l1190t2585r1763b2657],
7	—	CD	NUMBER	—	dep	3	SENT_414	[p30l1190t2585r1763b2657],
8	8	CD	NUMBER	8	dep	7	SENT_414	[p30l1190t2585r1763b2657],
9	.	.	O	.	_	0	SENT_414	[p30l1190t2585r1763b2657],

1	Forrest	NNP	O	Forrest	nn	2	SENT_415	[p30l161t2688r396b2744],
2	GL	NNP	O	GL	_	0	SENT_415	[p30l427t2686r550b2756],
3	,	,	O	,	_	0	SENT_415	[p30l427t2686r550b2756],
4	Akman	NNP	PERSON	Akman	nn	5	SENT_415	[p30l579t2686r819b2744],
5	S	NNP	O	S	appos	2	SENT_415	[p30l850t2686r904b2756],
6	,	,	O	,	_	0	SENT_415	[p30l850t2686r904b2756],
7	Doroshow	NNP	PERSON	Doroshow	nn	8	SENT_415	[p30l935t2684r1273b2745],
8	J	NNP	PERSON	J	appos	2	SENT_415	[p30l1298t2686r1347b2753],
9	,	,	O	,	_	0	SENT_415	[p30l1298t2686r1347b2753],
10	Rivera	NNP	PERSON	Rivera	nn	11	SENT_415	[p30l1380t2684r1595b2742],
11	H	NNP	O	H	appos	2	SENT_415	[p30l1624t2684r1698b2753],
12	,	,	O	,	_	0	SENT_415	[p30l1624t2684r1698b2753],
13	Kaplan	NNP	PERSON	Kaplan	nn	14	SENT_415	[p30l1732t2683r1965b2760],
14	WD	NNP	O	WD	appos	2	SENT_415	[p30l1991t2683r2141b2742],
15	.	.	O	.	_	0	SENT_415	[p30l1991t2683r2141b2742],

1	Genomic	JJ	MISC	genomic	amod	2	SENT_416	[p30l161t2781r458b2842],
2	sequence	NN	O	sequence	_	0	SENT_416	[p30l492t2799r789b2857],
3	and	CC	O	and	_	0	SENT_416	[p30l825t2781r943b2839],
4	expression	NN	O	expression	conj_and	2	SENT_416	[p30l978t2781r1317b2855],
5	of	IN	O	of	_	0	SENT_416	[p30l1353t2778r1420b2837],
6	a	DT	O	a	det	11	SENT_416	[p30l1449t2797r1482b2837],
7	cloned	VBN	O	clone	amod	11	SENT_416	[p30l1518t2779r1730b2839],
8	human	JJ	O	human	amod	11	SENT_416	[p30l1766t2779r1988b2837],
9	carbonyl	NN	O	carbonyl	nn	11	SENT_416	[p30l2023t2797r2144b2837, p30l159t2876r334b2953],
10	reductase	NN	O	reductase	nn	11	SENT_416	[p30l375t2876r686b2935],
11	gene	NN	O	gene	prep_of	2	SENT_416	[p30l726t2892r876b2951],
12	and	CC	O	and	_	0	SENT_416	[p30l919t2874r1037b2935],
13	daunorubicin	NN	O	daunorubicin	nn	15	SENT_416	[p30l1077t2872r1508b2933],
14	reductase	NN	O	reductase	nn	15	SENT_416	[p30l1548t2872r1857b2933],
15	activity	NN	O	activity	conj_and	11	SENT_416	[p30l1899t2872r2141b2949],
16	.	.	O	.	_	0	SENT_416	[p30l1899t2872r2141b2949],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_417	[p30l161t2971r290b3029],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_417	[p30l319t2971r667b3029],
3	1991	CD	DATE	1991	num	2	SENT_417	[p30l701t2969r1159b3040],
4	;	:	O	;	_	0	SENT_417	[p30l701t2969r1159b3040],
5	40:502	CD	NUMBER	40:502	number	6	SENT_417	[p30l701t2969r1159b3040],
6	-7	CD	NUMBER	-7	dep	2	SENT_417	[p30l701t2969r1159b3040],
7	.	.	O	.	_	0	SENT_417	[p30l701t2969r1159b3040],

1	Flynn	NNP	PERSON	Flynn	nn	2	SENT_418	[p30l161t3068r343b3142],
2	TG	NN	O	tg	_	0	SENT_418	[p30l363t3066r490b3135],
3	,	,	O	,	_	0	SENT_418	[p30l363t3066r490b3135],
4	Green	NNP	ORGANIZATION	Green	nn	5	SENT_418	[p30l515t3066r720b3127],
5	NC	NNP	ORGANIZATION	NC	appos	2	SENT_418	[p30l740t3066r865b3124],
6	.	.	O	.	_	0	SENT_418	[p30l740t3066r865b3124],

1	The	DT	O	the	det	3	SENT_419	[p30l887t3066r1016b3124],
2	aldo-keto	JJ	O	aldo-keto	amod	3	SENT_419	[p30l1038t3063r1342b3124],
3	reductases	NNS	O	reductase	_	0	SENT_419	[p30l1364t3063r1721b3124],
4	:	:	O	:	_	0	SENT_419	[p30l1364t3063r1721b3124],
5	an	DT	O	a	det	6	SENT_419	[p30l1748t3082r1822b3122],
6	overview	NN	O	overview	dep	3	SENT_419	[p30l1844t3064r2144b3124],
7	.	.	O	.	_	0	SENT_419	[p30l1844t3064r2144b3124],

1	In	IN	O	in	dep	3	SENT_420	[p30l161t3164r245b3219],
2	:	:	O	:	_	0	SENT_420	[p30l161t3164r245b3219],
3	Advances	NNS	O	advance	_	0	SENT_420	[p30l267t3161r582b3220],
4	in	IN	O	in	_	0	SENT_420	[p30l604t3161r665b3219],
5	experimental	JJ	O	experimental	amod	6	SENT_420	[p30l687t3159r1110b3235],
6	medicine	NN	O	medicine	prep_in	3	SENT_420	[p30l1132t3159r1425b3217],
7	and	CC	O	and	_	0	SENT_420	[p30l1449t3159r1565b3217],
8	biology	NN	O	biology	nn	10	SENT_420	[p30l1585t3157r1822b3233],
9	(	CD	NUMBER	(	num	10	SENT_420	[p30l1844t3157r1965b3235],
10	vol	NN	O	vol	conj_and	3	SENT_420	[p30l1844t3157r1965b3235],
11	328	CD	NUMBER	328	num	12	SENT_420	[p30l1987t3157r2141b3235],
12	)	NN	O	)	dep	10	SENT_420	[p30l1987t3157r2141b3235],
13	.	.	O	.	_	0	SENT_420	[p30l1987t3157r2141b3235],

1	Enzymology	NNP	O	Enzymology	_	0	SENT_421	[p30l161t3256r561b3332],
2	and	CC	O	and	_	0	SENT_421	[p30l581t3258r697b3317],
3	molecular	JJ	O	molecular	amod	4	SENT_421	[p30l717t3256r1042b3314],
4	biology	NN	O	biology	conj_and	1	SENT_421	[p30l1059t3256r1296b3330],
5	of	IN	O	of	_	0	SENT_421	[p30l1316t3254r1384b3314],
6	carbonyl	NN	O	carbonyl	nn	7	SENT_421	[p30l1399t3254r1675b3330],
7	metabolism	NN	O	metabolism	prep_of	4	SENT_421	[p30l1697t3253r2070b3314],
8	4	CD	NUMBER	4	amod	1	SENT_421	[p30l2090t3254r2141b3312],
9	.	.	O	.	_	0	SENT_421	[p30l2090t3254r2141b3312],

1	Weiner	NNP	PERSON	Weiner	nn	2	SENT_422	[p30l161t3351r403b3410],
2	H	NNP	PERSON	H	_	0	SENT_422	[p30l434t3351r511b3421],
3	,	,	O	,	_	0	SENT_422	[p30l434t3351r511b3421],
4	Crabb	NNP	PERSON	Crabb	nn	5	SENT_422	[p30l549t3351r745b3410],
5	DW	NNP	O	DW	appos	2	SENT_422	[p30l779t3351r931b3421],
6	,	,	O	,	_	0	SENT_422	[p30l779t3351r931b3421],
7	Flynn	NNP	PERSON	Flynn	nn	8	SENT_422	[p30l965t3351r1149b3423],
8	TG	NN	O	tg	appos	2	SENT_422	[p30l1181t3351r1308b3421],
9	,	,	O	,	_	0	SENT_422	[p30l1181t3351r1308b3421],
10	eds	NNS	O	ed	appos	2	SENT_422	[p30l1344t3349r1466b3407],
11	.	.	O	.	_	0	SENT_422	[p30l1344t3349r1466b3407],

1	New	NNP	LOCATION	New	nn	2	SENT_423	[p30l1502t3351r1648b3407],
2	York	NNP	LOCATION	York	_	0	SENT_423	[p30l1679t3349r1864b3407],
3	:	:	O	:	_	0	SENT_423	[p30l1679t3349r1864b3407],
4	Plenum	NNP	ORGANIZATION	Plenum	nn	5	SENT_423	[p30l1899t3347r2148b3407],
5	Press	NNP	ORGANIZATION	Press	dep	2	SENT_423	[p30l161t3447r346b3516],
6	,	,	O	,	_	0	SENT_423	[p30l161t3447r346b3516],
7	1993:251	CD	NUMBER	1993:251	num	8	SENT_423	[p30l384t3445r743b3505],
8	—	NN	O	—	appos	5	SENT_423	[p30l384t3445r743b3505],
9	7	CD	NUMBER	7	dep	8	SENT_423	[p30l384t3445r743b3505],
10	.	.	O	.	_	0	SENT_423	[p30l384t3445r743b3505],

1	DeFlora	NNP	O	DeFlora	nn	2	SENT_424	[p30l161t3541r435b3602],
2	A	NNP	O	A	_	0	SENT_424	[p30l457t3541r532b3611],
3	,	,	O	,	_	0	SENT_424	[p30l457t3541r532b3611],
4	Benatti	NNP	PERSON	Benatti	nn	5	SENT_424	[p30l561t3539r798b3600],
5	U	NNP	PERSON	U	appos	2	SENT_424	[p30l825t3541r901b3611],
6	,	,	O	,	_	0	SENT_424	[p30l825t3541r901b3611],
7	Guida	NNP	PERSON	Guida	nn	8	SENT_424	[p30l930t3539r1131b3600],
8	L	NNP	PERSON	L	appos	2	SENT_424	[p30l1158t3541r1221b3609],
9	,	,	O	,	_	0	SENT_424	[p30l1158t3541r1221b3609],
10	Zocchi	NNP	PERSON	Zocchi	nn	12	SENT_424	[p30l1250t3536r1473b3597],
11	E.	NNP	O	E.	nn	12	SENT_424	[p30l1500t3539r1565b3598],
12	Encapsulation	NNP	O	Encapsulation	appos	2	SENT_424	[p30l1594t3536r2059b3613],
13	of	IN	O	of	_	0	SENT_424	[p30l2083t3539r2151b3595],
14	adriamycin	NN	O	adriamycin	prep_of	12	SENT_424	[p30l165t3637r520b3714],
15	in	IN	O	in	_	0	SENT_424	[p30l549t3637r608b3696],
16	human	JJ	O	human	amod	17	SENT_424	[p30l636t3637r860b3696],
17	erythrocytes	NNS	O	erythrocyte	prep_in	14	SENT_424	[p30l889t3637r1299b3712],
18	.	.	O	.	_	0	SENT_424	[p30l889t3637r1299b3712],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_425	[p30l1330t3635r1478b3694],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_425	[p30l1504t3635r1643b3694],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_425	[p30l1670t3635r1841b3694],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_425	[p30l1869t3633r1960b3694],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_425	[p30l1989t3635r2151b3691],
6	1986	CD	DATE	1986	num	5	SENT_425	[p30l168t3730r702b3802],
7	;	:	O	;	_	0	SENT_425	[p30l168t3730r702b3802],
8	83:7029	CD	NUMBER	83:7029	number	9	SENT_425	[p30l168t3730r702b3802],
9	-33	CD	NUMBER	-33	dep	5	SENT_425	[p30l168t3730r702b3802],
10	.	.	O	.	_	0	SENT_425	[p30l168t3730r702b3802],

1	Carson	NNP	ORGANIZATION	Carson	nn	2	SENT_426	[p31l163t22r394b81],
2	PE	NNP	ORGANIZATION	PE	_	0	SENT_426	[p31l430t22r545b90],
3	,	,	O	,	_	0	SENT_426	[p31l430t22r545b90],
4	Flanagan	NNP	PERSON	Flanagan	nn	5	SENT_426	[p31l586t22r885b94],
5	CL	NN	O	cl	appos	2	SENT_426	[p31l926t22r1041b90],
6	,	,	O	,	_	0	SENT_426	[p31l926t22r1041b90],
7	Ickes	NN	PERSON	icke	nn	8	SENT_426	[p31l1082t20r1248b79],
8	CE	NN	O	ce	appos	2	SENT_426	[p31l1286t20r1407b87],
9	,	,	O	,	_	0	SENT_426	[p31l1286t20r1407b87],
10	Alving	NNP	PERSON	Alving	nn	13	SENT_426	[p31l1445t20r1659b94],
11	A.	NNP	O	A.	nn	13	SENT_426	[p31l1695t20r1767b76],
12	Enzymatic	JJ	O	enzymatic	amod	13	SENT_426	[p31l1808t18r2151b94],
13	deﬁciency	NN	O	deﬁciency	appos	2	SENT_426	[p31l165t117r486b192],
14	in	IN	O	in	_	0	SENT_426	[p31l554t117r612b176],
15	prirnaquine-sensitive	JJ	O	prirnaquine-sensitive	amod	16	SENT_426	[p31l680t117r1356b195],
16	erythrocytes	NNS	O	erythrocyte	prep_in	13	SENT_426	[p31l1424t117r1836b190],
17	.	.	O	.	_	0	SENT_426	[p31l1424t117r1836b190],

1	Science	NNP	O	Science	_	0	SENT_427	[p31l1906t112r2148b174],
2	1956	CD	DATE	1956	num	1	SENT_427	[p31l168t212r665b282],
3	;	:	O	;	_	0	SENT_427	[p31l168t212r665b282],
4	124:484	CD	NUMBER	124:484	number	5	SENT_427	[p31l168t212r665b282],
5	-5	CD	NUMBER	-5	dep	1	SENT_427	[p31l168t212r665b282],
6	.	.	O	.	_	0	SENT_427	[p31l168t212r665b282],

1	Beutler	NNP	PERSON	Beutler	nn	3	SENT_428	[p31l163t310r405b369],
2	E.	NNP	O	E.	nn	3	SENT_428	[p31l439t310r506b366],
3	The	NNP	O	The	_	0	SENT_428	[p31l542t310r669b366],
4	hernolytic	JJ	O	hernolytic	amod	5	SENT_428	[p31l705t308r1023b382],
5	effect	NN	O	effect	dep	3	SENT_428	[p31l1057t308r1230b364],
6	of	IN	O	of	_	0	SENT_428	[p31l1265t308r1333b366],
7	primaquine	NN	O	primaquine	nn	10	SENT_428	[p31l1362t305r1735b384],
8	and	CC	O	and	_	0	SENT_428	[p31l1773t305r1889b364],
9	related	JJ	O	related	nn	10	SENT_428	[p31l1922t306r2148b364],
10	compounds	NNS	O	compound	prep_of	5	SENT_428	[p31l165t403r555b479],
11	.	.	O	.	_	0	SENT_428	[p31l165t403r555b479],

1	A	DT	O	a	det	2	SENT_429	[p31l583t403r644b459],
2	review	NN	O	review	_	0	SENT_429	[p31l671t401r897b461],
3	.	.	O	.	_	0	SENT_429	[p31l671t401r897b461],

1	Blood	NN	O	blood	_	0	SENT_430	[p31l928t401r1122b459],
2	1959	CD	DATE	1959	num	1	SENT_430	[p31l1155t400r1652b470],
3	;	:	O	;	_	0	SENT_430	[p31l1155t400r1652b470],
4	14:103	CD	NUMBER	14:103	number	5	SENT_430	[p31l1155t400r1652b470],
5	-393	CD	NUMBER	-393	dep	1	SENT_430	[p31l1155t400r1652b470],
6	.	.	O	.	_	0	SENT_430	[p31l1155t400r1652b470],

1	Frischer	NN	PERSON	frischer	nn	2	SENT_431	[p31l166t498r433b557],
2	H	NN	O	h	_	0	SENT_431	[p31l462t498r539b566],
3	,	,	O	,	_	0	SENT_431	[p31l462t498r539b566],
4	Carson	NNP	ORGANIZATION	Carson	nn	5	SENT_431	[p31l574t498r803b557],
5	PE	NNP	ORGANIZATION	PE	appos	2	SENT_431	[p31l834t498r947b554],
6	.	.	O	.	_	0	SENT_431	[p31l834t498r947b554],

1	Multiple	JJ	O	multiple	amod	3	SENT_432	[p31l983t496r1260b570],
2	gene	NN	O	gene	nn	3	SENT_432	[p31l1291t512r1443b570],
3	interactions	NNS	O	interaction	nsubj	5	SENT_432	[p31l1475t496r1854b554],
4	"	``	O	"	punct	5	SENT_432	[p31l1888t496r1946b552],
5	*	VBP	O	*	_	0	SENT_432	[p31l1888t496r1946b552],
6	6	CD	NUMBER	6	dobj	5	SENT_432	[p31l1888t496r1946b552],
7	+	CC	O	+	_	0	SENT_432	[p31l1888t496r1946b552],
8	pharmacogenetics	NNS	O	pharmacogenetic	dobj	5	SENT_432	[p31l1977t494r2151b568, p31l166t590r617b667],
9	.	.	O	.	_	0	SENT_432	[p31l1977t494r2151b568, p31l166t590r617b667],

1	J	NN	O	j	nn	4	SENT_433	[p31l648t593r679b649],
2	Lab	NN	O	lab	nn	4	SENT_433	[p31l708t591r830b649],
3	Clin	NNP	O	Clin	nn	4	SENT_433	[p31l861t590r995b649],
4	Med	NNP	O	Med	_	0	SENT_433	[p31l1024t590r1172b649],
5	1981	CD	DATE	1981	num	4	SENT_433	[p31l1206t590r1664b658],
6	;	:	O	;	_	0	SENT_433	[p31l1206t590r1664b658],
7	97:760	CD	NUMBER	97:760	number	8	SENT_433	[p31l1206t590r1664b658],
8	—	CD	NUMBER	—	dep	4	SENT_433	[p31l1206t590r1664b658],
9	3	CD	NUMBER	3	dep	8	SENT_433	[p31l1206t590r1664b658],
10	.	.	O	.	_	0	SENT_433	[p31l1206t590r1664b658],

1	Luzzatto	NNP	PERSON	Luzzatto	nn	2	SENT_434	[p31l165t689r447b748],
2	L.	NNP	O	L.	_	0	SENT_434	[p31l482t689r543b745],
3	Glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	5	SENT_434	[p31l583t687r1273b763],
4	dehydrogenase	NN	O	dehydrogenase	nn	5	SENT_434	[p31l1309t687r1795b761],
5	deﬁciency	NN	O	deﬁciency	dep	2	SENT_434	[p31l1830t684r2151b759],
6	and	CC	O	and	_	0	SENT_434	[p31l168t786r284b842],
7	the	DT	O	the	det	10	SENT_434	[p31l310t786r410b842],
8	pentose	NN	O	pentose	nn	10	SENT_434	[p31l434t793r686b858],
9	phosphate	NN	O	phosphate	nn	10	SENT_434	[p31l712t784r1048b861],
10	pathway	NN	O	pathway	conj_and	5	SENT_434	[p31l1070t784r1356b858],
11	.	.	O	.	_	0	SENT_434	[p31l1070t784r1356b858],

1	In	IN	O	in	_	0	SENT_435	[p31l1385t784r1469b837],
2	:	:	O	:	_	0	SENT_435	[p31l1385t784r1469b837],
3	Handin	NNP	PERSON	Handin	pobj	1	SENT_435	[p31l1497t782r1740b840],
4	RI	NN	O	rus	dep	3	SENT_435	[p31l1766t784r1868b851],
5	,	,	O	,	_	0	SENT_435	[p31l1766t784r1868b851],
6	Lux	FW	LOCATION	lux	dep	3	SENT_435	[p31l1895t784r2017b840],
7	SE	NN	LOCATION	se	dep	3	SENT_435	[p31l2042t782r2148b849],
8	,	,	O	,	_	0	SENT_435	[p31l2042t782r2148b849],
9	Stossel	NNP	PERSON	Stossel	nn	10	SENT_435	[p31l165t880r387b939],
10	TP	NN	O	tp	appos	7	SENT_435	[p31l407t880r518b947],
11	,	,	O	,	_	0	SENT_435	[p31l407t880r518b947],
12	eds	NNS	O	ed	appos	3	SENT_435	[p31l540t880r663b936],
13	.	.	O	.	_	0	SENT_435	[p31l540t880r663b936],

1	Blood	NN	O	blood	_	0	SENT_436	[p31l684t878r897b936],
2	:	:	O	:	_	0	SENT_436	[p31l684t878r897b936],
3	principles	NNS	O	principle	dep	1	SENT_436	[p31l921t878r1237b955],
4	and	CC	O	and	_	0	SENT_436	[p31l1259t876r1374b936],
5	practice	NN	O	practice	dep	1	SENT_436	[p31l1394t878r1650b952],
6	of	IN	O	of	_	0	SENT_436	[p31l1672t876r1740b934],
7	hematology	NN	O	hematology	prep_of	3	SENT_436	[p31l1755t875r2148b950],
8	.	.	O	.	_	0	SENT_436	[p31l1755t875r2148b950],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_437	[p31l166t973r589b1047],
2	:	:	O	:	_	0	SENT_437	[p31l166t973r589b1047],
3	JB	NNP	ORGANIZATION	JB	nn	5	SENT_437	[p31l620t975r704b1031],
4	Lippincott	NNP	ORGANIZATION	Lippincott	nn	5	SENT_437	[p31l733t973r1071b1047],
5	Co.	NNP	ORGANIZATION	Co.	dep	1	SENT_437	[p31l1102t973r1230b1040],
6	,	,	O	,	_	0	SENT_437	[p31l1102t973r1230b1040],
7	1995:1897	CD	NUMBER	1995:1897	num	8	SENT_437	[p31l1266t970r1740b1031],
8	-923	CD	NUMBER	-923	appos	5	SENT_437	[p31l1266t970r1740b1031],
9	.	.	O	.	_	0	SENT_437	[p31l1266t970r1740b1031],

1	DeGowin	NNP	O	DeGowin	nn	2	SENT_438	[p31l166t1068r481b1127],
2	RL	NNP	O	RL	_	0	SENT_438	[p31l510t1071r630b1138],
3	,	,	O	,	_	0	SENT_438	[p31l510t1071r630b1138],
4	Eppes	NNP	PERSON	Eppes	nn	5	SENT_438	[p31l662t1071r862b1145],
5	RB	NN	O	rb	appos	2	SENT_438	[p31l891t1071r1016b1138],
6	,	,	O	,	_	0	SENT_438	[p31l891t1071r1016b1138],
7	Powell	NNP	PERSON	Powell	nn	8	SENT_438	[p31l1047t1068r1262b1125],
8	RD	NNP	O	RD	appos	2	SENT_438	[p31l1291t1066r1425b1136],
9	,	,	O	,	_	0	SENT_438	[p31l1291t1066r1425b1136],
10	Carson	NNP	ORGANIZATION	Carson	nn	11	SENT_438	[p31l1458t1066r1687b1125],
11	PB	NN	ORGANIZATION	pb	appos	2	SENT_438	[p31l1716t1066r1827b1122],
12	.	.	O	.	_	0	SENT_438	[p31l1716t1066r1827b1122],

1	The	DT	O	the	det	3	SENT_439	[p31l1858t1066r1983b1125],
2	haemolytic	JJ	O	haemolytic	amod	3	SENT_439	[p31l2014t1064r2153b1122, p31l166t1168r403b1239],
3	eﬂiects	NNS	O	eﬂiects	_	0	SENT_439	[p31l425t1165r628b1223],
4	of	IN	O	of	_	0	SENT_439	[p31l652t1168r720b1223],
5	diaphenylsulfone	NN	O	diaphenylsulfone	nn	8	SENT_439	[p31l740t1163r1294b1239],
6	(	CD	NUMBER	(	num	8	SENT_439	[p31l1321t1163r1535b1239],
7	DDS	NN	O	dd	nn	8	SENT_439	[p31l1321t1163r1535b1239],
8	)	NN	O	)	prep_of	3	SENT_439	[p31l1321t1163r1535b1239],
9	in	IN	O	in	_	0	SENT_439	[p31l1562t1163r1620b1221],
10	normal	JJ	O	normal	amod	11	SENT_439	[p31l1644t1163r1875b1221],
11	subjects	NNS	O	subject	prep_in	3	SENT_439	[p31l1899t1161r2153b1235],
12	and	CC	O	and	_	0	SENT_439	[p31l168t1261r284b1317],
13	in	IN	O	in	_	0	SENT_439	[p31l317t1261r375b1320],
14	those	DT	O	those	conj_and	11	SENT_439	[p31l411t1259r582b1319],
15	with	IN	O	with	_	0	SENT_439	[p31l613t1261r754b1317],
16	glucose	NN	O	glucose	nn	20	SENT_439	[p31l786t1259r1453b1333],
17	—	CD	NUMBER	—	num	20	SENT_439	[p31l786t1259r1453b1333],
18	6-phosphate	NN	O	6-phosphate	nn	20	SENT_439	[p31l786t1259r1453b1333],
19	dehydrogenase	NN	O	dehydrogenase	nn	20	SENT_439	[p31l1488t1257r1974b1331],
20	deﬁciency	NN	O	deﬁciency	prep_with	14	SENT_439	[p31l2009t1257r2151b1313, p31l168t1354r382b1430],
21	.	.	O	.	_	0	SENT_439	[p31l2009t1257r2151b1313, p31l168t1354r382b1430],

1	Bull	NN	O	bull	_	0	SENT_440	[p31l413t1354r545b1412],
2	WHO	WP	O	who	rcmod	1	SENT_440	[p31l574t1354r771b1412],
3	1966	CD	DATE	1966	dep	1	SENT_440	[p31l806t1351r1301b1423],
4	;	:	O	;	_	0	SENT_440	[p31l806t1351r1301b1423],
5	35:165	CD	NUMBER	35:165	num	6	SENT_440	[p31l806t1351r1301b1423],
6	-79	CD	NUMBER	-79	dep	1	SENT_440	[p31l806t1351r1301b1423],
7	.	.	O	.	_	0	SENT_440	[p31l806t1351r1301b1423],

1	Amitoi	NNP	PERSON	Amitoi	nn	3	SENT_441	[p31l793t1467r1044b1532],
2	,	,	O	,	_	0	SENT_441	[p31l793t1467r1044b1532],
3	Bhoomo	NNP	PERSON	Bhoomo	_	0	SENT_441	[p31l1084t1466r1409b1530],
4	,	,	O	,	_	0	SENT_441	[p31l1084t1466r1409b1530],
5	ond	JJ	O	ond	amod	6	SENT_441	[p31l1445t1469r1589b1528],
6	Frischer	NN	PERSON	frischer	appos	3	SENT_441	[p31l1623t1467r1895b1528],
7	597	CD	NUMBER	597	num	6	SENT_441	[p31l2012t1466r2133b1528],

1	Frischer	NN	PERSON	frischer	nn	2	SENT_442	[p31l140t1708r412b1766],
2	H	NN	PERSON	h	_	0	SENT_442	[p31l441t1708r516b1778],
3	,	,	O	,	_	0	SENT_442	[p31l441t1708r516b1778],
4	Mellovitz	NNP	PERSON	Mellovitz	nn	5	SENT_442	[p31l552t1708r856b1769],
5	R	NNP	PERSON	R	appos	2	SENT_442	[p31l888t1710r960b1781],
6	,	,	O	,	_	0	SENT_442	[p31l888t1710r960b1781],
7	Ahmad	NNP	PERSON	Ahmad	nn	8	SENT_442	[p31l992t1708r1233b1769],
8	T	NN	PERSON	t	appos	2	SENT_442	[p31l1265t1710r1330b1781],
9	,	,	O	,	_	0	SENT_442	[p31l1265t1710r1330b1781],
10	Nora	NNP	PERSON	Nora	nn	11	SENT_442	[p31l1364t1710r1529b1769],
11	MV	NNP	O	MV	appos	2	SENT_442	[p31l1561t1710r1703b1769],
12	.	.	O	.	_	0	SENT_442	[p31l1561t1710r1703b1769],

1	The	DT	O	the	det	2	SENT_443	[p31l1736t1710r1865b1769],
2	conversion	NN	O	conversion	_	0	SENT_443	[p31l1896t1728r2135b1769, p31l143t1805r273b1863],
3	of	IN	O	of	_	0	SENT_443	[p31l309t1807r377b1863],
4	primaquine	NN	O	primaquine	prep_of	2	SENT_443	[p31l409t1805r784b1884],
5	into	IN	O	into	_	0	SENT_443	[p31l820t1807r946b1866],
6	primaquine-aldehyde	NN	O	primaquine-aldehyde	prep_into	2	SENT_443	[p31l985t1805r1698b1884],
7	,	,	O	,	_	0	SENT_443	[p31l985t1805r1698b1884],
8	primaquinealcohol	NN	O	primaquinealcohol	prep_into	2	SENT_443	[p31l1736t1807r2135b1887, p31l143t1904r393b1976],
9	,	,	O	,	_	0	SENT_443	[p31l1736t1807r2135b1887, p31l143t1904r393b1976],
10	and	CC	O	and	_	0	SENT_443	[p31l422t1905r539b1962],
11	carboxyprimaquine	NN	O	carboxyprimaquine	prep_into	2	SENT_443	[p31l566t1905r1210b1982],
12	,	,	O	,	_	0	SENT_443	[p31l566t1905r1210b1982],
13	a	DT	O	a	det	16	SENT_443	[p31l1239t1923r1275b1964],
14	major	JJ	O	major	amod	16	SENT_443	[p31l1299t1904r1490b1980],
15	plasma	NN	O	plasma	nn	16	SENT_443	[p31l1514t1907r1742b1982],
16	metabolite	NN	O	metabolite	appos	6	SENT_443	[p31l1769t1904r2133b1966],
17	.	.	O	.	_	0	SENT_443	[p31l1769t1904r2133b1966],

1	J	NN	O	j	nn	4	SENT_444	[p31l140t2002r171b2059],
2	Lab	NN	O	lab	nn	4	SENT_444	[p31l200t2003r324b2062],
3	Clin	NNP	O	Clin	nn	4	SENT_444	[p31l355t2003r491b2062],
4	Med	NNP	O	Med	_	0	SENT_444	[p31l520t2002r666b2062],
5	1991	CD	DATE	1991	num	4	SENT_444	[p31l702t2003r1240b2073],
6	;	:	O	;	_	0	SENT_444	[p31l702t2003r1240b2073],
7	117:468	CD	NUMBER	117:468	number	8	SENT_444	[p31l702t2003r1240b2073],
8	-76	CD	NUMBER	-76	dep	4	SENT_444	[p31l702t2003r1240b2073],
9	.	.	O	.	_	0	SENT_444	[p31l702t2003r1240b2073],

1	Frischer	NN	PERSON	frischer	nn	2	SENT_445	[p31l143t2097r410b2156],
2	H	NN	O	h	_	0	SENT_445	[p31l432t2100r509b2168],
3	,	,	O	,	_	0	SENT_445	[p31l432t2100r509b2168],
4	Carson	NNP	ORGANIZATION	Carson	nn	5	SENT_445	[p31l538t2100r768b2159],
5	PE	NNP	ORGANIZATION	PE	appos	2	SENT_445	[p31l793t2100r905b2168],
6	,	,	O	,	_	0	SENT_445	[p31l793t2100r905b2168],
7	Bowman	NNP	PERSON	Bowman	nn	8	SENT_445	[p31l931t2100r1219b2159],
8	JE	NNP	O	JE	appos	2	SENT_445	[p31l1241t2102r1344b2170],
9	,	,	O	,	_	0	SENT_445	[p31l1241t2102r1344b2170],
10	Rieckrnann	NNP	O	Rieckrnann	nn	11	SENT_445	[p31l1371t2100r1744b2159],
11	KH	NNP	O	KH	appos	2	SENT_445	[p31l1769t2102r1902b2159],
12	.	.	O	.	_	0	SENT_445	[p31l1769t2102r1902b2159],

1	Visual	JJ	O	visual	amod	2	SENT_446	[p31l1928t2100r2135b2159],
2	test	NN	O	test	_	0	SENT_446	[p31l140t2204r255b2254],
3	for	IN	O	for	_	0	SENT_446	[p31l311t2197r405b2256],
4	erythrocytic	JJ	O	erythrocytic	amod	5	SENT_446	[p31l462t2195r845b2272],
5	g1ucose	NN	O	g1ucose	prep_for	2	SENT_446	[p31l901t2197r1569b2275],
6	—	CD	NUMBER	—	num	8	SENT_446	[p31l901t2197r1569b2275],
7	6-phosphate	NN	O	6-phosphate	nn	8	SENT_446	[p31l901t2197r1569b2275],
8	dehydrogenase	NN	O	dehydrogenase	dep	2	SENT_446	[p31l1628t2197r2133b2274],
9	,	,	O	,	_	0	SENT_446	[p31l1628t2197r2133b2274],
10	6	CD	NUMBER	6	num	13	SENT_446	[p31l143t2292r759b2370],
11	—	NN	O	—	nn	13	SENT_446	[p31l143t2292r759b2370],
12	phosphog1uconic	NN	O	phosphog1uconic	nn	13	SENT_446	[p31l143t2292r759b2370],
13	dehydrogenase	NN	O	dehydrogenase	dep	2	SENT_446	[p31l802t2292r1305b2371],
14	,	,	O	,	_	0	SENT_446	[p31l802t2292r1305b2371],
15	and	CC	O	and	_	0	SENT_446	[p31l1352t2295r1471b2354],
16	glutathione	NN	O	glutathione	nn	18	SENT_446	[p31l1514t2293r1883b2370],
17	reductase	NN	O	reductase	nn	18	SENT_446	[p31l1929t2295r2133b2354, p31l143t2398r268b2451],
18	deﬁciencies	NNS	O	deﬁciencies	dep	2	SENT_446	[p31l298t2392r690b2451],
19	.	.	O	.	_	0	SENT_446	[p31l298t2392r690b2451],

1	J	NN	O	j	nn	4	SENT_447	[p31l721t2392r752b2451],
2	Lab	NN	O	lab	nn	4	SENT_447	[p31l781t2392r905b2451],
3	Clin	NNP	O	Clin	nn	4	SENT_447	[p31l936t2394r1069b2453],
4	Med	NNP	O	Med	_	0	SENT_447	[p31l1098t2394r1247b2451],
5	1973	CD	DATE	1973	num	4	SENT_447	[p31l1281t2391r1779b2463],
6	;	:	O	;	_	0	SENT_447	[p31l1281t2391r1779b2463],
7	81:613	CD	NUMBER	81:613	number	8	SENT_447	[p31l1281t2391r1779b2463],
8	—	CD	NUMBER	—	dep	4	SENT_447	[p31l1281t2391r1779b2463],
9	24	CD	NUMBER	24	dep	8	SENT_447	[p31l1281t2391r1779b2463],
10	.	.	O	.	_	0	SENT_447	[p31l1281t2391r1779b2463],

1	Frischer	NN	PERSON	frischer	nn	2	SENT_448	[p31l140t2486r410b2548],
2	H	NN	O	h	_	0	SENT_448	[p31l436t2489r514b2557],
3	,	,	O	,	_	0	SENT_448	[p31l436t2489r514b2557],
4	Bowman	NNP	PERSON	Bowman	nn	5	SENT_448	[p31l543t2489r828b2548],
5	JE	NNP	O	JE	appos	2	SENT_448	[p31l855t2489r958b2559],
6	,	,	O	,	_	0	SENT_448	[p31l855t2489r958b2559],
7	Carson	NNP	ORGANIZATION	Carson	nn	8	SENT_448	[p31l989t2491r1222b2548],
8	PE	NNP	ORGANIZATION	PE	appos	2	SENT_448	[p31l1248t2491r1363b2562],
9	,	,	O	,	_	0	SENT_448	[p31l1248t2491r1363b2562],
10	et	FW	O	et	nn	11	SENT_448	[p31l1394t2498r1453b2548],
11	al.	FW	O	al.	appos	2	SENT_448	[p31l1482t2489r1552b2548],
12	.	.	O	.	_	0	SENT_448	[p31l1482t2489r1552b2548],

1	Erythrocytic	JJ	O	erythrocytic	amod	3	SENT_449	[p31l1584t2489r1985b2567],
2	glutathione	NN	O	glutathione	nn	3	SENT_449	[p31l2012t2489r2133b2566, p31l140t2588r410b2647],
3	reductase	NN	O	reductase	_	0	SENT_449	[p31l434t2588r764b2656],
4	,	,	O	,	_	0	SENT_449	[p31l434t2588r764b2656],
5	glucose-6	NN	O	glucose-6	nn	8	SENT_449	[p31l788t2588r1458b2665],
6	—	CD	NUMBER	—	num	8	SENT_449	[p31l788t2588r1458b2665],
7	phosphate	NN	O	phosphate	nn	8	SENT_449	[p31l788t2588r1458b2665],
8	dehydrogenase	NN	O	dehydrogenase	conj_and	3	SENT_449	[p31l1484t2588r1990b2665],
9	,	,	O	,	_	0	SENT_449	[p31l1484t2588r1990b2665],
10	and	CC	O	and	_	0	SENT_449	[p31l2016t2588r2133b2647],
11	6-phosphogluconic	JJ	O	6-phosphogluconic	amod	13	SENT_449	[p31l143t2683r759b2763],
12	dehydrogenase	NN	O	dehydrogenase	nn	13	SENT_449	[p31l809t2682r1296b2760],
13	deﬁciencies	NNS	O	deﬁciencies	conj_and	3	SENT_449	[p31l1350t2683r1724b2744],
14	in	IN	O	in	_	0	SENT_449	[p31l1776t2685r1835b2744],
15	populations	NNS	O	population	prep_in	13	SENT_449	[p31l1887t2685r2133b2762, p31l143t2780r296b2838],
16	of	IN	O	of	_	0	SENT_449	[p31l328t2782r396b2838],
17	the	DT	O	the	det	19	SENT_449	[p31l420t2780r521b2841],
18	United	NNP	LOCATION	United	nn	19	SENT_449	[p31l550t2780r777b2841],
19	States	NNPS	LOCATION	States	prep_of	15	SENT_449	[p31l809t2782r1018b2853],
20	,	,	O	,	_	0	SENT_449	[p31l809t2782r1018b2853],
21	South	NNP	LOCATION	South	nn	22	SENT_449	[p31l1049t2779r1238b2841],
22	Vietnam	NNP	LOCATION	Vietnam	conj_and	19	SENT_449	[p31l1267t2782r1566b2853],
23	,	,	O	,	_	0	SENT_449	[p31l1267t2782r1566b2853],
24	Iran	NNP	LOCATION	Iran	conj_and	19	SENT_449	[p31l1600t2784r1751b2850],
25	,	,	O	,	_	0	SENT_449	[p31l1600t2784r1751b2850],
26	and	CC	O	and	_	0	SENT_449	[p31l1783t2782r1899b2841],
27	Ethiopia	NNP	LOCATION	Ethiopia	conj_and	19	SENT_449	[p31l1931t2782r2133b2841, p31l140t2878r255b2952],
28	.	.	O	.	_	0	SENT_449	[p31l1931t2782r2133b2841, p31l140t2878r255b2952],

1	J	NN	O	j	nn	4	SENT_450	[p31l286t2880r317b2936],
2	Lab	NN	O	lab	nn	4	SENT_450	[p31l346t2878r470b2936],
3	Clin	NNP	O	Clin	nn	4	SENT_450	[p31l501t2878r634b2936],
4	Med	NNP	O	Med	_	0	SENT_450	[p31l663t2878r812b2936],
5	1973	CD	DATE	1973	num	4	SENT_450	[p31l846t2877r1344b2950],
6	;	:	O	;	_	0	SENT_450	[p31l846t2877r1344b2950],
7	81:603	CD	NUMBER	81:603	number	8	SENT_450	[p31l846t2877r1344b2950],
8	-12	CD	NUMBER	-12	dep	4	SENT_450	[p31l846t2877r1344b2950],
9	.	.	O	.	_	0	SENT_450	[p31l846t2877r1344b2950],

1	J	NN	O	j	nn	4	SENT_451	[p31l143t2975r174b3034],
2	acquet	NN	O	acquet	nn	4	SENT_451	[p31l180t2984r393b3053],
3	J	NN	O	j	nn	4	SENT_451	[p31l418t2975r449b3036],
4	M	NN	O	m	_	0	SENT_451	[p31l453t2975r539b3045],
5	,	,	O	,	_	0	SENT_451	[p31l453t2975r539b3045],
6	Galtier	NNP	PERSON	Galtier	nn	7	SENT_451	[p31l568t2975r798b3036],
7	M	NNP	O	M	appos	4	SENT_451	[p31l825t2975r909b3045],
8	,	,	O	,	_	0	SENT_451	[p31l825t2975r909b3045],
9	Bressolle	NNP	O	Bressolle	nn	10	SENT_451	[p31l938t2975r1236b3036],
10	F	NN	O	f	appos	4	SENT_451	[p31l1262t2977r1323b3048],
11	,	,	O	,	_	0	SENT_451	[p31l1262t2977r1323b3048],
12	Jourdan	NNP	PERSON	Jourdan	nn	13	SENT_451	[p31l1350t2975r1617b3036],
13	JA	NNP	O	JA	appos	4	SENT_451	[p31l1644t2977r1749b3036],
14	.	.	O	.	_	0	SENT_451	[p31l1644t2977r1749b3036],

1	A	DT	O	a	det	5	SENT_452	[p31l1776t2977r1837b3034],
2	sensitive	JJ	O	sensitive	amod	5	SENT_452	[p31l1861t2974r2135b3036],
3	and	CC	O	and	_	0	SENT_452	[p31l145t3073r261b3132],
4	reproducible	JJ	O	reproducible	amod	5	SENT_452	[p31l291t3072r706b3150],
5	HPLC	NN	O	hplc	_	0	SENT_452	[p31l735t3072r944b3132],
6	assay	NN	O	assay	dep	5	SENT_452	[p31l973t3091r1138b3148],
7	for	IN	O	for	_	0	SENT_452	[p31l1165t3073r1261b3132],
8	doxorubicin	NN	O	doxorubicin	prep_for	6	SENT_452	[p31l1290t3072r1675b3134],
9	and	CC	O	and	_	0	SENT_452	[p31l1704t3075r1823b3132],
10	pirarubicin	NN	O	pirarubicin	conj_and	8	SENT_452	[p31l1850t3072r2135b3151, p31l143t3172r252b3228],
11	.	.	O	.	_	0	SENT_452	[p31l1850t3072r2135b3151, p31l143t3172r252b3228],

1	J	NNP	O	J	nn	4	SENT_453	[p31l284t3172r317b3230],
2	Pharmacol	NNP	O	Pharmacol	nn	4	SENT_453	[p31l344t3172r692b3230],
3	Biomed	NNP	O	Biomed	nn	4	SENT_453	[p31l721t3172r976b3231],
4	Anal	NNP	O	Anal	_	0	SENT_453	[p31l1003t3172r1159b3230],
5	1992	CD	DATE	1992	num	4	SENT_453	[p31l1195t3171r1654b3245],
6	;	:	O	;	_	0	SENT_453	[p31l1195t3171r1654b3245],
7	10:343	CD	NUMBER	10:343	number	8	SENT_453	[p31l1195t3171r1654b3245],
8	-8	CD	NUMBER	-8	dep	4	SENT_453	[p31l1195t3171r1654b3245],
9	.	.	O	.	_	0	SENT_453	[p31l1195t3171r1654b3245],

1	Gewirtz	NNP	PERSON	Gewirtz	nn	2	SENT_454	[p31l147t3267r403b3327],
2	DA	NNP	PERSON	DA	_	0	SENT_454	[p31l436t3267r572b3338],
3	,	,	O	,	_	0	SENT_454	[p31l436t3267r572b3338],
4	Yanovich	NNP	PERSON	Yanovich	nn	6	SENT_454	[p31l608t3268r916b3327],
5	S.	NNP	O	S.	nn	6	SENT_454	[p31l952t3270r1007b3329],
6	Metabolism	NNP	O	Metabolism	appos	2	SENT_454	[p31l1045t3268r1432b3329],
7	of	IN	O	of	_	0	SENT_454	[p31l1468t3268r1536b3327],
8	the	DT	O	the	det	11	SENT_454	[p31l1565t3270r1668b3329],
9	anthracycline	NN	O	anthracycline	nn	11	SENT_454	[p31l1704t3268r2138b3345],
10	antibiotic	JJ	O	antibiotic	amod	11	SENT_454	[p31l145t3366r451b3425],
11	daunorubicin	NN	O	daunorubicin	prep_of	6	SENT_454	[p31l483t3363r912b3425],
12	to	TO	O	to	_	0	SENT_454	[p31l945t3375r1009b3425],
13	daunorubicinol	NN	O	daunorubicinol	nn	16	SENT_454	[p31l1042t3366r1536b3425],
14	and	CC	O	and	_	0	SENT_454	[p31l1570t3366r1686b3425],
15	deoxydaunorubicinol	NN	O	deoxydaunorubicinol	nn	16	SENT_454	[p31l1720t3366r2135b3443, p31l145t3464r433b3523],
16	aglycone	NN	O	aglycone	prep_to	11	SENT_454	[p31l466t3464r747b3539],
17	in	IN	O	in	_	0	SENT_454	[p31l781t3462r840b3521],
18	hepatocytes	NNS	O	hepatocyte	prep_in	16	SENT_454	[p31l874t3464r1256b3541],
19	isolated	VBN	O	isolate	partmod	18	SENT_454	[p31l1288t3464r1541b3523],
20	from	IN	O	from	_	0	SENT_454	[p31l1575t3464r1731b3523],
21	the	DT	O	the	det	22	SENT_454	[p31l1762t3464r1862b3523],
22	rat	NN	O	rat	prep_from	19	SENT_454	[p31l1896t3473r1985b3523],
23	and	CC	O	and	_	0	SENT_454	[p31l2019t3464r2138b3523],
24	the	DT	O	the	det	25	SENT_454	[p31l145t3560r243b3619],
25	rabbit	NN	O	rabbit	prep_from	19	SENT_454	[p31l274t3559r481b3618],
26	.	.	O	.	_	0	SENT_454	[p31l274t3559r481b3618],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	2	SENT_455	[p31l513t3559r800b3619],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_455	[p31l830t3560r1180b3621],
3	1986	CD	DATE	1986	num	2	SENT_455	[p31l1214t3559r1749b3632],
4	;	:	O	;	_	0	SENT_455	[p31l1214t3559r1749b3632],
5	35:4059	CD	NUMBER	35:4059	num	6	SENT_455	[p31l1214t3559r1749b3632],
6	~	NN	O	~	dep	2	SENT_455	[p31l1214t3559r1749b3632],
7	64	CD	NUMBER	64	dep	6	SENT_455	[p31l1214t3559r1749b3632],
8	.	.	O	.	_	0	SENT_455	[p31l1214t3559r1749b3632],

1	Cusack	NNP	ORGANIZATION	Cusack	nn	2	SENT_456	[p31l147t3658r379b3717],
2	BJ	NNP	ORGANIZATION	BJ	_	0	SENT_456	[p31l411t3658r511b3726],
3	,	,	O	,	_	0	SENT_456	[p31l411t3658r511b3726],
4	Mushlin	NNP	ORGANIZATION	Mushlin	nn	5	SENT_456	[p31l547t3654r814b3717],
5	PS	NNP	ORGANIZATION	PS	dep	2	SENT_456	[p31l848t3658r949b3728],
6	,	,	O	,	_	0	SENT_456	[p31l848t3658r949b3728],
7	Voulelis	NNP	O	Voulelis	nn	8	SENT_456	[p31l985t3656r1254b3717],
8	LD	NNP	O	LD	appos	5	SENT_456	[p31l1290t3658r1414b3726],
9	,	,	O	,	_	0	SENT_456	[p31l1290t3658r1414b3726],
10	Li	NNP	PERSON	Li	nn	11	SENT_456	[p31l1450t3658r1515b3717],
11	X	NNP	PERSON	X	appos	5	SENT_456	[p31l1549t3661r1622b3728],
12	,	,	O	,	_	0	SENT_456	[p31l1549t3661r1622b3728],
13	Boucek	NNP	PERSON	Boucek	nn	15	SENT_456	[p31l1658t3658r1904b3717],
14	RJ	NN	PERSON	rj	nn	15	SENT_456	[p31l1938t3658r2027b3717],
15	Jr	NNP	PERSON	Jr	appos	5	SENT_456	[p31l2058t3658r2135b3726],
16	,	,	O	,	_	0	SENT_456	[p31l2058t3658r2135b3726],

1	and	CC	O	and	_	0	SENT_457	[p32l145t20r261b77],
2	Olson	NNP	PERSON	Olson	nn	3	SENT_457	[p32l295t21r488b80],
3	RD.	NNP	O	RD.	dep	1	SENT_457	[p32l522t21r655b80],
4	.	.	O	.	_	0	SENT_457	[p32l522t21r655b80],

1	Daunorubicin-induced	JJ	O	daunorubicin-induced	amod	3	SENT_458	[p32l689t20r1427b80],
2	cardiac	JJ	O	cardiac	amod	3	SENT_458	[p32l1461t21r1694b80],
3	injury	NN	O	injury	_	0	SENT_458	[p32l1725t20r1913b99],
4	in	IN	O	in	_	0	SENT_458	[p32l1945t23r2003b80],
5	the	DT	O	the	det	6	SENT_458	[p32l2037t20r2138b77],
6	rabbit	NN	O	rabbit	prep_in	3	SENT_458	[p32l147t118r354b177],
7	:	:	O	:	_	0	SENT_458	[p32l147t118r354b177],
8	a	DT	O	a	det	9	SENT_458	[p32l395t137r428b177],
9	role	NN	O	role	dep	3	SENT_458	[p32l462t118r588b174],
10	for	IN	O	for	_	0	SENT_458	[p32l624t118r717b177],
11	daunorubicinol	NN	O	daunorubicinol	prep_for	9	SENT_458	[p32l753t115r1282b177],
12	?	.	O	?	_	0	SENT_458	[p32l753t115r1282b177],

1	Toxicol	NNP	O	Toxicol	nn	3	SENT_459	[p32l1318t118r1559b177],
2	Appl	NNP	O	Appl	nn	3	SENT_459	[p32l1593t118r1756b195],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_459	[p32l1787t118r2138b177],
4	1993	CD	DATE	1993	num	3	SENT_459	[p32l152t213r687b285],
5	;	:	O	;	_	0	SENT_459	[p32l152t213r687b285],
6	118:177	CD	NUMBER	118:177	number	7	SENT_459	[p32l152t213r687b285],
7	-85	CD	NUMBER	-85	dep	3	SENT_459	[p32l152t213r687b285],
8	.	.	O	.	_	0	SENT_459	[p32l152t213r687b285],

1	Galettis	NNP	PERSON	Galettis	nn	2	SENT_460	[p32l147t312r400b371],
2	P	NN	PERSON	p	_	0	SENT_460	[p32l436t312r498b380],
3	,	,	O	,	_	0	SENT_460	[p32l436t312r498b380],
4	Boutagy	JJ	PERSON	boutagy	amod	5	SENT_460	[p32l534t312r803b389],
5	J	NN	PERSON	j	appos	2	SENT_460	[p32l834t312r884b382],
6	,	,	O	,	_	0	SENT_460	[p32l834t312r884b382],
7	Ma	NNP	O	Ma	nn	8	SENT_460	[p32l922t312r1030b371],
8	DD	NNP	O	DD	appos	5	SENT_460	[p32l1063t312r1201b371],
9	.	.	O	.	_	0	SENT_460	[p32l1063t312r1201b371],

1	Daunorubicin	NN	O	daunorubicin	nn	2	SENT_461	[p32l1239t312r1694b371],
2	pharmacol	NN	O	pharmacol	_	0	SENT_461	[p32l1727t309r2138b387, p32l145t407r331b468],
3	<	JJR	O	<	amod	4	SENT_461	[p32l1727t309r2138b387, p32l145t407r331b468],
4	inetics	NNS	O	inetic	dep	2	SENT_461	[p32l1727t309r2138b387, p32l145t407r331b468],
5	and	CC	O	and	_	0	SENT_461	[p32l362t407r479b468],
6	the	DT	O	the	det	7	SENT_461	[p32l510t409r611b465],
7	correlation	NN	O	correlation	dep	2	SENT_461	[p32l642t407r1000b468],
8	with	IN	O	with	_	0	SENT_461	[p32l1026t407r1166b468],
9	P	NN	O	p	prep_with	7	SENT_461	[p32l1198t409r1673b484],
10	—	CD	NUMBER	—	num	9	SENT_461	[p32l1198t409r1673b484],
11	glycoprotein	NN	O	glycoprotein	dep	2	SENT_461	[p32l1198t409r1673b484],
12	and	CC	O	and	_	0	SENT_461	[p32l1704t409r1823b465],
13	response	NN	O	response	conj_and	11	SENT_461	[p32l1852t425r2138b486],
14	in	IN	O	in	_	0	SENT_461	[p32l147t505r206b564],
15	patients	NNS	O	patient	prep_in	11	SENT_461	[p32l231t507r488b582],
16	with	IN	O	with	_	0	SENT_461	[p32l510t505r652b564],
17	acute	JJ	O	acute	amod	18	SENT_461	[p32l679t514r849b564],
18	leukaemia	NN	O	leukaemia	prep_with	15	SENT_461	[p32l876t505r1226b564],
19	.	.	O	.	_	0	SENT_461	[p32l876t505r1226b564],

1	Br	NN	O	br	nn	3	SENT_462	[p32l1255t507r1335b564],
2	J	NN	O	j	nn	3	SENT_462	[p32l1357t504r1391b566],
3	Cancer	NN	O	cancer	_	0	SENT_462	[p32l1417t505r1650b564],
4	1994	CD	DATE	1994	dep	3	SENT_462	[p32l1676t504r2138b575],
5	;	:	O	;	_	0	SENT_462	[p32l1676t504r2138b575],
6	70:324	CD	NUMBER	70:324	number	7	SENT_462	[p32l1676t504r2138b575],
7	—	CD	NUMBER	—	dep	3	SENT_462	[p32l1676t504r2138b575],
8	9	CD	NUMBER	9	dep	7	SENT_462	[p32l1676t504r2138b575],
9	.	.	O	.	_	0	SENT_462	[p32l1676t504r2138b575],

1	Ramot	NN	O	ramot	nn	2	SENT_463	[p32l147t603r370b664],
2	B	NN	O	b	_	0	SENT_463	[p32l404t605r470b673],
3	,	,	O	,	_	0	SENT_463	[p32l404t605r470b673],
4	Fisher	NNP	PERSON	Fisher	nn	5	SENT_463	[p32l506t602r710b662],
5	S	NNP	O	S	appos	2	SENT_463	[p32l744t602r798b673],
6	,	,	O	,	_	0	SENT_463	[p32l744t602r798b673],
7	Szeinberg	NNP	LOCATION	Szeinberg	nn	8	SENT_463	[p32l834t602r1152b680],
8	A	NNP	O	A	appos	2	SENT_463	[p32l1184t605r1259b673],
9	,	,	O	,	_	0	SENT_463	[p32l1184t605r1259b673],
10	et	FW	O	et	nn	11	SENT_463	[p32l1295t612r1354b662],
11	al.	FW	O	al.	appos	2	SENT_463	[p32l1389t603r1458b662],
12	.	.	O	.	_	0	SENT_463	[p32l1389t603r1458b662],

1	A	DT	O	a	det	2	SENT_464	[p32l1491t605r1555b662],
2	study	NN	O	study	_	0	SENT_464	[p32l1584t603r1756b678],
3	of	IN	O	of	_	0	SENT_464	[p32l1787t602r1856b662],
4	subjects	NNS	O	subject	prep_of	2	SENT_464	[p32l1885t603r2138b680],
5	with	IN	O	with	_	0	SENT_464	[p32l145t701r285b760],
6	erythrocyte	NN	O	erythrocyte	nn	9	SENT_464	[p32l332t701r699b779],
7	glucose-6-phosphate	NN	O	glucose-6-phosphate	nn	9	SENT_464	[p32l746t701r1414b779],
8	dehydrogenase	NN	O	dehydrogenase	nn	9	SENT_464	[p32l1461t701r1948b779],
9	deﬁciency	NN	O	deﬁciency	prep_with	2	SENT_464	[p32l1998t698r2140b757, p32l149t800r363b875],
10	.	.	O	.	_	0	SENT_464	[p32l1998t698r2140b757, p32l149t800r363b875],

1	II	NNP	O	II	_	0	SENT_465	[p32l397t800r470b859],
2	.	.	O	.	_	0	SENT_465	[p32l397t800r470b859],

1	Investigation	NN	O	investigation	_	0	SENT_466	[p32l504t800r926b877],
2	of	IN	O	of	_	0	SENT_466	[p32l957t800r1025b859],
3	leukocyte	NN	O	leukocyte	nn	4	SENT_466	[p32l1052t799r1360b877],
4	enzymes	NNS	O	enzyme	prep_of	1	SENT_466	[p32l1394t816r1684b875],
5	.	.	O	.	_	0	SENT_466	[p32l1394t816r1684b875],

1	J	NNP	O	J	nn	3	SENT_467	[p32l1718t800r1749b856],
2	Clin	NNP	O	Clin	nn	3	SENT_467	[p32l1780t799r1916b859],
3	Invest	NNP	O	Invest	_	0	SENT_467	[p32l1947t802r2140b859],
4	1959	CD	DATE	1959	num	3	SENT_467	[p32l152t897r650b968],
5	;	:	O	;	_	0	SENT_467	[p32l152t897r650b968],
6	38:2234	CD	NUMBER	38:2234	number	7	SENT_467	[p32l152t897r650b968],
7	-7	CD	NUMBER	-7	dep	3	SENT_467	[p32l152t897r650b968],
8	.	.	O	.	_	0	SENT_467	[p32l152t897r650b968],

1	Ramot	NN	O	ramot	nn	2	SENT_468	[p32l152t996r373b1055],
2	B	NN	O	b	_	0	SENT_468	[p32l404t998r472b1067],
3	,	,	O	,	_	0	SENT_468	[p32l404t998r472b1067],
4	Szeinberg	NN	O	szeinberg	nn	5	SENT_468	[p32l506t996r826b1071],
5	A	NN	O	a	appos	2	SENT_468	[p32l855t996r930b1067],
6	,	,	O	,	_	0	SENT_468	[p32l855t996r930b1067],
7	Adam	NNP	PERSON	Adam	nn	8	SENT_468	[p32l962t996r1164b1055],
8	A	NNP	O	A	appos	2	SENT_468	[p32l1193t996r1268b1067],
9	,	,	O	,	_	0	SENT_468	[p32l1193t996r1268b1067],
10	et	FW	O	et	nn	11	SENT_468	[p32l1304t1005r1363b1055],
11	al.	FW	O	al.	appos	2	SENT_468	[p32l1396t994r1465b1053],
12	.	.	O	.	_	0	SENT_468	[p32l1396t994r1465b1053],

1	A	DT	O	a	det	2	SENT_469	[p32l1498t996r1559b1053],
2	study	NN	O	study	_	0	SENT_469	[p32l1589t994r1761b1071],
3	of	IN	O	of	_	0	SENT_469	[p32l1792t994r1860b1053],
4	subjects	NNS	O	subject	prep_of	2	SENT_469	[p32l1887t993r2142b1071],
5	with	IN	O	with	_	0	SENT_469	[p32l145t1093r285b1149],
6	erythrocyte	NN	O	erythrocyte	nn	7	SENT_469	[p32l332t1091r699b1168],
7	glucose	NN	O	glucose	prep_with	2	SENT_469	[p32l746t1091r1416b1171],
8	—	CD	NUMBER	—	num	11	SENT_469	[p32l746t1091r1416b1171],
9	6-phosphate	NN	O	6-phosphate	nn	11	SENT_469	[p32l746t1091r1416b1171],
10	dehydrogenase	NN	O	dehydrogenase	nn	11	SENT_469	[p32l1463t1091r1950b1168],
11	deﬁciency	NN	O	deﬁciency	dep	7	SENT_469	[p32l1998t1091r2142b1147, p32l149t1190r366b1267],
12	.	.	O	.	_	0	SENT_469	[p32l1998t1091r2142b1147, p32l149t1190r366b1267],

1	Investigation	NN	O	investigation	_	0	SENT_470	[p32l395t1190r817b1267],
2	of	IN	O	of	_	0	SENT_470	[p32l843t1190r912b1249],
3	platelet	NN	O	platelet	nn	4	SENT_470	[p32l934t1190r1178b1267],
4	enzymes	NNS	O	enzyme	prep_of	1	SENT_470	[p32l1207t1209r1497b1265],
5	.	.	O	.	_	0	SENT_470	[p32l1207t1209r1497b1265],

1	J	NNP	O	J	nn	3	SENT_471	[p32l1526t1192r1559b1249],
2	Clin	NNP	O	Clin	nn	3	SENT_471	[p32l1588t1190r1719b1249],
3	Invest	NNP	O	Invest	_	0	SENT_471	[p32l1748t1190r1943b1249],
4	1959	CD	DATE	1959	num	3	SENT_471	[p32l1975t1188r2138b1258],
5	;	:	O	;	_	0	SENT_471	[p32l1975t1188r2138b1258],
6	821659-61	CD	NUMBER	821659-61	dep	3	SENT_471	[p32l149t1287r477b1345],
7	.	.	O	.	_	0	SENT_471	[p32l149t1287r477b1345],

1	Brunetti	NNP	PERSON	Brunetti	nn	2	SENT_472	[p32l150t1384r423b1443],
2	P	NN	PERSON	p	_	0	SENT_472	[p32l450t1384r509b1452],
3	,	,	O	,	_	0	SENT_472	[p32l450t1384r509b1452],
4	Rosetti	NNP	PERSON	Rosetti	nn	5	SENT_472	[p32l541t1381r775b1443],
5	R	NNP	PERSON	R	conj_and	2	SENT_472	[p32l804t1384r875b1454],
6	,	,	O	,	_	0	SENT_472	[p32l804t1384r875b1454],
7	and	CC	O	and	_	0	SENT_472	[p32l906t1384r1023b1443],
8	Broccia	NNP	LOCATION	Broccia	nn	11	SENT_472	[p32l1049t1384r1298b1443],
9	G.	NNP	O	G.	nn	11	SENT_472	[p32l1327t1384r1400b1443],
10	New	NNP	O	New	nn	11	SENT_472	[p32l1429t1384r1578b1441],
11	contributions	NNS	O	contribution	conj_and	2	SENT_472	[p32l1605t1382r2034b1443],
12	on	IN	O	on	_	0	SENT_472	[p32l2063t1400r2145b1440],
13	the	DT	O	the	det	14	SENT_472	[p32l150t1482r250b1539],
14	subject	NN	O	subject	prep_on	11	SENT_472	[p32l318t1482r544b1557],
15	of	IN	O	of	_	0	SENT_472	[p32l608t1482r676b1539],
16	bioenzymology	NN	O	bioenzymology	prep_of	14	SENT_472	[p32l735t1480r1224b1557],
17	of	IN	O	of	_	0	SENT_472	[p32l1288t1482r1356b1539],
18	ictero-hemoglobinuric	JJ	O	ictero-hemoglobinuric	amod	19	SENT_472	[p32l1417t1480r2145b1555],
19	favism	NN	O	favism	prep_of	16	SENT_472	[p32l152t1578r377b1639],
20	.	.	O	.	_	0	SENT_472	[p32l152t1578r377b1639],

1	Note	VB	O	note	_	0	SENT_473	[p32l406t1578r567b1637],
2	III	NNP	O	III	dobj	1	SENT_473	[p32l598t1580r699b1637],
3	.	.	O	.	_	0	SENT_473	[p32l598t1580r699b1637],

1	Glucose-6-phosphate	JJ	O	glucose-6-phosphate	amod	3	SENT_474	[p32l732t1578r1423b1655],
2	dehydrogenase	NN	O	dehydrogenase	nn	3	SENT_474	[p32l1454t1578r1941b1653],
3	activity	NN	O	activity	_	0	SENT_474	[p32l1972t1576r2145b1637, p32l152t1676r232b1751],
4	of	IN	O	of	_	0	SENT_474	[p32l249t1676r317b1735],
5	hepatic	JJ	O	hepatic	amod	6	SENT_474	[p32l332t1676r571b1755],
6	parenchyme	NN	O	parenchyme	prep_of	3	SENT_474	[p32l589t1676r1002b1753],
7	.	.	O	.	_	0	SENT_474	[p32l589t1676r1002b1753],

1	Rassegna	NNP	PERSON	Rassegna	nn	4	SENT_475	[p32l1026t1678r1335b1751],
2	di	FW	O	di	nn	4	SENT_475	[p32l1355t1676r1414b1735],
3	Fisiopatologia	NNP	PERSON	Fisiopatologia	nn	4	SENT_475	[p32l1434t1674r1897b1753],
4	Clinica	NNP	PERSON	Clinica	_	0	SENT_475	[p32l1919t1673r2145b1735],
5	e	SYM	O	e	dep	6	SENT_475	[p32l152t1791r185b1832],
6	Terapeutica	FW	O	terapeutica	dep	4	SENT_475	[p32l214t1773r606b1850],
7	1960	CD	DATE	1960	dep	6	SENT_475	[p32l640t1772r1136b1843],
8	;	:	O	;	_	0	SENT_475	[p32l640t1772r1136b1843],
9	32:338	CD	NUMBER	32:338	dep	4	SENT_475	[p32l640t1772r1136b1843],
10	-50	CD	NUMBER	-50	rcmod	9	SENT_475	[p32l640t1772r1136b1843],
11	.	.	O	.	_	0	SENT_475	[p32l640t1772r1136b1843],

1	Gartler	NNP	O	Gartler	nn	2	SENT_476	[p32l152t1872r391b1931],
2	SM	NNP	O	SM	_	0	SENT_476	[p32l425t1872r553b1943],
3	,	,	O	,	_	0	SENT_476	[p32l425t1872r553b1943],
4	Gandini	NNP	PERSON	Gandini	nn	5	SENT_476	[p32l589t1870r854b1931],
5	E	NNP	O	E	appos	2	SENT_476	[p32l888t1872r956b1943],
6	,	,	O	,	_	0	SENT_476	[p32l888t1872r956b1943],
7	Ceppelini	NNP	O	Ceppelini	nn	8	SENT_476	[p32l992t1872r1307b1947],
8	R.	NNP	O	R.	appos	2	SENT_476	[p32l1341t1874r1414b1929],
9	G1ucose	NN	O	g1ucose	dep	8	SENT_476	[p32l1452t1870r2142b1948],
10	—	CD	NUMBER	—	number	11	SENT_476	[p32l1452t1870r2142b1948],
11	6	CD	NUMBER	6	dep	2	SENT_476	[p32l1452t1870r2142b1948],
12	—	NN	O	—	nn	14	SENT_476	[p32l1452t1870r2142b1948],
13	phosphate	NN	O	phosphate	nn	14	SENT_476	[p32l1452t1870r2142b1948],
14	dehydrogenase	NN	O	dehydrogenase	dep	11	SENT_476	[p32l154t1967r641b2044],
15	deﬁcient	JJ	O	deﬁcient	amod	16	SENT_476	[p32l675t1965r955b2028],
16	mutant	NN	O	mutant	dep	2	SENT_476	[p32l987t1976r1219b2028],
17	in	IN	O	in	_	0	SENT_476	[p32l1253t1967r1312b2026],
18	human	JJ	O	human	amod	20	SENT_476	[p32l1346t1967r1569b2026],
19	cell	NN	O	cell	nn	20	SENT_476	[p32l1602t1967r1712b2026],
20	culture	NN	O	culture	prep_in	16	SENT_476	[p32l1748t1967r1990b2026],
21	.	.	O	.	_	0	SENT_476	[p32l1748t1967r1990b2026],

1	Na	NN	O	na	_	0	SENT_477	[p32l2026t1967r2145b2023, p32l152t2074r282b2124],
2	.	.	O	.	_	0	SENT_477	[p32l2026t1967r2145b2023, p32l152t2074r282b2124],

1	ture	NN	O	ture	_	0	SENT_478	[p32l2026t1967r2145b2023, p32l152t2074r282b2124],
2	1962	CD	DATE	1962	num	1	SENT_478	[p32l316t2064r814b2135],
3	;	:	O	;	_	0	SENT_478	[p32l316t2064r814b2135],
4	193:602	CD	NUMBER	193:602	number	5	SENT_478	[p32l316t2064r814b2135],
5	-3	CD	NUMBER	-3	dep	1	SENT_478	[p32l316t2064r814b2135],
6	.	.	O	.	_	0	SENT_478	[p32l316t2064r814b2135],

1	Ninfali	JJ	PERSON	ninfali	amod	2	SENT_479	[p32l152t2164r375b2223],
2	P	NN	PERSON	p	_	0	SENT_479	[p32l409t2167r470b2235],
3	,	,	O	,	_	0	SENT_479	[p32l409t2167r470b2235],
4	Bresolin	NNP	PERSON	Bresolin	nn	5	SENT_479	[p32l506t2164r777b2223],
5	N	NNP	PERSON	N	appos	2	SENT_479	[p32l811t2164r884b2232],
6	,	,	O	,	_	0	SENT_479	[p32l811t2164r884b2232],
7	Baronciani	NNP	PERSON	Baronciani	nn	8	SENT_479	[p32l920t2162r1275b2223],
8	L	NNP	PERSON	L	appos	2	SENT_479	[p32l1309t2164r1374b2235],
9	,	,	O	,	_	0	SENT_479	[p32l1309t2164r1374b2235],
10	et	FW	O	et	nn	11	SENT_479	[p32l1408t2171r1469b2221],
11	al.	FW	O	al.	appos	2	SENT_479	[p32l1503t2162r1573b2221],
12	.	.	O	.	_	0	SENT_479	[p32l1503t2162r1573b2221],

1	Glucose	NN	O	glucose	_	0	SENT_480	[p32l1612t2159r2145b2239, p32l154t2260r336b2337],
2	—	CD	NUMBER	—	number	3	SENT_480	[p32l1612t2159r2145b2239, p32l154t2260r336b2337],
3	6	CD	NUMBER	6	num	7	SENT_480	[p32l1612t2159r2145b2239, p32l154t2260r336b2337],
4	—	NN	O	—	nn	7	SENT_480	[p32l1612t2159r2145b2239, p32l154t2260r336b2337],
5	phosphate	NN	O	phosphate	nn	7	SENT_480	[p32l1612t2159r2145b2239, p32l154t2260r336b2337],
6	dehydrogenase	NN	O	dehydrogenase	nn	7	SENT_480	[p32l365t2260r851b2337],
7	Lodi844C	NN	O	lodi844c	dep	1	SENT_480	[p32l881t2259r1217b2321],
8	:	:	O	:	_	0	SENT_480	[p32l881t2259r1217b2321],
9	a	DT	O	a	det	10	SENT_480	[p32l1251t2278r1284b2319],
10	study	NN	O	study	dep	1	SENT_480	[p32l1313t2260r1483b2335],
11	on	IN	O	on	_	0	SENT_480	[p32l1510t2278r1590b2319],
12	its	PRP$	O	its	poss	13	SENT_480	[p32l1618t2260r1689b2319],
13	expression	NN	O	expression	prep_on	10	SENT_480	[p32l1718t2260r2059b2335],
14	in	IN	O	in	_	0	SENT_480	[p32l2088t2260r2147b2316],
15	blood	NN	O	blood	nn	16	SENT_480	[p32l152t2358r338b2417],
16	cells	NNS	O	cell	prep_in	13	SENT_480	[p32l367t2357r505b2419],
17	and	CC	O	and	_	0	SENT_480	[p32l536t2358r652b2417],
18	muscle	NN	O	muscle	prep_in	13	SENT_480	[p32l682t2358r921b2417],
19	.	.	O	.	_	0	SENT_480	[p32l682t2358r921b2417],

1	Enzyme	NN	O	enzyme	_	0	SENT_481	[p32l952t2360r1215b2435],
2	1991	CD	DATE	1991	num	1	SENT_481	[p32l1248t2357r1668b2428],
3	;	:	O	;	_	0	SENT_481	[p32l1248t2357r1668b2428],
4	5:180	CD	NUMBER	5:180	number	5	SENT_481	[p32l1248t2357r1668b2428],
5	-7	CD	NUMBER	-7	dep	1	SENT_481	[p32l1248t2357r1668b2428],
6	.	.	O	.	_	0	SENT_481	[p32l1248t2357r1668b2428],

1	Ramot	NN	O	ramot	nn	2	SENT_482	[p32l154t2458r377b2515],
2	B	NN	O	b	_	0	SENT_482	[p32l404t2458r472b2529],
3	,	,	O	,	_	0	SENT_482	[p32l404t2458r472b2529],
4	Sheba	NN	ORGANIZATION	sheba	nn	5	SENT_482	[p32l501t2456r697b2515],
5	C	NN	ORGANIZATION	c	appos	2	SENT_482	[p32l728t2456r794b2526],
6	,	,	O	,	_	0	SENT_482	[p32l728t2456r794b2526],
7	Adam	NNP	PERSON	Adam	nn	8	SENT_482	[p32l820t2456r1023b2515],
8	A	NNP	PERSON	A	appos	2	SENT_482	[p32l1047t2458r1122b2526],
9	,	,	O	,	_	0	SENT_482	[p32l1047t2458r1122b2526],
10	Ashkenasi	NNP	O	Ashkenasi	nn	13	SENT_482	[p32l1149t2456r1488b2515],
11	I.	NNP	O	I.	nn	13	SENT_482	[p32l1517t2456r1557b2515],
12	Erythrocyte	NN	O	erythrocyte	nn	13	SENT_482	[p32l1588t2456r1971b2534],
13	Glucose-6-phosphate	NN	O	glucose-6-phosphate	appos	2	SENT_482	[p32l2000t2454r2145b2512, p32l156t2554r724b2631],
14	dehydrogenase	NN	O	dehydrogenase	nn	16	SENT_482	[p32l758t2552r1245b2629],
15	deﬁcient	JJ	O	deﬁcient	amod	16	SENT_482	[p32l1281t2552r1559b2613],
16	subjects	NNS	O	subject	dep	13	SENT_482	[p32l1593t2552r1865b2629],
17	:	:	O	:	_	0	SENT_482	[p32l1593t2552r1865b2629],
18	enzyme	NN	O	enzyme	nn	19	SENT_482	[p32l1905t2570r2147b2627],
19	level	NN	O	level	dep	2	SENT_482	[p32l156t2649r303b2707],
20	in	IN	O	in	_	0	SENT_482	[p32l335t2651r393b2710],
21	saliva	NN	O	saliva	prep_in	19	SENT_482	[p32l422t2649r616b2710],
22	.	.	O	.	_	0	SENT_482	[p32l422t2649r616b2710],

1	Nature	NNP	O	Nature	_	0	SENT_483	[p32l647t2651r875b2710],
2	1960	CD	DATE	1960	num	1	SENT_483	[p32l908t2648r1342b2722],
3	;	:	O	;	_	0	SENT_483	[p32l908t2648r1342b2722],
4	185:931	CD	NUMBER	185:931	dep	1	SENT_483	[p32l908t2648r1342b2722],
5	.	.	O	.	_	0	SENT_483	[p32l908t2648r1342b2722],

1	Chan	NNP	PERSON	Chan	nn	2	SENT_484	[p32l156t2748r329b2805],
2	TK	NN	O	tk	_	0	SENT_484	[p32l351t2748r474b2819],
3	,	,	O	,	_	0	SENT_484	[p32l351t2748r474b2819],
4	Todd	NNP	PERSON	Todd	nn	5	SENT_484	[p32l499t2746r671b2805],
5	D	NNP	PERSON	D	appos	2	SENT_484	[p32l698t2748r773b2819],
6	,	,	O	,	_	0	SENT_484	[p32l698t2748r773b2819],
7	Wong	NNP	PERSON	Wong	nn	8	SENT_484	[p32l800t2746r995b2823],
8	CC	NN	O	cc	appos	5	SENT_484	[p32l1019t2746r1141b2807],
9	.	.	O	.	_	0	SENT_484	[p32l1019t2746r1141b2807],

1	Tissue	NN	O	tissue	nn	3	SENT_485	[p32l1167t2746r1374b2805],
2	enzyme	NN	O	enzyme	nn	3	SENT_485	[p32l1399t2765r1645b2821],
3	levels	NNS	O	level	nsubj	6	SENT_485	[p32l1669t2746r1849b2805],
4	in	IN	O	in	_	0	SENT_485	[p32l1873t2746r1932b2805],
5	erythrocyte	NN	O	erythrocyte	prep_in	3	SENT_485	[p32l1959t2743r2147b2819, p32l156t2853r354b2921],
6	glucose	NN	O	glucose	_	0	SENT_485	[p32l383t2846r1053b2923],
7	—	CD	NUMBER	—	num	10	SENT_485	[p32l383t2846r1053b2923],
8	6-phosphate	NN	O	6-phosphate	nn	10	SENT_485	[p32l383t2846r1053b2923],
9	dehydrogenase	NN	O	dehydrogenase	nn	10	SENT_485	[p32l1082t2844r1569b2921],
10	deﬁciency	NN	O	deﬁciency	dobj	6	SENT_485	[p32l1598t2844r1936b2919],
11	.	.	O	.	_	0	SENT_485	[p32l1598t2844r1936b2919],

1	J	NN	O	j	nn	4	SENT_486	[p32l1965t2846r1997b2902],
2	Lab	NN	O	lab	nn	4	SENT_486	[p32l2026t2844r2149b2900],
3	Clin	NNP	O	Clin	nn	4	SENT_486	[p32l159t2941r292b3001],
4	Med	NNP	O	Med	_	0	SENT_486	[p32l321t2944r470b3001],
5	1965	CD	DATE	1965	num	4	SENT_486	[p32l503t2941r1000b3013],
6	;	:	O	;	_	0	SENT_486	[p32l503t2941r1000b3013],
7	66:937	CD	NUMBER	66:937	number	8	SENT_486	[p32l503t2941r1000b3013],
8	—	CD	NUMBER	—	dep	4	SENT_486	[p32l503t2941r1000b3013],
9	42	CD	NUMBER	42	dep	8	SENT_486	[p32l503t2941r1000b3013],
10	.	.	O	.	_	0	SENT_486	[p32l503t2941r1000b3013],

1	Oluboyede	JJ	O	oluboyede	amod	2	SENT_487	[p32l156t3041r511b3116],
2	OA	NN	O	oa	nsubj	13	SENT_487	[p32l545t3041r678b3112],
3	,	,	O	,	_	0	SENT_487	[p32l545t3041r678b3112],
4	Esan	NNP	ORGANIZATION	Esan	nn	5	SENT_487	[p32l712t3043r870b3100],
5	GJF	NNP	ORGANIZATION	GJF	appos	2	SENT_487	[p32l901t3041r1060b3112],
6	,	,	O	,	_	0	SENT_487	[p32l901t3041r1060b3112],
7	Francis	NNP	PERSON	Francis	nn	8	SENT_487	[p32l1093t3041r1330b3100],
8	TI	NNP	PERSON	TI	appos	2	SENT_487	[p32l1359t3041r1455b3109],
9	,	,	O	,	_	0	SENT_487	[p32l1359t3041r1455b3109],
10	Luzzatto	NNP	PERSON	Luzzatto	nn	11	SENT_487	[p32l1489t3041r1772b3098],
11	L.	NNP	O	L.	appos	2	SENT_487	[p32l1804t3041r1867b3098],
12	Genetically	RB	O	genetically	advmod	13	SENT_487	[p32l1901t3038r2147b3098, p32l157t3137r303b3215],
13	determined	VBD	O	determine	_	0	SENT_487	[p32l328t3137r703b3198],
14	deﬁciency	NN	O	deﬁciency	dobj	13	SENT_487	[p32l730t3137r1053b3215],
15	of	IN	O	of	_	0	SENT_487	[p32l1077t3137r1145b3196],
16	glucose	NN	O	glucose	nn	18	SENT_487	[p32l1165t3137r1407b3212],
17	6-phosphate	NN	O	6-phosphate	nn	18	SENT_487	[p32l1433t3137r1832b3215],
18	dehydrogenase	NN	O	dehydrogenase	prep_of	14	SENT_487	[p32l1859t3135r2149b3212, p32l156t3254r375b3310],
19	(	CD	NUMBER	(	num	20	SENT_487	[p32l413t3235r574b3313],
20	type	NN	O	type	tmod	13	SENT_487	[p32l413t3235r574b3313],
21	A	DT	O	a	det	23	SENT_487	[p32l608t3235r717b3310],
22	—	NN	O	—	nn	23	SENT_487	[p32l608t3235r717b3310],
23	)	NN	O	)	nsubjpass	25	SENT_487	[p32l608t3235r717b3310],
24	is	VBZ	O	be	auxpass	25	SENT_487	[p32l753t3237r801b3294],
25	expressed	VBN	O	express	rcmod	20	SENT_487	[p32l834t3235r1150b3310],
26	in	IN	O	in	_	0	SENT_487	[p32l1186t3235r1245b3291],
27	the	DT	O	the	det	28	SENT_487	[p32l1278t3235r1381b3294],
28	liver	NN	O	liver	prep_in	25	SENT_487	[p32l1415t3233r1571b3291],
29	.	.	O	.	_	0	SENT_487	[p32l1415t3233r1571b3291],

1	J	NN	O	j	nn	4	SENT_488	[p32l1607t3235r1640b3291],
2	Lab	NN	O	lab	nn	4	SENT_488	[p32l1674t3233r1798b3292],
3	Clin	NNP	O	Clin	nn	4	SENT_488	[p32l1834t3235r1969b3291],
4	Med	NNP	O	Med	_	0	SENT_488	[p32l2002t3233r2149b3291],
5	1979	CD	DATE	1979	num	4	SENT_488	[p32l161t3333r620b3403],
6	;	:	O	;	_	0	SENT_488	[p32l161t3333r620b3403],
7	93:783	CD	NUMBER	93:783	number	8	SENT_488	[p32l161t3333r620b3403],
8	—	CD	NUMBER	—	dep	4	SENT_488	[p32l161t3333r620b3403],
9	9	CD	NUMBER	9	dep	8	SENT_488	[p32l161t3333r620b3403],
10	.	.	O	.	_	0	SENT_488	[p32l161t3333r620b3403],

1	Kuffel	NNP	PERSON	Kuffel	nn	2	SENT_489	[p32l156t3430r354b3489],
2	MJ	NNP	PERSON	MJ	_	0	SENT_489	[p32l390t3430r511b3498],
3	,	,	O	,	_	0	SENT_489	[p32l390t3430r511b3498],
4	Reid	NNP	PERSON	Reid	nn	5	SENT_489	[p32l550t3430r706b3486],
5	JM	NN	O	jm	appos	2	SENT_489	[p32l739t3430r863b3498],
6	,	,	O	,	_	0	SENT_489	[p32l739t3430r863b3498],
7	Arnes	NNP	O	Arnes	nn	8	SENT_489	[p32l897t3430r1085b3488],
8	MM	NN	O	mm	appos	5	SENT_489	[p32l1123t3430r1282b3486],
9	.	.	O	.	_	0	SENT_489	[p32l1123t3430r1282b3486],

1	Anthracyclines	NNS	O	anthracycline	_	0	SENT_490	[p32l1318t3428r1805b3502],
2	and	CC	O	and	_	0	SENT_490	[p32l1843t3428r1960b3486],
3	their	PRP$	O	they	poss	6	SENT_490	[p32l1998t3428r2152b3486],
4	C-13	NN	MISC	c-13	nn	6	SENT_490	[p32l159t3530r308b3587],
5	alcohol	NN	O	alcohol	nn	6	SENT_490	[p32l342t3530r576b3589],
6	metabolites	NNS	O	metabolite	conj_and	1	SENT_490	[p32l605t3530r1002b3587],
7	:	:	O	:	_	0	SENT_490	[p32l605t3530r1002b3587],
8	growth	NN	O	growth	nn	9	SENT_490	[p32l1033t3530r1259b3606],
9	inhibition	NN	O	inhibition	dep	1	SENT_490	[p32l1290t3527r1603b3587],
10	and	CC	O	and	_	0	SENT_490	[p32l1635t3528r1751b3587],
11	DNA	NN	O	dna	nn	12	SENT_490	[p32l1780t3530r1960b3587],
12	damage	NN	O	damage	dep	1	SENT_490	[p32l1989t3530r2152b3585, p32l159t3642r266b3698],
13	following	VBG	O	follow	_	0	SENT_490	[p32l295t3624r599b3699],
14	incubation	NN	O	incubation	prep_following	9	SENT_490	[p32l629t3623r969b3685],
15	with	IN	O	with	_	0	SENT_490	[p32l996t3624r1136b3682],
16	human	JJ	O	human	amod	18	SENT_490	[p32l1167t3624r1390b3682],
17	tumor	NN	O	tumor	nn	18	SENT_490	[p32l1420t3633r1620b3682],
18	cells	NNS	O	cell	prep_with	14	SENT_490	[p32l1649t3623r1786b3682],
19	in	IN	O	in	_	0	SENT_490	[p32l1815t3624r1876b3680],
20	culture	NN	O	culture	prep_in	18	SENT_490	[p32l1905t3624r2149b3682],
21	.	.	O	.	_	0	SENT_490	[p32l1905t3624r2149b3682],

1	Cancer	NNP	O	Cancer	nn	3	SENT_491	[p32l159t3723r391b3780],
2	Chemother	NNP	O	Chemother	nn	3	SENT_491	[p32l420t3721r789b3782],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_491	[p32l818t3720r1168b3780],
4	1992	CD	DATE	1992	num	3	SENT_491	[p32l1202t3720r1622b3792],
5	;	:	O	;	_	0	SENT_491	[p32l1202t3720r1622b3792],
6	30:51	CD	NUMBER	30:51	num	7	SENT_491	[p32l1202t3720r1622b3792],
7	—	NN	O	—	dep	3	SENT_491	[p32l1202t3720r1622b3792],
8	7	CD	NUMBER	7	dep	7	SENT_491	[p32l1202t3720r1622b3792],
9	.	.	O	.	_	0	SENT_491	[p32l1202t3720r1622b3792],

1	36	CD	NUMBER	36	_	0	SENT_492	[p33l25t25r116b82],
2	.	.	O	.	_	0	SENT_492	[p33l25t25r116b82],

1	Stone	NNP	O	Stone	nn	2	SENT_493	[p33l161t23r345b80],
2	RM	NN	O	rm	_	0	SENT_493	[p33l386t23r530b91],
3	,	,	O	,	_	0	SENT_493	[p33l386t23r530b91],
4	Mayer	NNP	PERSON	Mayer	nn	5	SENT_493	[p33l573t23r784b98],
5	RJ	NN	PERSON	rj	appos	2	SENT_493	[p33l823t23r928b80],
6	.	.	O	.	_	0	SENT_493	[p33l823t23r928b80],

1	Treatment	NN	O	treatment	_	0	SENT_494	[p33l969t23r1316b82],
2	of	IN	O	of	_	0	SENT_494	[p33l1357t21r1425b82],
3	the	DT	O	the	det	5	SENT_494	[p33l1461t21r1562b80],
4	newly	RB	O	newly	advmod	5	SENT_494	[p33l1602t21r1788b96],
5	diagnosed	VBN	O	diagnose	prep_of	1	SENT_494	[p33l1827t20r2154b96],
6	adult	JJ	O	adult	amod	5	SENT_494	[p33l161t122r324b179],
7	with	IN	O	with	_	0	SENT_494	[p33l348t122r488b181],
8	de	FW	O	de	nn	9	SENT_494	[p33l520t122r595b179],
9	novo	FW	O	novo	prep_with	5	SENT_494	[p33l624t141r777b181],
10	acute	JJ	O	acute	amod	12	SENT_494	[p33l809t129r981b179],
11	myeloid	JJ	O	myeloid	amod	12	SENT_494	[p33l1010t122r1268b197],
12	leukemia	NN	O	leukemia	amod	5	SENT_494	[p33l1297t119r1610b179],
13	.	.	O	.	_	0	SENT_494	[p33l1297t119r1610b179],

1	Hematol	NNP	PERSON	Hematol	nn	4	SENT_495	[p33l1642t120r1927b179],
2	Oncol	NNP	PERSON	Oncol	nn	4	SENT_495	[p33l1956t120r2152b179],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_495	[p33l161t218r294b275],
4	North	NNP	PERSON	North	nsubj	6	SENT_495	[p33l323t219r516b277],
5	Am	VBP	O	be	cop	6	SENT_495	[p33l543t218r664b275],
6	1993	CD	DATE	1993	_	0	SENT_495	[p33l698t218r1120b286],
7	;	:	O	;	_	0	SENT_495	[p33l698t218r1120b286],
8	7:47	CD	TIME	7:47	num	9	SENT_495	[p33l698t218r1120b286],
9	-64	CD	NUMBER	-64	attr	6	SENT_495	[p33l698t218r1120b286],
10	.	.	O	.	_	0	SENT_495	[p33l698t218r1120b286],

1	37	CD	NUMBER	37	_	0	SENT_496	[p33l27t318r116b375],
2	.	.	O	.	_	0	SENT_496	[p33l27t318r116b375],

1	Reid	NNP	PERSON	Reid	nn	2	SENT_497	[p33l161t316r317b375],
2	JM	NN	O	jm	_	0	SENT_497	[p33l365t318r486b387],
3	,	,	O	,	_	0	SENT_497	[p33l365t318r486b387],
4	Pendergrass	NNP	ORGANIZATION	Pendergrass	nn	5	SENT_497	[p33l536t316r930b391],
5	TW	NNP	ORGANIZATION	TW	appos	2	SENT_497	[p33l978t316r1118b384],
6	,	,	O	,	_	0	SENT_497	[p33l978t316r1118b384],
7	Krailo	NNP	O	Krailo	nn	8	SENT_497	[p33l1167t316r1372b373],
8	MD	NNP	O	MD	appos	2	SENT_497	[p33l1422t316r1569b384],
9	,	,	O	,	_	0	SENT_497	[p33l1422t316r1569b384],
10	Hammond	NNP	PERSON	Hammond	nn	11	SENT_497	[p33l1618t313r1969b373],
11	GD	NN	O	gd	appos	2	SENT_497	[p33l2016t314r2154b382],
12	,	,	O	,	_	0	SENT_497	[p33l2016t314r2154b382],
13	598	CD	NUMBER	598	num	16	SENT_497	[p33l15t430r141b491],
14	Amitoi	NNP	O	Amitoi	nn	16	SENT_497	[p33l258t430r511b495],
15	,	,	O	,	_	0	SENT_497	[p33l258t430r511b495],
16	Bhoomo	NNP	PERSON	Bhoomo	appos	2	SENT_497	[p33l550t429r875b493],
17	.	.	O	.	_	0	SENT_497	[p33l550t429r875b493],

1	ond	NN	O	ond	nn	2	SENT_498	[p33l911t430r1057b491],
2	Frischer	NN	PERSON	frischer	_	0	SENT_498	[p33l1091t430r1363b491],

1	Ames	NNP	O	Ames	_	0	SENT_499	[p33l145t675r333b732],
2	MM	NN	O	mm	dep	1	SENT_499	[p33l355t673r514b732],
3	.	.	O	.	_	0	SENT_499	[p33l355t673r514b732],

1	Plasma	NN	O	plasma	nn	2	SENT_500	[p33l540t673r773b732],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_500	[p33l795t673r1374b748],
3	and	CC	O	and	_	0	SENT_500	[p33l1396t673r1515b732],
4	cerebrospinal	JJ	O	cerebrospinal	amod	6	SENT_500	[p33l1538t671r1978b748],
5	ﬂuid	NN	O	ﬂuid	nn	6	SENT_500	[p33l2000t671r2147b732],
6	concentrations	NNS	O	concentration	conj_and	2	SENT_500	[p33l147t770r627b829],
7	of	IN	O	of	_	0	SENT_500	[p33l675t770r743b829],
8	idarubicin	NN	O	idarubicin	prep_of	6	SENT_500	[p33l781t770r1111b829],
9	and	CC	O	and	_	0	SENT_500	[p33l1158t767r1275b827],
10	idarubicinol	NN	O	idarubicinol	prep_of	6	SENT_500	[p33l1320t767r1712b829],
11	in	IN	O	in	_	0	SENT_500	[p33l1757t770r1816b827],
12	pediatric	JJ	O	pediatric	amod	14	SENT_500	[p33l1859t768r2149b845],
13	leukemia	NN	O	leukemia	nn	14	SENT_500	[p33l145t865r444b926],
14	patients	NNS	O	patient	prep_in	6	SENT_500	[p33l473t867r752b942],
15	:	:	O	:	_	0	SENT_500	[p33l473t867r752b942],
16	a	DT	O	a	det	21	SENT_500	[p33l788t886r821b924],
17	Childrens	NNP	O	Childrens	nn	21	SENT_500	[p33l853t865r1168b926],
18	Cancer	NNP	O	Cancer	nn	21	SENT_500	[p33l1202t864r1434b926],
19	Study	NNP	O	Study	nn	21	SENT_500	[p33l1466t865r1650b942],
20	Group	NNP	O	Group	nn	21	SENT_500	[p33l1679t867r1893b942],
21	report	NN	O	report	dep	2	SENT_500	[p33l1926t874r2145b942],
22	.	.	O	.	_	0	SENT_500	[p33l1926t874r2145b942],

1	Cancer	NNP	O	Cancer	nn	2	SENT_501	[p33l147t963r380b1024],
2	Res	NNP	O	Res	_	0	SENT_501	[p33l409t965r532b1022],
3	1990	CD	DATE	1990	num	2	SENT_501	[p33l566t962r1067b1033],
4	;	:	O	;	_	0	SENT_501	[p33l566t962r1067b1033],
5	50:6525	CD	NUMBER	50:6525	number	6	SENT_501	[p33l566t962r1067b1033],
6	-8	CD	NUMBER	-8	dep	2	SENT_501	[p33l566t962r1067b1033],
7	.	.	O	.	_	0	SENT_501	[p33l566t962r1067b1033],

1	Gessner	NNP	ORGANIZATION	Gessner	nn	2	SENT_502	[p33l147t1059r414b1120],
2	T	NN	ORGANIZATION	t	_	0	SENT_502	[p33l432t1061r498b1129],
3	,	,	O	,	_	0	SENT_502	[p33l432t1061r498b1129],
4	Vaughan	NNP	ORGANIZATION	Vaughan	nn	5	SENT_502	[p33l520t1058r819b1136],
5	LA	NNP	ORGANIZATION	LA	appos	2	SENT_502	[p33l839t1058r963b1132],
6	,	,	O	,	_	0	SENT_502	[p33l839t1058r963b1132],
7	Beehler	NNP	PERSON	Beehler	nn	8	SENT_502	[p33l985t1059r1242b1118],
8	BC	NNP	O	BC	appos	2	SENT_502	[p33l1262t1059r1384b1129],
9	,	,	O	,	_	0	SENT_502	[p33l1262t1059r1384b1129],
10	Bartels	NNP	PERSON	Bartels	nn	12	SENT_502	[p33l1406t1058r1638b1118],
11	C	NNP	O	C	nn	12	SENT_502	[p33l1660t1061r1761b1132],
12	]	NN	O	]	appos	2	SENT_502	[p33l1660t1061r1761b1132],
13	,	,	O	,	_	0	SENT_502	[p33l1660t1061r1761b1132],
14	Baker	NNP	PERSON	Baker	nn	15	SENT_502	[p33l1783t1059r1980b1118],
15	RM	NN	O	rm	appos	2	SENT_502	[p33l2000t1059r2145b1118],
16	.	.	O	.	_	0	SENT_502	[p33l2000t1059r2145b1118],

1	Elevated	JJ	O	elevated	amod	2	SENT_503	[p33l145t1156r435b1217],
2	pentose	NN	O	pentose	_	0	SENT_503	[p33l464t1165r720b1233],
3	cycle	NN	O	cycle	dep	2	SENT_503	[p33l751t1156r909b1233],
4	and	CC	O	and	_	0	SENT_503	[p33l943t1158r1060b1217],
5	glucuronyltransferase	NN	O	glucuronyltransferase	dep	2	SENT_503	[p33l1091t1156r1798b1233],
6	in	IN	O	in	_	0	SENT_503	[p33l1829t1158r1888b1215],
7	dauno	NN	O	dauno	nn	11	SENT_503	[p33l1922t1156r2147b1217],
8	—	NN	O	—	nn	11	SENT_503	[p33l1922t1156r2147b1217],
9	rubicimresistant	JJ	O	rubicimresistant	amod	11	SENT_503	[p33l145t1250r678b1312],
10	P388	NN	O	p388	nn	11	SENT_503	[p33l705t1253r863b1312],
11	cells	NNS	O	cell	prep_in	3	SENT_503	[p33l892t1253r1050b1312],
12	.	.	O	.	_	0	SENT_503	[p33l892t1253r1050b1312],

1	Cancer	NNP	O	Cancer	nn	2	SENT_504	[p33l1084t1253r1316b1312],
2	Res	NNP	O	Res	_	0	SENT_504	[p33l1345t1255r1467b1312],
3	1990	CD	DATE	1990	num	2	SENT_504	[p33l1501t1253r2001b1323],
4	;	:	O	;	_	0	SENT_504	[p33l1501t1253r2001b1323],
5	503:921	CD	NUMBER	503:921	number	6	SENT_504	[p33l1501t1253r2001b1323],
6	-7	CD	NUMBER	-7	dep	2	SENT_504	[p33l1501t1253r2001b1323],
7	.	.	O	.	_	0	SENT_504	[p33l1501t1253r2001b1323],

1	Gola	NNP	PERSON	Gola	nn	5	SENT_505	[p33l147t1349r308b1410],
2	A.	NNP	PERSON	A.	nn	5	SENT_505	[p33l332t1351r407b1407],
3	Daunorubicin	NNP	PERSON	Daunorubicin	nn	5	SENT_505	[p33l439t1348r893b1407],
4	reductase	NN	O	reductase	nn	5	SENT_505	[p33l925t1348r1238b1407],
5	activity	NN	O	activity	_	0	SENT_505	[p33l1267t1349r1497b1423],
6	in	IN	O	in	_	0	SENT_505	[p33l1526t1349r1585b1407],
7	leukemia	NN	O	leukemia	nn	9	SENT_505	[p33l1614t1348r1913b1407],
8	leukocyte	NN	O	leukocyte	nn	9	SENT_505	[p33l1942t1349r2147b1409, p33l147t1454r273b1522],
9	homogenates	NNS	O	homogenate	prep_in	5	SENT_505	[p33l302t1447r754b1523],
10	.	.	O	.	_	0	SENT_505	[p33l302t1447r754b1523],

1	Arch	NNP	O	Arch	nn	4	SENT_506	[p33l783t1447r949b1506],
2	Immunol	NNP	O	Immunol	nn	4	SENT_506	[p33l978t1445r1277b1504],
3	Ther	NNP	O	Ther	nn	4	SENT_506	[p33l1306t1447r1465b1506],
4	Exp	NNP	O	Exp	_	0	SENT_506	[p33l1491t1447r1620b1522],
5	1979	CD	DATE	1979	num	4	SENT_506	[p33l1653t1444r2115b1518],
6	;	:	O	;	_	0	SENT_506	[p33l1653t1444r2115b1518],
7	27:815	CD	NUMBER	27:815	number	8	SENT_506	[p33l1653t1444r2115b1518],
8	—	CD	NUMBER	—	dep	4	SENT_506	[p33l1653t1444r2115b1518],
9	8	CD	NUMBER	8	dep	8	SENT_506	[p33l1653t1444r2115b1518],
10	.	.	O	.	_	0	SENT_506	[p33l1653t1444r2115b1518],

1	Vasanthakumar	NNP	O	Vasanthakumar	nn	2	SENT_507	[p33l145t1542r669b1601],
2	G	NNP	O	G	_	0	SENT_507	[p33l702t1542r777b1612],
3	,	,	O	,	_	0	SENT_507	[p33l702t1542r777b1612],
4	Ahmed	NNP	PERSON	Ahmed	nn	5	SENT_507	[p33l809t1540r1053b1601],
5	NK	NN	O	nk	appos	2	SENT_507	[p33l1084t1542r1215b1601],
6	.	.	O	.	_	0	SENT_507	[p33l1084t1542r1215b1601],

1	Uptake	NN	O	uptake	_	0	SENT_508	[p33l1248t1542r1490b1619],
2	and	CC	O	and	_	0	SENT_508	[p33l1524t1539r1643b1601],
3	metabolism	NN	O	metabolism	conj_and	1	SENT_508	[p33l1674t1542r2052b1601],
4	of	IN	O	of	_	0	SENT_508	[p33l2084t1542r2154b1601],
5	daunorubicin	NN	O	daunorubicin	prep_of	1	SENT_508	[p33l145t1638r578b1699],
6	by	IN	O	by	_	0	SENT_508	[p33l605t1640r680b1715],
7	human	JJ	O	human	amod	9	SENT_508	[p33l705t1637r930b1699],
8	myelocytic	JJ	O	myelocytic	amod	9	SENT_508	[p33l957t1638r1305b1715],
9	cells	NNS	O	cell	prep_by	1	SENT_508	[p33l1329t1638r1485b1697],
10	.	.	O	.	_	0	SENT_508	[p33l1329t1638r1485b1697],

1	Cancer	NNP	O	Cancer	nn	3	SENT_509	[p33l1517t1638r1749b1697],
2	Chemother	NNP	O	Chemother	nn	3	SENT_509	[p33l1776t1640r2147b1699],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_509	[p33l145t1734r495b1795],
4	1985	CD	DATE	1985	num	3	SENT_509	[p33l529t1734r953b1807],
5	;	:	O	;	_	0	SENT_509	[p33l529t1734r953b1807],
6	15:35	CD	TIME	15:35	number	7	SENT_509	[p33l529t1734r953b1807],
7	-9	CD	NUMBER	-9	dep	3	SENT_509	[p33l529t1734r953b1807],
8	.	.	O	.	_	0	SENT_509	[p33l529t1734r953b1807],

1	Sundman	NNP	PERSON	Sundman	_	0	SENT_510	[p33l147t1830r743b1908],
2	.	.	O	.	_	0	SENT_510	[p33l147t1830r743b1908],

1	—	NN	O	—	_	0	SENT_511	[p33l147t1830r743b1908],
2	.	.	O	.	_	0	SENT_511	[p33l147t1830r743b1908],

1	Engberg	NNP	PERSON	Engberg	nn	2	SENT_512	[p33l147t1830r743b1908],
2	B	NNP	PERSON	B	_	0	SENT_512	[p33l763t1833r828b1901],
3	,	,	O	,	_	0	SENT_512	[p33l763t1833r828b1901],
4	Tidefelt	NNP	O	Tidefelt	nn	5	SENT_512	[p33l853t1830r1104b1890],
5	U	NNP	O	U	appos	2	SENT_512	[p33l1124t1831r1201b1901],
6	,	,	O	,	_	0	SENT_512	[p33l1124t1831r1201b1901],
7	Liliemark	NNP	PERSON	Liliemark	nn	8	SENT_512	[p33l1225t1830r1534b1890],
8	J	NNP	PERSON	J	appos	2	SENT_512	[p33l1554t1831r1585b1890],
9	,	,	O	,	_	0	SENT_512	[p33l1588t1877r1601b1901],
10	Paul	NNP	PERSON	Paul	nn	11	SENT_512	[p33l1625t1831r1765b1892],
11	C.	NNP	PERSON	C.	appos	8	SENT_512	[p33l1790t1833r1855b1890],
12	Intracellular	JJ	PERSON	intracellular	amod	13	SENT_512	[p33l1880t1833r2147b1892, p33l143t1928r287b1989],
13	concentrations	NNS	O	concentration	dep	2	SENT_512	[p33l321t1930r782b1989],
14	of	IN	O	of	_	0	SENT_512	[p33l818t1928r886b1987],
15	anti	JJ	O	anti	amod	18	SENT_512	[p33l918t1930r1266b1989],
16	—	NN	O	—	nn	18	SENT_512	[p33l918t1930r1266b1989],
17	cancer	NN	O	cancer	nn	18	SENT_512	[p33l918t1930r1266b1989],
18	drugs	NNS	O	drug	prep_of	13	SENT_512	[p33l1302t1930r1472b2005],
19	in	IN	O	in	_	0	SENT_512	[p33l1507t1928r1566b1987],
20	leukemic	JJ	O	leukemic	amod	21	SENT_512	[p33l1600t1928r1886b1989],
21	cells	NNS	O	cell	prep_in	18	SENT_512	[p33l1919t1928r2052b1989],
22	in	IN	O	in	_	0	SENT_512	[p33l2088t1930r2147b1989],
23	Vitro	NNP	O	Vitro	prep_in	21	SENT_512	[p33l140t2026r287b2085],
24	vs	CC	O	vs	rcmod	23	SENT_512	[p33l309t2042r373b2082],
25	in	FW	O	in	prep	13	SENT_512	[p33l399t2026r458b2082],
26	vivo	FW	O	vivo	pobj	25	SENT_512	[p33l480t2024r625b2085],
27	.	.	O	.	_	0	SENT_512	[p33l480t2024r625b2085],

1	Cancer	NNP	O	Cancer	nn	3	SENT_513	[p33l654t2026r879b2085],
2	Chemother	NNP	O	Chemother	nn	3	SENT_513	[p33l906t2026r1266b2085],
3	Pharmacol	NNP	O	Pharmacol	_	0	SENT_513	[p33l1290t2023r1629b2085],
4	1990	CD	DATE	1990	num	3	SENT_513	[p33l1660t2026r2101b2097],
5	;	:	O	;	_	0	SENT_513	[p33l1660t2026r2101b2097],
6	25:252	CD	NUMBER	25:252	number	7	SENT_513	[p33l1660t2026r2101b2097],
7	-6	CD	NUMBER	-6	dep	3	SENT_513	[p33l1660t2026r2101b2097],
8	.	.	O	.	_	0	SENT_513	[p33l1660t2026r2101b2097],

1	Gianni	NNP	PERSON	Gianni	nn	2	SENT_514	[p33l145t2120r368b2180],
2	L	NNP	PERSON	L	_	0	SENT_514	[p33l388t2123r454b2192],
3	,	,	O	,	_	0	SENT_514	[p33l388t2123r454b2192],
4	Myers	NNP	PERSON	Myers	nn	5	SENT_514	[p33l478t2123r678b2198],
5	CE	NNP	O	CE	appos	2	SENT_514	[p33l700t2123r821b2180],
6	.	.	O	.	_	0	SENT_514	[p33l700t2123r821b2180],

1	The	DT	O	the	det	2	SENT_515	[p33l843t2120r972b2182],
2	role	NN	O	role	_	0	SENT_515	[p33l994t2123r1120b2180],
3	of	IN	O	of	_	0	SENT_515	[p33l1142t2120r1212b2180],
4	free	JJ	O	free	amod	6	SENT_515	[p33l1227t2120r1354b2182],
5	radical	NN	O	radical	nn	6	SENT_515	[p33l1376t2120r1596b2180],
6	formation	NN	O	formation	prep_of	2	SENT_515	[p33l1616t2121r1943b2182],
7	in	IN	O	in	_	0	SENT_515	[p33l1963t2121r2024b2182],
8	the	DT	O	the	det	9	SENT_515	[p33l2044t2123r2147b2182],
9	cardiotoxicity	NN	O	cardiotoxicity	prep_in	2	SENT_515	[p33l145t2218r588b2295],
10	of	IN	O	of	_	0	SENT_515	[p33l612t2220r680b2277],
11	anthracyclines	NNS	O	anthracycline	prep_of	9	SENT_515	[p33l705t2217r1185b2295],
12	.	.	O	.	_	0	SENT_515	[p33l705t2217r1185b2295],

1	In	IN	O	in	dep	4	SENT_516	[p33l1214t2220r1298b2279],
2	:	:	O	:	_	0	SENT_516	[p33l1214t2220r1298b2279],
3	Muggia	NNP	O	Muggia	nn	4	SENT_516	[p33l1329t2218r1576b2295],
4	FM	NNP	O	FM	_	0	SENT_516	[p33l1600t2220r1735b2291],
5	,	,	O	,	_	0	SENT_516	[p33l1600t2220r1735b2291],
6	Green	NNP	ORGANIZATION	Green	nn	7	SENT_516	[p33l1764t2220r1969b2279],
7	MD	NNP	ORGANIZATION	MD	appos	4	SENT_516	[p33l1996t2220r2145b2291],
8	,	,	O	,	_	0	SENT_516	[p33l1996t2220r2145b2291],
9	Speyer	NNP	O	Speyer	nn	10	SENT_516	[p33l143t2315r366b2392],
10	JL	NNP	O	JL	appos	4	SENT_516	[p33l392t2314r493b2383],
11	,	,	O	,	_	0	SENT_516	[p33l392t2314r493b2383],
12	eds	NNS	O	ed	appos	4	SENT_516	[p33l524t2314r648b2374],
13	.	.	O	.	_	0	SENT_516	[p33l524t2314r648b2374],

1	Cancer	NN	O	cancer	_	0	SENT_517	[p33l682t2317r914b2392],
2	treatment	NN	O	treatment	dep	1	SENT_517	[p33l945t2321r1266b2374],
3	and	CC	O	and	_	0	SENT_517	[p33l1297t2314r1414b2374],
4	the	DT	O	the	det	5	SENT_517	[p33l1445t2314r1546b2374],
5	heart	NN	O	heart	dep	1	SENT_517	[p33l1579t2315r1765b2376],
6	.	.	O	.	_	0	SENT_517	[p33l1579t2315r1765b2376],

1	Baltimore	NNP	LOCATION	Baltimore	_	0	SENT_518	[p33l1797t2315r2142b2376],
2	:	:	O	:	_	0	SENT_518	[p33l1797t2315r2142b2376],
3	Johns	NNP	ORGANIZATION	Johns	nn	6	SENT_518	[p33l143t2412r329b2471],
4	Hopkins	NNP	ORGANIZATION	Hopkins	nn	6	SENT_518	[p33l358t2412r636b2489],
5	University	NNP	ORGANIZATION	University	nn	6	SENT_518	[p33l665t2412r1004b2489],
6	Press	NNP	ORGANIZATION	Press	dep	1	SENT_518	[p33l1031t2414r1217b2482],
7	,	,	O	,	_	0	SENT_518	[p33l1031t2414r1217b2482],
8	199219-58	CD	NUMBER	199219-58	appos	6	SENT_518	[p33l1253t2411r1578b2473],
9	.	.	O	.	_	0	SENT_518	[p33l1253t2411r1578b2473],

1	Hershko	NNP	PERSON	Hershko	nn	2	SENT_519	[p33l143t2507r426b2567],
2	C	NNP	O	C	_	0	SENT_519	[p33l448t2508r516b2578],
3	,	,	O	,	_	0	SENT_519	[p33l448t2508r516b2578],
4	Link	NNP	O	Link	nn	5	SENT_519	[p33l541t2508r694b2569],
5	G	NNP	O	G	appos	2	SENT_519	[p33l716t2510r791b2578],
6	,	,	O	,	_	0	SENT_519	[p33l716t2510r791b2578],
7	Tzahor	NNP	O	Tzahor	nn	8	SENT_519	[p33l813t2510r1050b2569],
8	M	NNP	O	M	appos	2	SENT_519	[p33l1073t2510r1157b2580],
9	,	,	O	,	_	0	SENT_519	[p33l1073t2510r1157b2580],
10	et	FW	O	et	nn	11	SENT_519	[p33l1184t2517r1242b2566],
11	al.	FW	O	al.	appos	2	SENT_519	[p33l1267t2510r1337b2569],
12	.	.	O	.	_	0	SENT_519	[p33l1267t2510r1337b2569],

1	Anthracycline	NN	O	anthracycline	nn	2	SENT_520	[p33l1359t2510r1821b2585],
2	toxicity	NN	O	toxicity	nsubjpass	4	SENT_520	[p33l1843t2510r2078b2587],
3	is	VBZ	O	be	auxpass	4	SENT_520	[p33l2100t2512r2147b2569],
4	potentiated	VBN	O	potentiate	_	0	SENT_520	[p33l143t2601r521b2679],
5	by	IN	O	by	_	0	SENT_520	[p33l543t2604r618b2681],
6	iron	NN	O	iron	agent	4	SENT_520	[p33l640t2604r771b2663],
7	and	CC	O	and	_	0	SENT_520	[p33l795t2601r914b2663],
8	inhibited	VBN	O	inhibit	conj_and	4	SENT_520	[p33l936t2604r1228b2663],
9	by	IN	O	by	_	0	SENT_520	[p33l1248t2604r1326b2681],
10	deferoxamine	NN	O	deferoxamine	prep_by	8	SENT_520	[p33l1348t2604r1812b2665],
11	:	:	O	:	_	0	SENT_520	[p33l1348t2604r1812b2665],
12	studies	NNS	O	study	dep	10	SENT_520	[p33l1838t2604r2064b2665],
13	in	IN	O	in	_	0	SENT_520	[p33l2086t2606r2147b2665],
14	rat	NN	O	rat	nn	16	SENT_520	[p33l143t2709r232b2760],
15	heart	NN	O	heart	nn	16	SENT_520	[p33l261t2702r430b2758],
16	cells	NNS	O	cell	prep_in	12	SENT_520	[p33l459t2702r599b2760],
17	in	IN	O	in	_	0	SENT_520	[p33l629t2702r687b2758],
18	culture	NN	O	culture	prep_in	8	SENT_520	[p33l716t2699r963b2760],
19	.	.	O	.	_	0	SENT_520	[p33l716t2699r963b2760],

1	J	NN	O	j	nn	4	SENT_521	[p33l994t2702r1025b2760],
2	Lab	NN	O	lab	nn	4	SENT_521	[p33l1054t2699r1180b2758],
3	Clin	NNP	O	Clin	nn	4	SENT_521	[p33l1209t2700r1344b2760],
4	Med	NNP	O	Med	_	0	SENT_521	[p33l1373t2702r1522b2761],
5	l993	NN	O	l993	dep	4	SENT_521	[p33l1556t2702r2096b2774],
6	;	:	O	;	_	0	SENT_521	[p33l1556t2702r2096b2774],
7	122:245	CD	NUMBER	122:245	num	8	SENT_521	[p33l1556t2702r2096b2774],
8	~	NN	O	~	dep	4	SENT_521	[p33l1556t2702r2096b2774],
9	51	CD	NUMBER	51	dep	8	SENT_521	[p33l1556t2702r2096b2774],
10	.	.	O	.	_	0	SENT_521	[p33l1556t2702r2096b2774],

1	Gutteridge	NNP	PERSON	Gutteridge	nn	2	SENT_522	[p33l143t2796r500b2871],
2	JMC	NNP	O	JMC	_	0	SENT_522	[p33l547t2798r722b2857],
3	.	.	O	.	_	0	SENT_522	[p33l547t2798r722b2857],

1	Anthracycline	NN	O	anthracycline	_	0	SENT_523	[p33l769t2798r1229b2873],
2	toxicity	NN	O	toxicity	nn	8	SENT_523	[p33l1276t2798r1527b2873],
3	,	,	O	,	_	0	SENT_523	[p33l1276t2798r1527b2873],
4	iron	NN	O	iron	nn	8	SENT_523	[p33l1577t2798r1707b2857],
5	and	CC	O	and	_	0	SENT_523	[p33l1755t2798r1874b2857],
6	oxygen	NN	O	oxygen	nn	8	SENT_523	[p33l1919t2817r2145b2875],
7	J	NN	O	j	nn	8	SENT_523	[p33l1565t2893r1597b2953],
8	Lab	NN	O	lab	dep	1	SENT_523	[p33l1632t2890r1765b2951],
9	Clin	NNP	O	Clin	nn	11	SENT_523	[p33l1796t2893r1930b2953],
10	Med	NNP	O	Med	nn	11	SENT_523	[p33l1964t2890r2126b2951],
11	June	NNP	PERCENT	June	dep	8	SENT_523	[p33l1757t2990r1935b3052],
12	19	CD	PERCENT	19	num	13	SENT_523	[p33l1971t2989r2131b3050],
13	%	NN	PERCENT	%	dep	1	SENT_523	[p33l1971t2989r2131b3050],

1	radicals	NNS	O	radical	_	0	SENT_524	[p33l144t3229r408b3299],
2	,	,	O	,	_	0	SENT_524	[p33l144t3229r408b3299],
3	and	CC	O	and	_	0	SENT_524	[p33l448t3229r564b3288],
4	chelation	NN	O	chelation	nn	5	SENT_524	[p33l603t3229r901b3288],
5	therapy	NN	O	therapy	conj_and	1	SENT_524	[p33l939t3229r1200b3306],
6	.	.	O	.	_	0	SENT_524	[p33l939t3229r1200b3306],

1	J	NN	O	j	nn	4	SENT_525	[p33l1238t3231r1269b3285],
2	Lab	NN	O	lab	nn	4	SENT_525	[p33l1307t3229r1431b3285],
3	Clin	NNP	O	Clin	nn	4	SENT_525	[p33l1471t3229r1603b3288],
4	Med	NNP	O	Med	_	0	SENT_525	[p33l1642t3226r1790b3285],
5	1993	CD	DATE	1993	num	4	SENT_525	[p33l1830t3229r2129b3299],
6	;	:	O	;	_	0	SENT_525	[p33l1830t3229r2129b3299],
7	122	CD	NUMBER	122	num	9	SENT_525	[p33l1830t3229r2129b3299],
8	:	:	O	:	_	0	SENT_525	[p33l1830t3229r2129b3299],
9	228-9	CD	NUMBER	228-9	dep	4	SENT_525	[p33l144t3325r337b3381],
10	.	.	O	.	_	0	SENT_525	[p33l144t3325r337b3381],

1	Minotti	NNP	PERSON	Minotti	nn	2	SENT_526	[p34l142t27r380b86],
2	G	NNP	PERSON	G	_	0	SENT_526	[p34l402t27r475b97],
3	,	,	O	,	_	0	SENT_526	[p34l402t27r475b97],
4	Cavaliere	NNP	ORGANIZATION	Cavaliere	nn	5	SENT_526	[p34l501t24r795b86],
5	AF	NNP	ORGANIZATION	AF	appos	2	SENT_526	[p34l815t27r935b98],
6	,	,	O	,	_	0	SENT_526	[p34l815t27r935b98],
7	Mordente	NNP	O	Mordente	nn	8	SENT_526	[p34l957t27r1272b86],
8	A	NNP	O	A	appos	2	SENT_526	[p34l1291t27r1364b97],
9	,	,	O	,	_	0	SENT_526	[p34l1291t27r1364b97],
10	et	FW	O	et	nn	11	SENT_526	[p34l1388t36r1447b83],
11	al.	FW	O	al.	appos	2	SENT_526	[p34l1469t27r1537b86],
12	.	.	O	.	_	0	SENT_526	[p34l1469t27r1537b86],

1	Secondary	JJ	O	secondary	amod	3	SENT_527	[p34l1561t27r1887b105],
2	alcohol	NN	O	alcohol	nn	3	SENT_527	[p34l1907t27r2131b86],
3	metabolites	NNS	O	metabolite	nsubj	4	SENT_527	[p34l142t120r505b179],
4	mediate	VBP	O	mediate	_	0	SENT_527	[p34l527t121r779b179],
5	iron	NN	O	iron	nn	6	SENT_527	[p34l803t120r929b179],
6	delocalization	NN	O	delocalization	dobj	4	SENT_527	[p34l953t120r1387b179],
7	in	IN	O	in	_	0	SENT_527	[p34l1409t121r1467b181],
8	cytosolic	JJ	O	cytosolic	amod	9	SENT_527	[p34l1489t121r1758b197],
9	fractions	NNS	O	fraction	prep_in	4	SENT_527	[p34l1778t121r2048b181],
10	of	IN	O	of	_	0	SENT_527	[p34l2070t121r2138b179],
11	myocardial	JJ	O	myocardial	amod	12	SENT_527	[p34l142t218r486b292],
12	biopsies	NNS	O	biopsy	prep_of	9	SENT_527	[p34l506t216r756b292],
13	exposed	VBN	O	expose	partmod	12	SENT_527	[p34l775t216r1028b292],
14	to	TO	O	to	_	0	SENT_527	[p34l1045t225r1108b276],
15	anticancer	JJ	O	anticancer	amod	16	SENT_527	[p34l1128t218r1451b276],
16	anthracyclines	NNS	O	anthracycline	prep_to	13	SENT_527	[p34l1471t216r1928b292],
17	.	.	O	.	_	0	SENT_527	[p34l1471t216r1928b292],

1	Novel	JJ	O	novel	amod	2	SENT_528	[p34l1948t216r2133b276],
2	linkage	NN	O	linkage	_	0	SENT_528	[p34l144t311r369b385],
3	between	IN	O	between	_	0	SENT_528	[p34l409t311r673b369],
4	anthracycline	NN	O	anthracycline	nn	5	SENT_528	[p34l715t309r1129b385],
5	metabolism	NN	O	metabolism	prep_between	2	SENT_528	[p34l1172t309r1537b371],
6	and	CC	O	and	_	0	SENT_528	[p34l1579t311r1691b369],
7	iron-induced	JJ	O	iron-induced	amod	8	SENT_528	[p34l1734t311r2133b371],
8	cardiotoxicity	NN	O	cardiotoxicity	prep_between	2	SENT_528	[p34l142t406r576b482],
9	.	.	O	.	_	0	SENT_528	[p34l142t406r576b482],

1	J	NNP	O	J	nn	3	SENT_529	[p34l603t408r636b464],
2	Clin	NNP	O	Clin	nn	3	SENT_529	[p34l660t406r790b466],
3	Invest	NNP	O	Invest	_	0	SENT_529	[p34l817t408r1004b464],
4	1995	CD	DATE	1995	num	3	SENT_529	[p34l1033t406r1173b466],
5	;	:	O	;	_	0	SENT_529	[p34l1181t406r1567b478],
6	95:1595	CD	NUMBER	95:1595	num	7	SENT_529	[p34l1181t406r1567b478],
7	—	NN	O	—	dep	3	SENT_529	[p34l1181t406r1567b478],
8	605	CD	NUMBER	605	dep	7	SENT_529	[p34l1181t406r1567b478],
9	.	.	O	.	_	0	SENT_529	[p34l1575t454r1585b464],

1	Fiallo	NNP	O	Fiallo	nn	2	SENT_530	[p34l142t500r323b559],
2	M	NNP	O	M	_	0	SENT_530	[p34l358t503r442b573],
3	,	,	O	,	_	0	SENT_530	[p34l358t503r442b573],
4	Laigle	NNP	PERSON	Laigle	nn	5	SENT_530	[p34l478t500r673b577],
5	A	NNP	O	A	appos	2	SENT_530	[p34l704t505r776b573],
6	,	,	O	,	_	0	SENT_530	[p34l704t505r776b573],
7	Garnier-Suillerot	NNP	O	Garnier-Suillerot	nn	8	SENT_530	[p34l815t501r1352b561],
8	A	NNP	O	A	appos	2	SENT_530	[p34l1384t503r1458b573],
9	,	,	O	,	_	0	SENT_530	[p34l1384t503r1458b573],
10	et	FW	O	et	nn	11	SENT_530	[p34l1494t512r1550b561],
11	al.	FW	O	al.	appos	2	SENT_530	[p34l1586t503r1654b561],
12	.	.	O	.	_	0	SENT_530	[p34l1586t503r1654b561],

1	Interaction	NN	O	interaction	_	0	SENT_531	[p34l1692t503r2039b561],
2	of	IN	O	of	_	0	SENT_531	[p34l2072t503r2138b561],
3	iron-anthracycline	JJ	O	iron-anthracycline	amod	4	SENT_531	[p34l144t595r712b672],
4	complexes	NNS	O	complex	prep_of	1	SENT_531	[p34l757t597r1081b674],
5	with	IN	O	with	_	0	SENT_531	[p34l1123t597r1260b656],
6	living	NN	O	living	nn	7	SENT_531	[p34l1305t597r1472b674],
7	cells	NNS	O	cell	prep_with	4	SENT_531	[p34l1515t597r1666b656],
8	:	:	O	:	_	0	SENT_531	[p34l1515t597r1666b656],
9	a	DT	O	a	det	11	SENT_531	[p34l1715t616r1749b656],
10	microspectroﬂuorometric	JJ	O	microspectroﬂuorometric	amod	11	SENT_531	[p34l1794t599r2133b674, p34l144t692r629b753],
11	study	NN	O	study	dep	1	SENT_531	[p34l649t694r825b769],
12	.	.	O	.	_	0	SENT_531	[p34l649t694r825b769],

1	Biochim	NNP	PERSON	Biochim	nn	3	SENT_532	[p34l851t692r1113b753],
2	Biophys	NNP	PERSON	Biophys	nn	3	SENT_532	[p34l1135t692r1385b771],
3	Acta	NNP	PERSON	Acta	_	0	SENT_532	[p34l1404t694r1555b753],
4	1993	CD	DATE	1993	num	3	SENT_532	[p34l1582t694r2154b771],
5	;	:	O	;	_	0	SENT_532	[p34l1582t694r2154b771],
6	1177:236	CD	NUMBER	1177:236	number	7	SENT_532	[p34l1582t694r2154b771],
7	-44	CD	NUMBER	-44	dep	3	SENT_532	[p34l1582t694r2154b771],
8	.	.	O	.	_	0	SENT_532	[p34l1582t694r2154b771],

1	_	NN	O	_	_	0	SENT_533	[p34l1582t694r2154b771],
2	I-Iasinoff	NN	O	i-iasinoff	nn	3	SENT_533	[p34l142t787r422b848],
3	BB	NN	O	bb	dep	1	SENT_533	[p34l458t789r576b848],
4	.	.	O	.	_	0	SENT_533	[p34l458t789r576b848],

1	Oxyradical	JJ	O	oxyradical	amod	3	SENT_534	[p34l621t789r972b867],
2	production	NN	O	production	nn	3	SENT_534	[p34l1013t789r1371b864],
3	results	NNS	O	result	_	0	SENT_534	[p34l1414t789r1624b850],
4	from	IN	O	from	_	0	SENT_534	[p34l1665t789r1822b850],
5	Fe3	NN	O	fe3	nn	6	SENT_534	[p34l1863t789r2131b867, p34l144t883r530b945],
6	(	NN	O	(	prep_from	3	SENT_534	[p34l1863t789r2131b867, p34l144t883r530b945],
7	+	CC	O	+	_	0	SENT_534	[p34l1863t789r2131b867, p34l144t883r530b945],
8	)	NN	O	)	nn	10	SENT_534	[p34l1863t789r2131b867, p34l144t883r530b945],
9	doxorubicin	NN	O	doxorubicin	nn	10	SENT_534	[p34l1863t789r2131b867, p34l144t883r530b945],
10	complex	NN	O	complex	conj_+	6	SENT_534	[p34l557t886r829b963],
11	undergoing	VBG	O	undergo	partmod	3	SENT_534	[p34l854t883r1226b961],
12	self-reduction	NN	O	self-reduction	dobj	11	SENT_534	[p34l1252t884r1702b945],
13	by	IN	O	by	_	0	SENT_534	[p34l1729t884r1804b961],
14	its	PRP$	O	its	poss	16	SENT_534	[p34l1830t886r1903b945],
15	alphaketol	NN	O	alphaketol	nn	16	SENT_534	[p34l1932t886r2131b963, p34l142t978r304b1036],
16	group	NN	O	group	agent	11	SENT_534	[p34l333t999r539b1057],
17	.	.	O	.	_	0	SENT_534	[p34l333t999r539b1057],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	3	SENT_535	[p34l570t978r859b1041],
2	Cell	NNP	ORGANIZATION	Cell	nn	3	SENT_535	[p34l891t980r1018b1039],
3	Biol	NNP	O	Biol	_	0	SENT_535	[p34l1047t980r1180b1039],
4	1990	CD	DATE	1990	num	3	SENT_535	[p34l1213t980r1712b1050],
5	;	:	O	;	_	0	SENT_535	[p34l1213t980r1712b1050],
6	68:1331	CD	NUMBER	68:1331	number	7	SENT_535	[p34l1213t980r1712b1050],
7	-6	CD	NUMBER	-6	dep	3	SENT_535	[p34l1213t980r1712b1050],
8	.	.	O	.	_	0	SENT_535	[p34l1213t980r1712b1050],

1	Sprandel	NNP	LOCATION	Sprandel	nn	2	SENT_536	[p34l142t1076r431b1153],
2	U	NNP	LOCATION	U	_	0	SENT_536	[p34l471t1078r548b1146],
3	,	,	O	,	_	0	SENT_536	[p34l471t1078r548b1146],
4	Zoellner	NNP	PERSON	Zoellner	nn	7	SENT_536	[p34l591t1075r873b1137],
5	N.	NNP	PERSON	N.	nn	7	SENT_536	[p34l911t1078r984b1134],
6	Osmotic	NNP	PERSON	Osmotic	nn	7	SENT_536	[p34l1026t1076r1299b1137],
7	fragility	NN	O	fragility	appos	2	SENT_536	[p34l1338t1076r1590b1155],
8	of	IN	O	of	_	0	SENT_536	[p34l1628t1078r1696b1137],
9	drug	NN	O	drug	nn	11	SENT_536	[p34l1731t1076r1878b1155],
10	carrier	NN	O	carrier	nn	11	SENT_536	[p34l1918t1078r2133b1137],
11	erythrocytes	NNS	O	erythrocyte	prep_of	7	SENT_536	[p34l142t1174r555b1249],
12	.	.	O	.	_	0	SENT_536	[p34l142t1174r555b1249],

1	Res	NNP	O	Res	nn	3	SENT_537	[p34l587t1175r707b1233],
2	Exp	NNP	O	Exp	nn	3	SENT_537	[p34l736t1177r862b1249],
3	Med	NNP	O	Med	_	0	SENT_537	[p34l893t1174r1041b1231],
4	1985	CD	DATE	1985	num	3	SENT_537	[p34l1075t1174r1571b1245],
5	;	:	O	;	_	0	SENT_537	[p34l1075t1174r1571b1245],
6	185:77	CD	NUMBER	185:77	number	7	SENT_537	[p34l1075t1174r1571b1245],
7	-85	CD	NUMBER	-85	dep	3	SENT_537	[p34l1075t1174r1571b1245],
8	.	.	O	.	_	0	SENT_537	[p34l1075t1174r1571b1245],

1	Westbrook	NNP	PERSON	Westbrook	nn	2	SENT_538	[p34l140t1268r502b1326],
2	C	NNP	O	C	_	0	SENT_538	[p34l550t1270r618b1337],
3	,	,	O	,	_	0	SENT_538	[p34l550t1270r618b1337],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_538	[p34l670t1270r779b1328],
5	YM	NNP	PERSON	YM	appos	2	SENT_538	[p34l828t1270r975b1337],
6	,	,	O	,	_	0	SENT_538	[p34l828t1270r975b1337],
7	Jarabak	NNP	O	Jarabak	nn	11	SENT_538	[p34l1026t1270r1283b1328],
8	J.	NNP	O	J.	nn	11	SENT_538	[p34l1331t1270r1378b1326],
9	NADP-linked	NNP	O	NADP-linked	nn	11	SENT_538	[p34l1430t1270r1882b1329],
10	15hydroxyprostaglandin	NN	O	15hydroxyprostaglandin	nn	11	SENT_538	[p34l1936t1270r2131b1344, p34l142t1362r770b1440],
11	dehydrogenase	NN	O	dehydrogenase	appos	2	SENT_538	[p34l819t1362r1306b1443],
12	from	IN	O	from	_	0	SENT_538	[p34l1356t1365r1516b1424],
13	human	JJ	O	human	amod	14	SENT_538	[p34l1563t1365r1788b1424],
14	placenta	NN	O	placenta	prep_from	11	SENT_538	[p34l1837t1367r2131b1442],
15	:	:	O	:	_	0	SENT_538	[p34l1837t1367r2131b1442],
16	partial	JJ	O	partial	amod	17	SENT_538	[p34l140t1459r350b1536],
17	puriﬁcation	NN	O	puriﬁcation	dep	2	SENT_538	[p34l384t1458r760b1536],
18	and	CC	O	and	_	0	SENT_538	[p34l794t1461r912b1520],
19	characterization	NN	O	characterization	dep	2	SENT_538	[p34l944t1461r1470b1520],
20	of	IN	O	of	_	0	SENT_538	[p34l1503t1463r1571b1520],
21	the	DT	O	the	det	22	SENT_538	[p34l1600t1461r1700b1520],
22	enzyme	NN	O	enzyme	prep_of	17	SENT_538	[p34l1736t1480r1979b1538],
23	and	CC	O	and	_	0	SENT_538	[p34l2015t1461r2131b1520],
24	identiﬁcation	NN	O	identiﬁcation	prep_of	17	SENT_538	[p34l140t1552r569b1614],
25	of	IN	O	of	_	0	SENT_538	[p34l614t1553r682b1611],
26	an	DT	O	a	det	27	SENT_538	[p34l720t1574r797b1614],
27	inhibitor	NN	O	inhibitor	prep_of	22	SENT_538	[p34l838t1555r1120b1614],
28	in	IN	O	in	_	0	SENT_538	[p34l1162t1555r1221b1614],
29	placental	JJ	O	placental	amod	30	SENT_538	[p34l1262t1555r1557b1632],
30	tissue	NN	O	tissue	prep_in	27	SENT_538	[p34l1600t1555r1799b1614],
31	.	.	O	.	_	0	SENT_538	[p34l1600t1555r1799b1614],

1	Biochem	NNP	ORGANIZATION	Biochem	nn	4	SENT_539	[p34l1844t1557r2133b1616],
2	Biophys	NNP	ORGANIZATION	Biophys	nn	4	SENT_539	[p34l140t1648r401b1728],
3	Res	NNP	ORGANIZATION	Res	nn	4	SENT_539	[p34l430t1653r553b1710],
4	Commun	NNP	ORGANIZATION	Commun	_	0	SENT_539	[p34l582t1651r885b1710],
5	1977	CD	DATE	1977	num	4	SENT_539	[p34l918t1651r1375b1724],
6	;	:	O	;	_	0	SENT_539	[p34l918t1651r1375b1724],
7	76:943	CD	NUMBER	76:943	number	8	SENT_539	[p34l918t1651r1375b1724],
8	-9	CD	NUMBER	-9	dep	4	SENT_539	[p34l918t1651r1375b1724],
9	.	.	O	.	_	0	SENT_539	[p34l918t1651r1375b1724],

1	Tanaka	NNP	PERSON	Tanaka	nn	2	SENT_540	[p34l140t1747r378b1808],
2	MS	NN	O	m	_	0	SENT_540	[p34l409t1749r535b1819],
3	,	,	O	,	_	0	SENT_540	[p34l409t1749r535b1819],
4	Ohno	NNP	PERSON	Ohno	nn	5	SENT_540	[p34l573t1747r751b1808],
5	S	NNP	O	S	appos	2	SENT_540	[p34l785t1749r839b1819],
6	,	,	O	,	_	0	SENT_540	[p34l785t1749r839b1819],
7	Adachi	NNP	PERSON	Adachi	nn	8	SENT_540	[p34l872t1746r1099b1808],
8	S	NNP	O	S	appos	2	SENT_540	[p34l1133t1749r1186b1819],
9	,	,	O	,	_	0	SENT_540	[p34l1133t1749r1186b1819],
10	et	FW	O	et	nn	11	SENT_540	[p34l1222t1758r1281b1808],
11	al.	FW	O	al.	appos	2	SENT_540	[p34l1314t1749r1382b1808],
12	.	.	O	.	_	0	SENT_540	[p34l1314t1749r1382b1808],

1	Pig	NN	O	pig	nsubj	6	SENT_541	[p34l1418t1749r1518b1826],
2	testicular	JJ	O	testicular	amod	1	SENT_541	[p34l1550t1749r1838b1810],
3	20	CD	NUMBER	20	num	5	SENT_541	[p34l1872t1751r1942b1810],
4	betahydroxysteroid	NN	O	betahydroxysteroid	nn	5	SENT_541	[p34l1973t1751r2131b1810, p34l140t1842r599b1919],
5	dehydrogenase	NN	O	dehydrogenase	dep	1	SENT_541	[p34l630t1843r1099b1919],
6	exhibits	VBZ	O	exhibit	_	0	SENT_541	[p34l1132t1843r1366b1903],
7	carbonyl	NN	O	carbonyl	nn	9	SENT_541	[p34l1397t1845r1663b1919],
8	reductase-like	JJ	O	reductase-like	amod	9	SENT_541	[p34l1695t1845r2129b1906],
9	structure	NN	O	structure	dobj	6	SENT_541	[p34l140t1945r417b1996],
10	and	CC	O	and	_	0	SENT_541	[p34l446t1938r560b1996],
11	activity	NN	O	activity	dobj	6	SENT_541	[p34l587t1938r820b2014],
12	.	.	O	.	_	0	SENT_541	[p34l587t1938r820b2014],

1	J	NNP	O	J	nn	3	SENT_542	[p34l847t1940r878b1996],
2	Biol	NNP	O	Biol	nn	3	SENT_542	[p34l904t1938r1032b1996],
3	Chem	NNP	O	Chem	_	0	SENT_542	[p34l1059t1940r1249b1998],
4	1992	CD	DATE	1992	num	3	SENT_542	[p34l1278t1940r1827b2010],
5	;	:	O	;	_	0	SENT_542	[p34l1278t1940r1827b2010],
6	267:13451	CD	NUMBER	267:13451	number	7	SENT_542	[p34l1278t1940r1827b2010],
7	-5	CD	NUMBER	-5	dep	3	SENT_542	[p34l1278t1940r1827b2010],
8	.	.	O	.	_	0	SENT_542	[p34l1278t1940r1827b2010],

